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Summary 
Background 
Classification  systems  for  use  in  the  diagnosis  of  mental  disorders  have  been 
developed  based  on  a  categorical  model  of  psychopathology.  Although  current 
categorical diagnostic classification systems have been found to have good utility 
and  reliability,  studies  have  questioned  whether  these  systems  have  adequate 
validity.  Dimensional  models  of  psychopathology  have  been  examined  as  an 
alternative  to  categorical  diagnostic  classification  systems  and  found  to  be  more 
strongly related to clinical parameters, such as the severity and outcome of mental 
disorders. 
 
A  literature  review  found  a  small  evidence  base  on  dimensional  models  of 
psychopathology experienced by adults with intellectual disabilities. However, the 
findings were limited by small sample sizes, biased samples and inclusion of only a 
limited range of items of psychopathology. Furthermore, the methods of exploratory 
factor analysis used do not meet established best practice guidelines. 
 
Informed by the existing literature, this thesis aimed to; 
1.  identify  a  dimensional  model  of  psychopathology  experienced  by  adults  with 
intellectual disabilities 
2.  examine  the  associations  of  a  dimensional  model  of  psychopathology  with 
measures of the severity and outcome of mental disorders 
3.  compare  the  predictive  validity  of  dimensional  and  categorical  models  of 
psychopathology. 
 
Methods 
The  Psychiatric  Present  State-  Learning  Disabilities  (PPS-LD)  was  used  as  a 
structured instrument to collect psychopathology  data. Exploratory factor analysis 
(EFA)  following  best  practice  guidelines  was  used  to  identify  dimensions  of 
psychopathology.  Continuous  measures  representing  the  dimensions  of 
psychopathology  were  calculated.  Meeting  criteria  for  the  diagnosis  of  a  mental 
disorder from the Diagnostic Criteria for Psychiatric Disorders for use with Adults   xxi
with  Learning  Disabilities  (DC-LD)  was  used  as  the  variable  representing  the 
categorical model of psychopathology. 
 
Baseline data was collected on four measures of severity; the Health of the Nation 
Outcome  Scales-  Learning  Disabilities  (HoNOS-LD),  Global  Assessment  of 
Functioning  (GAF),  Clinical  Global  Impression  (CGI),  and  the  Camberwell 
Assessment of Needs for Adults with Developmental and Intellectual Disabilities- 
Research version (CANDID-R) unmet needs. These measures were completed again 
at follow up 4-5 years later and change over time used as a measure of longitudinal 
outcome.  
 
Bivariate  statistics  and  multivariate  linear  regression  were  used  to  examine  the 
associations of the dimensions of psychopathology, and DC-LD diagnosis, with the 
measures of the severity of and longitudinal outcome of mental disorders. Relevant 
socio-clinical  variables,  associated  with  psychopathology  in  previous  population-
based intellectual disabilities studies were included in the analyses: ; gender, age, 
living  circumstances,  level  of  intellectual  disabilities,  autism,  Down  syndrome, 
epilepsy, sensory impairments, mobility problems and incontinence. 
 
 
Key results 
A model of psychopathology with four dimensions was extracted from the EFA. This 
model  was  stable  in  two  additional  EFA  using  random  samples.  There  were  no 
significant correlations between the four dimensions which were labeled depressive, 
organic, behaviour-affective and anxiety. 
 
Only the anxiety dimension of psychopathology was not associated with any of the 
measures  of  severity  of  mental  disorders.  The  depression  dimension  was 
independently associated with severity on the HoNOS-LD (β=.413, p<.001), GAF 
(β=-.402,  p<.001)  and  the  CGI  (β=.457,  p<.001).  The  organic  dimension  was 
independently associated with severity on the HoNOS-LD (β=.205, p=.004), GAF 
(β=-.326 p<.001) and CGI (β=.266, p<.001). The behaviour-affective dimension was   xxii
independently associated with severity on the HoNOS-LD (β=.332, p<.001), GAF 
(β=-.286,  p<.001),  CGI  (β=.253,  p<.001)  and  CANDID-R  unmet  needs  (β=.178, 
p=.018). Level of intellectual disabilities was independently associated with severity 
on the HoNOS-LD and CANDID-R unmet needs. Finally, younger age (β=-.208, 
p=.010), living independently (β=-.599, p<.001) and not having a visual impairment 
(β=-.191, p=.009) were associated with greater CANDID-R unmet needs. 
 
None of the baseline measures of psychopathology were associated with longitudinal 
outcome  on  the  CANDID-R  unmet  needs.  Baseline  scores  on  the  depressive 
dimension were significantly associated with longitudinal outcome on the HoNOS-
LD (β=.297, p=.034), GAF (β=.342, p=.002) and CGI (β=.373, p=.001). Similarly, 
the  behaviour-affective  dimension  was  significantly  associated  with  longitudinal 
outcome  on  the  HoNOS-LD  (β=.292,  p=.033),  GAF  (β=.244,  p=.036)  and  CGI 
(β=.298,  p=.009).  The  organic  dimension  was  only  associated  with  longitudinal 
outcome  on  the  HoNOS-LD  (β=-.382,  p=.006).  Individuals  with  mild  intellectual 
disabilities  had  poorer  outcomes  on  all  four  measures  of  longitudinal  outcome. 
Hearing  impairment  was  associated  with  poorer  outcome  on  the  GAF  (β=-.483, 
p=.000)  and  CGI  (β=-.331,  p=.004),  and  poorly  controlled  seizures  with  poorer 
outcome on the CGI (β=-1.638, p=.004). 
 
The  variable  representing  the  categorical  model  of  psychopathology  was  only 
independently  associated  with  severity  on  the  HoNOS-LD  (β=.178,  p=.026),  and 
longitudinal  outcome  on  the  GAF  (β=.259,  p=.045)  and  CGI  (β=.257,  p=.044). 
However,  when  categorical  and  dimensional  models  were  both  included  in  the 
regression analyses only the dimensional model of psychopathology was retained as 
independently associated with these measures of severity and outcome.  
 
Conclusions 
The  description  of  a  stable  dimensional  model  demonstrates  the  value  of  using 
multivariate statistical methods to examine psychopathology experienced by adults 
with intellectual disabilities. Since the findings suggest that dimensional models have 
better validity than categorical models of psychopathology, the use of EFA, and other   xxiii
multivariate  methods,  could  contribute  to  the  development  of  valid  categorical 
diagnostic classification systems.  
 
The presence of affective items of psychopathology across the depressive, behaviour-
affective  and  anxiety  dimensions  highlights  the  possible  relevance  of  a  global 
affective  model  of  psychopathology.  Findings  reported  in  this  thesis  support  the 
potential relevance of models of affect regulation and affective arousal to developing 
an  understanding  of  psychopathology  experienced  by  persons  with  intellectual 
disabilities.  
 
There are similarities between the dimensional model in this thesis and the tripartite 
model of depression and anxiety psychopathology, described in the literature- which 
has  depressive,  anxiety  and  general  distress  dimensions.  Overlaps  between  the 
behaviour-affective dimension, and general distress dimension within the tripartite 
model, suggest that there may be an association between affective psychopathology 
and problem behaviours. However, it could be that this association is with affective 
psychopathology  in  the  general  distress  dimension,  rather  than  with  depressive 
psychopathology, as examined in previous studies. 
 
Confirmatory factor analyses should be considered to examine the four dimension 
model  of  psychopathology.  Future  studies  involving  individuals  with  intellectual 
disabilities  should  examine  the  relevance  and  validity  of  the  tripartite  model  of 
depression and anxiety psychopathology. 
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Chapter 1 Background 
1.1 Classification in medicine 
Classification and diagnosis are closely related and central to the contemporary practice 
of medicine. 
 
Classification is the “activity of ordering or arrangement of objects into groups or sets 
on the basis of their relationships”, and nosology is the application of classification in 
medicine (Parshall & Priest 1993). Taxonomy- is the theoretical study of classification, 
which is described as an attempt to move from the question of, “how we classify?” to 
“how should we classify?” (Frances et al. 1994). 
 
Most branches of science have established systems of classification. In medicine, the 
first  attempts  at  classification  are  traced  back  to  the  ancient  Greeks,  and  the 
philosophical  schools  of  Plato  and  Aristotle  (Parshall  &  Priest  1993).  Central  to 
classification in medicine (nosology) is the process of diagnosis.  
 
Medical diagnosis is described as “organising unorganised illness” (Balint 1964). There 
are  multiple  stages  involved  and  one  end-point  of  the  process  is  assigning  an 
individual’s symptoms and signs to a named categorical diagnosis (Elstein & Schwartz 
2002).  Therefore,  at  one  level,  the  process  of  diagnosis  is  a  form  of  classification. 
Throughout this thesis the term categorical diagnostic classification systems will be 
used  to  refer  to  the  current  classification  systems  used  in  medicine,  and  more 
particularly in the study of mental disorders, and psychiatry. 
 
Based  on  a  historical  view  of  the  development  of  classification,  a  model  of  the 
classification  of  health  and  disease  applicable  to  all  branches  of  medicine  was 
proposed,  illustrated  in figure  1.1  (Scadding  1988).  In  Scadding’s  model  (Scadding 
1988), the development of a classification system begins with the clinical description of 
symptoms and signs, gradually integrating the more robust/ scientific characteristics- 
disorder  of  structure,  disorder  of  function,  and  aetiological  description.  This  model 
illustrates  that,  as  knowledge  of  health  and  disease  move  forward,  classification 
systems become increasingly sophisticated.    2 
 
 
Figure 1.1. Scadding’s hierarchical model of the characteristics of classification 
systems for disease. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.1.1 Approaches to developing systems of classification  
The  classification  of  intellectual  disabilities  is  used  to  illustrate  two  different 
approaches to classification. 
 
Intellectual disabilities is the internationally accepted term used to describe the needs of 
individuals  with  significant  limitations  both  in  intellectual  functioning  and  adaptive 
behavior as expressed in conceptual, social, and practical skills- originating before age 
 
4. Discovery of the aetiology/ causation of a disease 
 
3. Recognition of a functional abnormality- pathophysiology 
 
2. Recognition of a structural abnormality- anatomy 
 
1. Clinical description of signs and symptoms   3 
18 (American Association on Intellectual and Developmental Disabilities 2010). Such 
needs necessitate additional support from an individual's family, community and/ or 
services.  
 
1.1.1.1 A “top-down” consensus approach to classification 
Historical conceptualisations of intellectual disabilities used socially derived definitions 
to classify individuals as belonging to a distinct category. Eminent theorists, and social 
commentators of the day presented their opinions, influenced by broader social systems 
and ideas (Berrios 1999). This is an example of a “top down” approach to classification 
which results in categorical definitions. The 13
th century legal system provided one of 
the earliest proposals to separate intellectual disabilities (termed idiocy) from mental 
disorders  (lunacy).  Such  categories  were  defined  on  the  basis  of  unifying 
characteristics;  for  example,  individuals  with  intellectual  disabilities  were  seen  as 
having  a  permanent  disability,  present  from  birth;  whilst  mental  disorders  were 
believed to be acquired after birth, with some possibility of change over time (Digby 
1996). Further sub-categorisation emerged in the 18
th and 19
th century- using the terms 
such as feeble-minded, idiocy and imbecility - based largely on an individual’s ability 
to carry out work (Berrios & Porter 1998).  
 
1.1.1.2 A “bottom-up” statistical approach 
An  alternative  to  categorisation  in  classification  is  the  study  and  description  of 
individual human traits, or dimensions, which is considered to provide a more detailed 
representation  of  the  complex  pattern  of  similarities  and  differences  between 
individuals (Sternberg & Kaufman 1998). 
 
In the late 19
th and early 20
th century, researchers with an interest in understanding the 
construct of intelligence began the development of “bottom- up” empirical methods 
used in the study of traits and dimensions (Brody 2000). These statistical methods, such 
as factor analysis, have subsequently provided evidence comparing dimensional models 
with categorical diagnostic classification systems for mental disorders (Krueger 1999; 
Brown & Barlow 2005). 
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One  of  the  earliest  individuals  interested  in  examining  dimensions  underlying 
intelligence was Charles Spearman. As part of his work, Spearman developed factor 
analytic  methods  to  examine  whether  a  single  underlying  intelligence  factor  could 
explain correlations between separate dimensions of intellectual functioning- such as 
sensory perception, memory, attention etc.  Spearman’s work, alongside that of Jensen, 
Eysenck and others contributed to a theory of general intelligence- the g factor, with an 
alternative  theory  of  multiple  intelligences  proposed  by  Thurstone,  Gardner  and 
Sternberg  (Deary  2001).  This  early  work  on  general  intelligence  made  a  clear 
contribution  to  ideas  around  the  normal  distribution  of  intelligence,  and  intelligent 
quotient (IQ) testing - both of which are integral to current definitions of intellectual 
disabilities.  
 
1.1.2 Intellectual disabilities in current classification systems  
Both the “top-down” and “bottom-up” approaches have had an influence on the criteria 
for  intellectual  disabilities  in  contemporary  classification  systems.  These  criteria 
comprise three parts: 
·  a measure of intellectual functioning- usually IQ 
·  a measure of adaptive functioning 
·  a time/ duration criterion. 
 
These parts from the definition used in the Diagnostic Statistical Manual of Mental 
Disorders,  Fourth  Edition,  Text  Revision  (DSM-IV-TR;  (American  Psychiatric 
Association  2000)  categorical  diagnostic  classification  system  (which  uses  the  term 
mental retardation) are presented in table 1.1.  
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Table 1.1 Diagnostic criteria for intellectual disabilities from DSM-IV-TR 
 
  DSM-IV-TR 
Intellectual 
functioning 
Significantly sub-average intellectual functioning: An IQ 
of  approximately  70  or  below  on  an  individually 
administered IQ test.  
Adaptive behaviour  Concurrent  deficits  or  impairments  in  present  adaptive 
functioning (i.e., the person's effectiveness in meeting the 
standards expected for his or her age by his or her cultural 
group)  in  at  least  two  of  the  following  areas: 
communication,  self-care  and  home  living,  social  skills, 
use  of  community  resources,  self-direction,  functional 
academic skills, work, leisure, health issues, safety 
Age of onset  The age of onset is before 18 years old 
 
 
The other commonly used categorical diagnostic classification system in medicine is 
the International Statistical Classification of Diseases, Tenth Edition (ICD-10; (World 
Health  Organisation  1993).  The  description  of  the  ICD-10  term  mental  retardation 
below is provided, 
 
“A  condition  of  arrested  or  incomplete  development  of  the  mind,  which  is 
especially  characterized  by  impairment  of  skills  manifested  during  the 
developmental period, skills which contribute to the overall level of intelligence, 
i.e. cognitive, language, motor, and social abilities. Retardation can occur with or 
without any other mental or physical condition.” 
 
This is followed by the use of IQ as the basis to further categorise individuals with mild 
(approximate  IQ  range  50-69),  moderate  (approximate  IQ  range  35-49),  severe 
(approximate IQ range 20-34) and profound (IQ under 20) intellectual disabilities.  
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The inclusion of IQ measurements within the criteria for intellectual disabilities shows 
that a categorical diagnosis can make use of the “top-down” consensus and “bottom-
up” statistical processes.   
 
1.2 Classification systems for mental disorders 
Psychopathology  is  defined  as  the  study  of  abnormal  experience,  cognition  and 
behaviour  (Sims  2003).  It  is,  both,  a  core  skill  in  psychiatry  and  the  basis  for  the 
classification  of  mental  disorders  (Wallace  1994).  A  categorical  model  of 
psychopathology is used in current categorical diagnostic classification systems. 
 
The two main, generic classification systems for mental disorders, ICD and DSM, have 
acted as the basis for the development of categorical diagnostic classification systems 
for  the  classification  of  mental  disorders  experienced  by  adults  with  intellectual 
disabilities-  the  ICD-10  Guide  to  Mental  Retardation  (ICD-10-MR;  World  Health 
Organisation  1996);  the  Diagnostic  Criteria  for  Psychiatric  Disorders  for  use  with 
Adults with Learning Disabilities (DC-LD: Royal College of Psychiatrists 2001) and 
the  Diagnostic  Manual-Intellectual  Disability:  a  textbook  of  diagnosis  of  mental 
disorders  in  persons  with  intellectual  disability  (DM-ID:  Fletcher  et  al.  2007). 
Therefore, examining ICD and DSM is necessary before a more detailed description of 
these categorical diagnostic classification systems specific to intellectual disabilities.  
  
1.2.1 The requirements for a good classification system of mental disorders. 
Any  classification  system  for  mental  disorders  will  be  used  for  multiple  purposes, 
simultaneously (Johnstone 1998): 
·  communication with service users, carers and professionals 
·  clinical decision making 
·  strategic development of services 
·  research 
·  teaching and training 
·  legal purposes 
·  service commissioning and reimbursement. 
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Although  each  of  these  purposes  has  different  requirements,  there  is  a  degree  of 
consensus  about  the  core  characteristics  which  a  classification  system  should  have; 
utility- defined in terms of comprehensiveness and ease of use- reliability and validity 
(Kendler 1990; Kendell & Jablensky 2003).  
 
Reliability  refers  to  the  consistency,  or  repeatability,  with  which  a  decision,  or 
statement, is made. Although there are many types of reliability, the key one in the 
diagnosis and classification of mental disorders is inter-rater reliability (Helzer et al. 
1977).    Inter-rater  reliability  refers  to  the  level  of  agreement  in  the  diagnoses 
independently reached by two, or more, clinicians or researchers.  
 
As well as reliability, the validity of categorical diagnostic classification systems has 
also been examined. Validity is defined as the, “…best available approximation to the 
truth or falsity of a given inference, proposition or conclusion…”  (Cook & Campbell 
1979).  There  are  many  types  of  validity,  the  use  of  which  are  determined  by  the 
context. The three types of validity relevant to diagnosis in mental disorders are each 
given below with a short description: 
·  face validity- the criteria and diagnostic category seem to represent the experiences 
of individuals with mental disorders, and clinicians 
·  discriminant  validity-  the  criteria  used  to  define a  specific  diagnostic  categories 
adequately distinguish it from neighbouring, related categories 
·  predictive validity- a diagnostic category makes it possible to predict outcome or 
prognosis. 
 
1.2.2 A history of the classification of mental disorders 
During the classical Greek era, a system of classification based on psychopathology 
described five categories of mental disorder; phrenitis (delirium), mania, melancholia, 
hysteria  and  epilepsy.  Galen  adopted  the  first  aetiologically  based  model  for  the 
classification  of  mental  disorders  comprising  the  vesanias,  which  were  caused  by 
poisons,  the  lunacies  caused  by  phases  of  the  moon,  and  the  hereditary  insanities 
(Everitt & Landau 1998). As medical knowledge developed, Galen’s early shift towards   8 
the higher levels of classification on Scadding’s hierarchical model (figure 1; Scadding 
1988) was not sustained.  
 
In the 19
th, and early 20
th, centuries the process of developing a classification system 
for  mental  disorders  was  dominated  by  the  “famous  professor  principle”  (Kendler 
1990). Similar to the “top-down” approach to the definition of intellectual disabilities, 
described in section 1.1.1.1, European professors of psychiatry put forth their own ideas 
on classification. Amongst the many eminent names that contributed to thinking on 
classification,  Kraepelin  is  most  often  cited  as  significantly  influencing  the 
development  of  ideas  on  classification  (Moller  2008).  Postulating  that all  psychotic 
disorders  converge  in  “natural  disease  entities”  he  produced  his  basic  idea  that 
psychotic  disorders  can  be  dichotomized  into  “dementia  praecox”  and  “manic 
depressive  insanity”  (Kraepelin  1921).  This  idea  of  distinct  categories  of  mental 
disorders  informed  the  development  of  current  categorical  diagnostic  classification 
systems- ICD and DSM.   
 
1.2.3 International Classification of Disease (ICD) 
In 1853, two medical statisticians presented a list of causes of death which became 
known as Bertillon’s Classification of the Cause of Death. Subsequent revisions lead to 
the  International  List  of  Causes  of  Death.  This  was  used  by  the  World  Health 
Organisation (WHO) as the basis for the publication of the International Classification 
of Diseases, Injuries and Causes of Death (ICD-6) in 1948. Published in revised form 
approximately  every  10  years,  the  most  recent  edition  was  published  as  ICD-10  in 
1993.  
 
ICD-10 aims to provide comprehensive coverage of all causes of morbidity across all 
the  major  body  systems  across.  Organised  into  separate  chapters  for  diseases  with 
shared  aetiology,  chapter  V  is  for  the  classification  of  Mental  and  behavioural 
disorders.  Although  ICD-10  is  viewed  as  the  main  classification  system  in  use 
internationally,  the  majority  of  the  developments  in  the  classification  of  mental 
disorders  have  been  taken  forward  by  the  American  Psychiatric  Association,  in 
subsequent editions of the DSM. Since these innovations in DSM have generally been   9 
incorporated  into  the  ICD  Mental  and  behavioural  disorders  chapter,  a  fuller 
description of DSM is given here, and reference made to ICD where appropriate. 
 
1.2.4 Diagnostic and Statistical Manual of Mental Disorders (DSM) 
In 1952, the American Psychiatric Association published DSM-I. Both DSM-I, and also 
DSM-II  published  in  1968,  were  designed  primarily  for  the  specific  purpose  of 
counting the number of cases of individuals with specific diagnoses (Kraemer 2007). 
To meet this requirement, the early versions of DSM clearly had a focus on ensuring 
adequate face validity i.e. the descriptions of clinical syndromes matched the views of 
experts (Kendler 1990).  
 
An influential paper by Robins and Guze (1970), extended the focus on face validity to 
a  more  research  based  approach  to  validity-  suggesting  five  criteria  for  diagnostic 
validity, added to by Kendell (1989) to comprise: 
·  identification and description of a syndrome- face validity 
·  demonstration of boundaries between syndromes- discriminant validity 
·  follow up studies and course of illness- predictive validity 
·  outcome of therapeutic trials- predictive validity 
·  family studies- pathophysiology and aetiology 
·  association with a biological or psychological abnormality- pathophysiology and 
aetiology. 
 
This shift to a research-based development process created a clear break point in the 
revision of classification systems. Studies had shown that DSM-III had poor inter-rater 
reliability (Kreitman et al. 1961; Sandifer et al. 1968). The International Pilot Study of 
Schizophrenia examined diagnosis in nine countries (Carpenter. et al. 1973) and found 
that  schizophrenia  was  diagnosed  significantly  more  frequently  at  the  centre  in  the 
United  States  of  America  (U.S.A.)  and  the  Union  of  Soviet  Socialist  republics 
(U.S.S.R.), than in other countries. As a consequence of these findings attempts were 
made to improve the reliability of categorical diagnoses through the introduction of 
operationalised criteria in classification systems.  
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Via  the  specific  description  of  operationalised  criteria,  including  items  of 
psychopathology, DSM-III provided a classification system that could be more readily 
observed  and replicated across settings,  and between observers. This  was shown to 
improve upon the poor reliability DSM-II (Kreitman et al. 1961; Sandifer et al. 1968) 
in the DSM-III field trials (Spitzer et al. 1979), and subsequent studies (Mellsop et al. 
1991). The operationally defined criteria were further refined in DSM-IV, and ICD-10 
and have been shown to have good reliability (Klin et al. 2000; Brown et al. 2001). As 
a consequence, it has been suggested that the major improvements in reliability have 
been achieved (Kendell 2002). 
 
DSM-IV was published in 1994, with a text revision, DSM-IV-TR, following in 2000. 
For these, there was considerable time and resource spent in examining any evidence 
that could inform the diagnostic criteria in DSM-IV. Prior to publication, extensive 
field trials were carried out with the draft criteria, again largely focusing on the inter-
rater reliability and face validity of the classification system. DSM-IV-TR has been 
used as the basis for the development of DM-ID. 
 
There  has  been  a  recent  focus  on  a  more  evidence-based  approach  to  developing 
classification systems for mental disorders. However, overall the “top-down” consensus 
approach has had the biggest influence. 
 
1.3 Mental disorders and intellectual disabilities 
As described in section 1.1.1, mental disorders and intellectual disabilities have been 
conceptualised  as  separate  categories  for  several  centuries.  Interest  in  the  study  of 
mental disorders experienced by individuals with intellectual disabilities has developed 
gradually since early case reports in the 19
th century (Clouston 1883). This gathered 
pace  in  the  mid  20
th  century,  with  the  recognition  that  individuals  with  intellectual 
disabilities experience higher rates of mental disorders than individuals who do not 
have intellectual disabilities. 
 
In 1936, a study of the 2134 individuals in the Severalls Mental Hospital categorised 
the mental disorders of the inpatient sample as schizophrenia, organic insanities, manic   11 
depressive insanity, epileptic psychosis, and cases without definite psychotic symptoms 
(explained  as  neurosis,  psychoneurosis,  emotional  instability,  and  mental  defect 
uncomplicated by mental disorder). These categories were in keeping with the use of 
terminology  to  describe  mental  disorders  at  that  time.  The  level  of  abilities  of 
participants  was  also  assessed,  and  intellectual  disabilities  classified  using  the 
historical terms dull, feebleminded, imbecile and idiot (Duncan et al. 1936). Within the 
40.8% of the sample assessed as having intellectual disabilities (defined as having an 
equivalent mental age of less than 10), there were high rates of schizophrenia, manic 
depressive insanity and epileptic psychosis. The authors concluded that there may be a 
shared  aetiological  factor  between  manic-depression  and  intellectual  disabilities 
(Duncan 1936). Subsequent studies confirmed the increased rates of mental ill health in 
adults  with  intellectual  disabilities-  using  a  similar  inpatient  sample  in  a  large 
institution and the available categorical diagnostic system of the time (Penrose 1938; 
Pollock 1945; Heaton-Ward 1977; Reid 1972; Corbett 1979; Wright 1982). Even in the 
earliest  of  these  studies  the  limitations,  of  the  available  classification  systems  for 
mental disorders, based  on categorical models of psychopathology, when used with 
persons with intellectual disabilities were recognised (Duncan et al. 1936).  
 
1.3.1  The  classification  of  mental  disorders  experienced  by  individuals  with 
intellectual disabilities  
The use of generic classification systems, such as ICD and DSM, for the diagnosis of 
mental disorders in persons with intellectual disabilities is recognised to be problematic 
(Reid 1983; Sovner 1986; Sturmey 1993; Clarke et al. 1994; Einfeld & Aman 1995; 
Einfeld & Tonge 1999; Cooper et al. 2003). Since they were designed for the diagnosis 
of mental disorders in the general population, they: 
·  are reliant on verbal communication 
·  require an understanding of abstract and complex concepts beyond the cognitive 
abilities of many individuals with intellectual disabilities  
·  do  not  include  problem  behaviours  and  other  psychopathology  relevant  to 
intellectual disabilities. 
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Therefore, ICD and DSM are less reliable and valid for the assessment and diagnosis of 
mental  disorders  in  individuals  with  intellectual  disabilities  (Cooper  et  al.  2003). 
Various  authors  have  debated  whether  to  amend  existing  systems  of  classification, 
particularly for use with individuals with mild intellectual disabilities (Sovner & Hurley 
1983; Reid 1983; Sovner 1986; Bruininks 1991; Sturmey 1993; Clarke et al. 1994; 
Einfeld & Tonge 1999; Clarke & Gomez 1999; Cooper & Bailey 2001) or to publish 
classification  systems  specific  to  intellectual  disabilities.  Ultimately,  a  combined 
approach has been adopted, with the publication of three classification systems, based 
upon ICD and DSM, designed for specific use in the diagnosis of mental disorders, 
experienced  by  individuals  with  intellectual  disabilities-  ICD-10-MR  (World  Health 
Organisation  1996);  DC-LD  (Royal  College  of  Psychiatrists,  2001)  and  the  DM-ID 
(Fletcher  et  al.  2007).      The  publication  of  these  specific  systems  may  act  as  an 
important  stimulus  to  take  forward  developments  in  research  and  clinical  practice; 
aiming  to  improve  the  outcomes  and  quality  of  life of  individuals  with  intellectual 
disabilities experiencing mental disorders.  
 
1.3.1.1 ICD-10 Guide to Mental Retardation (ICD-10-MR) 
The World Health Organisation published the ICD-10 Guide to Mental Retardation in 
1996 (World Health Organisation 1996). Although it has never been adopted as part of 
routine clinical practice, or used extensively in research, it represented the first attempt 
to tackle the challenges inherent in the classification of mental disorders experienced by 
persons with intellectual disabilities. 
 
Similar to ICD-10 and DSM-IV-TR, ICD-10-MR proposed a multi-axial classification 
system, with five axes: 
·  axis I -severity of intellectual disabilities and problem behaviours 
·  axis II-associated medical conditions not causative of intellectual disabilities 
·  axis III-associated psychiatric disorders 
·  axis IV-global assessment of psychosocial disability 
·  axis V-abnormal psychosocial conditions. 
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With regards to the classification of mental disorders using axis III, ICD-10-MR did not 
change any of the psychopathology, duration or impairment criteria compared to the 
generic  ICD-10.  Rather,  the  guide  makes  comment  where  there  are  specific  issues 
relevant  to  a  particular  diagnosis  in  individuals  with  intellectual  disabilities.  For 
example, a comment is made on the association of Down syndrome with Alzheimer's 
disease,  and  the  need  to  rule  out  hypothyroidism  as  a  differential  diagnosis  for 
depressive symptoms in persons with Down syndrome. Given that ICD-10-MR did not 
really address any of the issues relevant to assessing and diagnosing mental disorders in 
individuals with intellectual disabilities, it is not surprising that it has never been taken 
up and used by professionals working in clinical practice, or research. One study that 
trialed its use in the diagnosis of mental disorders experienced by young people with 
intellectual  disabilities  highlighted  some  of  the  inconsistencies  and  discrepancies 
(Einfeld & Tonge 1999). It was concluded that there was a need to establish working 
groups to further develop a reliable and valid classification system. 
 
1.3.1.2  Diagnostic  Criteria  for  Psychiatric  Disorders  for  use  with  Adults  with 
Learning Disabilities (DC-LD) 
An expert working group, of specialists in intellectual disabilities psychiatry, developed 
the  DC-LD  on  behalf  of  the  Royal  College  of  Psychiatrists  (Royal  College  of 
Psychiatrists 2001). Using ICD-10 and DSM-IV as a basis, the working group set out 
with the aim of developing a classification system that would be reliable and valid for 
use in research and clinical settings (Cooper et al. 2003). Similar to the development of 
DSM-IV, the working group used a consensus process, informed by comprehensive 
literature searches and a field trial of the draft criteria. This lead to the publication of 
DC-LD, in 2001.  
 
Although DC-LD has a multiaxial system of classification, it is quite distinct from that 
in ICD-10-MR: 
·  axis I-severity of learning disabilities 
·  axis II-cause of intellectual disabilities 
·  axis III-psychiatric disorders 
-  DC-LD level A: developmental disorders   14 
-  DC-LD level B: psychiatric illness 
-  DC-LD level C: personality disorders 
-  DC-LD level D: problem behaviours 
-  DC-LD level E: other disorders. 
 
 
The  introduction  to  DC-LD  emphasises  the  importance  of  using  a  hierarchical 
approach  to  classification.  When  an  item  of  psychopathology  is  identified,  it  is 
recommended that the person making the diagnosis moves systematically down the 
axes, and five levels in axis III- considering, at each stage, the appropriate axis, or 
level, to consider the item of psychopathology as part of classification. It is relevant to 
note  that  an  item  of  psychopathology  can  be  attributed,  and  used  as  part  of 
classification,  in  several  axes,  or  levels,  in  the  hierarchical  system.  However,  the 
introduction  to  DC-LD  emphasises  the  need  to  give  careful  consideration  before 
counting psychopathology twice within the hierarchical model of classification. 
 
The  format  and  content  of  DC-LD  addresses  many  of  the  previously  expressed 
concerns  over  the  use  of  ICD-10  and  DSM-IV,  when  diagnosing  mental  disorders 
experienced by persons with intellectual disabilities. Furthermore, DC-LD specifically 
addresses some of the criticisms of ICD-MR made by Einfeld and Tonge (Einfeld & 
Tonge 1999). For example, whereas ICD-10-MR included problem behaviours in the 
same  axis  as  severity  of  intellectual  disabilities  (Einfeld  &  Tonge  1999),  DC-LD 
conceptualises problem behaviours as a separate level within psychiatric disorders in 
axis III.  
 
In contrast to ICD-10-MR, DC-LD has altered some of the ICD-10 criteria for certain 
categorical  diagnoses  of  mental  disorders.  For  example,  a  DC-LD  diagnosis  of 
depressive episode can be made if one key depressive symptom, from a choice of two-
either depressed mood or loss of interest or pleasure in activities-is identified; whereas 
in ICD-10, two key depressive symptoms, from a choice of three -depressed mood, loss 
of interest or pleasure in activities, and loss of energy-are required. Overall, only minor 
modifications to ICD-10 criteria were made on the basis that there was evidence to   15 
support the changes, and it is stated that further research is needed to  examine the 
reliability and validity of the modifications that have been made (Royal College of 
Psychiatrists 2001).  
 
Some initial work examining the utility of DC-LD has been published. A retrospective 
case note study, carried out in an institution in Ireland, looked at the utility of DC-LD 
to classify mental disorders in 113 adults with intellectual disabilities. The majority of 
participants (87.6%) had severe or profound intellectual disabilities. This study reported 
improved  utility  of  DC-LD  to  diagnose  problem  behaviours  and  eating  disorders, 
compared  to  ICD-10  and  DSM  IV.  However,  a  significant  number  of  “residual 
category” or “not otherwise specified” diagnoses were recorded, as DC-LD or ICD-10 
criteria were not fully met.  
 
Cooper et al (2007a) applied DC-LD, ICD-10 and DSM-IV-TR diagnostic criteria to a 
large  sample  of  adults with  intellectual  disabilities,  who  had  been  assessed  using  a 
comprehensive, standardised process. The prevalence of mental disorders using DC-LD 
criteria was more than double the prevalence when ICD-10 and DSM-IV-TR criteria 
were used. Furthermore, DC- LD diagnoses showed a greater level of agreement with 
the gold standard consensus clinicians’ diagnoses, than ICD-10 and DSM-IV-TR. This 
provides evidence for the utility and face validity of DC-LD.  
 
Finally, Hove and Havik (2008) used the operationalised DC-LD criteria to develop 10 
psychopathology  and  eight  problem  behaviour  checklists.  Informants  working  with 
adults  with  intellectual  disabilities,  comprising  paid  carers  and  health  care  staff, 
completed  the  checklists  for  583  individuals.  The  checklists  were  found  to  have 
acceptable internal, and inter-rater reliability, and specificity-although sensitivity was 
found to be poor. 
 
Further research examining the reliability, validity and utility of DC-LD is required. 
However, these initial studies suggest that it is an important initial step in tackling some 
of  the  problems  associated  with  the  use  of  ICD  and  DSM  categorical  diagnostic   16 
classification systems for mental disorders experienced by individuals with intellectual 
disabilities. 
 
1.3.1.3 Diagnostic Manual-Intellectual Disability (DM-ID) 
DM-ID  can  be  used  to  make  diagnoses  in  children  and  adults  with  intellectual 
disabilities. Similar to DC-LD, an expert consensus process was used to produce the 
DM-ID. For each section in DSM-IV-TR, a detailed literature review was carried out to 
examine the evidence on the diagnosis of particular categories of disorders, and this 
was used to inform the adaptation of DSM-IV-TR criteria. 
 
In a general DM-ID chapter on assessment and diagnosis (Hurley et al. 2007), it is 
suggested  that  all  five  axes  of  DSM-IV-TR  can  be  used  with  individuals  with 
intellectual disabilities: 
·  axis I- mental disorders, other than personality disorders and intellectual disabilities 
·  axis II- for coding level of intellectual disabilities and personality disorders 
·  axis  III-  medical  disorders  relevant  to  any  medical  disorders,  or  the  cause  of 
intellectual disabilities 
·  axis IV- allows coding of relevant psychosocial and environmental stressors 
·  axis V- the Global Assessment of Functioning (GAF), is a rating scale to allow 
clinicians to rate an  individual’s overall level of functioning. 
 
DM-ID states that axes I-V should be used as part of a multi-axial diagnosis for adults 
with intellectual disabilities. The majority of DM-ID reviews the use of criteria for axis 
I  and  axis  II  diagnostic  categories  for  persons  with  intellectual  disabilities.  It  is 
suggested  that  axis  III  should  be  used  as  it  stands  in  DSM-IV-TR,  and  modified 
versions of axes IV and V can be used. 
 
There are potential problems in using axis V, the GAF, to rate the overall functioning of 
individuals with intellectual disabilities (Hurley 2001; Shedlack et al. 2005). One issue 
arises because clinicians are asked to rate overall functioning based on the impairments 
due to mental disorders, which in DSM-IV-TR would include intellectual disabilities. 
This  could  lead  to  persons  with  severe  intellectual  disabilities,  but  with  no  mental   17 
disorders such as depression or schizophrenia, being rated with very low scores, despite 
leading happy, fulfilling lives. Since the impact on functioning of impairments due to 
physical  disabilities  is  excluded  from  the  axis  V  rating,  it  has  been  suggested  that 
intellectual disabilities be viewed similarly (Hurley 2001). As individuals would not be 
starting  with  artificially  low  scores  this  would make  it  more  likely  that  changes  in 
functioning due to mental disorders could be reliably rated.  
 
Examining  DM-ID,  there  are  very  few  adaptations  to  the  DSM-IV-TR  criteria  for 
individual  diagnostic  categories.  More  commonly,  qualifying  statements  are  made 
about  individual  criteria,  often  separately  for  individuals  with  mild/  moderate  and 
severe/ profound intellectual disabilities. Thus, DM-ID is largely identical to DSM-IV-
TR with suggestions to clinicians on how best to apply criteria.  
 
A field trial was carried out to examine the clinical usefulness of the DM-ID (Fletcher 
et al. 2009). Sixty three clinicians in 11 countries were asked to make use of the DM-
ID with individuals on their existing clinical caseloads and to provide a DSM-IV-TR 
and DM-ID diagnoses for each case. The clinicians were also asked to complete a short 
questionnaire, with six specific items rating the usefulness of the DM-ID. Although no 
data on the reliability or validity of the DM-ID was presented, overall, DM-ID was 
rated as clinically useful in reaching a diagnosis in 51.7% of the 845 cases, and easy or 
very  easy  to  use  in  67.9%  of  cases.  Importantly,  clinicians  rated  it  as  useful  in 
diagnosing clinical disorders across the full range of abilities and the authors tentatively 
suggest DM-ID may have advantages over DSM-IV-TR experienced by  individuals 
with intellectual disabilities (Fletcher et al. 2009). 
 
To date, only one study examining the reliability, validity or utility of DM-ID has been 
published.  A  retrospective  case  note  review  of  clinic  attendees  with  intellectual 
disabilities  concluded  that  many  individuals  with  depression  would  not  meet  the 
adapted DM-ID criteria for depressive disorder (Hurley 2008). This was attributed to 
the communication skills of people with intellectual disabilities making self-report of 
symptoms difficult, and the limitations around informant report of symptoms. 
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1.3.2 Summary of the classification of mental disorders in intellectual disabilities 
The general requirements for a good classification system of mental disorders have 
been  described.  Specific  categorical  diagnostic  classification  systems  for  mental 
disorders  experienced  by  persons  with  intellectual  disabilities  have  been  published. 
However, few published studies have examined whether DC-LD and DM-ID meet the 
requirements for a good classification system. Since the generic ICD-10 and DSM-IV 
categorical diagnostic classification systems were used to develop DC-LD and DM-ID, 
the next section reviews the evidence on generic ICD and DSM classification systems.  
 
1.4  The  advantages  and  disadvantages  of  categorical  diagnostic 
classification systems  
1.4.1 Advantages of categorical diagnostic classification systems  
ICD  and  DSM  are  able  to  fulfill  many  of  the  purposes,  and  characteristics  of  an 
adequate system described in section 1.2.1. They have lead to enhanced communication 
with  service  users  and  amongst  professionals,  improved  reliability,  and  have  been 
widely  utilized  in  research  and  teaching  (Kendell  &  Jablensky  2003).  Categorical 
diagnoses act as a short hand description of an individual’s experiences, symptoms and 
presentation to clinical services. The improved reliability of communication between 
professionals, associated with existing categorical classification systems is reported as 
the most valued feature of DSM and ICD (Mellsop et al. 2007; Bell et al. 2008). 
 
With  respect  to  communication  with  service  users,  using  a  diagnostic  term  that  is 
familiar to an individual can have a positive impact. Although, more often categorical 
diagnoses are linked to the stigmatization of individuals with mental disorders, research 
has also described the positive effects that some individuals experience when they are 
told  of  a  recognizable  diagnosis  (Dinos  et  al.  2004;  Holm-Denoma  et  al.  2008). 
Moreover,  at  a  population  level  the  use  of  categorical  diagnoses  provide  a  shared 
language essential for anti-stigma (Crisp et al. 2005; Mehta et al. 2009) and public 
mental health campaigns (Jorm et al. 1999). 
 
The  improved  reliability  of  the  diagnostic  process  through  the  use  of  categorical 
diagnostic  classification  systems  was  discussed  previously  whilst  describing  the   19 
changes in DSM. This has encouraged the development of semi-structured diagnostic 
interviews.  Beginning  with  the  development  of  the  Diagnostic  Interview  Schedule 
(Robins  et  al.  1981),  which  produced  diagnoses  based  on  DSM-III,  the  major 
diagnostic  interview  schedules  identify  disorders  described  in  the  ICD  and  DSM 
diagnostic classification systems: 
·  Schedules for Clinical Assessment in Neuropsychiatry (SCAN; (Wing et al. 1990)- 
ICD-10 and DSM-IV 
·  Structured Clinical Interview for DSM IV (SCID; First et al. 1994)- DSM-IV 
·  Composite International Diagnostic Interview (CIDI; (Kessler & Ustun 2004) 
·  Clinical Interview Schedule- Revised (CIS-R; (Lewis et al. 1992). 
 
This link between classification systems and diagnostic interviews is useful for certain 
types of research, such as epidemiological studies. 
 
 ICD-10 and DSM have also been used as the framework to design outcome measures 
used in clinical and research settings. The clearest example of this is the Patient Health 
Questionnaire (PHQ-9), widely used as an outcome measure for depression. The PHQ-
9 comprises the nine DSM-IV criteria for depression, self- scored on a scale of 0 (not at 
all) to 3 (nearly every day), and has been shown to be reliable and valid (Lowe et al. 
2004).  
 
This relationship between ICD, DSM, diagnostic interviews and outcome measures has 
encouraged  the  consistent  use  of  methods  in  clinical  practice  and  research, 
internationally. 
 
1.4.2 Disadvantages of categorical diagnostic classification systems 
1.4.2.1 Evidence on the validity of categorical diagnostic classification systems 
The discriminant validity of a categorical diagnosis depends upon being able to clearly 
demonstrate a boundary between the category in question, and alternative categories. 
For example, Kraepelin’s dichotomous boundary between schizophrenia and bipolar 
disorder is widely utilised in clinical practice and research. In “carving nature at the 
joints” (Pickles & Angold 2003), categorical diagnostic classification systems seek to   20 
delineate categories from one another, and also to establish a discontinuity between 
normality and pathology, defined as a category, or syndrome.  
 
One  approach  to  examining  the  validity  of  a  categorical  system  of  diagnosis  is  to 
consider  the  distribution  of  psychopathology.  If  diagnostic  categories  are  valid,  we 
might  expect  to  identify  a  natural  breakpoint,  or  “point  of  rarity“(Sneath  1957), 
between  neighbouring  categories,  or  find  that  psychopathology  has  a  bimodal 
distribution (Murphy 1964; Everitt 1981; Meehl 1995). A commonly cited example of a 
bimodal distribution is the frequency peak at the tail of the normally distributed IQ 
distribution curve. This is believed to represent individuals with intellectual disabilities 
associated with genetic, and other biological, syndromes or causes.  
 
In the case of psychopathology, researchers have sought to examine points of rarity, or 
a bimodal distribution, to discriminate between: 
·  normality and caseness  
·  neighbouring, categorically defined diagnoses. 
 
To examine if there is a categorical breakpoint between normality and caseness, a study 
examined  non-psychotic  psychopathology,  in  a  nationally  representative  sample  of 
9556 UK adults from the National Household Psychiatric Morbidity study (Melzer et 
al.  2002).  The  CIS-R  (Lewis  et  al.  1992)  was  used  to  collect  the  data  on 
psychopathology  and  analysis  carried  out  to  identify  the  best  fitting  theoretical 
distribution curve. The best fit for the distribution was a single exponential curve with 
no points of rarity or frequency peaks to distinguish between normality from caseness. 
No evidence to support a bimodal distribution of psychopathology was  found (Melzer 
et al. 2002). Although the study had a large sample size and used a structured method 
to  identify  psychopathology,  the  exclusion  of  individuals  with  psychopathology 
suggestive of psychosis could have impacted on the findings. In particular, the finding 
that psychopathology has a continuous distribution cannot be generalized to diagnostic 
categories of schizophrenia, schizoaffective and bipolar disorders. 
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Large studies, of non-clinical populations, have been used to explore the distribution of 
specific types of psychopathology in order to identify whether a bimodal distribution 
can identify a cut-off point for a diagnostic category. Studies focused on psychotic 
symptoms (Allardyce et al. 2007b), depressive symptoms (Flett et al. 1997; Solomon et 
al. 2001) and anxiety symptoms (Anderson et al. 1993) all seem to conclude that there 
is a continuous distribution of these types of psychopathology in the population. Similar 
findings have been reported for the distribution of psychopathology in representative 
samples of children and adolescents  (Levy et al. 1997; van den Oord et al. 2003). 
Although more readily accepted for anxiety and depressive symptoms, which have long 
been  conceptualised  as  variations  on  normal  human  emotional  experience,  the 
suggestion  that  psychotic  psychopathology  exists  on  a  continuum  that  extends  into 
normal experience is perhaps more surprising. However, multiple studies support this 
continuous  distribution  of  positive  psychotic  symptoms  in  non-clinical  populations 
(Allardyce et al. 2007b), with rates between 4% (Eaton et al. 1991) and 17.5% (van Os 
et al. 2000). 
 
Further evidence in support of a continuous distribution of psychopathology emerges 
from studies examining sub-threshold clinical syndromes, in non-clinical samples. In 
the  case  of  affective  disorders,  high  rates  of  sub-threshold  depressive  (Angst et  al. 
1997; Wagner et al. 2000; Cuijpers et al. 2004; Chuan et al. 2008) and hypomanic 
symptoms  (Angst  et  al.  2003;  Kessler  et  al.  2006;  Merikangas  et  al.  2007)  are 
described. These studies used established structured methods to assess psychopathology 
but have not all used representative, population-based samples (Wagner et al. 2000) 
and not all the studies found that these sub-threshold syndrome were associated with 
impairment (Angst & Merikangas 1997). Despite these limitations in some studies, the 
concept  of  depressive  (Angst  &  Merikangas  1997)  and  bipolar  spectrum  disorders 
(Judd  &  Akiskal  2003)  have  emerged,  with  similar  arguments  being  made  for 
schizophrenia  (Siever  &  Davis  2004),  and  obsessional  (Bienvenu  et  al.  2000) 
spectrums.  
 
A second method used to examine the discriminant validity of categorical models of 
psychopathology  is  to  study  categories  with  a  postulated  overlap,  or  some  shared   22 
features. With regard to such neighbouring categorical diagnoses, most studies have 
focused  on  psychopathology  in  the  psychoses.  Krapelin’s  original  dichotomisation 
continues  to  influence  work  attempting  to  delineate  psychosis  associated  with 
schizophrenia and affective disorders; although it is interesting to note that Kraepelin 
recognized the problems discriminating between the two when he wrote, ’. . . it is 
becoming increasingly clear that we cannot distinguish satisfactorily between these two 
illnesses  .  .  .’  (Taylor  1992).  Early  studies,  examining  psychopathology,  failed  to 
identify  points  of  rarity,  or  a  bimodal  distribution,  that  could  distinguish  between 
schizophrenia  and  the  affective  psychoses  (Kendell  &  Gourlay  1970;  Kendell  & 
Brockington  1980).  Nor  has  more  recent  work  found  that  psychopathology 
discriminates between the categories of psychoses described in ICD and DSM.  
 
Two studies used factor analysis to examine the psychopathology experienced by adults 
meeting the criteria for schizophrenia, schizoaffective disorder and affective psychoses- 
using DSM-III-R in a study with 314 participants (Peralta et al. 1997) and ICD-10 with 
387 participants (Murray et al. 2005). Factors extracted, that included positive, negative 
and  disorganization  psychopathology,  were  scored  highly  in  participants  with  and 
without schizophrenia, and depressive and mania/ hypomania factors scored highly in 
individuals  diagnosed  with  schizophrenia.  Although  these  findings  require  further 
validation,  particularly  using  categorical  diagnostic  classification  systems  using 
operationalised  criteria,  such  as  DSM-IV-TR,  they  suggest  an  overlap  between 
diagnostic categories. This area of work has moved beyond just psychopathology with 
detailed reviews reaching the conclusion that the overlapping psychopathology, risk 
factors and outcomes of schizophrenia and psychotic bipolar disorder argue against the 
existence of separate diagnostic categories (Maier et al. 2006).  
 
A further challenge to the categorical classification of psychopathology has come from 
the  evidence  that  individuals  with  mental  disorders  have  very  high  levels  of 
comorbidity. The suggestion is that the high levels of comorbidity in epidemiological 
studies are due to the poor discriminant validity of diagnostic categories, such that the 
boundaries between categories are not valid, and so individuals end up meeting criteria   23 
for more than one diagnosis. This issue has raised concerns that current categories are 
not representative of distinct clinical entitities (Mineka et al. 1998). 
 
The extent of comorbidity experienced by persons with mental disorders first became 
clear during the Epidemiological Catchment Area (ECA) study (Bourdon et al. 1992). 
Of the 28.1% of participants with one diagnosis, over 60% had two or more diagnoses. 
Similarly, the National Comorbidity Survey (Kessler et al. 1994) reported that of 29.5% 
of participants with one diagnosis in the prior 12 month period, 56% had two or more 
diagnoses. In the follow up National Comorbidity Survey- replication study (Kessler et 
al. 2005) of 26.2% of participants meeting criteria for at least one diagnosis over the 
prior 12 month period, 45% met criteria for two or more diagnoses. Such consistently 
high rates of comorbidity raised concerns about the validity of the categories defined 
within the classification systems, which in these studies was DSM. 
 
There  are  cases  where  an  individual  meeting  criteria  for  more  than  one  diagnosis 
represents the presence of distinct, yet comorbid, psychopathology. However, the more 
common finding is that the multiple diagnoses are similar enough to one another to 
suggest a shared pathophysiology, or aetiology. For example, one study reported high 
rates of comorbid depressive and anxiety diagnoses (Brown et al. 2001). The Anxiety 
Disorder Interview Schedule for DSM-IV: Lifetime Version (ADIS-IV-L;  (Di Nardo et 
al.  1993)  was  used  to  assess  psychopathology  in  1,  127  individuals  attending  two 
specialist centres for the management of anxiety disorders in the U.S.A. Fifty seven 
per-cent of participants had current co-morbid mood and anxiety disorders, and the rate 
of lifetime comorbidity was 81% (Brown et al. 2001). Given that the recruiting sites 
were specialist treatment centres for anxiety disorders it could be that the sample is 
biased towards inclusion of individuals with severe, treatment resistant disorders. This 
may have influenced the high rates of comorbidity. 
 
The predictive validity of a diagnostic classification system is considered by some to be 
the  single  most  important  requirement  (Kendell  1989;  Kendell  &  Jablensky  2003). 
However,  less  research  has  focused  on  this  aspect  of  the  validity  of  categorical 
diagnostic classification systems, than discriminant validity. Early studies reported that   24 
the  criteria  for  a  categorical  diagnosis  of  schizophrenia  were  not  associated  to  an 
individual’s  prognosis  (Hawk  et  al.  1975;  Brockington  et  al.  1978).  This  raised 
concerns that categorical diagnostic classification systems had poor predictive validity. 
However,  more  recent  studies  have  suggested  that  the  inclusion  of  operationalised 
criteria  within  the  categorical  diagnosis  of  schizophrenia  has  improved  predictive 
validity (Mason et al. 1997). However, other studies have found that ICD-10 and DSM-
IV categorical diagnostic classification systems may lack predictive validity when used 
to classify a broader range of mental disorders (Jager et al. 2004). Overall, the evidence 
base on the predictive validity of categorical diagnostic classification systems in at an 
early stage. There is a recognized need to study this further (Kendell & Jablensky 2003; 
Vieta & Phillips 2007). 
 
1.4.2.2 The use of categorical models of psychopathology in research 
The  evidence  suggesting  that  categorical  diagnostic  classification  systems  may  lack 
discriminant and predictive validity raises concerns about their utility in research.  
 
It is recognised that the use of a categorical variable to describe what is actually a 
continuous  variable,  will  affect  the  power  and  precision  of  research  (Cohen  1983; 
MacCallum  et  al.  2002;  Altman  &  Royston  2006).  The  evidence  described  above 
suggests  that  psychopathology  appears  to  have  a  continuous  distribution  in  the 
population.  Although  it  is  a  common  practice,  the  two  general  criticisms  of 
dichotomizing a continuous variable are that it is leads to a loss of data - affecting the 
power of studies - and distorts the understanding of the relationship between variables. 
A calculation of the extent of the loss of power, estimated that three times the sample 
size is needed for equivalent power, compared to use of a continuous variable (Neale et 
al. 1994).  
 
These  issues  are  highly  pertinent  to  psychopathology  research,  for  example  as 
described  affecting  the  results  in  a  randomised  controlled  trial  of  CBT  for  eating 
disorders  (Kraemer  2007).  An  initial  analysis  using  a  categorical  outcome  measure 
found no evidence for the efficacy of the intervention. Reanalysis using a dimensional 
outcome  measure  suggested  that  the  effects  of  the  intervention  are  statistically   25 
significant,  and  potentially  clinically  relevant.  It  was  argued  that  the  loss  of  power 
associated  with  the  use  of  categorical  outcome  measures,  creates  a  need  for 
unnecessarily  large  sample  sizes  and  then  misinterpretation  of  clinically  relevant 
findings.  
 
As has already been stated, the DSM-I and DSM-II categorical systems of classification 
were originally devised for use in epidemiological research (Kraemer 2007). Whilst 
existing systems appear to meet criteria for use in this type of work, a case is emerging 
around  the  limitations  of  the  use  of  categorical  diagnostic  classification  systems  in 
biological research in the field of mental disorders, such as genetics, and neuroscience 
(van  Praag  1997;  Verhoeven  &  Tuinier  2001).  Whilst  the  methods  in  research  in 
genetics and neuroscience have developed considerably, further developments are held 
back by the diagnostic categories in use.  
 
Studies have shown an overlap in the genetics of separate diagnostic categories. The 
genetic  overlap  between  bipolar  disorder  and  schizophrenia  (Craddock  et  al.  2006; 
Maier  2008)  and  between  anxiety  and  mood  disorders  (Kendler  et  al.  2008)  adds 
weight  to  the  argument  above.  This  apparent  lack  of  validity  of  the  diagnostic 
categories hinders genetic aetiological research. In light of this, and other problems that 
have emerged in the interface between genetics and diagnoses, researchers have begun 
to examine associations between genetics and more detailed phenotypes, to allow a 
degree of separation from the limitations imposed by diagnostic categories. 
 
Research in psychosis has begun to identify endophenotypes that it is hoped will be of 
greater relevance to genetic studies than categorical diagnoses (Craddock et al. 2006; 
Cardno et al. 2008). Endophenotypes are identifiable, quantitative clinical features, or 
functional impairments. These tend to be continuous, or dimensional, in nature and are 
often  measurable  using  objective,  laboratory  tests-for  example,  neuropsychological 
batteries of assessment (Gottesman & Gould 2003; Braff et al. 2007). Examples of 
endophenotypes studied include, measures of verbal memory, and neurophysiological 
measures  such  as  the  P50  event  related  suppression.  Of  course,  this  approach  still 
involves  challenges  to  successfully  identify  the  relevant  components  of  the  adult    26 
phenotype to study. However, initial findings linking endophenotypes to genetic factors 
in schizophrenia (Greenwood et al. 2007) and depression (Nash et al. 2004) are of 
interest. 
 
As well as considering the impact on genetic research, it is also relevant to consider the 
use  of  categorical  diagnostic  classification  systems  of  psychopathology  in  neuro-
scientific research. Similar to genetic research, scientists working in neuro-imaging, 
and related fields, have begun to identify neuro-endophenotypes (Glahn et al. 2007) 
and link these to models of psychopathology distinct from diagnostic categories (Pan et 
al. 2009). Furthermore, the opportunity to combine work on neuro- imaging, genetics 
and endophenotypes offers promise to the understanding of the development of the 
normally  developing  human  brain  (Lenroot  &  Giedd  2008),  as  well  as  the 
pathophysiology of mental disorders (Potkin et al. 2009).  
 
Although  the  relationship  between  ICD,  DSM,  diagnostic  interviews  and  outcome 
measures is a potential advantage, this is also a potential limitation to developing the 
evidence  base.  The  clearest  example  of  this  has  been  described  in  relation  to  the 
inclusion of the clinical significance criterion in DSM-IV (Spitzer & Wakefield 1999). 
Some authors have argued that this additional criterion improves the validity of the 
classification system because individuals diagnosed with a disorder have higher levels 
of suicidality, disability and service utilization (Narrow et al. 2002). However, this 
would  seem  to  be  a  tautology,  since  the  disorder  is  defined  in  terms  of  “clinically 
significant distress or impairment in social, occupational, or other important areas of 
functioning” (American Psychiatric Association 2000). 
 
Similar problems arise in relation to outcome measures developed from ICD and DSM. 
There is evidence to support the use of the PHQ-9 as an outcome measure (Kroenke et 
al. 2001). However, given that the nine DSM-IV criteria for depressive disorder were 
the basis for it’s original development, the findings are again potentially subject to a 
tautology (Lowe et al. 2004), similar to the one described for the significance criterion. 
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In summary, although the improved reliability of categorical diagnostic classification 
systems  was  an  important  step  forward,  the  concerns  over  validity  raises  questions 
about the need for alternative, or complementary approaches. The lack of evidence to 
support  the  validity  of  categories  suggests  this  may  be  impacting  upon  research  to 
elucidate the aetiology of mental disorders (Hyman 2002), and preventing any move 
towards the higher levels of Scadding’s hierarchical model of diagnosis (figure 1.1). 
Although the publication of DSM-III in 1980 has had a positive effect on classification, 
the groups working on DSM-V recognize that very little progress has been made on 
developing an understanding of the aetiology and pathophysiology of mental disorders 
(First 2009).  
 
1.4.3  Summary  of  the  advantages  and  disadvantages  of  categorical  diagnostic 
classification systems 
Existing categorical diagnostic classification systems are based on a categorical model 
of  psychopathology.  These  systems  fulfill  many  of  the  requirements  for  a  good 
classification  system  in  1.2.1  and  are  valued,  and  widely  used  in  clinical  practice. 
However,  research  has  highlighted  limitations  surrounding  the  validity  of  these 
systems, which may be a particular issue for research. Given these limitations there is a 
need to further consider categorical and other models of psychopathology. 
 
1.5 Dimensional models of psychopathology 
The main alternative to classification systems of mental disorders that are based on 
categorical  models  of  psychopathology  are  based  on  dimensional  models  of 
psychopathology.  Before  reviewing  the  intellectual  disabilities  literature  on 
dimensional models of psychopathology, an overview is provided of relevant findings 
from studies that did not include adults with intellectual disabilities. 
 
1.5.1 Research on dimensions of psychopathology 
In  contrast  to  the  “top-down”  development  of  existing  categorical  diagnostic 
classification  systems,  via  the  consensus  of  experts  process,  dimensional  models  of 
psychopathology  have  been  derived  from  studies  that  used  statistical  methods  to 
examine the underlying structure of psychopathology.   28 
 
Much of this work has developed from the factor analytic methods used by Spearman 
in the study of intelligence. Early studies used factor analysis to study psychopathology 
in  an  attempt  to  identify  broad  dimensions  of  psychopathology,  and  examine  the 
tendency of symptoms to cluster together (Wittenborn 1951; Lorr 1957). A review of 
the  early  work  using  exploratory  factor  analysis,  identified  12  dimensions  of 
psychopathology  from  observer  psychopathology  ratings  of  inpatients,  listed  below 
with the key characteristic symptoms cited in the review (Bolton 1973): 
·  Paranoid Delusions (feels systematically persecuted; believes others influence him; 
believes people talk about him) 
·  Thinking Disorganization (irrelevant speech; disoriented; emotional disharmony) 
·  Anxiety-Depression  (doubts  he  can  be  helped;  feelings  of  impending  doom; 
unrealistic self-blame) 
·  Excitement- Hostility (initiates physical assaults; destructive; obscene)  
·  Excitement-Depression (shouts, sings, and talks loudly; irritable; temper tantrums) 
·  Withdrawal-Retardation (speech is slowed or deliberate; shut-in personality; lacks 
motivation) 
·  Perceptual  Distortions  (visual  hallucinations;  auditory  hallucinations;  tactile 
hallucinations) 
·  Phobic-Compulsive  Reaction  (behavior  disrupted  by  phobias;  compulsive  acts 
occur daily; obsessional thinking) 
·  Paranoid (grandiose convictions; dramatically attention-demanding; voices praise or 
extol him)  
·  Motor Disturbances (manneristic movements; giggling; assumes bizarre postures)  
·  Deterioration (incontinent because of own negligence; foreign objects in mouth; 
unaware of the feelings of others) 
·  Conversion  Hysteria  (no  organic  basis  for  complaints;  organic  pathology  with 
emotional basis; use made of physical disease symptoms). 
 
From these early broad dimensions, research on adult psychopathology has examined 
dimensions  related  to  specific  domains  of  psychopathology,  such  as  psychosis.  As 
discussed  in  section  1.4.2.1,  studies  included  individuals  meeting  criteria  for   29 
schizophrenia,  schizo-affective  disorder  and  affective  psychoses  on  the  basis  of 
categorical diagnostic classification systems (Peralta et al. 1997; Murray et al. 2005). 
Since  categorical  models  are  used  to  define  potential  participants,  the  dimensions 
identified are not generalisable beyond individuals with these specific mental disorders.  
 
The  studies  examining  dimensions  of  psychopathology  with  relevance  to  a  broader 
range of individuals has used common forms of psychopathology in large, population-
based, non-clinical samples (Krueger 1999; Vollebergh et al. 2001; Slade & Watson 
2006;  Slade  2007).  These  studies  have  tended  to  focus  on  affective,  neurotic, 
interpersonal and substance misuse psychopathology. This is because the non-clinical 
nature of the samples used in these studies, means that psychotic psychopathology does 
not occur at a high enough frequency for inclusion in the factor analyses. Once again 
these  studies  examined  dimensions  of  psychopathology  using  categorical  models  of 
psychopathology as an integral part of the research methodology. In each of the four 
studies,  the  psychopathology  experienced  by  participants  was  classified  based  on 
criteria within ICD-10 (Slade & Watson 2006; Slade 2007), DSM-III-R (Krueger 1999; 
Vollebergh et al. 2001) and DSM-IV (Slade & Watson 2006) categorical diagnostic 
classification systems. Multivariate statistical methods were then used to examine how 
the  categorical  diagnoses  correlate.  The  findings  seem  relatively  consistent  across 
studies,  with  dimensions  of  psychopathology  mapping  onto  two  higher  order 
dimensions-  labeled  internalizing  and  externalizing  (Slade  &  Watson  2006;  Slade 
2007). This consistent description of two higher order, internalizing and externalizing, 
dimensions of psychopathology is proposed as a way of conceptualising the high levels 
of  comorbidity  (i.e.  the  poor  discriminant  validity  described  in  section  1.4.2.1)  of 
categorical diagnostic classification systems (Krueger & Markon 2006; Slade 2007). 
However,  given  that  the  categorical  diagnostic  classification  systems  were  used  to 
diagnose  participants’  mental  disorders  it  does  not  appear  that  these  studies  are 
identifying the underlying dimensional structure of psychopathology. 
 
Internalising  and  externalizing  dimensions  of  psychopathology  were  originally 
described from studies involving children and adolescents as participants. In contrast to 
adult studies, the methods used did not use categorical models of psychopathology.    30 
These  studies  used  factor  analysis,  and  other  multivariate  methods,  to  examine  the 
structure  underlying  psychopathology  assessed  with  a  instruments  that  included 
individual  items  of  psychopathology.  For  example,  the  Child  and  Adolescent 
Psychopathology Scale (CAPS; Lahey et al. 2004) includes all non-psychosis DSM-IV 
and  ICD-10  items  of  psychopathology  relevant  to  mental  disorders  experienced  by 
children and adolescents. Principal components analysis was used to examine 1, 382 
informant ratings of psychopathology experienced by a representative sample of 4-17 
year olds in Georgia, U.S.A. Six stable dimensions of psychopathology were identified 
labeled  as  hyperactivity-impulsivity,  depression,  inattention,  conduct  disorder, 
separation  anxiety/  fears  and  social  anxiety  (Lahey  et  al.  2004).  The  significant 
correlations between the six dimensions agreed with earlier conceptions of two higher–
order,  internalizing  (depression,  separation  anxiety/  fears  and  social  anxiety)  and 
externalising (hyperactivity-impulsivity, inattention, conduct disorder) dimensions of 
psychopathology (Achenbach 1966; Achenbach & Edelbrock 1978; Cantwell 1996). 
These  studies  included  children  and  adolescents  who  did  not  have  intellectual 
disabilities.  Therefore,  the  findings  may  not  be  generalisable  to  psychopathology 
experienced by individuals with intellectual disabilities. However, the results highlight 
the  value  of  using  factor  analysis  to  identify  dimensions  underlying  items  of 
psychopathology, rather than the methods in adult studies that used categorical models 
of psychopathology (Krueger 1999; Vollebergh et al. 2001; Slade &  Watson 2006; 
Slade  2007).  An  important  aspect  of  the  conceptualization  of  internalizing  and 
externalizing dimensions of psychopathology is these have consistently been shown to 
apply in studies that have included participants from early childhood (Achenbach et al. 
1987; van den Oord et al. 1995) through adolescence (Leung & Wong 1998; Seiffge-
Krenke  &  Kollmar  1998).  This  is  potentially  of  interest  to  the  field  of  intellectual 
disabilities where there is a need to study psychopathology in individuals with widely 
varying developmental levels.   
 
1.5.2 Comparing dimensional and categorical models of psychopathology 
As well as research to identify the structure of dimensional models of psychopathology, 
studies have begun to examine the potential relevance of the models. Since they are less 
well  established  than  categorical  diagnostic  classification  systems,  less  research  has   31 
looked  specifically  at  the  advantages  and  disadvantages  of  dimensional  models  of 
psychopathology. Rather, there has been a focus on examining whether dimensional 
models are of value in relation to questions over the validity of classification systems 
using a categorical model of psychopathology. As discussed above, the research on 
adult  psychopathology  has  focused  on  a  narrower  range  of  psychopathology,  than 
studies  including  children  and  adolescents  as  participants.  However,  these  serve  to 
illustrate potential uses of dimensional models of psychopathology. 
 
1.5.2.1 Models of psychopathology and the severity of mental disorders 
Two cross-sectional studies examining the association of a multi-dimensional model of 
psychopathology and the severity of mental disorders were identified. 
 
A  study  of  706  participants  recruited  to  a  randomized  controlled  trial  of  case 
management in individuals with psychosis, compared the associations of dimensional 
and categorical models of psychopathology with measures of the severity of mental 
disorders (van Os et al. 1999). To identify the dimensional model, principal component 
analysis  (PCA)  was  used  to  identify  dimensions  of  psychopathology  from  the 
Operational Criteria Checklist for Psychotic Illness (OCCPI; McGuffin et al. 1991). 
The  categorical  diagnoses  from  ICD-10  and  DSM-III-R  were  generated  using  the 
Operational Criteria for Psychotic Illness (OPCRIT; McGuffin et al. 1991). Clinical 
measures,  including  measures  of  the  severity  of  mental  disorders  were  used  in  the 
analysis:  quality  of  life  (Lancashire  Quality  of  Life  Profile,  Oliver  et  al.  1997), 
satisfaction  with  services,  movement  disorders  (Abmormal  Involuntary  Movement 
Scale, AIMS; Guy et al. 1986), social disability (Disability Assessment Schedule, DAS; 
Jablensky et al. 1980), unmet and met needs (Camberwell Assessment of Need, CAN; 
Phelan et al. 1995), living independently, occupational status, suicidality, misuse of 
drugs  and  alcohol;  neuropsychological  functioning  [National  Adult  reading  Test, 
NART; (Nelson 1982); Trail Making Test b, TRAILS B; (Reitan 1958)], course of 
illness WHO Life Chart (World Health Organisation 1992), service use in the previous 
two years (days in hospital, psychotherapy use), and psychotropic medication use in the 
previous  two  years  (antidepressants,  anitpsychotics  &  lithium).  The  measures  of 
severity  were  used  as  the  dependant  variables  in  regression  analyses  including  the   32 
measures of psychopathology as the independent variables, and adjusting for gender, 
age, occupational status, and ethnicity.  Four dimensions were identified and labeled 
depressive,  manic,  negative  and  positive  psychopathology.  The  multi-dimensional 
model of psychopathology was more strongly associated with 15 of 18 measures of 
severity; categorical diagnosis was more strongly associated with employment status, 
use  of  antipsychotics  and  use  of  lithium.  When  both  models  were  included  in  an 
analysis,  the  dimensional  and  categorical  models  were  both  associated  with  social 
disability, employment status, suicidality and use of antidepressants and lithium; the 
dimensional model was significantly associated with 12 of the remaining 13 measures 
of severity and neither model was associated with antipsychotic use. Therefore, it was 
concluded  that  the  multi-dimensional  model  of  psychopathology  was  more  strongly 
associated with measures of severity than the categorical model (van Os et al. 1999a). 
 
The second study looked only at depressive psychopathology (Prisciandaro & Roberts 
2009), collected using the Composite International Diagnostic Interview (CIDI; Robins 
et al. 1988) from 8098 participants in the National Comorbidity Study (NCS; Kessler et 
al.  1994).  Since  the  psychopathology  data  was  binary,  weighted  least  squares 
estimation was used in the exploratory factor analysis. The categorical diagnoses from 
the  DSM-III-R  were  generated  using  the  NCS  diagnostic  algorithm  (Kessler  et  al. 
1994). The variables representing the severity of mental disorders were: 
·  Interference with activities- interference with life and activities; work impairment & 
social impairment 
·  Treatment  seeking-  contact  with  mental  health  professionals;  psychiatric 
hospitalization and use of psychotropic medications. 
 
These measures of severity were used as the dependant variables in regression analyses 
with the measures of psychopathology as independent variables, unadjusted for socio-
clinical variables. Two dimensions were identified and labelled cognitive-affective and 
somatic.  The  dimensional  model  of  depressive  psychopathology,  and  categorical 
diagnoses were both significantly associated with both measures of severity. However, 
when the analyses including both dimensional measures and categorical diagnoses were 
carried out, categorical diagnoses were not independently associated with the measures   33 
of severity. The authors concluded that the dimensional model of depression was more 
strongly associated with the measures of severity (Prisciandaro & Roberts 2009). 
 
Therefore, from these two studies it appears that dimensional models are more strongly 
associated than categorical models of psychopathology to measures of the severity of 
mental disorders. 
 
1.5.2.2  Models  of  psychopathology  and  the  longitudinal  outcome  of  mental 
disorders 
Three  studies  comparing  the  associations  of  dimensional  and  categorical  models  of 
psychopathology with measures of the outcome of mental disorders were identified. 
 
 A cohort of 337  admissions, with at least one psychotic symptom, to two  London 
hospitals were assessed using the Present State Examination (PSE; (Wing et al. 1974) 
and the data used to complete the Operational Criteria Checklist for Psychotic Illness 
(OCCPI; McGuffin et al. 1991). ICD-10 and DSM-III-R categorical diagnoses were 
generated with the OPCRIT computer program (McGuffin et al. 1991). PCA was used 
to identify dimensions of psychopathology from the baseline OCCPI and factor scores 
calculated. Follow-up interviews after four years were carried out with 166 (49%) of 
participants and nine outcome measures completed- the DAS (Jablensky et al. 1980), 
Lager negative symptom scale (Lager et al. 1985; van Os et al. 1996), usual negative 
symptoms,  usual  symptom  severity,  course  of  illness,  time  in  hospital,  time  living 
independently, unemployment and employment status at follow-up. The nine outcome 
measures  were  used  as  the  dependent  variables  in  regression  anlyses,  adjusted  for 
gender, catchment area and duration of illness. Seven factors were identified from the 
PCA  and  labeled  inappropriate-catatonia,  delusions-hallucinations,  mania,  insidious-
blunting, depressions, lack of insight and paranoid delusions. The multi-dimensional 
model was found to be significantly associated with all nine measures of outcome. The 
categorical diagnoses were only associated with the score on the DAS (Jablensky et al. 
1980)  and  employment  status  at  follow  up.  When  the  dimensional  model  and 
categorical  diagnoses  were  both  included  in  a  regression  analyses,  the  dimensional 
model was a consistently better predictor of outcome and course of illness. One aspect   34 
of the study that may have impacted on the results is a sampling bias towards including 
individuals with more severe disorders. The initial sample included inpatients and the 
loss to follow-up of 51% of the initial participants may have biased the sample further. 
Individuals  with  more  severe  disorders  are  more  likely  to  remain  in  contact  with 
services, and are therefore more readily identified at the time of follow up. As well as 
affecting the generalisability of the findings, inclusion of more severe disorders may 
have  impacted  differently  on  the  multi-dimensional  and  categorical  models  of 
psychopathology (van Os et al. 1996). 
 
In  a  study  of  a  sub-sample  of  the  694  participants  in  the  Maudsley  Family  Study, 
psychopathology  on  the  OPCRIT  from  191  individuals  with  psychotic  or  mood 
disorders was used in PCA to identify a multi-dimensional model of psychopathology 
(Dikeos et al. 2006). OPCRIT categorical diagnoses from DSM-IV were included in 
the  analyses.  The  associations  of  the  dimensional  and  categorical  models  were 
compared  to  measures  of  longitudinal  outcome  -  employment,  social  adjustment, 
personality  disorder,  potential  stressor  triggering  episode,  age  of  onset,  impairment 
during episodes, quality of remisson between episodes, deterioration from pre-morbid 
functioning, response to anti-psychotics and overall course of illness. Five dimensions 
of psychopathology were identified- described as mania, reality distortion, depression, 
disorganization and negative symptomatology- and regression factor scores calculated 
for  each  dimensions.  In  regression  analyses,  adjusted  for  gender,  age,  occupational 
status, and ethnicity, the categorical diagnoses were associated with pre-morbid social 
adjustment,  mode  of  onset,  no  remission  between  episodes,  no  response  to  anti-
psychotics  and  bad  overall  course  of  illness.  The  multi-dimensional  model  of 
psychopathology was associated with these same parameters and stressors. When both 
models were included in the analyses, the dimensional and categorical models were 
both retained as independently associated with the measures of outcome. 
 
The final study identified, used a different methodology, examining the correlations 
between  change  in  dimensional  measures  of  of  psychopathology  and  outcome. 
Psychopathology  data  was  used  from  708  participants  recruited  to  a  randomized 
controlled trial of case management in individuals with psychosis and followed up for   35 
two  years  (van  Os  et  al.  1999b).  PCA  was  used  to  identify  dimensions  of 
psychopathology from the OCCPI data (McGuffin et al. 1991).   Categorical diagnoses 
were  also  generated  OPCRIT  (McGuffin  et  al.  1991).    Using  twenty  measures  of 
outcome, change over time in the multi-dimensional model of psychopathology was 
found  to  be  strongly  associated  with  the  measures  of  outcome,  than  categorical 
diagnoses.  
 
The  findings  comparing  the  associations  of  dimensional  and  categorical  models  of 
psychosis  are  inconsistent;  one  study  reporting  that  the  dimensional  models  of 
psychopathology were more strongly associated with measures of longitudinal outcome 
of mental disorders (van Os et al. 1996; van Os et al. 1999b) and one concluded that 
they were similar and complementary (Dikeos et al. 2006). 
 
1.5.3 Summary of research on dimensional models of psychopathology 
There is evidence that dimensional models are a useful alternative to categorical models 
of  psychopathology  incorporated  in  current  categorical  diagnostic  classification 
systems. The evidence suggests that: 
·  identified dimensions of psychopathology may be correlated to form higher order 
dimensions of psychopathology 
·  dimensional  models  appear  more  strongly  associated than  categorical  models  of 
psychopathology with the severity of mental disorders  
·  since the findings on predictive validity to date are inconsistent, further work is 
required  to  examine  the  associations  of  dimensional  and  categorical  models  of 
psychopathology with longitudinal outcome. 
 
1.6  Dimensional  models  of  psychopathology  and  intellectual 
disabilities 
This section examines previous studies that have used multivariate statistical methods 
to  identify  dimensional  models  of  psychopathology  experienced  by  adults  with 
intellectual  disabilities.  As  discussed  above,  general  research  has  compared  the 
associations of dimensional and categorical models with the severity and outcome of   36 
mental disorders. Thus, research is reviewed that could inform studies to examine the 
utility of dimensional models of psychopathology in adults with intellectual disabilities. 
 
1.6.1 Studies using exploratory factor analysis to identify dimensional models of 
psychopathology in intellectual disabilities 
There is less published evidence on dimensional models of psychopathology in adults 
with  intellectual  disabilities.  Work  to  date  has  mainly  been  by  research  groups 
examining the psychometric properties of rating scales, or interview schedules, for the 
identification  and  measurement  of  psychopathology  in  individuals  with  intellectual 
disabilities.  
 
Table 1.2 outlines the results from studies that have used empirical methods to examine 
dimensions of psychopathology in adults with intellectual disabilities. Over and above 
the small number of studies in table 1.2, there are some limitations in the evidence 
which makes interpretation of the results from these studies difficult.  
 
Several factors relating to the samples used in the studies cited in table 1.2 are relevant. 
General guidelines on the sample size required for factor analysis is that a ratio of cases 
to variables should be at least 5:1 (Costello & Osborne 2005), with a total sample size 
of 300 (Tabachnik & Fidell 2001). The only studies meeting these criteria are one of 
the five using the Psychopathology Instrument for Mentally Retarded Adults (PIMRA; 
Balboni et al. 2000), the three studies using the Psychiatric Assessment Schedule for 
Adults with Developmental Disabilities Checklist (PAS-ADD checklist; Moss et al. 
1998; Sturmey et al. 2005; Hatton & Taylor 2008) and the studies using the Diagnostic 
Assessment of the Severely Handicapped, version II (DASH-II; Sturmey et al. 2004) 
and the Brief Symptom Inventory (BSI; Kellett et al. 2004). Although these guidelines 
are not absolute, they have been demonstrated to affect the power and reliability of the 
results of factor analyses (Costello & Osborne 2005).    37 
Table 1.2. Studies of the dimensions of psychopathology in adults with intellectual disabilities 
 
 
Authors  Sample  Measure of 
psychopathology 
Methods  Number of factors 
retained  
(% variance) 
Dimension names  
(eigenvalue, % variance, 
number of items) 
Matson et 
al. 1984 
N= 110 clinic 
sample, 
borderline= 
8.1%, mild= 
47.3%, 
moderate= 
40.9%, severe= 
3.7%; Mean 
age= 45.9 (18-
71, SD N/A
1) 
PIMRA- 56 
psychopathology 
items derived from 
DSM-III criteria for 
schizophrenia, 
affective, 
psychosexual, 
adjustment, anxiety, 
somatoform and 
personality 
disorders. Self-
report and informant 
versions available. 
PCA
2, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35. Only factors 
with at least five 
items are reported. 
Self- report version 2 
(N/A)  
Informant version 3 
(N/A) 
Self-report: Anxiety (N/A, N/A, 
8 items), Social adjustment (N/A, 
N/A, 5 items); Informant: 
Affective (N/A, N/A, 14 items), 
Somatoform (N/A, N/A, 5 items), 
Psychosis (N/A, N/A, 5 items)  
Linaker 
1991 
N= 169 
inpatients; mild= 
3.6%, moderate= 
20.1%, severe= 
50.9%, 
profound= 
15.2%, 
unknown= 9.7%. 
Mean age= 40.4 
(16-65, SD N/A) 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35.  
9 (49.3%)  Somatoform (5.06, 10.3%, 8), 
gender identity (3.68, 7.5%, 3), 
hostility (3.11 6.3%, 4), 
psychosis (2.66, 5.4%, 5), self-
consciousness (2.29, 4.7%, 4), 
adjustment problem (2.25, 4.6%, 
4), anxiety (1.88, 3.8%, 3), 
autistic traits (1.69, 3.4%’ 3), 
avoidant/ anxious (1.53 3.1%, 3) 
Balboni et 
al. 2000 
N=652 mixed 
sample- 
community (411) 
institution (241); 
mild= 34%, 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
7 (34.5%)  Anxiety (6.03, 10.8%, 11), 
Adjustment problem (3.28, 5.9%, 
7), Somatoform (2.74, 4.9%, 9), 
Schizophrenic isolation (2.01, 
3.6%, 5), Schizophrenic   38 
moderate= 39%, 
severe/profound= 
27%. Mean age= 
33.6 (17-74, SD 
N/A) 
0.35  bizarreness (1.96, 3.5%, 5), 
Soundness (1.75, 3.1%, 6), 
gender identity (1.50, 2.7%, 5) 
Gustafsson 
& 
Sonnander 
2005 
N= 101, mixed 
sample- 
community (30), 
institution (71); 
mild= 25.7%, 
moderate= 
32.9%, 
severe/profound= 
41.4%. Mean 
age= 50.2 (24-
94, SD= 14.3) 
PIMRA- informant 
version 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, ≥ 
3 items/ factor 
with loading ≥ 0.4 
5 (51%)  Somatoform (4.29, 16.5%, 5), 
Psychosis (3.17, 12.2%, 7), 
Psychosexual (2.37, 9.1%, 4), 
Adjustment problem (1.85, 7.1%, 
5), Anxiety (1.56, 6.0%, 5) 
Watson et 
al. 1988 
N= 160 mixed 
sample living in 
community (95) 
& institutuional 
(65) settings; 
borderline= 
19.4%, mild= 
47.5%, 
moderate= 
33.1%. 
Mean age= 29.4 
(18-67, SD= 
11.4) 
PIMRA  Self & informant 
version; PCA, 
varimax rotation, 
factor extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35 
4 (N/A)  Self- report: Anxiety ; Social 
adjustment; Identity/ reality 
concern; Unlabelled 
Informant: Affective concerns; 
Social adjustment; Somatoform; 
Unlabelled (Problem behaviours) 
Moss et al. 
1998 
N= 201 
community 
sample; Mean 
age= 44 (18-83, 
SD N/A)  
PAS-ADD 
checklist- 29 item 
screening 
instrument, 
completed by 
PCA, quartimax 
rotation, item 
loading ≥ 0.5 
8 (N/A)  Depression (N/A, N/A, 6), 
Restlessness (N/A, N/A, 4), 
Phobic anxiety (N/A, N/A, 5), 
Psychosis (N/A, N/A, 3), 
Hypomania (N/A, N/A, 3),   39 
informant to identify 
possible mental ill-
health 
Autistic spectrum (N/A, N/A, 3), 
Depression (N/A, N/A, 2), Non-
specific (N/A, N/A, 2) 
Sturmey et 
al. 2005 
N=226 clinic 
attendees; mild= 
68%, moderate= 
20%, 
severe/profound= 
12%. Mean age= 
34 (Range N/A, 
SD= 13.5) 
PAS-ADD checklist  PCA, quartimax 
rotation, factor 
extraction 
eigenvalue ≥ 1, 
item loading ≥ 0.5 
9 initially but only 3 
factors interpretable 
(34.6%) 
Mood (5.33, 19.7%, 8); Sleep 
(2.20, 8.1%, 3); Psychosis (1.83, 
6.3%, 3) 
Hatton & 
Taylor 
2008 
N= 1, 115 
administrative 
sample (98% 
response rate); 
Mean age= 44.0 
(17-92, SD= 
15.19) 
PAS-ADD checklist  PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
rotated factors 
account > 5% 
variance, 
sufficient factors 
included to 
account > 60% 
variance  
7 (61.25%)  Depression 1 (4.19, 15.50%, 7); 
Sleep problems (2.46, 9.10, 3); 
Organic problem (2.35, 8.70%, 
4); Panic (2.11, 7.80%, 3); 
Psychosis (2.09, 7.72%, 4); 
Hypomania (1.72, 6.37%, 3); 
Depression 2 (1.64, 6.06%, 2) 
 
 
Hove & 
Havik 
2008 
N= 593 
administrative 
sample (66% 
response rate); 
mild= 23%, 
moderate= 44%, 
severe= 19%, 
profound= 14%. 
Mean age= 42 
(18-97, SD= 
14.5) 
P-AID
3- 18 
checklists of 
psychpathology and 
problem behaviours, 
derived from DC-
LD - 260 items rated 
by informant, scores 
psychpathology and 
problem behaviours 
PCA of checklist 
sum scores, 
varimax rotation, 
factor extraction 
eigenvalue ≥ 1, 
item loading ≥ 0.3 
4 (54.9%)  Problem behaviour I -includes 
OCD (4.56, 17.5%, 7), Anxiety 
(2.21, 14.5%, 5), Severe 
psychopathology- depression, 
dementia, mania, psychosis (1.91, 
14.5%, 4), Wandering/ sexual 
problem behaviours (1.21, 8.2%, 
2) 
Sturmey et  Three samples:  RSMB
4- 38 item  PCA, varimax  Sample 1= 1 factor  Sample 1: General factor (6.55,   40 
al. 1996  Sample 1 n= 180 
community 
sample, Sample 
2 n= 102 college 
sample, Sample 
3 n= 71 
institutional 
sample. Age and 
ability level N/A 
screening instrument 
for identification of 
emotional and 
behaviour problems 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
(25.2%); Sample 2 & 
3= 3 factors (Sample 
2 44.2%; Sample 3 
41.5%) 
25.2%, 26); Sample 2: 
Extrapersonal maladaptive 
behaviour (6.24, 24%, 9), 
Psychosis (2.94, 11.3%, 8), 
Intrapersonal maladaptive 
behaviour (2.31, 8.9%, 6); 
Sample 3: Extrapersonal 
maladaptive behaviour (5.62, 
21.6%, 11), Psychosis (2.91, 
11.2%, 10), Intrapersonal 
maladaptive behaviour (2.26, 
8.7%, 8) 
Sturmey et 
al. 2003 
N= 163 clinic 
sample; 
borderline= 3%, 
mild= 22%, 
moderate= 28%, 
severe= 38%, 
profound= 9%. 
Mean age= 54 
(30-84, SD= 
10.7) 
MOSES
5- 40 items 
of psychopathology 
& behaviour, 
interviewer rated 
based on informant 
report and 
observation  
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
3 (42.2%)  Self- care (8.0, 20.6%, 6), 
Irritability/ depression (5.6, 
14.6%, 11), Withdrawal (2.7, 
7.0%, 8) 
Sturmey et 
al. 2004 
N= 451 
institutional 
sample; severe= 
11%, profound= 
89%. Mean age= 
48 years (Range 
N/A, SD=15) 
DASH-II- 84 items 
of psychopathology 
and behaviour 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.5, 
item loading ≥ 
0.35 
5 (26%)  Emotional lability/ antisocial 
(9.1, 11.1%, 9), Langauge 
disorder (3.9, 4.8%, 4), 
Dementia/ anxiety (2.9, 3.6%, 7), 
Sleep disorder (2.8, 3.4%, 3), 
Psychosis (2.5, 3.1%, 3) 
Tsiouris et 
al. 2003 
N=92; mild= 
24%, moderate= 
30.4%, severe= 
26%, profound= 
10.9%, 
CBCPID
6- 30 items, 
psychopathology 
and problem 
behaviour over past 
two weeks 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 0.3 
1 (9.4%)  Depression (6, 9.4%, 5)   41 
unknown= 8.7%. 
Mean age= 42.6 
(Range N/A, 
SD= 17.4) 
Kellett et 
al. 2004 
N=335, sample 
of clinic 
attendees with 
mild intellectual 
disabilities. 
Mean age= 33.0 
(16-64, SD= 
10.65) 
BSI- 53 item self- 
report inventory of 
psychopathology, 
rated on five point 
Likert scale 
PCA, varimax 
rotation, factor 
extraction  
eigenvalue> 1.0, 
item loading ≥ 
0.35 
8 (50.26%)  Depression (16.19, 30.56%, 13), 
Anxiety (2.32, 4.39%, 11), 
Somatisation (1.91, 3.61%, 10), 
Cognitive impairment (1.73, 
3.27%, 8), Suicidal ideation 
(1.62, 3.06%, 6), Paranoia (1.44, 
2.72%, 5), Hostility (1.39, 2.63%, 
7), Anger (1.37, 2.59%, 4) 
 
  
1 N/A not available from the details provided in the paper 
2 PCA Principal components analysis 
3 P-AID Psychopathology Checklists for Adults with Intellectual Disability 
4 RSMB Reiss Screen For Maladaptive Behaviours 
5 MOSES  Multi-dimensional Observational Scale for Elderly Subjects 
6 CBCPID Clinical Behaviour Checklist for People with Intellectual Disabilities
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There appear to be some common dimensions identified across studies. Table 1.3 lists 
those  dimensions  identified  in  at  least  two  studies  that  used  different  instruments. 
Additional details of the instruments, dimensional labels and the relevant items of 
psychopathology extracted in the dimension are also provided.  
 
Table 1.3 Dimensions of psychopathology identified across studies in adults with 
intellectual disabilities 
 
 
General 
description of 
common factor 
Instrument   Dimension name- eigenvalue, % 
variance, number of items (Authors)  
 
Anxiety- N/A, N/A, 8  
(Matson et al. 1984) 
PIMRA-self report 
Anxiety- N/A (Watson et al. 1998) 
Anxiety- 1.88, 3.8%, 3 (Linaker 1991) 
Affective concerns- N/A  
(Watson et al. 1998)  
Anxiety- 6.03, 10.8%, 11  
(Balboni et al. 2000) 
PIMRA- informant 
Anxiety- 1.56, 6.0%, 5  
(Gustafsson & Sonnander 2005) 
P-AID  Anxiety- 2.21, 14.5%, 5  
(Hove & Havik 2008) 
DASH-II  Dementia/ anxiety- 2.9, 3.6%, 7  
(Sturmey et al. 2004) 
Anxiety 
BSI  Anxiety- 2.32, 4.39%, 11  
(Kellet et al. 2004) 
PIMRA- informant  Affective- N/A, N/A, 14   
(Matson et al. 1984) 
PAS-ADD 
checklist 
Depression 1- N/A, N/A, 6; Depression 
2- N/A, N/A/ 2 (Moss et al. 1998) 
PAS-ADD 
checklist 
Mood- 5.33, 19.7%, 8  
(Sturmey et al. 2005) 
PAS-ADD 
checklist 
Depression 1- 4.19, 15.50%, 7; 
Depression 2- 1.64, 6.06%, 2  
(Hatton & Taylor 2008) 
MOSES  Irritability/ depression- 5.6, 14.6%, 11 
(Sturmey et al. 2003) 
Depression 
CBCPID  Depression- 6, 9.4%, 5  
(Tsiouris et al. 2003) 
  BSI  Depression- 16.19, 30.56%, 13  
(Kellet et al. 2004)   43 
PAS-ADD 
checklist 
Hypomania- N/A, N/A, 3  
(Moss et al. 1998) 
Mania/ hypomania  
PAS-ADD 
checklist 
Hypomania- 1.72, 6.37%, 3  
(Hatton & Taylor 2008) 
Psychosis- N/A, N/A, 5   
(Matson et al. 1984) 
Psychosis- 2.09, 7.72%, 4 (Linaker 1991) 
Schizophrenic isolation- 2.01, 3.6%, 5 
(Balboni et al. 2000) 
Schizophrenic bizarreness- 1.96, 3.5%, 5 
(Balboni et al. 2000) 
PIMRA- informant 
Psychosis- 3.17, 12.2%, 7   
(Gustafsson & Sonnander 2005) 
PAS-ADD 
checklist 
Psychosis- N/A, N/A, 3 (Moss et al. 
1998) 
PAS-ADD 
checklist 
Psychosis- 1.83, 6.3%, 3  
(Sturmey et al. 2005) 
PAS-ADD 
checklist 
Psychosis- 2.09, 7.72%, 4   
(Hatton & Taylor 2008) 
RSMB  Psychosis- 2.94, 11.3%, 8  
(Sturmey et al. 1996) 
Psychosis  
DASH-II  Psychosis- 2.5, 3.1%, 3   
(Sturmey et al. 2004) 
P-AID  Problem behaviour I (includes OCD)- 
4.56, 17.5%, 7  
Problem behaviour II- 1.21, 8.2%, 2 
(Hove & Havik 2008) 
RSMB  Extrapersonal maladaptive behaviour - 
6.24, 24%, 9 
Intrapersonal maladaptive behaviour- 
2.31, 8.9%, 6  
(Sturmey et al. 1996) 
DASH-II  Emotional lability/ antisocial- 9.1, 
11.1%, 9 (Sturmey et al. 2004) 
Problem behaviours  
PIMRA- informant  Unlabelled (problem behaviours)- N/A 
(Watson et al. 1998) 
DASH-II   Sleep- 2.20, 8.1%, 3   
(Sturmey et al. 2005) 
Sleep problems- 2.46, 9.10, 3   
(Hatton & Taylor 2008) 
Sleep problems 
PAS-ADD 
checklist 
Sleep disorder- 2.8, 3.4%, 3   
(Sturmey et al. 2004) 
Somatoform- N/A, N/A, 5  
(Matson et al. 1984) 
Somatoform  PIMRA- informant 
 
  Somatoform difficulty-N/A  
(Watson et al. 1988)    44 
Somatoform- 5.06, 10.3%, 8  
(Linaker 1991) 
Somatoform- 2.74, 4.9%, 9 
(Balboni et al. 2000) 
Somatoform- 4.29, 16.5%, 5  
(Gustafsson & Sonnander 2005)  
BSI  Somatisation- 1.91, 3.61%, 10   
(Kellet et al. 2004) 
PIMRA- informant  Autistic traits- 1.69, 3.4%, 3   
(Linaker 1991) 
Autism 
PAS-ADD 
checklist 
Autistic spectrum - N/A, N/A, 3  
(Moss et al. 1998) 
PIMRA- informant  Avoidant/ anxious- 1.53 3.1%, 3  
(Linaker 1991) 
Phobic anxiety- N/A, N/A, 5  
(Moss et al.1998) 
Phobic anxiety/ 
avoidance 
PAS-ADD 
checklist 
Panic- 2.11, 7.80%, 3  
(Hatton & Taylor 2008) 
 
 
From table 1.3, it appears that the dimensions of anxiety, depression, psychosis and 
problem behaviours are extracted more  consistently across studies, using  a  greater 
range  of  assessment  instruments  of  psychopathology.  This  suggests  that  these 
dimensions may have greater validity, compared to the sleep problems, somatoform, 
autism and phobic anxiety/avoidance dimensions- each of which are only  reported 
across two instruments. However, part of this effect may be explained by the format 
and content of the specific instruments used in the different studies. For example, the 
PIMRA only has one question on sleep problems and therefore it is unlikely that a 
sleep problems dimension would ever be identified using the PIMRA.  
 
A further point of interest is the variation across studies that use the same instrument. 
Throughout table 1.3, it is evident that even where an instrument identifies a similar 
dimension across studies, the individual items that load onto the dimension can vary 
considerably. For example, the anxiety dimension of psychopathology is consistently 
identified across the studies that use the PIMRA. However, despite some degree of 
overlap, the individual items that loaded onto the dimension can vary between studies. 
Examining the three studies that have examined the dimensional structure of the PAS-  45 
ADD checklist, there appears to be greater consistency in the items that load on to the 
relevant dimensions.  
 
The significant variation between samples is relevant. The inclusion of only inpatients 
(Linaker 1991), or participants with mild intellectual disabilities (Kellett et al. 2004) 
most clearly affects the generalisability of results. The samples in other studies vary 
considerably in sampling strategy, the distribution of level of intellectual disabilities 
and age. This variation in samples will interact with the wide variation in content, and 
approach of the instruments used to assess psychopathology across the studies in table 
1.2. For example, the use of a self report instrument with participants who have mild 
intellectual disabilities (Kellet et al. 2004) is likely to produce very different results to 
a study using a sample of adults with severe or profound intellectual disabilities, in 
which paid carers provide proxy reports of psychopathology (Sturmey et al. 2004). 
Assessing psychopathology across a range of developmental samples is a challenge in 
any  study.  Potentially,  at  least,  this  is  a  reason  for  further  research  to  examine 
dimensional models of psychopathology in persons with intellectual disabilities. 
 
With regard to the assessments of psychopathology, it is also worth noting that the 
only instruments assessing psychopathology for which there is more than one relevant 
published study are the PIMRA and PAS-ADD checklist. The PIMRA and the PAS-
ADD  checklist  are  screening  instruments,  and  the  PAS-ADD  checklist  includes  a 
restricted  range  of  psychopathology  (29  items  of  psychopathology).  Therefore,  no 
comprehensive assessment of psychopathology has more than one exploratory factor 
analysis reported in the literature. 
 
A final point of note is that all the studies in table 1.2 use PCA as the method of factor 
analysis.  However,  PCA  was  designed  for  use  with  continuous  variables  and  the 
variables  in  all  the  psychopathology  instruments  of  assessment  in  table  1.2  are 
categorical- either binary or ordinal. The use of PCA in factor analyses of categorical 
variables has been shown to identify unstable and unreliable models (Linting et al. 
2007). Therefore, specific methods of factor analysis using categorical variables have 
been developed (Wood et al. 2002; Meulman & Heiser 2004). Since these methods   46 
were  not  used  in  the  studies  in  table  1.2,  the  models  are  likely  to  have  limited 
reliability and stability. 
 
Overall, relatively few studies have used factor analysis to examine the dimensions of 
psychopathology in adults with intellectual disabilities and there are methodological 
limitations and variation across studies.  
 
1.7 The associations of psychopathology with socio-clinical variables  
The  studies  in  section  1.5.2  that  compared  the  associations  of  dimensional  and 
categorical  models  of  psychopathology  with  the  severity  and  outcome  of  mental 
disorders controlled for a small number of potential confounders, such as gender, age, 
occupational  status  and  ethnicity  (van  Os  et  al.  1999a;  van  Os  et  al.  1999b).  
Therefore,  the  evidence  on  the  association  of  socio-clinical  variables  with 
psychopathology in adults with intellectual disabilities was reviewed.  
 
Population based studies of adults with intellectual studies are less likely to report 
findings significantly affected by sampling bias. Therefore, table 1.4 summarises the 
findings from studies that used population based samples to examine the independent 
associations of socio-clinical variables with psychopathology. The majority of studies 
in table 1.4 identified used categorical diagnostic classification systems, although two 
studies used continuous measures, not derived empirically using multivariate statistics 
(Taylor et al. 2004; Hove & Havik 2010). 
 
 
Several socio-clinical variables were associated with psychopathology across studies 
in  table  1.4-  gender,  age,  living  circumstances,  level  of  intellectual  disabilities, 
epilepsy and Down syndrome.  These are examined separately in more detail below, 
followed  by  a  discussion  of  the  other  socio-clinical  variables  shown  to  be  less 
consistently associated with psychopathology.    47 
Table 1.4: Population based studies examining the associations of psychopathology and socio-clinical variables  
 
Authors  Sample (percentage 
of identified 
population) 
Measure of 
psychopathology 
Socio-clinical variables included in 
analysis 
Socio-clinical variables 
significantly associated with 
psychopathology  
Cooper & 
Bailey (2001) 
A random sample of 
207 adults from the 
Leicestershire 
Learning Disabilities 
Register. 109 men 
and 98 women. Mild 
ID
114.2%, moderate 
22.2%. severe 40.3% 
and 23.3% profound. 
Psychiatric 
disorder diagnosed 
with the 
Diagnostic 
Criteria for 
Research- ICD-10. 
Level of intellectual disabilities-   Lower ability level associated 
with a greater risk of having a 
diagnosed psychiatric 
disorder. 
Taylor et al. 
(2004) 
1115 (98%) adults. 
664 men, 491 
women. Mean age= 
43.97 (SD±15.19 
years, range 17-92). 
PAS-ADD 
checklist 
subscales: 
·  affective/ 
neurotic 
·  psychosis 
·  organic 
age; gender, residence type  Female gender- affective/ 
neurotic 
Younger age- affective/ 
neurotic 
Living in hospital- psychosis 
Cooper et al. 
2007a; 
Cooper et al. 
2007b; 
Cooper et al. 
2007c; Jones 
et al. 2008 
1023 adults (562 
men, 461 women; 
mean age= 43.9 
±12.6 years: mild ID 
38.9%, moderate 
24.2%, severe 18.9%, 
profound ID18.0% 
2 Mental ill health 
(excluding 
specific phobias 
and autism 
spectrum 
disorders)  
3 Psychotic 
disorder 
4 Current DC-LD 
depressive episode 
5 DC-LD problem 
behaviours 
age; gender; marital status; level of 
ability; presence of visual impairment; 
presence of hearing impairment; 
presence 
of epilepsy; presence of severe physical 
disabilities (quadriplegia); presence of 
mobility impairment; presence of 
communication impairment; presence of 
incontinence 
of urine; presence of incontinence 
of bowels; type of living or support 
arrangement; whether previously a 
longstay 
hospital resident, area-based measure 
of deprivation for the area in which the 
2 Female gender, lower ability 
level, number of life events, 
number of GP appointments, 
severe physical disability/ 
quadriplegia, not having 
mobility problems, urinary 
incontinence, smoker, living 
with a paid carer (rather than 
living with a family carer) 
3 Visual impairment, ex long-
stay hospital resident, 
smoker, not having epilepsy 
4 Female gender, number of 
life events, number of GP 
appointments, not having a   48 
person 
lived; whether the person had any type 
of daytime occupation; number of 
consultations 
with the general practitioner or family 
physician within the preceding 12-month 
period; number of hospital admissions in 
the preceding 12-month period; number 
of 
life events in the preceding 12-month 
period; whether the person smoked 
hearing impairment, smoker 
5 Male gender, lower ability 
level, living in a congregate 
care setting, or with paid 
carer 
support (rather than living 
with a family carer), having 
attention deficit hyperactivity 
disorder (ADHD), urinary 
incontinence, visual 
impairment, not having Down 
syndrome, not having severe 
physical disability/ 
quadriplegia. 
Bailey 2007  Random sample of 
121 adults with 
moderate- profound 
ID. Men 62.0% and 
women 38.0%. 
(Mean age = 38.5 
years, SD= 1.30, 
range 20-77). 
Diagnosed with a 
mental disorder 
using DC-LD 
criteria 
Age; gender; developmental age in 
months; life event in last year; number of 
professionals, apart from GP involved in 
care; number of antipsychotic 
medications, number of physical 
illnesses; HoNOS
6 score; HoNOS-LD
7 
score. 
Higher HoNOS score and 
lower developmental age 
were associated with 
diagnosis of mental disorder. 
Hassiotis et 
al. 2008 
105 adults with 
borderline ID from 
the British National 
Survey of Psychiatry 
Morbidity (69 men, 
46 women) of 
specialist intellectual 
disability mental 
health services.  
Common mental 
disorders 
(agoraphobia, any 
phobia, depressive 
episode)
8 
 
age; gender; social class; marital status; 
ethnicity; education level; debts; income 
support 
1.Younger age 
2. Female gender 
3. Asian ethnicity 
4. Social class 
5. Debts 
6. Receiving income support   49 
Hove & Havik 
(2010) 
593 (65.8%)  adults. 
315 men, 278 
women; mean age 
41.8 (SD = 14.53, 
range 18–97). mild  
ID 21.6%, moderate 
41.0%, severe 18.0% 
and profound ID 
13.0% 
 
P-AID checklists 
for: 
·  dementia  
·  psychosis 
·  depression 
·  mania 
·  anxiety 
disorders 
·  problem 
behaviours 
·  overall mental 
ill-health
9 
age; gender; autism, genetic syndrome; 
neurological 
conditions; level of intellectual 
disabilities  
1. Older age- dementia 
2. Younger age- problem 
behaviour 
3. Autism- psychosis, 
anxiety, OCD
10, problem  
behaviour, overall mental ill-
health 
4. Genetic syndrome- 
dementia 
5. No neurological condition- 
anxiety 
6. Social care- dementia, 
psychosis, depression, mania, 
anxiety disorders, problem 
behaviours, overall mental ill-
health
 
7. More severe ID- anxiety, 
OCD, problem behaviours, 
overall mental ill-health 
 
1 ID  Intellectual disabilities 
2 Cooper et al. 2007a  
3 Cooper et al. 2007b 
4 Cooper et al. 2007c 
5 Jones et al. 2008 
6 HoNOS  Health of the Nation Outcome Scale (Wing et al. 1998) 
7 HoNOS-LD  Health of the Nation Outcome Scale- Learning Disabilities (Roy et al. 2002) 
8 Diagnosed with ICD-10 
9 Total score from sum of individual checklists 
10 OCD  Obsessional Compulsive Disorder   50 
1.7.1 Psychopathology and gender 
Female  gender  was  found  to  be  associated  with  an  increased  risk  of  having  a 
diagnosed mental disorder (Cooper et al. 2007a), affective/ neurotic psychopathology 
(Taylor  et  al.  2004;  Cooper  et  al.  2007c;  Hassiotis  et  al.  2008)  and  problem 
behaviours (Jones et al. 2008). Thus it appears that similar to findings from studies 
involving adults who do not have intellectual disabilities (Kessler et al. 1993; Bijl et 
al. 2002; Kessler et al. 2005), women with intellectual disabilities experience higher 
rates of affective/ neurotic psychopathology.  
 
Relevant  to  this  thesis,  an  argument  has  been  made  that  the  use  of  categorical 
diagnostic  classification  systems  may  contribute  to  bias  in  the  studies  that  find 
significant  gender  differences.  It  is  suggested  that  the  criteria  within  certain 
categorical  diagnoses  may  preferentially  represent  the  presentation  of 
psychopathology  for  either  women  or  men  (Hartung  &  Widiger  1998).  Indeed, 
whereas  higher  prevalence  rates  of  depressive  disorders  are  consistently  found  in 
studies using categorical models of depressive psychopathology, this was not the case 
in  a  study  comparing  dimensional  and  categorical  models  of  psychopathology 
(Hildebrandt et al. 2003). 
 
1.7.2 Psychopathology and age 
The relationship between age and psychopathology is of particular relevance to fields 
of  study  that  make  use  of  developmental  models  of  psychopathology,  such  as 
intellectual disabilities and the study of mental disorders experienced by children and 
adolescents.  
 
The  overall  risk  of  having  any  diagnosed  mental  disorder  was  not  independently 
associated  with  age  in  the  population  based  epidemiological  studies  in  table  1.4 
(Bailey 2007; Cooper et al. 2007a). This contrasts from studies of adults who do not 
have intellectual disabilities where the overall rates of mental disorders decrease with 
increasing age (Kessler et al. 1993; Bijl et al. 2002).  
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For  more  specific  psychopathology,  younger  age  in  table  1.4  was  associated  with 
affective/ neurotic psychopathology (Taylor et al. 2004; Hassiotis et al. 2008) and 
problem behaviours (Hove & Havik 2010). Older age was found to be associated with 
organic disorders (specifically dementia) in one study (Hove & Havik 2010) but not 
another (Taylor et al. 2004). 
 
1.7.3 Psychopathology and living circumstances 
It appears from the studies outlined in table 1.4 that living in circumstances with some 
degree of paid support is independently associated with psychopathology. Comparison 
between  the  studies  is  made  difficult  by  the  different  samples,  measures  of 
psychopathology  and  descriptors  of  living  circumstances  used.  However,  living  in 
hospital was found to be associated with psychosis (Taylor et al. 2004); compared to 
individuals living with family carers, living in a congregate setting such as nursing 
home was  associated with problem behaviours (Jones et al. 2008) and  individuals 
living  with  paid  carer  support  were  more  likely  to  be  diagnosed  with  any  mental 
disorder (Cooper et al. 2007a) and problem behaviours (Jones et al. 2008).  
 
It  is  difficult  to  be  clear  about  the  direction  of  the  association  between 
psychopathology  and  living  circumstances.  On  the  one  hand,  perhaps  individuals 
experiencing psychopathology are more likely to move to circumstances in which they 
receive some degree of paid support as part of a management plan. Alternatively, there 
could be factors associated with living with paid support that increase an individual’s 
risk of psychopathology, or act as precipitants for mental disorders. Either way, the 
findings  from  the  studies  to  date  highlight  the  relevance  of  studying  further  these 
associations. 
 
1.7.4 Psychopathology and level of intellectual disabilities 
As  well  as  highlighting  the  need  to  examine  the  relationship  between  age  and 
psychopathology, the use of developmental models of psychopathology in the field of 
intellectual  disabilities  also  places  a  focus  on  the  need  to  understand  how 
psychopathology relates to an individual’s level of intellectual disabilities.  
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In  table  1.4,  lower  ability  level  was  associated  with  increased  risk  of  having  any 
mental disorder (Cooper & Bailey 2001;Cooper et al. 2007a; Bailey 2007; Hove & 
Havik 2010), and problem behaviours (Jones et al. 2008, Hove & Havik 2010).  
 
There are concerns that existing categorical diagnostic classification systems may be 
less reliable and valid when used to understand psychopathology in individuals with 
severe and profound intellectual disabilities. As described in section 1.5.1, a potential 
strength of dimensional models of psychopathology is their applicability across the 
range  of  developmental  levels  across  childhood  and  adolescence  (Achenbach, 
Edelbrock & Howell 1987; van der Oord, Koot et al. 1995; Leung & Wong 1998; 
Krenke  &  Kollmar  1999).  The  functional  range  of  abilities  of  adults  with  mild-
profound intellectual disabilities can be conceptualised as similar to the developmental 
levels  across  childhood  and  adolescence  (World  Health  Organisation  1994). 
Therefore, it is noteworthy in table 1.4 that few studies have examined the relationship 
between dimensional models of psychopathology and level of intellectual disabilities. 
Two studies use specific psychopathology checklists of symptoms (Taylor et al. 2004; 
Hove & Havik 2010) but only the study using the P-AID checklists examines the 
association between psychopathology and level of intellectual disabilities (Hove & 
Havik 2010). Given the potential advantages to, and the limited number of studies, 
using dimensional models of psychopathology across the full range of abilities there is 
a clear need for further work in this area.  
 
1.7.5 Psychopathology and epilepsy 
Epilepsy  is  the  clinical  variable  most  often  examined  against  psychopathology  in 
epidemiological studies. In table 1.4 it was not having epilepsy that was independently 
associated with a higher risk of psychosis (Cooper et al. 2007b) and anxiety (Hove & 
Havik 2010).  
 
No studies explicitly using dimensional models of psychopathology to examine the 
association with epilepsy were identified. However, a different approach was adopted 
in  a  population  based  study,  which  used  data  from  the  Leicestershire  Learning 
Disability  Register  to  examine  the  relationship  between  epilepsy  and  individual   53 
psychological symptoms and problem behaviours (McGrother et al. 2006). Adjusting 
for  age,  sex  and  level  of  understanding  (based  on  three  categories  describing  an 
individual’s  understanding  of  verbal  communication),  epilepsy  was  significantly 
associated  with  having  one  or  more  psychological  symptoms,  experiencing  mood 
swings,  or  lethargy.  Reporting  any  type  of  problem  behaviour,  or  the  specific 
behaviours- attention seeking, night-time disturbance, and uncooperative behaviours- 
were also significantly associated with epilepsy. Given the inconsistent findings from 
studies using categorical models of psychopathology, this study suggests the potential 
value of using alternative models of psychopathology to examine the relationships 
with clinical variables, such as epilepsy. 
 
1.7.6 Psychopathology and Down syndrome 
Individuals  with  Down  syndrome  were  found  to  have  lower  rates  of  problem 
behaviours (Jones et al. 2008), and higher levels of organic psychopathology (Hove & 
Havik 2010) in the studies summarised in table 1.4.  
 
There were no significant associations between overall risk of mental disorders and 
Down  syndrome  in  table  1.4.  However,  two  other  population  based  studies,  have 
suggested that adults with Down syndrome experience lower rates of mental disorders 
than adults with intellectual disabilities who do not have Down syndrome (Mantry et 
al.  2007;  Morgan  et  al.  2008).  This  confirms  the  findings  from  several  previous 
studies  that,  similarly,  used  categorical  models  of  psychopathology  (Myers  & 
Pueschel 1991; Collacott et al. 1992; Haveman et al. 1994). 
 
Apart from the Norwegian study above (Hove & Havik 2010), relatively few studies 
have  examined  psychopathology  in  adults  with  Down  syndrome  and  intellectual 
disabilities using dimensional or continuous models of psychopathology. On the basis 
of the association of Down syndrome and dementia, several studies have examined 
qualitative differences in the organic psychopathology in adults with Down syndrome 
relative to comparison groups (Cooper & Prasher 1998; Ball et al. 2006; Deb et al. 
2007).  However,  no  other  studies  were  identified  that  used  other  dimensions  of 
psychopathology, in adults with Down syndrome.   54 
1.7.7 Psychopathology and other socio-clinical variables 
Sections  1.7.1-  1.7.6  above  considered  those  variables  identified  as  significantly 
associated with psychopathology across more than one of the population based studies 
in table 1.4. However, there are other socio-clinical variables identified as potentially 
relevant by a significant association in a single study. 
 
1.7.7.1 Psychopathology and autism 
Autism was found to be associated with higher scores on checklists for psychosis, 
OCD,  anxiety,  problem  behaviours  and  overall  mental  ill-health  (Hove  &  Havik 
2010).  However,  another  study  did  not  find  an  independent  association  between 
autism  and  problem  behaviours  (Jones et  al.  2008).  The  two  studies  that  reported 
contrasting  findings  on  problem  behaviours  used  different  methods  to  identify  a 
diagnosis  of  autism.  One  study  used  carer  report  of  a  known  diagnosis  of  autism 
(Hove & Havik 2010), whilst the diagnosis was made as part of a comprehensive 
psychiatric assessment, using a structured checklist of ICD-10 criteria in the second 
study.  
 
One other study using continuous models of psychopathology was identified reporting 
psychopathology  in  adults  with  autism  and  intellectual  disabilities  (Hill  &  Furniss 
2006).  They  studied  82  individuals  with  autism  and  intellectual  disabilities,  and 
examined psychopathology using the DASH-II  (Matson et al. 1991). Compared to 
participants  with  intellectual  disabilities  who  di  not  have  autism,  individuals  with 
autism were found to have higher mean scores on the DASH-II subscales representing 
organic, anxiety, mania, PDD/ autism and stereotypy dimensions of psychopathology 
(Hill & Furniss 2006). This study is included because it used a continuous measure of 
psychopathology,  which  is  closer  to  a  dimensional  model  than  the  categorical 
diagnoses used in the majority of studies in table 1.4. However, since this study used a 
clinic sample, the likely sampling bias makes the findings less reliable than reported in 
the population based studies.   
 
Looking further at studies using a categorical model of psychopathology, an analysis 
was  done  using  the  Glasgow  data  (Cooper  et  al.  2007a)  using  a  matched  control   55 
design to examine the prevalence and incidence of mental disorders in adults with 
autism  and  intellectual  disabilities  (Melville  et  al.  2008).  No  difference  in  the 
prevalence, or incidence of any mental disorder, or problem behaviours was found 
between  the  participants  with  autism  and  intellectual  disabilities,  compared  to  the 
participants with intellectual disabilities who do not have autism. Overall then, there 
remains  some  ambiguity  about  the  exact  association  between  autism  and 
psychopathology.  However,  from  the  findings  described  above  it  appears  that 
continuous models of psychopathology are of potential relevance. 
 
1.7.7.2 Psychopathology and sensory impairments, incontinence and mobility 
Fewer studies have examined the relationships between psychopathology and sensory 
impairments,  mobility  problems  and  incontinence  in  adults  with  intellectual 
disabilities.  
 
From the Greater Glasgow population based epidemiological studies using categorical 
models  of  psychopathology  in  table  1.4,  there  is  evidence  for  an  independent 
association between urinary incontinence and the risk of any mental disorder (Cooper 
et al. 2007a) and problem behaviours (Jones et al. 2008). An association between 
urinary incontinence and mental disorders has also been described in adults who do 
not have intellectual disabilities (cited in Mantry et al. 2008).  
 
From  the  Glasgow  studies,  the  associations  with  mobility  problems,  visual 
impairment,  and  hearing  impairment  are  more  complex.  There  is  an  association 
between having a visual impairment and psychosis (Cooper et al. 2007b) and problem 
behaviours  (Jones  et  al.  2008).  However,  the  association  is  reversed  for  mobility 
problems and hearing impairment. There is an independent association between not 
having mobility problems and being diagnosed with any mental disorder (Cooper et 
al. 2007a), and not having a hearing impairment and affective disorders (Cooper et al. 
2007c).  
 
There  is  a  higher  prevalence  of  sensory  impairments  in  adults  with  intellectual 
disabilities.  Some  evidence  suggests  that  there  is  an  association  between   56 
psychopathology  and  hearing  (van  Gent  et  al.  2007)  and  visual  impairments 
(Lupsakko  et  al.  2002)  in  individuals  who  do  not  have  intellectual  disabilities. 
However,  no  studies  were  identified  showing  a  significant  association  between 
categorical  models  of  psychopathology  and  sensory  impairments  in  adults  with 
intellectual disabilities (Carvill 2001). 
 
Overall,  there  is  limited  evidence  for  a  relationship  between  psychopathology  and 
sensory  impairments,  continence  and  mobility  problems  in  adults  with  intellectual 
disabilities. Since dimensional models of psychopathology may have greater power 
when  examining  correlations  between  variables  (Cohen  1983;  MacCallum  et  al. 
2002), it may be particularly useful to explore the relationships between variables for 
which there is less evidence of an association with psychopathology. Therefore, the 
relationships between psychopathology and visual impairment, hearing impairment, 
mobility problems, urinary and bowel incontinence will be examined in this thesis. 
 
1.7.8  Summary  of  findings  on  socio-clinical  variables  associated  with 
psychopathology in intellectual disabilities 
The  evidence  suggests  that  socio-clinical  variables  likely  to  be  associated  with 
psychopathology  are  gender,  age,  living  circumstances,  level  of  intellectual 
disabilities,  a  diagnosis  of  autism,  Down  syndrome,  epilepsy,  visual  impairment, 
hearing impairment, mobility problems, urinary incontinence and bowel incontinence. 
These are potential confounders in the relationship between psychopathology and the 
severity and outcome of mental disorders. 
  
1.8 Psychopathology and measures of the severity of mental disorders  
General research suggests that, compared to categorical models of psychopathology, 
dimensional models may be more strongly associated with measures of severity. This 
section, examines the evidence for the relationship between psychopathology and the 
severity of mental disorders experience by adults with intellectual disabilities.  
 
A single instrument was used to measure the severity and outcome of mental disorders 
for  example  in  the  studies  comparing  dimensional  and  categorical  models  of   57 
psychopathology from the UK700 study (van Os et al. 1999a; van Os et al. 1999b). 
The term severity of mental disorders is used to describe a cross-sectional measure. 
Longitudinal outcome is the term used to describe results from a follow-up study, 
where  a  measure  is  completed  on  at  least  two  occasions.  Studies  examining  the 
longitudinal outcome in intellectual disabilities are examined in section 1.9. 
 
No intellectual disabilities studies comparing the associations between dimensional 
and categorical models of psychopathology with severity of mental disorders were 
identified. Indeed, few studies have sought to understand how psychopathology relates 
to the severity of mental disorders experienced by adults with intellectual disabilities. 
To take account of the limited evidence–base, it is necessary to consider the results 
from a broader range of studies than would be necessary in other fields of research, for 
example, the studies which are not primarily designed to answer questions relating to 
psychopathology  and  severity,  or  have  samples  including  persons  with  intellectual 
disabilities  and  other  cognitive  impairments  (Endermann  &  Zimmermann  2009). 
Nonetheless, these studies offer some insight into our current understanding of the 
relationship between psychopathology and the severity of mental disorders.  
 
Quality of life was the measure of severity of mental disorders used in the studies 
summarised  in  table  1.5.  These  three  studies  used  continuous  measures  of 
psychopathology, derived from the use of structured instruments for the assessment of 
psychopathology.    58 
Table 1.5: Cross sectional studies reporting the associations between psychopathology and measures of severity for individuals 
with intellectual disabilities  
 
Authors  Sample  Measures of 
severity  
Variables included 
in analysis 
Significant 
correlates of 
outcome  
Comments 
Lunsky & Benson 
2001 
84 adults with mild 
intellectual 
disabilities living 
in the community. 
41 men, 43 
women; mean 
age=38 years 
(range 20-65).  
Quality of Life 
Questionnaire
1 
(QoLQ)
 
 
1. Depressive 
psychopathology- 
Birleson Depressive 
Short Scale
2 (BDS-S) 
2. Social support self-
report for mentally 
retarded adults
3 
(SSSR) 
3. Residential 
loneliness 
questionnaire
4 (RLQ) 
4. Social strain- 
Inventory of Negative 
Social Interactions
5 
(INSI)  
1. SSSR (r=.23, 
p<.05) 
2. RLQ (r=-.28, 
p<.05) 
3. BDS-S (r=-.55, 
p<.001) 
 
Only bivariate 
correlation results for 
the depressive 
psychopathology 
variable are reported 
in the paper 
 
Beadle-Brown et 
al. 2009 
86 adults with 
intellectual 
disabilities 
followed up over 
25 years (Original 
Camberwell 
cohort- 166 
children with 
intellectual 
disabilities living 
in a defined 
geographical area 
Quality of Life- 
Lifestyle 
Satisfaction Scale
6 
(LSS)  
1. Skills & behaviour 
Schedule of 
Handicaps 
Behaviours and 
Scales
7 (HBS)  
2. Adaptive 
functioning- Adaptive 
Behaviour Skills- part 
2 (ABS)
8 
3. Performance IQ  
4. Type of residential 
placement 
1. ABS (t=2.347, 
p<.05) 
2. IQ below 50 
(t=-3.295, p<.001) 
3. Presence of 
problem behaviour 
(t=-2.206, p<.05) 
 
Proxy respondents 
completed the LSS 
for 72 (84%) of the 
sample. Small study 
of inter-rater 
reliability showed 
that proxy responses 
had good level of 
agreement with 
responses from 
participants with mild 
intellectual   59 
in London. Mean 
age=34 years 
(SD=4.3; range 27-
41) 
5. Social impairment 
6. Presence of 
challenging behaviour 
(Y/N) 
7. IQ below 50 
disabilities. 
Endermann & 
Zimmermann 
(2009) 
36 individuals 
(90% of total 
population) 
admitted, in 2005, 
to specialist 
epilepsy unit for 
individuals with 
cognitive 
impairments. 22 
men, 14 women; 
mean age= 25.6 
years (S.D. = 6.0; 
median = 24.0; 
range = 18–40) 
Health Related 
Quality of Life 
(HRQoL)- Quality 
of Life in Epilepsy 
Inventory -31 
(QOLIE-31)
9 
1. Age at onset of 
epilepsy 
2. Number of 
different seizure 
types 
3. Duration of 
epilepsy 
4.  Number of AEDs 
5.  Neuroticism- 
NEO-FFI 
6.  Anxiety- HADS
10 
7.  Depression- 
HADS 
Lower HRQoL: 
1. Younger age at 
onset of epilepsy 
(β=-.27, p<.05) 
2.  Higher 
neuroticism- NEO-
FFI 
11(β=-.72, 
p<.001) 
 
Neuroticism, anxiety 
and depression were 
all significantly 
correlated (p<.001) 
with HRQoL in the 
bivariate analyses, so 
only neuroticism was 
used in the 
multivariate analysis. 
The assumption is 
made that the results 
would have been the 
same if anxiety or 
depression had been 
used. 
 
1 Schalock & Keith 1993 
2 Birleson 1981 
3 Lunsky & Benson 1997 
4 Chadsey-Rusch et al. 1992 
5 Lakey et al. 1994 
6 Harner & Heal 1993 
7 Wing & Gould 1978 
8 Nihira et al. 1993 
9 Cramer et al. 1998 
10 HADS:  Hospital Anxiety and Depression Scale (Zigmond & Snaith 1983) 
11 NEO-FFI: Neo- Five Factor Inventory (Costa Jr & McCrae 1989)   60 
The only finding reported across more than one study is the significant correlation 
between  depressive  psychopathology  and  lower  quality  of  life  in  adults  with  mild 
intellectual disabilities (Lunsky & Benson 2001; Endermann & Zimmermann 2009). 
One  study  found  that  a  measure  representing  the  anxiety  dimension  of 
psychopathology (Endermann & Zimmermann 2009), and another that the presence of 
problem  behaviour  (Beadle-Brown  et  al.  2009),  are  correlated  with  measures  of 
severity.  
 
These studies are limited in the scope of the evidence they provide on the relationship 
between psychopathology and measures of severity. Firstly, each of the three studies 
only uses one measure  of severity, which is a  quality of life measure  in all three 
studies. This is an issue because it is generally recognised that there are advantages to 
the  use  of  multiple  measures  of  severity  and  outcome  (Slade  2002).  The  second 
limitation is related to the limited range of psychopathology included in the analyses. 
None of the studies have used a broad measure of psychopathology, and two studies 
have only included a measure of a single form of psychopathology (Lunsky & Benson 
2001: Beadle-Brown et al. 2009). As a consequence there are unanswered questions 
about  the  relationship  between  different  types  of  psychopathology  and  severity- 
specifically with reference to problem behaviours and other psychopathology. Finally, 
the findings are limited by aspects of the samples used.  Only the study by Beadle-
Brown et al. (2009) used participants with a range of abilities. The other two studies 
were limited to participants with mild intellectual disabilities (Lunsky & Benson 2001; 
Endermann  &  Zimmermann  2009)  and  Endermann  &  Zimmermann  (2009)  only 
included individuals with complex epilepsy. Given these limitations, combined with 
the small number of studies, caution is needed regarding the generalisability of the 
findings.   
 
In terms of other variables found to be associated with severity, the main finding of 
interest is that a lower level of adaptive functioning and lower IQ was correlated with 
increased severity (Beadle-Brown et al. 2009). This could not be examined in the two 
other  studies  which  were  limited  to  participants  with  mild  intellectual  disabilities 
(Lunsky & Benson 2001; Endermann & Zimmermann 2009).  
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There  is  a  far  larger  body  of  evidence  examining  the  cross-sectional  correlations 
between  variables  that  correlate  with  quality  of  life  than  is  shown  in  table  1.5 
(Schalock 2004). However, these are the only studies identified that included some 
measure  of  psychopathology  in  the  analysis.  This  is  surprising  as  research  that 
involves adults with mental disorders who do not have intellectual disabilities has 
closely studied the relationship between psychopathology and quality of life (Ruggeri 
et al. 2002; Eack & Newhill 2007) as well as other measures of severity (Malla et al. 
2002; Drukker et al. 2008). Such work has offered insights into the extent to which 
psychopathology contributes to the severity of a disorder, or need for care. 
 
1.8.1 Summary of findings on the association of psychopathology and the severity 
of mental disorders in intellectual disabilities 
Overall,  there  is  limited  evidence  on  the  relationship  of  psychopathology  and  the 
severity of mental disorders experienced by adults with intellectual disabilities. No 
studies comparing the associations between dimensional and categorical models of 
psychopathology with severity of mental disorders were identified. However, using 
continuous  measures,  depressive,  anxiety  and  problem  behaviour  psychopathology 
were  associated  with  greater  severity.  Increased  severity  of  intellectual  disabilities 
may be associated with the severity of mental disorders.  
 
1.9  Psychopathology  and  the  longitudinal  outcome  of  mental 
disorders  
The final area where dimensional models of psychopathology have been found to be 
of interest is in studying the relationships between psychopathology and longitudinal 
outcome. 
 
No studies of the associations between dimensional models of psychopathology and 
longitudinal outcome in adults with intellectual disabilities and mental disorders were 
identified. Therefore, to describe the evidence base that psychopathology is related to 
outcome of mental disorders experienced by adults with intellectual disabilities, the 
findings from two types of longitudinal studies are discussed: 
·  studies of adults with intellectual disabilities and mental disorders using specific 
clinical services   62 
·  examining  childhood  psychopathology,  and  other  socio-clinical  variables,  as 
predictors of adult outcomes. 
 
 1.9.1 Longitudinal studies examining psychopathology in users of specific clinical 
services 
The studies identified, which consider the association between psychopathology and 
outcome, are limited to studies of users of inpatient services for adults with intellectual 
disabilities and mental disorders.   The three studies are summarised in table 1.6.    63 
Table 1.6: Studies reporting psychopathology as a predictor of outcome for individuals with intellectual disabilities  
 
Authors  Sample  Measures of 
outcome (duration 
of follow-up) 
Predictors of 
outcome included in 
analysis 
Significant 
predictors of 
outcome (t, p) 
Comments 
van Minnen et al. 
1997 
50 individuals mild 
intellectual 
disabilities, 
randomised to 
inpatient (20 men, 
5 women; mean 
age=31.4±12.6 
years) or outreach 
(18 men, 7 women; 
mean 
age=31.0±10.8 
years) treatment.  
Combined score 
from the PIMRA 
and RSMB (28 
weeks) 
 
1. Psychopathology- 
combined PIMRA & 
RSMB score 
2. Aggressive 
behaviour- SAB
1 
3. Social competence- 
SCS
2 
4. Previous 
hospitalizations at 
baseline  
1. Aggressive 
behaviour- SAB (-
3.14, .003) 
2. Social 
competence- SCS 
(2.03, .049) 
3. Previous 
hospitalizations at 
baseline (1.99, 
.052) 
The analysis 
examining predictors 
of outcome  included 
participants in both 
treatment groups  
Final model 
explained 46% of the 
variance in the 
outcome. 
 
Xenitidis et al. 
2004 
71 individuals 
admitted to 
inpatient services 
over 35 month 
period (36 men, 35 
women. Mean 
age=34.55 years 
(SD ±13.11); Mild 
ID= 58, Moderate= 
10, Severe= 3 
1. Total number of 
symptoms on the 
PAS-ADD
3 
2. Disability- total 
DAS
4 score  
3. Behavioural 
impairment- DAS- 
behavioural score  
4. Overall 
functioning- GAF  
5. Severity of Mental 
Health Problem- 
total TAG
5 score (12 
months) 
1. Gender 
2. Age 
3. Psychopathology- 
total PAS-ADD 
symptoms  
4. Autism 
5. Epilepsy 
6. Length of inpatient 
stay 
7. Diagnosis of 
psychosis 
8. Legal status  
None  Outcome measure 
was calculated as 
mean of baseline and 
follow-up score. 
Each of the 5 
outcome measures 
used as dependant 
variable in 
multivariate analyses 
to examine predictors 
of outcome    64 
 
Spiller et al. 2007  Random sample of 
115 users (69 men, 
46 women) of 
specialist 
intellectual 
disability mental 
health services. 
Mild ID = 72, 
moderate= 29, 
severe= 14. 
Service consumption  1. ICD-10 categorical 
diagnosis 
2. Psychosis 
symptom score 
3. Affective/ neurotic 
symptom score 
4. Organic symptom 
score 
5. Gender 
6. Age 
7. Ethnicity 
8. Level of ID 
9. Residence type 
10.  Contact with 
behaviour support 
team 
Heavy service use 
associated with: 
1. Diagnosis of 
schizophrenia 
spectrum disorder 
(F20-27) 
2. Higher baseline 
affective/ neurotic 
symptom score 
 
Categorical diagnoses 
made by two 
consultant 
psychiatrists  based 
on data from a 
standardised 
assessment.. 
Affective/ neurotic, 
organic and psychotic 
psychopathology 
scores were 
calculated from the 
PAS-ADD checklist 
completed by an 
informant. 
 
 
1SAB Scale for Aggressive Behaviour for People with Mental Retardation (Kraijer & Kema 1981) 
2 SCS Social Competence Sclae for People with Mental Retardation (Kraijer & Kema 1981) 
3 PAS-ADD Psychiatric Assessment Schedule for Adults with Developmental Disability (Moss et al. 1997)
 
4 DAS
  Disability Assessment Scale (Holmes et al. 1982)
 
5 TAG Threshold Assessment Grid (Slade et al. 2000)
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Although there are different findings across the three studies, the results are of interest 
to  examining  the  relationship  between  psychopathology  and  longitudinal  outcome. 
Therefore, it is worth examining the methodology and results of the studies in more 
detail  (Van  Minnen  et  al.  1997;  Xenitidis  et  al.  2004,  Spiller  et  al.  2007).  To 
summarise the results: 
·  two studies found that general measures of psychopathology were not predictive of 
outcome (Van Minnen et al. 1997; Xenitidis et al. 2004)  
·  higher scores on a continuous measure of neurotic/ affective psychopathology and 
a categorical diagnosis of a schizophrenia spectrum disorder predicted increased 
service  use,  but  not  continuous  measures  of  psychosis  and  organic 
psychopathology (Spiller et al. 2007)  
·  only one study included problem behaviour at baseline as an independent variable, 
and found it predicted poorer outcome (Van Minnen et al. 1997)  
 
The  only  consistent  finding  across  studies  was  that  an  overall  measure  of 
psychopathology- measured with the PIMRA and RSMB in one study (Van Minnen et 
al. 1997) and the PAS-ADD in another (Xenitidis et al. 2004)- was not associated with 
longitudinal outcome. Since the measures of psychopathology used in these studies 
were incorporated into the measures of outcome at follow up, it is surprising that 
neither study found a significant association. One possible explanation relates to the 
process used to complete the measures of psychopathology and the reliability of the 
measures. Both studies collected data prospectively, but it is not clear whether the 
same  raters  completed  the  measures  at  baseline  and  follow-up.  The  inter-rater 
reliability of the psychopathology items on the Dutch version of the PIMRA (van 
Minnen et al. 1994) and RSMB (van Minnen et al. 1995), and the PAS-ADD (Moss et 
al. 1998) have all been shown to be low. Such low reliability could affect the findings 
of  prospective  follow-up  studies,  and  may  explain  the  absence  of  a  correlation 
between psychopathology at baseline and follow-up. 
 
 In  keeping  with  the  finding  in  the  cross-sectional  study  by  Endermann  & 
Zimmermann  (2009)  discussed  in  section  1.8,  a  continuous  measure  of  neurotic/ 
affective psychopathology was found to be significantly associated with outcome in 
users of specialist intellectual disabilities mental health services (Spiller et al. 2007). It   66 
is noteworthy that the psychosis and organic dimensions of psychopathology did not 
predict outcome (Spiller et al. 2007). Since only 7 (6.2%) of the participants had a 
diagnosis of dementia, the reason that the organic dimension of psychopathology did 
not  predict  outcome  may  be  due  to  the  small  number  of  participants  with 
psychopathology  on  this  dimension.  However,  as  28  (24.3%)  of  participants  were 
diagnosed with a schizophrenia spectrum disorder (ICD-10 categories F20-27) this is 
unlikely  to  be  the  case  for  the  psychosis  dimension  of  psychopathology.  and 
furthermore, the categorical measure of psychosis did predict outcome. A more likely 
explanation  is  that  the  psychosis  dimension  on  the PAS-ADD  checklist  comprises 
only three items (suspicious/ paranoid; strange experiences; strange beliefs) whereas 
the neurotic/ affective dimension has 19 individual items of psychopathology (Moss et 
al. 1998). The lack of coverage of psychosis psychopathology has been previously 
recognised (Cooper et al. 2007a) and makes it likely that even individuals with active 
psychosis  may  not  score  on  this  psychopathology  dimension  of  the  PAS-ADD 
checklist. A specific measure of problem behaviours was also associated with outcome 
(van Minnen et al. 1997). However, these findings are as likely to be affected by 
issues related to inter-rater reliability described previously. 
 
A final point of interest from table 1.6 is the differing result for the two studies that 
examine level of ability as a predictor of outcome (Van Minnen et al. 1997; Spiller et 
al.  2007).  Although  not  identical  to  level  of  intellectual  disabilities,  a  measure  of 
social competence was found to be a significant predictor of outcome in the study by 
van  Minnen  et  al.  (1997);  whilst  level  of  intellectual  disabilities  did  not  predict 
outcome in the study by Spiller et al. (2007). Although it did not include any measure 
of psychopathology in the analysis, one other study has examined the specific question 
of whether individuals with more severe intellectual disabilities have poorer outcomes 
from the use of a specialist inpatient service (Lunsky et al. 2010). This study found 
that the GAF score at follow up was significantly correlated with the binary measure 
of the level of intellectual disability (mild, moderate/severe). Participants with mild 
intellectual disabilities experienced a significant improvement in the GAF score, but 
participants  with  moderate/  severe  intellectual  disabilities  did  not.  However,  the 
authors conclude that the between groups differences in the change in the GAF is 
attributable to a lack of sensitivity of the GAF when used to measure outcome in   67 
individuals  with  more  severe  intellectual  disabilities.  From  the  description  of  the 
methods used to score the GAF, it appears that the effect of a person’s intellectual 
disabilities on functioning was used in scoring the GAF. A potential solution to this 
problem, as described in section 3.4.3.3, is the use of the modified scoring system 
(Hurley 2001).  
 
The  suggestion  that  lower  ability  levels  are  associated  with  increased  severity  of 
mental disorders has been described in the study by Beadle-Brown et al. (2009) in 
section 1.8, and van Minnen et al. (1997) and Lunsky et al. (2010) in this section. 
However,  since  Lunsky  et  al.  (2010)  discount  their  finding  that  more  severe 
intellectual disabilities is predictive of poorer outcome on methodological grounds, 
and  Spiller et  al.  (2007)  did  not  find  that  level  of  intellectual  disabilities  predicts 
outcome, the exact relationship between level of intellectual disabilities and outcome 
requires further study. 
 
1.9.2 Longitudinal studies examining childhood psychopathology and outcomes in 
adulthood 
The  results  presented  in  this  thesis  relate  to  psychopathology  and  outcomes  in 
adulthood. Therefore, studies that follow-up children with intellectual disabilities do 
not provide directly comparable findings. In particular, the measures used to assess 
psychopathology in childhood and the length of follow up affect the generalisability of 
the results to the work of this thesis. Furthermore, since three of the studies in table 
1.7 below use psychopathology as the adult measure of outcome these studies could be 
considered as studies of the stability of psychopathology.  Despite these limitations, 
given  the  small  number  of  relevant  studies  on psychopathology  and  outcome  it  is 
worth  considering  the  evidence  from  longitudinal  studies  from  childhood  to 
adulthood.  
 
Overall, it appears from the results of the studies in table 1.7, that socio-economic 
disadvantage in childhood (McCarthy 2008) and level of ability (Maughan et al. 1999; 
McCarthy 2008; Beadle-Brown et al. 2009) are potentially more important childhood 
predictors of adult outcome than psychopathology. 
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Table 1.7: Longitudinal studies reporting childhood psychopathology, and other variables, as predictors of adult outcomes  
 
Authors  Sample  Measures of 
outcome  
Childhhood 
variables included in 
analysis 
Significant 
predictors of 
outcome  
Comments 
Maughan et al. 
(1999) 
122 adults with 
mild intellectual 
disabilities 
interviewed at age 
33 years (51% of 
275 in original 
birth cohort). 49 
men, 51 women. 
Adult 
Psychopathology- 
Malaise Inventory 
(Rodgers et al. 1999) 
 
1. Childhood social 
disadvantage
1 
2. Childhood sensory 
and neurological 
impairment 
3. General level of 
ability in childhood- 
reading 
comprehension and 
mathematics 
4. Childhood 
behaviour problems- 
Bristol Social 
Adjustment Guides 
(BSAG:(Stott 1978)
2 
5. Contact with 
psychiatric services 
before age 16 
Data used in 
analysis was 
gathered at age 11 
and 16 years old. 
1. Childhood 
social 
disadvantage (OR 
= 1.4, CI = 1.0-2.0, 
P = 0.07) 
2. Childhood 
sensory and 
neurological 
problems (OR = 
3.1, CI = 1.0-9.6, P 
= 0.05) 
 
Additional data is 
provided for a 
comparison sample of 
8554 individuals who 
do not have 
intellectual 
disabilities (71.1% of 
original birth cohort) 
Beadle-Brown et 
al. (2009) 
86 adults with 
intellectual 
disabilities 
followed up over 
25 years (Original 
Camberwell 
cohort- 166 
children with 
intellectual 
disabilities living 
1. Quality of Life- 
Lifestyle 
Satisfaction Scale 
(LSS; Harner & 
Heal 1993)  
Childhood ratings 
carried out at age 11 
years.  
1. Skills & behaviour- 
Schedule of 
Handicaps 
Behaviours and 
Scales (HBS; Wing & 
Gould 1978)
3 
2. Adaptive 
Higher quality of 
life age 33 was 
only significantly 
associated with 
higher independent 
living skills in 
childhood (F = 
5.847, P < 0.02) 
 
Proxy respondents 
completed the LSS 
for 72 (84%) of the 
sample. Small study 
of inter-rater 
reliability showed 
that proxy responses 
had good level of 
agreement with 
responses from   69 
in a defined 
geographical area 
in London. Mean 
age=34 years 
(SD=4.3; range 27-
41) 
functioning- Adaptive 
Behaviour Skills- part 
2 (ABS) 
3. Cognitive ability- 
Leiter International 
Performance Scales 
(Leiter 1980) &  the 
Reynell Language 
Development Scales 
(Reynell 1987) 
4. Time spent in 
institutional care 
5. Social impairment  
6. Autistic on ICD-10 
participants with mild 
intellectual 
disabilities. 
McCarthy & Boyd 
2001 
52 individuals with 
Down syndrome- 
28 men, 24 
women; mean age= 
26.63 years, SD = 
3.45, range= 22- 33 
years (Original 
childhood cohort of 
193; mean age 
10.65 years, SD = 
3.49, range= 6-17 
years).  
Adult psychiatric 
disorder- assessed 
using the PAS-ADD 
(Moss et al. 1997) 
1. Childhood level of 
functioning- Adaptive 
Behaviour Scale 
(ABS; Nihira et al. 
1974) 
2. Problem 
behaviours- Rutter 
A2 & B2 scales 
(Rutter 1970) 
3. ICD-10 psychiatric 
disorder 
4. Childhood 
externalising disorder  
5. Social class- based 
on father’s 
occupation 
6. Quality of parental 
marriage 
7. Parental ill-health 
Parental social 
class (p<.05)  
 
Social class was 
dichotomised into 
two group comprising 
classes I-III 
(professional/ 
managerial/ skilled) 
and  IV-V (semi-
skilled/ unskilled).   70 
McCarthy (2008)  50 individuals with 
Down syndrome- 
26 men, 24 
women; mean age= 
26.6 years, SD = 
3.48, range= 22- 33 
years (Original 
childhood cohort of 
193; mean age 
10.65 years, SD = 
3.49, range= 6-17 
years). 
Adult problem 
behaviours- 
Additional 
Behavioural 
Inventory (ABI; 
(Turner & Sloper 
1996) 
1. Childhood level of 
functioning- Adaptive 
Behaviour Scale 
(ABS; Nihira et al. 
1974) 
2. Problem 
behaviours- Rutter 
A2 & B2 scales  
3. ICD-10 psychiatric 
disorder 
4. Childhood 
externalising disorder  
5. Social class- based 
on father’s 
occupation 
6. Quality of parental 
marriage 
7. Parental ill-health 
1. ABS 
2. ICD-10 
psychiatric 
disorder 
3. Social class 
Social class was 
dichotomised into 
two group comprising 
classes I-II 
(professional/ 
managerial) and  III-
V (skilled/ semi-
skilled/ unskilled). 
 
 
† Eight-point social disadvantage index, including measures of childhood social class, family size, housing tenure and receptions into care. 
‡ The BSAG was used to construct separate scales representing antisocial problems, emotional problems and restlessness 
§ Used to derive separate scales for the analysis comprising basic self-care skills, educational skills, communication skills, independent living 
skills, social skills, abnormal behaviour and behaviour problems   71 
Only the study examining problem behaviours in adults with Down syndrome found 
that  childhood  psychopathology  was  a  significant  predictor  of  outcome  (McCarthy 
2008). Children with Down syndrome who met the criteria for a categorical diagnosis 
of  an  ICD-10  psychiatric  disorder  were  more  likely  to  have  a  severe  problem 
behaviour, aged 33 years old (McCarthy 2008), although this was not a significant 
predictor of having an ICD-10 psychiatric disorder in adulthood (McCarthy & Boyd 
2001). Furthermore, problem behaviours in childhood did not predict adult outcome in 
the other three studies (Maughan et al. 1997; Beadle-Brown et al. 2009; McCarthy & 
Boyd 2001).  These inconsistent findings across studies are in keeping with the results 
described in the longitudinal studies of service users in section 1.9.2.1 above.  
 
Interestingly,  Maughan  et  al.  (1997)  suggest  that  the  lack  of  association  between 
psychopathology in childhood and adulthood may be due to the poor sensitivity of the 
family and teacher-rated measures of childhood psychopathology.  Since such ratings 
of  psychopathology  are  used  across  all  four  of  the  studies  in table  1.7,  this  could 
perhaps partly explain the finding that childhood psychopathology is not a significant 
predictor of outcome in adulthood. Further limitations of the studies described here are 
the  use  of  single  measures  of  outcome  across  all  four  studies,  samples  limited  to 
individuals with mild intellectual disabilities (Maughan et al. 1997) or Down syndrome 
(McCarthy  &  Boyd  2001;  McCarthy  2008)  and  the  inclusion  of  measures  of 
psychopathology that are limited in scope.  
 
1.9.3  Summary  of  findings  on  the  association  of  psychopathology  and  the 
longitudinal outcome of mental disorders in intellectual disabilities 
Overall,  there  is  limited  evidence  on  the  relationship  of  psychopathology  and  the 
outcome of mental disorders experienced by adults with intellectual disabilities. No 
studies examining dimensional models of psychopathology and outcome, or comparing 
the associations between dimensional and categorical models of psychopathology with 
the outcome of mental disorders were identified. However, using continuous measures, 
neurotic/  affective  and  problem  behaviour  psychopathology  were  associated  with 
longitudinal  outcome.  Further  research  on  the  association  of  level  of  intellectual 
disabilities and outcome is required. 
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1.10 Conclusions from the review of the literature  
The  classification  of  mental  disorders  is  dependent  on  the  assessment  of 
psychopathology and the use of categorical diagnostic classification systems, that are 
based on a categorical model of psychopathology. An important development was the 
publication  of  specific  categorical  diagnostic  classification  systems  for  the 
classification  of  mental  disorders  experienced  by  individuals  with  intellectual 
disabilities-  DC-LD  and  DM-ID.  These  are  based  on  the  generic  ICD  and  DSM 
categorical diagnostic classification systems. Few studies have examined the properties 
of DC-LD and DM-ID. However, research examining the characteristics of ICD and 
DSM  has  highlighted  important  strengths  and  limitations  of  categorical  diagnostic 
classification systems, particularly with  regard to  validity  and their utility in some 
types of research. As a consequence, dimensional models of psychopathology have 
been  proposed  as  an  important  corollary  to  categorical  diagnostic  classification 
systems.  
 
The work done to examine the dimensions of psychopathology experienced by adults 
with intellectual disabilities is limited by small sample sizes, biased samples and the 
use  of  assessments  that  include  a  limited  range  of  items  of  psychopathology. 
Furthermore,  the  methods  of  exploratory  factor  analysis  used  have  methodological 
problems.  
 
Socio-clinical  variables  are  important  to  consider  as  potential  confounders  in 
examining  the  relationship  between  psychopathology  and  other  aspects  of  mental 
disorders.  No  studies  have  examined  the  associations  of  dimensional  models  of 
psychopathology and socio-clinical variables. However, studies have identified socio-
clinical variables that are associated with categorical models of psychopathology.  
 
There has been general research published comparing the associations of dimensional 
and categorical models of psychopathology with the severity and outcome of mental 
disorders.  No studies were identified examining the relevance of dimensional models 
of psychopathology to the severity and outcome of mental disorders experienced by 
adults with intellectual disabilities. Similarly, no studies comparing dimensional and 
categorical  models  of  psychopathology  in  intellectual  disabilities  were  identified. 
Therefore,  relevant  intellectual  disabilities  research  using  categorical  models,  or 
continuous measures, of psychopathology is needed.    73 
 
Studies  examining  the  relationship  between  psychopathology  and  the  severity  of 
mental disorders have tended to make use of measures of psychopathology which are 
limited  in  scope,  eg.  using  either  a  broad,  general  measure  of  psychopathology  or 
focussing  on  a  single  continuous  measure  of  psychopathology,  such  as  depressive 
psychopathology  or  problem  behaviours.  The  samples  included  in  the  studies  are 
biased  towards  individuals  with  mild  intellectual  disabilities.  Finally,  rather  than 
making  use of  comprehensive assessments  of severity,  studies have largely  used a 
single measure of severity- which to date have all been based on quality of life. 
 
The longitudinal studies examining psychopathology and outcome are limited by the 
focus on users of inpatient services as participants. Since this is likely to comprise 
individuals with the most severe mental disorders it introduces potential sampling bias, 
and limits the generalisability of the findings. The measures of psychopathology used 
in the studies have largely focussed on problem behaviour psychopathology, or have 
only used overall measures of psychopathology. Only a single study, used more than 
one measure of outcome (Spiller et al. 2007), in contrast to the recommended use of 
multiple  measures  of  outcome  in  mental  disorder  studies  (Slade  2002).    Finally, 
although  one  study  includes  several  continuous  measures  of  psychopathology 
(Xenitidis et al. 2004), these are not empirically derived from the PAS-ADD checklist, 
which is limited in scope and validity.   
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Chapter 2: Research aims and hypotheses 
2.1 Research aims  
Informed by the existing literature, five broad research aims were formulated: 
1.  To explore the dimensional structure of psychopathology experienced by adults 
with intellectual disabilities 
2.  To  examine  the  associations  of  a  dimensional  model  of  psychopathology  with 
socio-clinical variables 
3.  To examine the relationship of a dimensional model of psychopathology with the 
severity of mental disorders. 
4.  To understand the relationship between a dimensional model of psychopathology 
and the longitudinal outcome of mental disorders  
5.  To  compare  the  associations  of  dimensional  and  categorical  models  of 
psychopathology with the severity and outcome of mental disorders, experienced 
by adults with intellectual disabilities. 
 
2.2. Research hypotheses 
To meet these aims 12 null hypotheses were formulated for examination: 
 
Null hypothesis one: 
There are no stable, identifiable dimensions of psychopathology experienced by adults 
with intellectual disabilities. 
 
Null hypothesis two: 
There  are  no  significant  correlations  between  the  individual  dimensions  of 
psychopathology experienced by adults with intellectual disabilities. 
 
Null hypothesis three: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables: 
·  gender  
·  age 
·  living circumstances 
·  level of intellectual disabilities 
·  diagnosis of autism   75 
·  Down syndrome 
·  epilepsy 
·  sensory impairments 
·  mobility problems 
·  incontinence. 
 
Null hypothesis four: 
There  are  no  significant  cross-sectional,  multivariate  relationships  between 
dimensional measures of psychopathology and socio-clinical variables. 
 
Null hypothesis five: 
There  are  no  significant  bivariate  relationships  between  dimensional  measures  of 
psychopathology and measures of the severity of mental disorders: 
·  Health of the Nation Outcome Scales- Learning Disabilities total score (HoNOS-
LD)  
·  Global Assessment of Functioning (GAF) 
·  Clinical Global Impression (CGI) 
·  Camberwell Assessment of Need for Adults with Developmental and Intellectual 
Disabilities (CANDID) - unmet needs, and met needs.  
 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables and 
measures of the severity of mental disorders. 
 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures of 
psychopathology,  socio-clinical  variables  and  measures  of  the  severity  of  mental 
disorders. 
 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with measures of the severity of mental disorders. 
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Null hypothesis nine: 
Dimensional  measures  of  psychopathology  are  not  significantly  correlated  to  the 
longitudinal outcome of mental disorders. 
 
Null hypothesis ten: 
Socio-clinical measures are not significantly associated with the longitudinal outcome 
of mental disorders. 
 
Null hypothesis eleven: 
Dimensional  measures  of  psychopathology  and  socio-clinical  variables  are  not 
independently associated with the longitudinal outcome of mental disorders. 
 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with the longitudinal outcome of mental disorders. 
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Chapter 3: Methods 
There are two study designs used to answer the research hypotheses: 
1.  A  cross-sectional  study  examining  the  relationships  between  psychopathology, 
socio-clinical variables and measures of severity (research hypotheses one- eight) 
2.  A four-five year follow-up study to examine outcome baseline psychopathology 
and  socio-clinical  variables  as  predictors  of  longitudinal  outcome  (research 
hypotheses nine- twelve). 
 
An illustration of the samples, measures and variables used to examine the research 
hypotheses is shown in figure 3.1.   
 
Data  collected  from  three  samples  of  participants  is  used  to  answer  the  research 
questions addressed in this thesis. PPS-LD data from both samples was used for the 
exploratory factor analyses to identify dimensions of psychopathology. Data on socio-
clinical variables and outcome measures was collected in studies involving individuals 
in samples 2 and 3 as participants. 
 
Professor S-A. Cooper collected all the data from sample 1. The data was entered into a 
database by a member of administrative staff.Data from sample 2 was collected by 
intellectual disabilities psychiatrists working in the University Centre of Excellence in 
Developmental  Disabilities  (UCEDD).  Professor  S-A.  Cooper,  higher  trainees  in 
intellectual  disabilities  psychiatry  and  basic  trainees  in  psychiatry  were  involved  at 
different  stages  in  collecting  the  data.  Craig  Melville  worked  in  the  UCEDD  from 
August 2001-August 2002, and again from August 2003 onwards. During these time 
periods he was directly involved in data collection, and in the training and supervision 
of other psychiatrists collecting data. All sample 2 data used in the analyses in this 
thesis was taken from clinical case notes and entered into a database by Craig Melville. 
 
All data for sample 3 was collected during face-to face interviews with participants and 
carers and entered into a database by Craig Melville.   78 
Figure 3.1: Study design to illustrate samples, measures and variables to examine research hypotheses 
 
 
 
Samples 
 
 
Time point 
 
   
Measures 
 
 
 
 
 
Variables 
Sample 2 
N=150 
Sample 1 
N=274 
· dimension factor scores 
· dimension symptom counts 
· overall symptom count 
PPS-LD  
psychopathology 
Time 1  Time 2 
Socio-clinical variables  Measures of severity 
and outcome 
· gender 
· age 
· living circumstances 
· level of intellectual disabilities 
· epilepsy 
· autism  
· Down syndrome 
· sensory impairments 
· mobility problems 
· incontinence 
· HoNOS-LD total score 
· CANDID- total, met & unmet needs 
· GAF score 
· CGI 
Sample 3 
N=40   79 
 
3.1 Study participants 
 
3.1.1 Sample 1- North Northamptonshire 
Individuals in Sample 1 comprised all adults with intellectual disabilities living in North 
Northamptonshire, and referred to specialist intellectual disabilities psychiatric services 
during  1994-1999.  The  psychopathology  data  collected  using  the  Psychopathology 
Present State-Learning Disabilities (PPS-LD) has not been reported previously.  
 
3.1.2 Sample 2- Glasgow 
Sample  2  comprises  all  individuals  referred  to  the  clinical  service  of  the  Glasgow 
University Centre for Excellence in Developmental Disabilities (UCEDD) between 2001 
and 2004. Participants were referred to the UCEDD clinical service for a full assessment 
of their needs, on the basis that symptoms, or changes in behaviour, were recognised as 
suggestive of mental disorders, warranting further assessment by specialist intellectual 
disabilities services. 
 
3.1.3 Sample 3 
Sample 3 (n=40, 26.7%) is a sub-sample of sample 2. Participants in sample 2 (n=150) 
were all invited to meet with C.Melville and take part in a follow-up interview. The mean 
time between the baseline assessment and follow-up interview was 52.3 months (range= 
46-69; SD=6.9).  
 
3.1.4 Comparison of samples 
A comparison of the socio-clinical variables in the three samples are shown in tables 3.1 
and 3.2.  80 
Table 3.1: Socio-clinical characteristics of samples 1 and 2 
 
Sample 1 
(n=274) 
Sample 2 
(n=150) 
   
Variable 
N  %  N  %  Statistic (p value) 
Female  134  48.9  68  45.3  Gender 
  Male  140  51.1  82  54.7 
χ²= 0.50 (.48) 
Mild  35  14.1  34  22.6 
Moderate  54  21.7  32  21.3 
Severe  73  29.3  33  22.0 
Level of 
intellectual 
disabilities 
  Profound  87  34.9  51  34.0 
 
χ²= 1.95 (.16) 
No  174  63.7  105  70.0 
Yes, seizures well 
controlled 
51  18.7  29  19.3 
Epilepsy 
 
Yes, seizures poorly 
controlled 
48  17.6  16  10.7 
χ²= 2.64 (.10) 
Good  29  10.6  72  48.3 
Good with glasses  153  55.8  50  33.7 
Poor with glasses  62  22.6  9  6.0 
Visual impairment  8  2.9  9  6.0 
Vision † 
 
Severe visual impairment  18  6.6  9  6.0 
χ²=.736 (.391) 
Good  230  90.6  131  87.9 
Good with hearing aid  9  3.5  6  4.0 
Poor with hearing aid  1  0.4  4  2.7 
Hearing impairment  13  5.1  5  3.4 
Hearing † 
 
Severe hearing 
impairment 
1  0.4  3  2.0 
χ²= 2.942 (.086) 
Full mobility  187  73.0  112  75.2 
Independent but poor  21  8.2  13  8.7 
Uses a stick/ walking aid  5  2.0  2  1.3 
Uses wheelchair outside  13  5.1  14  9.4 
Always uses wheelchair   12  4.7  2  1.3 
Mobility † 
 
Unable to weight bear  18  7.0  6  4.0 
χ²= 0.297 (.586) 
Fully continent  165  60.2  97  64.7 
Occasional accidents  45  16.4  16  10.7 
Incontinent only at night  12  4.4  8  5.3 
Urinary 
incontinence 
† 
Incontinent  52  19.0  29  19.3 
χ²= 0.141 (.708) 
Fully continent  202  73.7  112  74.7 
Occasional accidents  31  11.3  10  6.7 
Incontinent only at night  2  .7  1  .7 
Bowel 
incontinence 
† 
Incontinent  39  14.2  27  18.0 
χ²= 0.235 (.628) 
† At least one cell count was too small for analyses and therefore, for the purposes of 
the statistical analyses the variable was collapsed to the binary categories shown in 
table 3.5   81 
Table 3.2: Socio-clinical characteristics of samples 2 and 3 
Sample 2 
(n=150) 
Sample 3 
(n=40) 
   
Variable  
N  %  N  %  Statistic (p value) 
Female  68  45.3  22  45.0  Gender 
  Male  82  54.7  18  55.0 
χ²= 1.932 (0.165) 
 
Mild  34  22.6  6  15.0 
Moderate  32  21.3  8  20.0 
Severe  33  22.0  10  25.0 
Level of 
intellectual 
disabilities 
  Profound  51  34.0  16  40.0 
χ²= 2.215 (0.529) 
Lives independently  27  18.1  5  12.5 
Family carer support   35  23.5  8  20.0 
Living 
circumstances 
Paid carer support   87  58.4  27  67.5 
χ²= 2.014 (0.365) 
Yes  24  16  6  15.0  Autism 
No  126  84  34  85.0 
χ²= 0.248 (0.618) 
Yes  19  12.7  6  15.0  Down 
syndrome  No  131  87.3  34  85.0 
χ²= 0.050 (0.824) 
No  105  70.0  28  70.0 
Yes, seizures well 
controlled 
29  19.3  8  20.0 
Epilepsy 
 
Yes, seizures poorly 
controlled 
16  10.7  4  10.0 
χ²= .010 (0.995) 
Good  72  48.3  21  52.5 
Good with glasses  50  33.7  14  35.0 
Poor with glasses  9  6.0  1  2.5 
Visual impairment  9  6.0  2  5.0 
Vision † 
 
Severe visual impairment  9  6.0  2  5.0 
χ²=4.153 (.528) 
Good  131  87.9  33  82.5 
Good with hearing aid  6  4.0  2  5.0 
Poor with hearing aid  4  2.7  3  7.5 
Hearing impairment  5  3.4  1  2.5 
Hearing † 
 
Severe hearing impairment  3  2.0  1  2.5 
χ²= 5.543 (0.353) 
Full mobility  112  75.2  33  82.5 
Independent but poor  13  8.7  3  7.5 
Uses a stick/ walking aid  2  1.3  0  0 
Uses wheelchair outside  14  9.4  1  2.5 
Always uses wheelchair   2  1.3  0  0 
Mobility † 
 
Unable to weight bear  6  4.0  3  7.5 
χ²= 8.915 (0.178) 
Fully continent  97  64.7  25  62.5 
Occasional accidents  16  10.7  3  7.5 
Incontinent only at night  8  5.3  1  2.5 
Urinary 
incontinence † 
Incontinent  29  19.3  11  27.5 
χ²= 3.219 (0.359) 
Fully continent  112  74.7  29  72.5 
Occasional accidents  10  6.7  0  0 
Incontinent only at night  1  .7  1  2.5 
Bowel 
incontinence † 
Incontinent  27  18.0  10  25.0 
χ²= 7.852 (0.063) 
† At least one cell count was too small for analyses and therefore, for the purposes of the 
statistical analyses the variable was collapsed to the binary categories shown in table 3.5   82 
Data on the age of sample 1 participants at the time of data collection was available for 
269  (98.2%)  individuals,  who  had  a  mean  age  of  34.7  years  (range=  16-76;  SD= 
13.0).The socio-clinical characteristics of the 150 individuals included in sample 2 are 
shown above in table 3.1. For sample 2, data on the age of the participants at the time of 
data collection was available for the whole sample, who had a mean age of 43.5 years 
(range= 17-74; SD= 13.0). The only between group difference for samples 1 and 2 was a 
significant difference in the mean age of samples 1 and 2 (t= - 6.7, p< 0.001).  
 
There was no significant difference (t= -.20; p=.984) in the mean age of sample 2 and 
sample 3 (43.53 years, SD= 11.94), or the socio-clinical variables in table 3.2, Therefore, 
sample 3 is representative of participants in sample 2. 
 
3.2 Ethical approval  
Participants in samples 2 and 3 lived in Scotland. The Adults with Incapacity (Scotland) 
Act, 2000 (Scottish Executive 2000) requires that research that involves adult participants 
who, potentially, do not have the capacity to make an informed decision on participating 
in  research  be  considered  for  ethical  approval  by  a  designated  Multi-centre  Research 
Ethics Committee (MREC).  
 
Participants  had  the  full  range  of  intellectual  disabilities,  therefore,  some  individuals 
would not have the capacity to make an informed decision on participating in research. 
Ethical  approval  was,  therefore,  obtained  from  Scotland  Research  Committee  A  (the 
MREC  that  deals  with  all  applications  for  ethical  approval  of  studies  involving 
participants who do not have capacity) and site specific approval was obtained from the 
local research ethics committee (LREC) of NHS Greater Glasgow, Primary Care Trust.  
 
3.3 Consent for participation in research 
In Scotland, research involving adults who do not have the capacity to make an informed 
decision regarding their participation as covered by part five of the Code of Practice of 
the Adults with Incapacity (Scotland) Act, 2000 (Scottish Executive 2000). As stated in 
the Act,   83 
“Research on adults incapable of consenting is authorised under the Act provided that: 
it will further knowledge; 
it is of benefit to the adult or others in a similar condition; 
it entails little or no risk or discomfort; 
the adult is not objecting; 
consent has been obtained from a person with relevant powers; and 
the research has been approved by The Ethics Committee.”  
 
Since  the  provisions  of  the  act  make  it  clear  that  assessment  of  capacity  should  be 
decision specific, and not an all or nothing statement on the capacity of an individual, 
researchers are required to assess the capacity of each potential participants. Based on the 
Adults with Incapacity (Scotland) Act, 2000 (Scottish Executive 2000), to assess capacity 
the researcher should assess whether an individual can: 
·  Understand in simple language what is involved in the research study, its purpose and 
nature and why it is being proposed  
·  Understand any principle benefits, risks and alternatives 
·  Understand  in  broad  terms  what  will  be  the  consequences  of  taking  part  in  the 
research 
·  Retain the information long enough to use it and weigh it in the balance in order to 
arrive at a decision  
·  Express their decision, consistently, on whether to participate in research.  
If  an  individual  is  assessed  as  having  capacity  to  make  an  informed  decision  about 
participation  in  research,  they  are  invited  to  choose  whether  they  would  like  to 
participate- in which case they are invited to sign a consent form. In circumstances where 
an individual does not have capacity, the Adults with Incapacity (Scotland) Act, 2000 
(Scottish Executive 2000) allows provision for consent to be given by the individual’s 
nearest relative, or welfare guardian. The letters of invitation to potential participants, 
information sheets and consent forms are reproduced in appendix I and II. 
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3.4 Measures 
All participants were assessed using a standardised methodology to assess the needs of 
individual's, based on a biopsychosocial-developmental model of health. The methods 
used include: 
·  Psychiatric  examination-  a  detailed  clinical  history  and  mental  state  examination; 
with  an  emphasis  on  assessing  change  in  a  person’s  experiences,  and  level  of 
functioning,  within  the  context  of  the  individual’s  development.  To  ensure  the 
consistency,  and  comprehensiveness  of  the  assessment,  areas  to  be  specifically 
enquired about, in all sub-sections of the history, are included in a written protocol 
used in every new assessment (further details are provided in table 3.3) 
·  A checklist of psychopathology – the Present Psychiatric State – Learning Disabilities 
(PPS-LD: Cooper 1997) 
·  A  standardised  measure  of  level  of  adaptive  functioning  –  Vineland  Adaptive 
Behaviour Scale – survey form (Sparrow et al. 1984). 
 
The  standardised  psychiatric  examination  schedule  is  based  on  accepted  practice  for 
taking a clinical history and mental state examination, with specified items to be assessed 
in  each  subsection,  as  outlined  in  table  3.3  below.  Additional  information  on  an 
individual’s development, health and functioning are sought from an informant, such as a 
family or paid carer. Relevant information on previous contact with health care services 
is summarised from case notes- often requested from statutory health care services, or 
institutions where individuals previously lived.  
 
Information from the psychiatric examination, and any relevant details from an informant 
history and case note review, is used to make a categorical diagnosis using the DC-LD 
(Royal College of Psychiatrists 2001), ICD-10 (World Health Organisation 1994) and 
DSM-IV-TR (American Psychiatric Association 2000). 
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3.4.1 Measures of psychopathology  
3.4.1.1 Psychiatric Present State- Learning Disabilities (PPS-LD) 
The  Psychiatric  Present  State-  Learning  Disabilities  examination  (PPS-LD)  was 
developed specifically for the identification of psychopathology experienced by adults 
with intellectual disabilities (Cooper 1997). The development of the PPS-LD was based 
upon the Schedules for Clinical Assessment in Neuropsychiatry (SCAN: World Health 
Organisation 1992). In comparison to SCAN, the PPS-LD uses language appropriate to 
the developmental level of persons with intellectual disabilities and includes items of 
psychopathology that are absent from the SCAN which commonly present in adults with 
intellectual  disabilities.  The  PPS-LD  is  designed  to  identify  a  broad  range  of 
psychopathology,  including  symptoms  relevant  to  anxiety  disorders,  obsessive-
compulsive disorders, affective disorders, cognitive impairment, and psychosis. In total 
there are 112 items on the instrument- 90 items on psychopathology, and 22 mental state 
items observed at the time of assessment.    86 
Table 3.3: An outline of the standardised UCEDD psychiatric examination 
 
Subsection of history and examination  Details 
History of presenting complaints  Current psychopathology- form, duration and severity. Triggers and life events.  
Specifically  assess  whether  any  psychopathology  suggestive  of  ADHD,  ASD 
(reciprocal  social  interaction,  social  communication,  repetitive  &  restricted 
repertoire of activities), and/ or problem behaviours are present. PPS-LD for the 
assessment of psychopathology 
Past psychiatric history  Any episodes of mental disorders documented in case notes- symptomatology, 
diagnosis, treatment, and outcome. Dates of episodes of mental disorders. 
Past medical history  Any physical disorders documented in case notes- symptomatology, diagnosis, 
treatment and outcome. Specifically assess whether epilepsy is present or not, and 
status  of  vision  and  hearing  (and  when  last  tested),  mobility,  hand  use  and 
continence.  Relevant  investigations  and  results.  Make  statement  on  risk  of 
osteoporosis, GORD, nutrition/ weight status and mental disorders. 
Drug history  Current medication- name, dose, administration and side effects. Include previous 
allergies or adverse events. 
Personal and developmental history  Chronological account of all available history, noting the source. Any relevant 
developmental  history.  Cause  of  intellectual  disabilities.  Current  Vineland 
Adaptive Behaviour Scales scoring  
Current social circumstances  Describe  current  accommodation  and  level  of  support.  Detail  occupational/ 
leisure activities/ hobbies. Social network and contact with family and friends.   
Detail smoking, alcohol and drug intake. Professional supports e.g. detail current 
contact  with  intellectual  disabilities  health  services.  e.g.  dietician, 
physiotherapist, community nurse etc. 
Family history  Parents’ and siblings’ occupation, place of residence and health.  Note any family 
history of psychiatric illness, epilepsy or learning disabilities.  
Mental state examination  Appearance  and  behaviour;  speech;  mood  and  affect;  thought  form-  rate, 
associations  and  possession;  thought  content-  overvalued  ideas,  delusions; 
perceptions  –  psychotic  phenomena,  illusions;  cognition  –  attention, 
concentration,  memory,  interest;  insight.  List  positive  and  relevant  negative 
findings from PPS-LD   87 
 
Psychiatrists  with  specialist  training  and  experience  of  working  with  adults  with 
intellectual disabilities are trained to use the PPS-LD. The PPS-LD can be completed 
with the individual with intellectual disabilities alone, with both the individual and a 
relevant  informant,  or  with  an  informant  alone.  Prompts  and  appropriate  questions 
relevant  to  each  item  of  psychopathology  are  provided,  with  follow-up,  clarifying 
questions available, to be used flexibly, depending on a respondent’s initial answer. All 
the items of psychopathology in the PPS-LD are rated by the psychiatrist. 
 
Psychopathology is rated based on an individual's functioning in the previous four weeks. 
The scoring system varies between items, with most rated on a binary scale (0=no, 2= 
yes). Three items of psychopathology (worry/ apprehension, tearfulness and reduced self 
care) are scored on a three point scale (0=no, 1=a bit, 2=yes).  Several questions on the 
PPS-LD rate several items of psychopathology together. For example, the question on 
sleep rates whether six forms of sleep disturbance are present (initial insomnia, mid-
insomnia, early morning wakening, increased sleep during the day, reversed sleep pattern 
and reduced need for sleep). Other questions that rate multiple items of psychopathology 
are on diurnal mood variation (no DMV, worse in evening, worse in morning), and the 
mental state item on affect (euthymic, irritable affect, depressed affect, euphoric affect).  
 
An item of psychopathology is scored positively, if it has been present in the past four 
weeks and associated with significant impairment. However, if on further questioning an 
interviewer determines that the item of psychopathology is long-standing, there is  an 
option  to  rate  the  item  as  a  trait  characteristic  (trait=7).  Similarly,  when  an  item  of 
psychopathology is present, but is clearly a feature of an autism spectrum disorder a 
separate score can be recorded. For example, rituals as such as obsessional checking and 
repetitive behaviours could be rated positively (score = 2), or present as part of an autism 
spectrum disorder (score = 4).  
 
The  rating  of  certain  items  of  psychopathology  is  more  dependent  than  others  on  an 
individual's level of communication, or intellectual disabilities. The clearest example of 
this is where an individual does not have any verbal communication, which makes it 
impossible  to  rate  items  that  require  some  degree  of  self-report  e.g.  hopelessness, 
intrusive obsessional thoughts and terms of psychosis. For the purposes of completing the 
PPS-LD, if an individual does not use verbal communication at a level where they speak   88 
in sentences, such items are not rated. Similarly, if for any reason the interviewer is 
unsure whether an item of psychopathology is present or not, this is indicated on the 
interview schedule and the reason written in long hand. Common reasons for this can be 
to do with an individual's level of intellectual disabilities, or an informant being unable to 
give  a  clear  description  due  to  a  lack  of  knowledge  of  a  particular  aspect  of  an 
individual’s lifestyle e.g. sleep. 
 
Data  collected  using  the  PPS-LD  was  used  in  this  thesis  for  the  exploratory  factor 
analysis  to  identify  underlying  dimensions  of  psychopathology  experienced  by  adults 
with intellectual disabilities during episodes of mental disorders.  
 
3.4.1.2 DC-LD categorical diagnosis of mental disorder 
As part of the standardised method of assessment, a decision is made as to whether the 
psychopathology an individual has experienced meets the criteria for any diagnoses from 
one, or more, categorical diagnostic classification systems.  Since the publication of the 
DC-LD, a consensus process has been used to decide if an individual meets the criteria 
for diagnoses from DC-LD, ICD-10 and DSM-IV-TR. For the purposes of this thesis, the 
diagnoses  from  DC-LD  are  used,  as  the  categorical  model  of  psychopathology  for 
comparison with the dimensional model of psychopathology. Details of DC-LD are in 
section 1.3.1.2. The DC-LD diagnoses for samples 2 and 3 are shown in table 3.4. 
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Table 3.4 DC-LD categorical diagnoses for samples 2 and 3. 
 
Sample 2  Sample 3  DC-LD mental disorders  DC-LD diagnostic category  Diagnostic 
code  N  %  N  % 
Unspecified dementia  B1.1  3  2  1  2.5 
Dementia in Alzheimer’s disease, unspecified  B1.2  1  0.67  0  0 
Dementia 
Vascular dementia, unspecified  B1.3  1  0.67  0  0 
Schizophrenic/ delusional episode  B3.1  5  3.33  2  5.0 
Schizoaffective episode  B3.2  1  0.67  1  2.5 
Non-affective psychotic 
disorders 
Other non-affective psychotic episode  B3.3  1  0.67  1  2.5 
Depressive episode  B4.1  45  30.67  9  22.5 
BPAD
1, current depressive episode   B4.1i  1  0.67  1  2.5 
BPAD, currently in remission  B4.1ii  1  0.67  1  2.5 
Recurrent depressive disorder, currently in 
episode 
B4.1iii  6  4  2  5.0 
Depressive episode with psychotic symptoms  B4.1xa  1  0.67  1  2.5 
Manic episode  B4.2  1  0.67  0  0 
Affective disorders 
Bipolar affective disorder, current episode 
mixed 
B4.3i  1  0.67  2  5.0 
Agoraphobia  B5.1  3  2  1  2.5 
Specific phobia  B5.3  3  2  0  0 
Panic disorder  B5.4  2  1.3  0  0 
Generalised anxiety disorder  B5.5  4  2.7  2  5.0 
Obsessional compulsive disorder  B5.8  2  1.2  1  2.5 
Adjustment disorder  B5.10  4  2.7  0  0 
Neurotic & stress related 
disorders 
Post-traumatic stress disorder  F43.1 †  1  0.67  0  0 
Eating disorder  Pica  B6.9  1  0.67  0  0 
Hyperkinetic disorders  Attention-deficit hyperactivity disorder  B7.1  5  3.33  1  2.5 
Physically aggressive behaviour  D1.3  2  1.2  0  0  Problem behaviours 
Self-injurious behaviour  D1.5  1  0.67  0  0 
Does not meet criteria for 
any categorical diagnosis  
N/A  N/A  54  36.0  14  35.0 
1 Bipolar Affective Disorder  † ICD-10 diagnostic code   90 
3.4.2 Socio-clinical variables 
The socio-clinical variables in the analyses were chosen on the basis of the literature 
review of the associations of psychopathology and socio-clinical variables in section 1.7: 
·  gender  
·  age in years, at time 1 (the time of referral to specialist services) 
·  living circumstances  
·  level of intellectual disabilities 
·  diagnosis of autism 
·  Down syndrome 
·  epilepsy 
·  visual impairment 
·  hearing impairment 
·  mobility problems 
·  urinary incontinence 
·  bowel incontinence 
 
The  variable  describing  an  individual’s  living  circumstances  was  based  on  the 
accommodation where the person lived. The different geographical settings that sample 1 
and sample 2 lived in meant that the original categories used for data collection were not 
identical. Therefore, to allow comparison the categories were collapsed into three- lives 
independently  with  no  support  from  paid  carers;  lives  in  own  tenancy,  or  registered 
residential/  nursing  home  with  support  from  paid  carers;  lives  with  parents  or  other  
family members. 
 
The  variables  epilepsy,  visual  impairment,  hearing  impairment,  mobility  problems, 
urinary incontinence and bowel incontinence are coded as part of the PPS-LD. For the 
epilepsy variable, seizures are categorized as well controlled if they occur at a frequency 
of once per month, or less and poorly controlled at a frequency of more than once a 
month. Since several cell counts were too low for the purposes of statistical analyses, the 
original categories in the PPS-LD for visual impairment, hearing impairment, mobility 
problems,  urinary  incontinence  and  bowel  incontinence  were  collapsed  to  binary 
categories. This is shown in table 3.5.  
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Table 3.5: Transformation of variables for purposes of analyses 
 
 
Variable name  PPS-LD category  Collapsed  binary 
category 
Good 
Good with glasses 
Good 
Poor with glasses 
Poor 
 
 
Visual 
impairment 
Severe visual impairment 
 
Visual impairment 
Good 
Good with hearing aid 
Good 
Poor with hearing aid 
Poor 
 
Hearing 
impairment 
Severe hearing impairment 
 
Hearing impairment 
Full mobility  Full mobility 
Independent but poor 
Uses stick or frame 
Uses a wheelchair only when 
outside 
Uses a wheelchair all the time 
 
 
 
Mobility 
problems 
Cannot weight bear/ immobile 
 
 
Mobility problems 
Continent  Continent 
Occasional accidents 
Incontinent at night only 
 
Urinary 
continence 
Incontinent 
Incontinent 
Continent  Continent 
Occasional accidents 
Incontinent at night only 
 
Bowel continence 
Incontinent 
Incontinent 
 
A diagnosis of autism which had previously made and recorded in the case notes was 
reviewed  as  part  of  the  structured  psychiatric  assessment.  In  circumstances  where  an 
individual was believed to have autism by family or paid carers, or clinical services, but 
no formal record of the process and diagnosis was available a diagnostic assessment was 
carried out at the time of the original psychiatric assessment. 
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3.4.2.1 Level of intellectual disabilities- Vineland’s Adaptive Behaviour Scales 
The Vineland’s Adaptive Behaviour Scales are widely used as a measure of intellectual 
functioning, and adaptive behaviour. The instrument is completed with a carer, or other 
informant, and assesses a person’s level of abilities in three domains: 
·  Communication  
·  Daily Living Skills 
·  Social Functioning. 
 
A  standardised  scoring  system  generates  raw  scores  for  each  domain.  Using  tables 
derived  from  population  normative  data,  age  equivalent  scores  for  each  domain  are 
calculated.  These  age  equivalent  scores  are  indicative  of  the  level  of  intellectual 
disabilities as described in ICD-10: 
·  0- 3 years equivalent to profound intellectual disabilities 
·  3-6 years equivalent to severe intellectual disabilities 
·  6-9 years equivalent to moderate intellectual disabilities 
·  9-12 years equivalent to mild intellectual disabilities. 
 
 
3.4.3 Measures of severity and outcome 
It is suggested that severity and outcome measurement in mental disorders should involve 
the use a battery of measures, encompassing multiple domains (Jacobson et al. 1999; 
Slade 2002). Models of outcome measurement have been proposed for use in mental 
health for adults who do not have intellectual disabilities.  For example, a systematic 
review of the use of outcome measures, categorised them into seven domains- well being, 
cognition/  emotion,  behaviour,  physical  health,  interpersonal,  society,  services  (Slade 
2002).  Although  studies  involving  participants  with  intellectual  disabilities  have  used 
instruments  relevant  to  these  domains,  outcome  measures  in  general  are  less  well 
established  in  the  field  of  intellectual  disabilities.  Few  studies  have  established  the 
psychometric  properties  of  instruments  used  to  measure  outcome,  and  in  particular 
evidence is lacking on the sensitivity to change of measures used in mental ill health. 
 
In order to examine the research null hypotheses, measures were chosen that could be 
applied across all level of abilities, and diagnoses of mental disorders. 
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3.4.3.1 Health of the Nation Outcome Scales- Learning Disabilities (HONOS-LD) 
The Health of the Nation Outcome Scales (HoNOS) are a family of parallel instruments 
developed as a measure of outcome for use with individuals with mental disorders (Wing 
1998). Conceived as a simple scale to provide a structured measurement of outcome, the 
HoNOS scales encompass key aspects of mental health and social functioning. Unlike 
most outcome measures, HoNOS is designed to be used with individuals with mental 
disorders, regardless of the diagnosis and the original version has been used to measure 
outcome in research and routine clinical practice. The original generic scale has been 
shown to be reliable, valid and sensitive to change (Pirkis et al. 2005) and served as the 
basis  for  the  development  of  versions  of  the  HoNOS  for  use  with  children  and 
adolescents  (HoNOSCA),  older  people  (HoNOS65+)  and  groups  of  individuals  with 
different needs, such as adults with intellectual disabilities.  
 
The Health of the Nation Outcome Scales for People with Learning Disabilities (HoNOS-
LD) was developed to take into account the specific needs of individuals with intellectual 
disabilities (Roy et al. 2002). HoNOS-LD has 22 items, which are rated on a five point 
scale (0= no problem, 1 = mild problem, 2 = moderate problem, 3 =severe problem, 4 = 
very severe problem). For each individual item, there is a specific descriptor for each 
rating on the five-point scale. The scores for each of the 22 items are added together to 
give a total (HoNOS-LD total, range = 0-44). In table 3.6 below, the names of the items 
included in HoNOS-LD are provided. 
 
The  original  work  to  develop  HoNOS-LD  suggested  it  had  adequate  reliability,  and 
validity and sensitivity to change to be used as a measure of outcome (Roy et al. 2002). 
Subsequently, there have been relatively few published studies that have reported on its 
use in research, or clinical settings. A recent study reported that it is a more reliable and 
valid measure of outcome in adults with mild/borderline intellectual disabilities than the 
generic  HoNOS  (Tenneij  et  al.  2009).  Significant  between  group  differences  in  the 
HoNOS-LD total score (Dowling et al. 2006) were described in a randomised controlled 
trial of a bereavement intervention, confirming that it has adequate sensitivity to change. 
Finally,  in  a  follow-up  study  to  look  at  the  effectiveness  of  a  specialist  intellectual 
disabilities clinical service, HoNOS-LD was shown to have good discriminant validity- 
between inpatient and community service users- and was sensitive to change over time 
(Hall et al. 2006).    94 
 
3.4.3.2 Camberwell Assessment of Need- Intellectual Disabilities (CANDID) 
The measurement of the needs of individuals with mental disorders is well established, 
with  several  available  instruments  and  a  significant  theoretical  and  research  evidence 
base.  
 
A commonly used instrument to measure needs is the Camberwell Assessment of Need 
(CAN), which has been shown to have good reliability and validity (Phelan et al 1995). 
Needs measured using the CAN have been shown to be associated with quality of life 
(Slade  et  al.  1999;  Slade  et  al.  2004)  and  has  been  used  to  examine  the  utility  of 
dimensions of psychopathology (van Os et al. 1999a). Similar to the HoNOS, the CAN 
has been used to develop a family of instruments for use across different clinical groups.  
 
For  the  purpose  of  measuring  need  in  adults  with  intellectual  disabilities  and  mental 
disorders,  the  Camberwell  Assessment  of  Need  for  Adults  with  Developmental  and 
Intellectual Disabilities (CANDID; Xenitidis et al. 2000) was developed by modifying 
the CAN (Phelan et al. 1995). Like all versions of the CAN, there is a short (CANDID-S) 
and a research version of the CANDID (CANDID-R). The description below refers to the 
CANDID-R  which  was  the  version  used  in  the  study  described  in  this  thesis.  The 
CANDID-R  measures  need  across  25  domains  (see  table  3.6),  in  keeping  with  a 
biopsychosocial model of health. The timescale used to rate the CANIDID-R is the four 
weeks prior to the interview and participants are asked to rate whether a need is present, 
and if so whether it is currently met or unmet  Only if a need is present are the other three 
sections of CANDID-R completed-section 2 rates how much help the person receives 
from friends or relatives with the need; section 3 rates how much help the person receives 
from local services; section 4 rates whether the person is receiving the right type of help, 
and their satisfaction with the amount of help they receive). For rating need in the 25 
domains, there are four possible scores: 
·  no need (score=0) 
·  met need (score=1) 
·  unmet need (score=2) 
·  unknown (score=9). 
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The ratings for each domain are combined to give three summary variables- total number 
of unmet needs,  total number of met needs,  total number of needs (calculated by adding 
together  the  number  of  met  and  unmet  needs).  In  conceptualising  results  from  the 
CANDID-R as a measure of outcome it is worth noting that a lower number of unmet 
needs, and higher number of met needs are considered indicative of a better outcome. 
 
It  is  standard  practice  to  report  all  three  summary  variables,  as  will  be  done  for 
descriptive  statistics  in  the  results  in  chapter  4.  Since  the  total  needs  variable  is  a 
composite of the unmet and met needs variable, including it in statistical analyses would 
contravene best practice guidance on avoiding the use of data more than once in analyses. 
Therefore,  the  total  needs  variable  was  not  included  in  bivariate  and  multivariate  to 
answer the research hypotheses. 
 
CANDID been shown to be a reliable and valid measure of met, and unmet health needs 
in adults with intellectual disabilities (Xenitidis et al. 2000). CANDID-S has been used in 
several studies since its publication and found to be a valid measure of need (Strydom et 
al. 2005; Hall et al. 2006), have discriminant validity (Hall et al. 2006) and be sensitive 
to change over time (Hall et al. 2006). 
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Table 3.6: Individual items rated on the HONOS-LD and CANDID 
 
 
HoNOS-LD items   CANDID items 
1. Behaviour problems- directed to others  1. Accommodation 
2. Behaviour problems- directed to self  2. Food 
3a. Behaviour destructive to property  3. Looking after the home 
3b. Problems with personal behaviours  4. Self-care 
3c. Stereotyped and ritualistic behaviours  5. Daytime activities 
3d. Anxiety, phobias, obsessive compulsive behaviour  6. General physical health 
3e. Other problem behaviours  7. Eyesight/ hearing 
4. Attention and concentration  8. Mobility 
5. Memory and orientation  9. Seizures 
6. Communication (problems in understanding)  10. Major mental health problems 
7. Communication (problems in expression)  11. Other mental health problems 
8. Problems with hallucinations and delusions  12. Information 
9. Problems with mood changes  13. Exploitation risk 
10. Problems with sleeping  14. Safety to self 
11. Problems with eating and drinking  15. Safety to others 
12. Physical problems  16. Inappropriate behaviour 
13. Seizures  17. Substance misuse 
14. Activities of daily living at home  18. Communication 
15. Activities of daily living outside the home  19. Social relationships 
16. Level of self-care  20. Sexual expression 
17. Problems with relationships  21. Caring for someone else 
18. Occupation and activities  22. Basic education 
23. Transport 
24. Money budgeting 
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3.4.3.3 Global Assessment of Functioning (GAF) 
In keeping with recommendations to include a global measure of functioning in multi- 
dimensional batteries of outcome measures, the GAF (American Psychiatric Association 
2000)  was  used.  It  was  completed  based  on  case  note  data  for  all  participants  from 
sample  two,  and  completed  a  second  time  for  individuals,  from  sample  two,  who 
participated in the follow-up, research interview.  
 
GAF provides a single measure of social, occupational and psychological functioning in 
adults, on a continuous scale ranging from 1-100, with 100 representing the best possible 
functioning. The 100 point scale is divided into 10 subsections, each one covering 10 
points  on  the  scale  e.g.  1-10,  11-20  etc.  Each  subsection  has  written  symptom  and 
behavioural descriptors.  
 
The instructions for completing the GAF in DSM-IV TR were followed, rating the week 
prior to the interview date. Starting at the top subsection (100-91) the person scoring the 
GAF considers, “ is either the individuals symptom severity OR level of functioning 
worse than indicated in the range description?”. If so, the person scoring the GAF moves 
down the scale until the subsection with descriptors that best matches the individual’s 
symptom severity OR level of functioning is reached, whichever is worse. The person 
then double checks that the correct subsection has been selected, the lower subsection has 
examined to ensure that the descriptors are too severe on both symptom severity and 
length of functioning. To determine the specific GAF rating within the 10- point range, 
the person scoring the GAF consider whether the individual is functioning at the higher 
or lower end of the 10 point range, and selects an appropriate score. 
 
There is a little available data on the psychometric properties of the GAF from studies 
including  adults  with  intellectual  disabilities  as participants.  One  study  examined  the 
inter-rater reliability of GAF scores rated by 19 health professionals, some of whom did 
not  work  with  persons  with  intellectual  disabilities.  Participants  rated  case  vignettes 
describing  psychopathology  experienced  by  adults  with  intellectual  disabilities  on  the 
caseloads of psychiatrists. The participants received training to use the GAF as indicated 
in DSM-III-R (Oliver et al. 2003). Overall inter-rater reliability was fair (r= .49), and the 
authors concluded that the GAF was unreliable for use in intellectual disabilities, if used 
as described in DSM-III-R.   98 
 
A second study used the GAF as one of several measures of the severity and outcome of 
mental disorders in adults with intellectual disabilities (Hall et al. 2006). Two groups of 
service  users  were  included  in  the  study-  inpatients  (n=  19)  and  outpatients  (n=  18) 
receiving  care  from  specialist,  community  intellectual  disabilities  services.  Other 
measures used at baseline and follow-up at six months were the HoNOS-LD, CANDID-S 
and the Threshold Assessment Grid (TAG, Slade et al. 2000). The TAG is a method of 
assessing  clinical  risk  developed  for  use  with  adults  who  do  not  have  intellectual 
disabilities. All ratings were completed by unblinded intellectual disabilities psychiatrists, 
who rated the standard scoring method for the GAF. Although the two groups differed on 
the HoNOS-LD (t= -2.068, p= .046), CANDID-S unmet needs (U=72.5, p= .040) and 
TAG (t=-4.038, p<.001) at baseline, there was no between group difference in the GAF 
scores  (t=1.424,  p=.163).  Whilst  the  GAF  had  poor  discriminant  validity  between 
inpatient and community service users, it had similar sensitivity to change to the HoNOS-
LD, CANDID-S and TAG- in both groups (Hall et al. 2006). 
 
The issues with the inter-rater-reliability and discriminant validity of the GAF in these 
studies is likely to be due to the use of the standard method of scoring (Oliver et al. 2003; 
Hall  et  al.  2006).  A  problem  arises  when  scoring  the  GAF  for  individuals  with 
intellectual disabilities because the impact of a person’s intellectual disabilities on  level 
of functioning, could give an artificially low score (Hurley, 2001; Shedlack et al. 2005; 
Hurley et al. 2007). To take account of this, the GAF was rated in this thesis using an 
adapted methodology (Hurley, 2001). Similar to the recommended scoring system for 
persons  with  physical  disabilities,  the  impact  on  functioning  of  impairments  due  to 
intellectual disabilities is excluded from the GAF rating. The rating is based solely on 
symptoms and level of functioning where there has been a clear change in functioning 
related to the onset of psychopathology, associated with an episode of a mental disorder.  
 
3.4.3.4 Clinical Global Impression (CGI) 
Given the limited evidence on the use of the GAF in studies with adults with intellectual 
disabilities as participants, the CGI was rated as a second global measure of functioning, 
at the same time as the GAF. 
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The CGI scales are designed to be completed by a clinician. Only the CGI scale that rates 
severity of illness was used for the study. The most severe level of illness over the past 
week was rated, on a seven point scale: 
1.  normal, not ill at all 
2.  borderline mentally ill 
3.  mildly ill 
4.  moderately ill 
5.  markedly ill 
6.  severely ill 
7.  among the most severely ill. 
 
The CGI has been shown to be reliable in studies that include adults who do not have 
intellectual disabilities as participants (Dahlke et al. 1992; Zaider et al. 2003). However, 
although  the  CGI  has  been  used  in  adults  with  mental  disorders  and  intellectual 
disabilities (Van den Borre et al. 1993; McDougle et al. 1998) no studies have previously 
examined the psychometric properties of the CGI when used in intellectual disabilities 
research.  
 
3.4.3.5 Calculating the scores for the measures of longitudinal outcome 
Cross-sectional scores at time 1 for the five measures were used as the measure of the 
severity of mental disorders. For individuals in sample 2, who participated in the follow-
up study, the longitudinal measures of outcome used in the analyses were based on the 
change in the measures of severity between time 1 and time 2. For each measure, this was 
calculated by subtracting the score on the measure of outcome at time 2 (follow up) from 
the score at time 1 (baseline). 
 
The scoring format of the GAF differs from the other four measures. A higher score on 
the GAF represents a lower severity, whereas for the HoNOS-LD, CGI and CANDID-R a 
higher score represents a greater severity. Therefore, to facilitate comparison across the 
five  measures  the  polarity  of  the  GAF  score  representing  longitudinal  outcome  was 
reversed. 
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Therefore, for all measures: 
·  a negative score represents a poorer outcome than a positive score i.e. the score on the 
measure at time 2 is greater than at time 1 
·  a higher positive score represents a better longitudinal outcome than a lower positive 
score 
·  a  higher  negative  score  represents  a  poorer  longitudinal  outcome  than  a  lower 
negative score.  
 
Table 3.7 provides details of the methods of assessment used to collect data from the 
three samples, organised in the domains of psychopathology, level of functioning and the 
severity of mental disorders. 
 
Table 3.7: Methods of assessment used to collect data from samples 1, 2 and 3 
 
 
  Domain and method of assessment  
Sample  Psychopathology  Level of functioning  Severity 
Sample 1  Standardised psychiatric 
examination 
PPS-LD 
Vineland’s Adapative 
Behaviour Scales 
N/A 
Sample 2  Standardised psychiatric 
examination 
PPS-LD 
 
Vineland’s Adapative 
Behaviour Scales 
HoNOS-LD 
GAF 
CGI 
CANDID-R 
Sample 3  Standardised psychiatric 
examination 
PPS-LD 
Vineland’s Adapative 
Behaviour Scales 
HoNOS-LD 
GAF 
CGI 
CANDID-R 
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3.5 Statistics and analysis of data 
Quantitative data relevant to the work reported in this thesis was first entered into SPSS 
version 15.0. However, since the data from the PPS-LD for use in the EFA is binary 
appropriate  methods  of  factor  analysis  were  used,  using  TESTFACT  4  software 
(Woods et al. 2003). 
 
A  general  description  of  statistical  methods  used  to  test  multiple  null  research 
hypotheses is given followed by any methods specific to each null hypothesis. 
 
3.5.1 Methods to assess whether variables are distributed normally 
Parametric statistical tests are preferred in any analysis, since they are more reliable and 
powerful than non-parametric tests. A key assumption in the use of parametric tests is 
that the variables used in the analysis are normally distributed. Therefore, to decide on 
the  use  of  parametric  or  non-parametric  tests,  the  distribution  of  the  continuous 
measures of psychopathology, age and measures of severity and outcome was explored 
using  a  histogram  and  normal  distribution  plot.    Statistical  tests  of  the  skewness, 
kurtosis and difference of the distribution from normality were also calculated. 
 
The  histogram  and  normal  distribution  plot  allowed  a  visual  comparison  of  the 
distribution of the variable of interest against the normal distribution. In the histograms, 
a line representing the normal distribution is superimposed on the histogram. A variable 
with a normal distribution will be represented by a straight diagonal line in a normal 
probability plot. Superimposing a straight line on the normal probability plot allows 
visual  inspection  of  how  similar  the  distribution  of  a  variable  is  to  the  normal 
distribution.  
 
Skewness refers to the symmetry of the distribution. A normally distributed variable is 
symmetrically  distributed  around  the  mean  and  has  a  skewness  score  of  zero.  If  a 
variable has a frequency distribution clustered around the lower values, and a longer 
tail moving towards the higher values then it has a positive skew, and the skewness 
score will be greater than zero. Alternatively, higher frequencies of the higher values 
and a longer tail towards the lower values is a negative skew and the skewness score is 
less than zero.  
   102 
Kurtosis refers to the peakedness of a distribution. Whereas the normal distribution 
follows the shape of a bell, variables with high frequencies of values in the tails on 
either side of the mean, have a flat distribution and a negative kurtosis score- described 
as a platykurtic distribution. If there is a higher frequency of values clustering close to 
the mean the variable will have a pointed distribution and a positive kurtosis score- 
described as a leptokurtic distribution. 
 
To obtain a standardised measure of skewness and kurtosis, the z-scores are calculated, 
by dividing the original scores by the standard error of the respective score. If the z-
score is greater than 1.96 the skewness or kurtosis of the distribution differs from the 
normal distribution at a level of significance of p < .05, with the significance level 
increasing to p < .01 if the z-score is greater than 2.58 and p < .001 above z-scores of 
3.58. 
 
As  well  as  the  skewness  and  kurtosis  z-scores,  there  are  two  tests  available  that 
examine  whether  the  overall  distribution  differs  significantly  from  normality-  the 
Kolmogorov-Smirnov  and  Shapiro-Wilk  test.  Since  the  Shapiro-Wilk  test  is  more 
reliable, particularly when used with samples greater than 30, only it was used in the 
analyses. The closer the Shapiro-Wilk test score is to 1, the closer the distribution is to 
a normal distribution, and p values represent the significance of any difference from 
normality. 
 
Where the graphical and statistical methods suggest the distribution of a variable differs 
significantly from normality, data transformations were carried out in an attempt to 
move  the  distribution  closer  to  normality.  These  transformations  are  of  particular 
relevance when the distribution of a variable differs from the normal distribution due to 
skewness, rather than kurtosis. Three data transformations for positively skewed data 
are taking the square root (√ X), the logarithm (log
10 X) and the inverse of the variable 
(1/X). Since these have an increasing hierarchical effect on positively skewed data they 
were used sequentially. The square root transformation was tried first and the graphical 
and  statistical  methods  described  above  were  then  repeated  to  test  whether  the 
distribution was now closer to normality. If there was still a significant difference from 
normality, the logarithmic transformation and, if needed, the inverse transformations   103 
were  tested  using  similar  methods.  The  least  transformation  which  moves  the 
distribution of the variable closer to normality was used.   
 
There are problems with the use of square root, logarithmic and inverse transformations 
with variables with negative values, zeros or many scores between zero and one. This is 
an issue that is relevant to all the variables but particularly the dimension factor scores, 
which include negative values. To take account of this, prior to any transformation a 
constant was added to each individual variable to anchor them all at a minimum score 
of one. For the dimension symptom counts and overall measures of psychopathology, 
one was added to each variable score so that the minimum score of each variable is one. 
Since  the  dimension  factor  scores  have  negative  values  a  different  method  of 
calculating the constant was needed. First the minimum value for the dimension factor 
score was identified. This minimum value was converted to a positive integer and the 
constant calculated by adding one. For example, for a dimension with a minimum score 
factor score of – 1.92, the constant is calculated as 1.92 + 1 and added to the original 
score for each case.  
 
These methods were used to examine the distribution of measures of psychopathology, 
age  and  measures  of  severity  and  outcome,  prior  to  their  use  in  bivariate  and 
multivariate analyses.  
 
3.5.2 Methods to test null research hypothesis one 
 
Data on psychopathology from the PPS-LD was used to examine null hypothesis one, 
rather than data collected using the standardised psychiatric examination. 
 
Psychopathology data collected using the PPS-LD has improved reliability compared to 
psychopathology  data  collected  using  the  standardised  psychiatric  examination.  The 
Null hypothesis one: 
There  are no stable, identifiable dimensions of psychopathology  experienced by 
adults with intellectual disabilities. 
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reliability of the PPS-LD is maximised by the structured format, use of language and 
prompts appropriate to the level of functioning of adults with intellectual disabilities and 
the  consistent  description  of  criteria  which  are  required  to  be  met  for  the  item  of 
psychopathology to be rated positively.  
 
Further contributions to the reliability of the use of the PPS-LD come from training on 
the  use  of  the  PPS-LD.  All  intellectual  disabilities  psychiatrists  involved  in  data 
collection  received  training  on  the  use  of  the  PPS-LD,  including  shadowing  a  senior 
intellectual disabilities psychiatrist to observe the use of the PPS-LD, and completing the 
PPS-LD in parallel with the senior intellectual disabilities psychiatrist to check the inter-
reliability reliability of the ratings of psychopathology. 
 
3.5.2.1 Exploratory factor analysis to identify dimensions of psychopathology 
To examine the dimensions of psychopathology experienced by adults with intellectual 
disabilities an exploratory factor analysis (EFA) was carried out on data gathered using 
the PPS-LD. Factor analysis is a commonly used statistical method that examines the 
correlations between variables, in order to identify variables that cluster together  and 
define  latent  dimensions  underlying  a  dataset.  A  model  is  created  with  a  number  of 
common factors, with variables clustering together and loading onto specific common 
factors and not others. Like any statistical analysis, the reliability of the factor analysis is 
dependant on the quality of the available data. Furthermore, there are some key decisions 
for  the  researcher  to  make,  depending  on  the  data  and  aims  of  the  analysis.  For  the 
purposes of this EFA published “best practice” guidelines were followed (Costello & 
Osborne 2005) for: 
·  the sample size and case: variable ratio 
·  the statistical method used for factor extraction– common factor analysis 
·  method to decide on number of factors retained for rotation after factor extraction- 
scree test 
·  method of rotation- oblique 
·  minimum accepted item loading to a factor to ensure factor reliability= 0.32  
·  minimum number of items loading onto a factor to ensure factor stability= 3. 
 
Expanded details of these aspects of the EFA are given in separate sections below.    105 
 
3.5.2.2 Sample size required for exploratory factor analysis 
General guidelines on the sample size required to generate a stable factor solution from 
EFA  suggest  that  the  ratio  of  cases  to  variables  should  be  at  least  5:1  (Costello  & 
Osborne 2005), with a total sample size of 300 (Tabachnik & Fidell 2001). To achieve 
these two requirements, PPS-LD data from sample 1 (n=274) and sample 2 (n=150) was 
merged  to  give  a  sample  size  of  424.  Since  the  EFA examines  associations  between 
variables, cases that only scored positively for one or less items of psychopathology (n= 
84) were excluded leaving 340 cases for the EFA, with a case: variable of 8:1 (outlined in 
figure 3.2). 
 
3.5.2.3 Items of psychopathology included in the EFA 
All items on the PPS-LD were converted to a binary score (0=not present, 2=present). 
For  the  three  items  scored  on  a  three  point  scale  (worry/  apprehension,  tearfulness, 
reduced self care), where an individual scored positively, regardless of the extent (1=a 
bit,  2=yes)  the  item  was  scored  as  present.  Since  this  thesis  is  focussed  on 
psychopathology experienced as part of an episode of mental disorders, where an item 
was rated as present as a trait/ characteristic (trait=7) this was converted to a score of not 
present. 
 
For  the  two  PPS-LD  questions  that  rate  multiple  items  of  psychopathology  (sleep 
problems and diurnal mood variation) separate variables were created: 
1.  Original question- sleep problems  
·  initial insomnia (0=not present, 2=present) 
·  mid-insomnia (0=not present, 2=present) 
·  early morning wakening (0=not present, 2=present) 
·  increased sleep during the day (0=not present, 2=present) 
·  reversed sleep pattern (0=not present, 2=present) 
·  reduced need for sleep (0=not present, 2=present) 
2.  Original question- diurnal variation in mood 
·  mood worse in evening (0=not present, 2=present) 
·  mood worse in morning (0=not present, 2=present) 
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3.5.2.4 Selection of items of psychopathology for entry into the EFA 
To maximise the stability of the solution extracted via the EFA careful consideration was 
given to which items from the PPS-LD to include in the EFA. Only items from the PPS-
LD directly related to the presence of a specific item of psychopathology were considered 
for inclusion in the EFA. Figure 3.2 outlines the process used to decide which of the PPS-
LD items were used for the EFA. 
 
Since the mental state items and items of psychopathology are fundamentally different, it 
was decided to exclude the 22 items of the examination from the EFA. These mental state 
items  are  rated  by  the  clinician  rating  the  PPS-LD  based  on  observation  during  the 
clinical interview. In contrast, the items of psychopathology are rated based upon the 
description by participants and carers of the person’s mood, behaviour and functioning 
over  the  past  four  weeks.  Exclusion  of  the  mental  state  items  left  90  items  of 
psychopathology for possible inclusion in the EFA.   107 
Figure 3.2: Flowchart of selection of PPS-LD items for inclusion in exploratory factor 
analysis  
 
 
Does PPS-LD item relate directly to psychopathology 
over past 4 weeks  
Is the item of psychopathology scored positively in 
at least 5% of the sample? 
No 
N= 14 
Yes  
N= 41 
Is rating of the item dependant on the participant 
communicating verbally in sentences? 
No 
N= 55 
Yes 
N= 11 
EFA including items of psychopathology able to 
be rated for entire sample  
 
Number of items = 41 
Number of cases = 330 
Case: item ratio = 8:1 
Total PPS-LD items (excluding MSE items) 
N= 90 
Yes (Table 8) 
N= 66 
No- exclusion of items 
rating onset, duration and 
previous psychopathology 
N= 24   108 
Twenty four items relating to the presence of physical health problems, previous episodes 
of  mental  disorders,  onset  of  symptoms  and  previous  response  to  treatment  were 
excluded, leaving a total number of 66 PPS-LD items shown in table 3.5.  
 
There are 11 items in the PPS-LD which are highly dependant on verbal communication, 
and recommended not to be rated unless an individual uses sentences to communicate. A 
significant number of individuals in sample 1 and sample 2 were unable to self-report on 
these items of psychopathology. Therefore, as indicated in table 3.7, these items were 
excluded from the exploratory factor analysis.  
 
The reliability of a factor solution can be affected by the inclusion of items that score 
positively infrequently (low variance), or where two or more items are strongly correlated 
(correlation coefficient > 0.9 = high collinearity). To screen for this the frequency of 
occurrence of, and correlation between, individual items were examined. 
 
There were 14 items of psychopathology from the PPS-LD which scored positively in 
less than 5% of cases, and were excluded from the EFA (see table 3.7). Since there were 
no items with correlations > 0.9, no items met the criteria for high collinearity. Therefore, 
a total of 41 items of psychopathology from the PPS-LD were retained for inclusion in 
the EFA, highlighted in bold in table 3.7.  
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Table 3.8: Items of psychopathology in the PPS-LD  
 
 
  I. Worry, anxiety and phobias  34  Loss of financial skills * 
1  Worrying  35  Word finding problems * 
2  Generalised anxiety  36  Change in personality 
3  Agoraphobia  37  Loss of energy 
4  Social phobia *  38  Increased energy levels 
5  Animal phobia    V. Sleep, appetite, & concentration 
6  Specific phobia  39  Initial insomnia 
7  Increased need for reassurance  40  Mid-insomnia 
8  Increased somatic complaints   41  Early morning wakening 
  II. Obsessional phenomena  42  Increased daytime sleeping 
9  Rituals  43  Reversed sleep pattern * 
10  Excessive orderliness  44  Reduced need for sleep * 
11  Obsessional cleanliness *  45  Loss of appetite 
12  Intrusive, distressing thoughts †  46  Increased appetite 
  III. Changes in mood  47  Weight loss 
13  Low mood  48  Increased weight 
14  Increased mood lability  49  Diurnal variation-worse in the 
morning 
15  Irritable mood  50  Diurnal variation-worse in the 
evening 
16  Social withdrawal  51  Less able to concentrate 
17  Anhedonia  52  Loss of interest in sex * 
18  Tearfulness    VI. Changes in behaviour 
19  Ideas of guilt †  53  Increased verbal aggression 
20  Preoccupied with morbid thoughts †  54  Reduced verbal aggression * 
21  Loss of self-esteem †  55  Increased physical aggression 
22  Loss of hope for the future †  56  Reduced physical aggression * 
23  Expansive mood *  57  Self harm/ self-injurious behaviour 
  IV. Functioning, activities & 
energy 
58  Inappropriate sexual behaviour/ 
libido 
24  Reduced quantity of speech  59  Reckless, irresponsible behaviour * 
25  Increased quantity of speech  60  Social disinhibition * 
26  Reduced self-care skills    VII. Psychosis 
27  Reduced cognitive functioning  61  Delusions † 
28  Forgetting names  62  Auditory hallucinations † 
29  Gets lost in familiar places  63  Visual hallucination † 
30  Reduced verbal comprehension  64  Schneider’s first rank symptoms † 
31  Memory problems  65  Impossible, bizarre delusions † 
32  Mixing up day and night *  66  Mood incongruous delusions † 
33  Loss of literary skills*     
 
* Items rated positively in less than 5% of cases 
† Items only rated if the individual communicates verbally in sentences. 
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3.5.2.5 Extraction of factors 
The two commonest methods of factor analysis used are common factor analysis (CFA) 
and  principal  components  analysis  (PCA).  There  are  concerns  over  the  use  of  these 
methods  with  categorical  data,  and  several  alternative  statistical  methods  have  been 
developed to take account of this, such as non-linear PCA, used in CATPCA in SPSS 
(Meulman  et  al.  2004),  and  item  factor  analysis,  used  in  TESTFACT  (Woods  et  al. 
2003). Item factor analysis and TESTFACT were used as these were more specifically 
developed  for  use  with  binary  data,  and  have  been  used  previously  in  EFA  of 
psychopathology binary data (Allardyce et al. 2007a). 
 
A  key  decision  for  a  researcher  is  the  number  of  factors  to  extract.  The  first  factor 
extracted  comprises  the  combination  of  items  accounting  for  the  greatest  amount  of 
variance.  Subsequent  factors  extracted  account  for  gradually  reducing  amounts  of 
variance (Field 2005a). Rather than accepting the maximum number of factors extracted, 
the majority of which account for a too small an amount of variance to be relevant, and 
are unstable, the researcher has to decide how many factors to extract for the final factor 
solution.  Although  there  are  no  absolute  rules  on  which  to  base  this  decision,  some 
general guidance is available on how best to manually select the number of factors to 
extract. 
 
One method is to base the decision on the eigenvalues of extracted factors (reported for 
studies in table 1.2). The eigenvalue is the sum of the squared item loadings on a factor, 
and represents the total amount of variance accounted for by a factor.  To calculate the 
proportion of the total variance accounted for by a factor the eigenvalue of the factor is 
divided by the number of the variables in the factor analysis. For example, if there are 20 
variables in the dataset, an extracted factor with an eigenvalue of 1, accounts for 0.05, or 
5%, of the total variance.  Commonly, researchers take the decision to include all factors 
with an eigenvalues greater than one. However, recommended best-practice suggests that 
this is the least appropriate strategy (Costello & Osborne 2005). Research has suggested 
that there are some circumstances when extracting all factors with an eigenvalue greater 
than one is more likely to be accurate, such as when the number of variables is less than 
30. However, as long as the sample size is more than 200 the recommended method is to 
use the scree test (Field  2005a).   111 
The scree test is carried out by plotting each eigenvalues (y-axis) against the relevant 
factor (x-axis). Such a scree plot has a typical shape (see figure 3.3 for an example), 
characterised by a steep line, representing the eigenvalues of the initial factors extracted, 
followed by a long tail of factors accounting for a smaller proportion of the total variance, 
with much smaller eigenvalues. The initial number of factors to extract is one less than 
the factor at which the break point in the scree plot occurs.  
 
In figure 3.3 below, the break point occurs at factor 4 and so the suggested starting point 
is  the  extraction  of  three  factors.  However,  it  is  common  practice  to  also  carry  out 
analyses extracting one more and one less factor than suggested by the scree plot. To 
decide on the final factor solution, interpretation of the three analyses is carried out to 
examine aspects relevant to factor stability- the number of items loading onto a factor, 
and the strength of the item loadings- and finally the practical relevance of the factor 
solutions. It can be seen from figure 3.3 that extracting factors with eigenvalues above 
one would suggest a six factor solution, and can, therefore, potentially produce a quite 
different factor solution.  
 
Figure 3.3: The use of eigenvalues in a scree plot to determine the number of 
factors to extract 
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3.5.2.6 The significance of item loadings on factors 
When a factor analysis is carried out, a loading for each item to the individual factors is 
calculated. The researcher decides which items are significant to the factor, usually by 
examining the size of the item loadings on the factor. A standard approach- again based 
on general guidance, rather than hard and fast rules- is to set a cut off for the minimum 
item loading accepted as significant.  
 
An item loading is the correlation of the item and the factors, and so the squared item 
loading represents the amount of an item’s total variance accounted for by the factor. 
The minimum item loading accepted as significant is usually taken as 0.32, since this 
translates to the factor accounting for 10% of the variance of the item (Field 2005a). A 
second approach links the statistical significance of an item loading to the sample size, 
with the recommendation that for a sample size of 200 a significant item loading is 
greater than 0.364, and for a sample size of 300 an item loading of 0.298 is significant. 
Since the sample size used in the EFA reported in chapter 3 is greater than 300, a 
minimum item loading of 0.32 will ensure greater stability of the factor solution.  
 
A second issue relevant to factor stability is the number of items with loadings above 
the accepted cut-off for significance- in this case, 0.32. The consensus is that factors 
with less than three items with significant loadings are unstable (Costello & Osborne 
2005).  Hence,  it  was  decided  that  only  factors  with  three  or  more  items,  and  with 
loadings greater than 0.32 would be retained in the final factor solution 
 
3.5.2.7 Rotation of factors  
Best practice suggests that rotation of initial factors should always be carried out to 
examine  whether  it  produces  a  clear  and  more  meaningful  solution  (Costello  & 
Osborne 2005). 
 
In exploratory factor analysis, the initial solution extracts factors based on the relative 
size of their contribution to the total variance. This tends to lead to the extraction of one 
general factor accounting for a large part of the variance, and several additional factors 
making smaller, and smaller, contributions to the overall variance (Field 2005a). As 
part of this initial solution items can load onto several different factors- known as cross-
loading. By maximising the loading of individual items onto the factor they make the   113 
biggest contribution to,  rotation of the factors  minimises the cross-loading of items 
across  multiple  factors  and  therefore,  derives  a  factor  solution  that  is  more 
straightforward, and potentially easier to interpret (Field 2005a). 
 
A graphical representation of factor solutions helps to explain rotation of factors (Field 
2005a). Figure 3.4 below has a graphical representation of a factor analysis. Six items 
included in the factor analysis are represented in the figure by the letters a-f. A two 
factor solution is shown with factor I represented on the x axis and factor II on the y 
axis (adapted from Field 2005a). The loadings for individual items to the two factors 
can be derived by drawing a perpendicular line to factor I (x-axis) and factor II (y-axis). 
It is clear that there are two clusters of items a-c and d-f. For the unrotated factors, the 
axes are represented by the x and y axes, the axes for the orthogonal rotated factors by 
broken lines and the axes for the oblique rotated factors by bold lines.  
 
From the un-rotated solution, variables a-c have high loadings on factor I, and d-f have 
moderate loadings on both factors (cross-loading).  
 
There  are  two  methods  of  rotation-  orthogonal  and  oblique.  The  assumption  for 
orthogonal rotation is that the factors are uncorrelated, and therefore the axes are held at 
90 degrees to one another. In an oblique rotation, the factors are allowed to correlate 
and so the axes are free floating (not always maintained at 90 degrees). The oblique 
rotation in figure 4 shows that when the axes are allowed to correlate, items can load 
together strongly to the most relevant factor. Following the oblique rotation the high 
loading of items a-c on factor I are maintained whilst maximising the loading of items 
d-f on factor II on which it has the greater loadings.  
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Figure 3.4:  Graphical representation of orthogonal and oblique rotations of a 
two factor solution 
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Since oblique rotation is recommended as best practice (Costello & Osborne 2005), and 
previous research highlighted the potential relevance of correlations between dimensions 
of psychopathology in defining higher order internalising and externalising dimensions, 
an oblique rotation using the PROMAX methodology used in the EFA.  
 
Orthogonal 
rotation factor II 
Oblique rotation 
factor II 
Orthogonal 
rotation factor I 
Oblique rotation 
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3.5.2.8 Examining the stability of the factor solution 
To assess the stability of the factor solution the sample (n=330) was randomly split and 
the factor analysis repeated separately for the two random samples (Tabachnik & Fidell 
2001). To maintain the minimum case: item ratio of 5:1 each sample needed a minimum 
of 205 cases.  
 
SPSS was used to select a random sample of 205 cases from the 330 used in the EFA.  
The EFA extracting four factors was run for this first random sample. A second random 
sample  of  205  cases  was  selected  from  the  original 330  and  the  EFA  run  again.  To 
compare  the  stability  of  the  factor  solution  across  the  two  halves,  Pearson  product 
moment correlations were done to compare the item loadings between the two factor 
solutions (Tabachnik & Fidell 2001).  
 
3.5.2.9 Calculation of measures representing dimensions of psychopathology 
The  rotated  factor  solution  was  used  to  derive  measures  for  each  dimension  of 
psychopathology,  based  on  calculated  factor  scores.    A  factor  score  is  a  composite 
measure representing the degree to which an individual scores positively on the items 
with high loadings onto a dimension (Hair et al. 1998a). For example, if an exploratory 
factor analysis extracts a dimension labelled depression, an individual’s factor score on 
the  hypothetical  depression  dimension  represents  the  extent  to  which  they  reported 
experiencing the items of psychopathology loading above the accepted cut-off on the 
dimension. Factor scores have been used in previous studies examining the relationship 
between dimensions of psychopathology, socio-clinical variables and outcome (Van Os 
et al. 1996; van Os et al 1999a; van Os et al 1999b; Dikeos et al. 2006; Prisciandaro & 
Roberts 2009). The regression method is used to calculate the dimension factor scores 
(Hair et al. 1998a). 
 
It is recommended that more than one method be used to derive measures representing 
the dimensions extracted from an EFA (Grice 2001). The second measures used here 
were the dimension symptom counts. These have been used for comparison with the 
dimension factor scores in previous studies of psychopathology (Van Os et al. 1996; van 
Os et al 1999a). Whereas dimension factor scores are a composite measure of all the 
items used in the EFA, the dimension symptom count are based solely on items shown to 
load significantly to the individual factors (Hair et al. 1998a). Using the example of a   116 
hypothetical  depressive  dimension  of  psychopathology,  whereas  the  dimension  factor 
score includes a score representing the items with significant loadings to the factor, and 
the  other  items  of  psychopathology,  the  dimension  symptom  count  only  counts  the 
number of the items with significant loadings that an individual scores positively for. 
Therefore, dimension symptom counts are more in keeping with a summated scale model 
(Hair et al. 1998a) to represent the dimension of psychopathology, and are used here as 
the coarse measure of the dimensions of psychopathology. The use of these different 
measures  to  represent  dimensions  of  psychopathology  in  the  statistical  analyses,  will 
allow  consideration  of  the  potential  advantages  and  disadvantages  of  each  scoring 
method. 
 
To  further  examine  the  utility  of  measures  of  the  dimensions  of  psychopathology 
identified  in  the  EFA,  two  overall  measures  of  psychopathology  relevant  to  the 
dimensions were also used in the analyses. The total dimension factor score and the total 
dimension symptom count for each participant were calculated by adding together the 
individual scores for the identified dimensions.  
 
A  third  overall  measure  of  psychopathology,  unrelated  to  the  dimensional  model  of 
psychopathology was derived from the PPS-LD. The EFA PPS-LD symptom count- 41 is 
calculated for each participant by counting the number of items of psychopathology rated 
positively, from the 41  PPS-LD items of psychopathology included in  the EFA. The 
inclusion  of  the  three  overall  measures  of  psychopathology  allow  consideration  of 
whether  the  dimensional  model  of  psychopathology  can  be  used  to  derive  an  overall 
measure of greater relevance than the simple EFA PPS-LD symptom count- 41. 
 
3.5.3 Methods to test null research hypothesis two 
 
Null hypothesis two: 
There are no significant correlations between the individual dimensions of 
psychopathology experienced by adults with intellectual disabilities. 
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3.5.3.1 Examining the correlations between individual dimensions of 
psychopathology 
Research  on  dimensional  models  of  psychopathology  experienced  by  children, 
adolescents and adults, who do not have intellectual disabilities, has identified higher 
order  internalising  and  externalising  dimensions  (see  section  1.5.1:  Achenbach  & 
Edelbrock 1978; Cantwell 1996; Slade  & Watson 2006; Slade 2007).  To examine 
whether the higher order dimensions are relevant to psychopathology experienced by 
adults with intellectual disabilities, the Pearson correlation coefficients for individual 
dimensions identified in the EFA are examined.  
 
3.5.4  Methods  used  to  test  null  research  hypotheses  examining  bivariate 
associations 
 
 
Where  continuous  measures  are  normally  distributed,  the  Pearson  correlations  are 
used to examine bivariate correlations between variables. For variables which have a 
distribution significantly different from normality, non-parametric methods are used to 
calculate Spearman’s correlation coefficient.  
Null hypothesis three: 
There  are  no  significant  cross-sectional,  bivariate  relationships  between 
dimensional measures of psychopathology and socio-clinical variables 
Null hypothesis five: 
There are no significant bivariate relationships between dimensional measures  
of psychopathology and measures of the severity of mental disorders: 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables  
and measures of the severity of mental disorders. 
Null hypothesis nine: 
Dimensional measures of psychopathology are not significantly correlated to  
the longitudinal outcome of mental disorders. 
Null hypothesis ten: 
Socio-clinical measures are not significantly associated with the longitudinal 
outcome of mental disorders.   118 
 
For the binary categorical variables (gender, diagnosis of autism, Down syndrome, 
visual impairment, hearing impairment, urinary incontinence, bowel incontinence and 
mobility problems) Student t-tests were used to examine whether there are significant 
between group differences in continuous variables with a normal distribution.  The 
Mann-Whitney  test  was  used  to  examine  between  group  differences  in  continuous 
variables with distributions significantly different from normality. 
 
For  the  categorical  variables  with  more  than  two  groups  (level  of  intellectual 
disabilities and epilepsy), analysis of variance (ANOVA) is used to test whether there 
is  a  significant  difference  in  the  means  of  continuous  variables  with  a  normal 
distribution. Where there is a significant between group difference on the ANOVA, 
post-hoc  Bonferroni  comparison  tests  are  used  to  examine  which  pairwise  group 
differences are significant. For variables that do not have a normal distribution, the χ² 
from the Kruskall-Wallis test is used as the non-parametric equivalent to the ANOVA. 
Post-hoc  Mann-Whitney  tests  are  used  to  examine  individual  between  group 
differences. 
 
The parametric Student t-test and ANOVA are based on the assumption that there is 
homogeneity of variance in the data. Levene’s test for equality of variances is used to 
examine if there is homogeneity of variance in data used in the Student t-test and 
ANOVA.  If  the  result  from  the  Levene’s  test  is  significant  (p  <  .05)  the  results 
reported are for equal variances not assumed. In the case of ANOVA the Welch F 
statistic is reported if Levene’s test indicates that the assumption of homogeneity of 
variance is violated. 
 
For  all  bivariate  analyses,  associations  with  a  significance  value  of  p  <  .05  are 
highlighted in the results tables. However, to take account of multiple testing, inflating 
the risk of a Type I error, a Bonferroni correction was used to adjust the level of 
significance according to the number of  groups, by dividing the  accepted level of 
significance for single tests (p < .05) by the number of comparisons (one less than the 
number of groups). Each categorical group is used as the index variable against which 
the other categorical groups are compared in the post-hoc tests i.e. mild intellectual 
disabilities  was  used  as  the  index  variable  against  which  moderate,  severe  and   119 
profound  intellectual  disabilities  are  compared-  then  repeated  with  the  moderate 
intellectual disabilities group as the index variable. Thus, the number of comparisons 
for each of the four groups defining the level of intellectual disabilities variable is 
three (mild-moderate, mild-severe, mild-profound etc). Therefore, the accepted level 
of significance is p < .0167 (.05/3). The accepted level of significance for the epilepsy 
variable- defined with three groups and therefore requiring two comparisons against 
each  index  categorical  group  (no  epilepsy-  well  controlled  seizures,  no  epilepsy- 
poorly controlled seizures) is p < .025. 
 
3.5.5  Methods  used  to  test  null  research  hypotheses  examining  multivariate 
associations 
 
Null hypothesis four: 
There  are  no  significant  cross-sectional,  multivariate  relationships  between 
measures of psychopathology and socio-clinical variables. 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures 
of  psychopathology,  socio-clinical  variables  and  measures  of  the  severity  of 
mental disorders. 
Null hypothesis eight: 
There  are  no  significant  differences  in  the  associations  of  dimensional  and 
categorical models of psychopathology with measures of the severity of mental 
disorders  
Null hypothesis eleven: 
Dimensional  measures  of  psychopathology,  and  socio-clinical  variables  at 
baseline,  are  not  independently  associated  with  the  longitudinal  outcome  of 
mental disorders. 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders.   120 
Since  the  dependent  variables  of  interest  are  continuous  variables  (measures  of 
psychopathology, severity and outcome) linear regressions were used to explore the 
independent  relationships  with  the  measures  of  psychopathology  and  socio-clinical 
variables. Given the exploratory nature of the analyses, measures of psychopathology 
and socio-clinical variables associated with the measures of outcome at a significance 
of p < .1 were included in the linear regression analyses. 
 
Stepwise backward linear regression was used for all analyses. At each step of the 
analysis,  the  independent  variable  with  the  lowest  correlation  to  the  dependant 
variable is removed. However, a removal criterion was set in order that only those 
variables with of p<.05 were retained within the final model. 
 
To include categorical variables in linear regression analysis dummy variables were 
used  for  any  variables  with  more  than  two  groups,  such  as  the  variables  living 
circumstances,  level  of  intellectual  disabilities  and  epilepsy.  All  other  categorical 
variables with two groups are already coded as binary measures and can be used in 
linear regression. 
 
The number of dummy variables required is one less than the number of groups in the 
original variable. In the case of level of intellectual disabilities there are four groups 
(mild, moderate, severe and profound) so three dummy variables are required. These 
dummy variables are established against mild intellectual disabilities as the baseline 
variable, such that this group are recoded as 0 in all the dummy variables. Each other 
group is coded as 1 only once, for the dummy variable with the same name.   
 
To examine if the assumption of homoscedasticity for linear regression is met, and 
check for cases which are outliers, plots of the residuals were examined for all the 
final  regression  models  (Field  2005).  Residuals  are  the  values  representing  the 
difference between the value predicted by the regression model and the value observed 
in the sample. Therefore, the closer the regression model fits the data the closer to zero 
the residuals are. 
 
To allow comparison of residuals across regression models that use different variables 
in the analyses, standardised residuals are calculated. This is achieved by converting   121 
the residuals into z-scores, calculated by taking each residual value, subtracting the 
mean of all the residuals, and dividing by the standard deviation of all the residuals, 
This converts the residuals to a known distribution, with a mean of zero and a standard 
distribution of one. By calculating standardised residuals across regression models, 
rules based on the normal distribution can be set as to what constitutes an acceptable 
standardised residual (Field 2005b): 
·  standardised residuals greater than 3.29 are highly likely to be outliers 
·  if more than 1% of the sample have standardised residuals greater than 2.58 the 
level of error in the model is unacceptable 
·  if more than 5% of the sample have standardised residuals greater than 1.96 the 
regression model is a poor representation of the data. 
 
In  all  cases  plots  of  the  standardised  residuals  against  the  standardised  predicted 
values were made, examining the data points against the criteria above, and looking 
for evidence of heteroscedasticity on the basis that there unequal variance across the 
range  of  the  standardised  predicted  values.  In  order  to  assist  in  the  process  of 
identifying  outliers  with  standardised  residuals  greater  than  1.96,  case-wise 
diagnostics reporting the observed value, predicted value, residual and standardised 
residual are reported for all cases. 
 
To test for strong correlations between significant predictors in the regression models 
(multicollinearity) the variance inflation factor (VIF) for each significant dependant 
variable is calculated. These are compared against the guidelines that suggest a VIF 
above 10 is indicative of significant multicollinearity (Field 2005b), and an average 
VIF for the dependant variables retained in the model greater than 1 is suggestive that 
multicollinearity is influencing the results of the regression. 
 
For the final regression models, four test statistics are reported for each independent 
variable retained in the model: 
·  unstandardised coefficient (B) 
·  standard error of B 
·  standardised coefficient (β) 
·  significance (p). 
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For multiple linear regression, these statistics represent the effect of the independent 
variable  on  the  dependent  variable  when  the  effects  of  all  other  variables  are 
controlled for (Hair et al. 1998b). The unstandardised and standardised coefficients 
provide a measure of the extent to which a change in the independent variable affects 
the dependent variable (Hair et al. 1998b). The unstandardised coefficient represents 
the change in the dependant variable if the independent variable changes by a single 
unit. Since the standardised coefficients are comparable across variables, regardless of 
the unit of measurement, they are perhaps of greater relevance for regression models 
with multiple variables, as used here. The standardised coefficient is the number of 
standard deviations the independent variable increases by if the dependent variable 
changes by a single standard deviation (Hair et al. 1998b).  
 
An overall statistic (R²) is provided for each regression model to represent how well 
the model represents the data. The R² statistic is a measure of the proportion of the 
overall variance in the dependent variable explained by the final regression model. It 
can be converted to a percentage such that if R²= .50 then the model explains 50% of 
the variance in the dependent variable (Hair et al. 1998b). 
 
3.5.5.1 Regression analyses using the measures of longitudinal outcome as the 
dependent variable 
There  is  a  recognized  need  to  consider  the  potential  influence  on  a  measure  of 
longitudinal outcome, calculated as a change score over time, of the baseline score on 
the measure at time 1 (Lord 1967).  Since the baseline score and the longitudinal 
change score can be correlated, various methods of adjusting for the baseline value are 
described (Wainer 1991).  
 
In  this  thesis,  the  regression  analyses  that  used  longitudinal  change  scores  as  the 
dependant variable were adjusted for the baseline score on the measure. This approach 
adopted is in keeping with previous studies examining the associations of dimensional 
and categorical models of psychopathology with longitudinal outcome (van Os et al. 
1996; Dikeos et al. 2006). 
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3.5.6 Methods used to test null research hypotheses comparing dimensional and 
categorical models of psychopathology 
 
A binary variable representing a categorical model of psychopathology was derived on 
the basis of whether or not an individual meets criteria for a DC-LD diagnosis of 
mental  disorder.  As  shown  in  table  3.4,  at  baseline  96  (64%)  individuals  met  the 
criteria for a DC-LD categorical diagnosis. 
 
Comparisons  are  made  between  the  relationships  of  dimensional  and  categorical 
models  to  the  measures  of  the  severity  and  the  longitudinal  outcome  of  mental 
disorders.  To  achieve  this,  the  measures  of  severity  and  outcome  are  used  as  the 
dependant variables in three separate linear regression models using: 
1.  only the variables representing the dimensional of psychopathology  
2.  only the binary variable representing the categorical model of psychopathology 
3.  the  variables  representing  both  the  dimensional  and  categorical  models  of 
psychopathology 
 
The regression analyses, including the dimensional measures of psychopathology, are 
carried out in relation to null hypotheses seven and eleven. The same socio-clinical 
variables  included  in  these  analyses,  on  the  basis  of  the  results  of  the  bivariate 
analyses, were included in the two other sets of linear regression described above. 
These separate analyses are run for each of the measures of severity and outcome.  
 
Null hypothesis eight: 
There  are  no  significant  differences  in  the  associations  of  dimensional  and 
categorical  models  of  psychopathology  with  measures  of  the  severity  of  mental 
disorders  
Null hypothesis twelve: 
There  are  no  significant  differences  in  the  associations  of  dimensional  and 
categorical  models  of  psychopathology  with  the  longitudinal  outcome  of  mental 
disorders   124 
The three regression models above with each measure of severity and outcome as the 
dependant  variable  are  compared  to  examine  if  the  variables  representing  the 
dimensional and categorical models are retained as significant (van Os et al. 1996). 
Two results from the regression analyses were examined to compare  the dimensional 
and categorical models of psychopathology: 
·  the  standardised  coefficient  (β)-  representing  the  size  of  the  effect  of  each 
psychopathology variable on the dependent variable  
·  R²-  the  proportion  of  the  variance  of  the  dependent  variable  explained  by  the 
overall regression model. 
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Chapter 4: Results 
This chapter is organised in relation to the 12 research hypotheses from chapter 2. For 
convenience, these are stated at the start of the relevant section. 
 
4.1 Identifying dimensions of psychopathology from the PPS-LD 
 
 
As described in section 3.5.2.4, problems can arise in EFA if there are items included 
which are not significantly correlated with any other items, or if variables are too 
highly  correlated  (multi-collinearity,  defined  as  r  ≥  .9).  This  was  checked  in  a 
correlation matrix. All items of psychopathology were significantly correlated with at 
least one other item and there were no items with correlation co-efficients above 0.9. 
Therefore, all 41 items were retained for the EFA. 
 
 
The scree plot in figure 4.1 below was used as a guide to the predicted number of 
factors to extract from the EFA. From an initial EFA, the eigenvalues of the factors 
extracted were plotted and the scree plot examined to find the break point in the slope 
between the initial steep gradient- representing the initial factors with greater, more 
significant,  eigenvalues-  and  the  more  gradual  sloping  gradient,  with  the  smaller 
eigenvalues representing the vast majority of factors.  
 
 
 
 
Null hypothesis one: 
There are no stable, identifiable dimensions of psychopathology experienced by 
adults with intellectual disabilities. 
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Figure 4.1: Scree plot of eigenvalues of first 20 factors extracted. 
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In figure 4.1, the eigenvalues of the first 20 factors extracted are plotted. It appears 
that the break point occurs at factor 4, suggesting that the final solution will have three 
extracted  factors.  Guidelines  for  EFA  best  practice  (Costello  &  Osborne  2005) 
recommend  examining  the  solutions  with  one  more,  and  one  less  factors,  than 
suggested by the scree plot. This allows consideration of the relevance and coherence 
of different factor solutions. Therefore, the factor solutions with two, three and four 
factors extracted were examined. 
 
In tables 4.1, 4.2 and 4.3 below, the non-rotated and the rotated (Promax oblique 
rotation is used in all EFAs) solutions are shown for the two, three and four factor   127 
solutions. The loading for each item of psychopathology to the specific factors is 
reported and loadings greater than or equal to 0.32 highlighted in bold. 
 
Based  on  the  number  of  items  loading  onto  the  factors  and  the  size  of  the  item 
loadings, all three solutions in tables 4.1, 4.2 and 4.3 have adequate stability. Since the 
four factor solution accounts for a greater percentage of the total variance, if the items 
loading  onto  the  four  factors  seem  coherent  and  interpretable  then  the  four  factor 
solution would be accepted as the final solution. To consider this further the four 
factors were examined in some detail.  
 
The  nature  of  EFA  is  such  that  as  the  number  of  factors  extracted  increases  the 
percentage  of  the  total  variance  explained  by  each  additional  factor  decreases. 
Therefore, we might expect that there would be fewer items loading significantly onto 
these factors with lower percentage variances, and the actual items loadings would be 
smaller.  
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Table 4.1: Non-rotated and rotated two factor solutions for EFA with 41 items of 
psychopathology. 
 
Non-rotated solution  Rotated solution 
Factor  Factor 
  
1  2  1  2 
worry  .145  .169  .225  -.102 
generalised anxiety  .113  .220  .232  -.163 
agoraphobia  .103  .062  .123  -.017 
animal phobia  .034  .128  .107  -.110 
specific phobia  -.091  -.054  -.109  .017 
rituals  -.081  -.040  -.091  .005 
orderliness  -.139  -.042  -.140  -.017 
low mood  .662  .158  .641  .119 
labile mood  .343  .260  .445  -.108 
irritability  .460  .290  .560  -.089 
social withdraw  .631  .082  .567  .178 
anhedonia  .707  .019  .589  .269 
talk loss  .552  -.209  .318  .423 
talk gain  .091  .121  .151  -.078 
tearfulness  .469  .193  .506  .006 
reduced self care  .663  -.170  .433  .431 
loss of energy  .588  -.190  .359  .419 
increased energy  .074  .269  .231  -.226 
loss of cognitive skills  .322  -.651  -.151  .750 
name loss  .202  -.575  -.200  .629 
place loss  .161  -.666  -.291  .698 
reduced comprehension  .336  -.653  -.141  .758 
loss of memory  .282  -.694  -.211  .775 
change in personality  .321  -.535  -.077  .639 
initial insomnia   .228  .257  .349  -.151 
mid-insomnia   .276  .230  .371  -.107 
early morning wakening   .195  .231  .306  -.140 
increased daytime sleep  .255  -.052  .175  .153 
loss of appetite  .512  .156  .517  .059 
increased appetite  .069  -.058  .020  .083 
weight loss  .386  .170  .423  -.005 
weight gain  .023  .001  .020  .008 
diurnal variation - evening  .161  .081  .183  -.011 
diurnal variation -morning  .173  .187  .260  -.108 
reduced concentration  .534  .071  .481  .149 
increased verbal aggression  .367  .298  .488  -.135 
increased physical aggression  .332  .311  .469  -.161 
need for reassurance  .490  .131  .483  .074 
self harm/ SIB  .214  .302  .367  -.201 
somatic concerns  .226  .152  .281  -.053 
sexual behaviour  .190  .147  .249  -.063 
eigenvalue  5.16  3.51  4.84  4.03 
% total variance  12.5  8.54  11.80  9.83   129 
Table 4.2: Non-rotated and rotated three factor solution for the EFA of 41 items 
of psychopathology 
Non-rotated solution  Rotated solution  
Factor  Factor 
  
1  2  3  1  2  3 
worry  .145  .169  -.026  .146  -.123  .112 
generalised anxiety  .113  .220  -.085  .177  -.201  .073 
agoraphobia  .103  .062  -.131  .187  -.079  -.046 
animal phobia  .034  .128  .026  .018  .096  .097 
specific phobia  -.091  -.054  -.076  -.009  -.006  -.127 
rituals  -.081  -.040  .271  -.281  .122  .185 
orderliness  -.139  -.042  .247  -.304  .098  .143 
low mood  .662  .158  -.225  .674  -.048  .129 
labile mood  .343  .260  .260  .070  -.035  .477 
irritability  .460  .290  .336  .096  .000  .601 
social withdraw  .631  .082  -.226  .643  .011  .080 
anhedonia  .707  .019  -.313  .758  .054  .002 
talk loss  .552  -.209  -.172  .505  .274  -.042 
talk gain  .091  .121  .353  -.203  .057  .397 
tearfulness  .469  .193  -.031  .385  -.057  .241 
reduced self care  .663  -.170  -.068  .505  .311  .109 
loss of energy  .588  -.190  -.296  .633  .217  -.127 
increased energy  .074  .269  .254  -.117  -.121  .376 
loss of cognitive skills  .322  -.651  .149  .024  .737  -.061 
name loss  .202  -.575  .182  -.078  .648  -.041 
place loss  .161  -.666  .207  -.139  .729  -.078 
reduced comprehension  .336  -.653  .266  -.060  .790  .045 
loss of memory  .282  -.694  .197  -.049  .784  -.054 
change in personality  .321  -.535  .121  .061  .621  -.029 
initial insomnia   .228  .257  .166  .063  -.102  .352 
mid-insomnia   .276  .230  .076  .166  -.101  .278 
early morning wakening   .195  .231  .158  .042  -.091  .320 
increased daytime sleep  .255  -.052  -.120  .272  .070  -.033 
loss of appetite  .512  .156  -.454  .751  -.180  -.127 
increased appetite  .069  -.058  .295  -.196  .189  .254 
weight loss  .386  .170  -.350  .579  -.186  -.078 
weight gain  .023  .001  .253  -.187  .107  .229 
diurnal variation - evening  .161  .081  -.057  .172  -.051  .049 
diurnal variation -morning  .173  .187  .185  -.001  -.047  .315 
reduced concentration  .534  .071  .176  .249  .155  .387 
increased verbal aggression  .367  .298  .496  -.099  .031  .709 
increased physical aggression  .332  .311  .441  -.078  -.013  .655 
need for reassurance  .490  .131  .037  .337  .032  .278 
self harm/ SIB  .214  .302  .398  -.128  -.055  .569 
somatic concerns  .226  .152  .100  .101  -.034  .243 
sexual behaviour  .190  .147  .199  -.005  -.001  .314 
eigenvalue  5.16  3.51  2.32  4.16  3.61  3.30 
% total variance  12.50  8.54  5.66  10.15  8.80  8.04 
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Table 4.3: Non-rotated and rotated four factor solution for EFA of 41 items of 
psychopathology 
Non-rotated solution  Rotated solution 
Factor  Factor 
 
1  2  3  4  1  2  3  4 
worry  .145  .169  -.026  .543  .022  -.045  -.173  .603 
generalised anxiety  .113  .220  -.085  .513  .056  -.126  -.193  .570 
agoraphobia  .103  .062  -.131  .365  .104  -.027  -.223  .378 
animal phobia  .034  .128  .026  .017  .007  -.093  .078  .052 
specific phobia  -.091  -.054  -.076  -.019  -.002  -.009  -.105  -.055 
rituals  -.081  -.040  .271  .108  -.293  .134  .108  .130 
orderliness  -.139  -.042  .247  .153  -.325  .117  .047  .163 
low mood  .662  .158  -.225  -.083  .665  -.055  .165  .016 
labile mood  .343  .260  .260  -.047  .063  -.040  .448  .101 
irritability  .460  .290  .336  -.031  .084  -.002  .552  .153 
social withdraw  .631  .082  -.226  -.012  .625  .013  .086  .067 
anhedonia  .707  .019  -.313  -.098  .759  .044  .063  -.035 
talk loss  .552  -.209  -.172  -.094  .524  .260  .021  -.083 
talk gain  .091  .121  .353  .313  -.269  .100  .194  .410 
tearfulness  .469  .193  -.031  -.058  .376  -.061  .248  .050 
reduced self care  .663  -.170  -.068  -.006  .504  .309  .111  .048 
loss of energy  .588  -.190  -.296  -.045  .637  .211  -.078  -.043 
increased energy  .074  .269  .254  .263  -.183  -.082  .199  .374 
loss of cognitive skills  .322  -.651  .149  .039  .054  .733  -.063  -.030 
name loss  .202  -.575  .182  -.106  -.020  .625  .025  -.173 
place loss  .161  -.666  .207  .043  -.105  .724  -.082  -.045 
reduced comprehension  .336  -.653  .266  .161  -.053  .802  -.030  .112 
loss of memory  .282  -.694  .197  .028  -.013  .777  -.052  -.049 
change in personality  .321  -.535  .121  .129  .065  .631  -.081  .082 
initial insomnia   .228  .257  .166  .350  -.025  -.051  .136  .469 
mid-insomnia   .276  .230  .076  .036  .141  -.093  .230  .140 
early morning wakening   .195  .231  .158  .083  .011  -.077  .242  .188 
increased daytime sleep  .255  -.052  -.120  -.132  .295  .052  .042  -.125 
loss of appetite  .512  .156  -.454  .097  .704  -.161  -.154  .140 
increased appetite  .069  -.058  .295  .309  -.251  .229  .071  .355 
weight loss  .386  .170  -.350  .012  .553  -.179  -.070  .055 
weight gain  .023  .001  .253  .263  -.236  .141  .070  .339 
diurnal variation - evening  .161  .081  -.057  .346  .092  -.001  -.128  .382 
diurnal variation -morning  .173  .187  .185  -.225  .034  -.077  .392  -.131 
reduced concentration  .534  .071  .176  -.077  .255  .144  .388  .046 
increased verbal aggression  .367  .298  .496  -.290  -.054  -.009  .775  -.096 
increased physical aggression  .332  .311  .441  -.394  -.013  -.066  .779  -.212 
need for reassurance  .490  .131  .037  .210  .278  .063  .147  .321 
self harm/ SIB  .214  .302  .398  -.169  -.107  -.077  .588  -.011 
somatic concerns  .226  .152  .100  .202  .048  -.005  .115  .287 
sexual behaviour  .190  .147  .199  -.141  .015  -.020  .350  -.051 
eigenvalue  5.16  3.51  2.32  1.85  4.02  3.57  3.06  2.23 
% total variance  12.50  8.54  5.66  4.51  9.80  8.70  7.47  5.44   131 
Although the labelling and interpretation of the dimensions extracted from EFA is a 
crucial part of the research process, this aspect is discussed less often in best practice 
guidelines  (Costello  &  Osborne  2005),  or  textbooks  on  factor  analysis.  Since 
interpretation of the results of EFA is largely subjective researchers are recommended 
to fully consider alternative labels for extracted factors (Ford et al, 1986), aiming for a 
simple, recognisable label that adequately represents the items that load to the factor 
(Child, 2006). 
 
Factor one in the rotated solution comprises nine items of psychopathology; 
·  low mood 
·  social withdrawal 
·  anhedonia 
·  reduced verbal communication 
·  tearfulness 
·  reduced self-care 
·  lower energy levels 
·  loss of appetite 
·  weight loss 
 
Since eight of the nine items have loadings to the depressive dimension greater than 
0.5, this dimension would be expected to have good reliability and stability (Hair et al 
1998a).  It  is  perhaps  surprising  that  none  of  the  four  items  relating  to  sleep  load 
significantly to the depressive dimension. However, overall, the dimension appears 
coherent and is readily interpretable. 
 
Several possible factor labels to represent this dimension of psychopathology were 
considered including depressive, internalising psychopathology and bio-psycho-social 
withdrawal. 
 
Two  main  reasons  to  label  this  dimension  of  psychopathology  with  the  term 
depressive were considered. The nine items of psychopathology extracted in this first 
dimension  are  included  amongst  criteria  for  depressive  disorders  in  existing 
categorical diagnostic classification systems. There is overlap between the items of 
psychopathology extracted here from the PPS-LD data, and items of psychopathology   132 
in dimensions labelled with the term depressive in studies in table 1.2. Thus, using the 
depressive label would be consistent with existing categorical diagnostic classification 
systems, previous studies and would be familiar to clinicians and researchers. 
 
All  nine  items  of  psychopathology  represent  affective  or  behaviour  changes  that 
largely  impact  on  the  individual,  rather  than  other  people  or  the  surrounding 
environment. Therefore, this dimension could be appropriately labelled with the term 
internalising psychopathology. However, as described in section 1.5.1, this is a term 
that  is  commonly  used  to  describe  a  higher  order  dimension  of  psychopathology 
experienced by children and adolescents. The higher order internalising dimension of 
psychopathology  represents  a  dimension  that  includes  a  broader  range  of 
psychopathology than the nine items extracted here, including affective, generalised 
anxiety, phobic and panic psychopathology. Since the internalising term is a distinct 
concept in the psychopathology literature, to avoid confusion it was decided not to use 
this as a label for the first dimension. 
 
It was recognised that at least some of the items of psychopathology extracted in the 
first dimension were not directly related to changes in affect or mood. For example 
social withdrawal, reduced verbal communication and reduced self-care all represent 
changes in behaviour that can occur without any affective changes. The label psycho-
social  withdrawal  was considered  as  it  seemed  to  describe  both  the  affective  and 
behavioural change represented by the majority of items of psychopathology in the 
first factor. However, this label does not really capture three items of psychopathology 
that  are  often  to  be  considered  biological  in  nature-  lower  energy  levels,  loss  of 
appetite  and  weight  loss.  Therefore,  bio-psycho-social  withdrawal  may  be  a  more 
comprehensive representation of the items of psychopathology extracted in the first 
factor. 
 
Although  the  depressive  and  bio-psycho-social  withdrawal  labels  both  appear  to 
adequately represent the nine items of psychopathology in the first dimension, it was 
decided to label this as a depressive dimension. The reason for this is that it is in 
keeping with the labelling of similar dimensions in previous intellectual disabilities 
studies, thus facilitating comparison with previous research. 
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The second dimension extracted from the PPS-LD data had six items: 
·  change in cognitive functioning 
·  forgetting the names of familiar people 
·  getting lost in familiar places 
·  reduced verbal comprehension 
·  memory problems 
·  change in personality. 
 
Labels considered in naming this dimension of psychopathology included confusion, 
organic  and  cognitive  impairment.  Since  the  label  confusion  was  felt  to  be  non-
specific, and could be interpreted as representing an individual’s experience of brief 
periods  of  subjective  uncertainty,  it  was  discounted  and  organic  and  cognitive 
considered further. 
 
Both  these  terms  meet  the  criteria  of  being  good  descriptions  of  the  six  items  of 
psychopathology in the second dimension of psychopathology extracted. Clinicians 
and researchers would be likely to readily accept that there is a relationship between 
the items of psychopathology and either of these terms. One issue considered was the 
fact that change in cognitive functioning was one of the items of psychopathology that 
loaded to the dimension. Since the term organic could encompass this and the five 
additional items it was decided that it was preferable as the label for this dimension. 
 
One point of interest from the depressive and organic dimensions is that the item of 
psychopathology indicative of a reduction in self-care skills is primarily loaded onto 
the depressive dimension. Although the reduced self-care item has a loading of 0.309 
to the organic dimension (accepted as significant by some of the studies in table 1.2), 
there is a stronger loading of 0.504 to the depressive dimension. Nonetheless, overall 
the  organic  dimension  does  appear  coherent  and  relevant  to  the  assessment  of 
psychopathology and mental disorders. 
 
The  third  dimension  extracted  in  the  EFA  was  more  problematic  to  label.  This 
dimension included eight individual items of psychopathology: 
·  increased mood lability 
·  increased irritability   134 
·  diurnal variation in mood-worse in the morning 
·  reduced concentration 
·  increased verbal aggression  
·  increased physical aggression 
·  increased self-injurious or self-harming behaviour 
·  a change in sexual behaviour. 
 
Of the eight items of psychopathology that loaded to this dimension four represented 
changes  in  behaviour  (verbal  aggression,  physical  aggression,  self-injurious  and 
change  in  sexual  behaviour)  and  three  involved  affective  changes  (mood  lability, 
increased irritability, diurnal variation in mood-worse in the morning). Although the 
final item of psychopathology (reduced concentration) stood alone, it was recognised 
that it is often described by individuals experiencing affective changes. Therefore, this 
dimension was conceptualised as being made up of four items of behaviour change 
and four affective items.  
 
Clearly, the labels affective change and behaviour change would only represent half of 
the items in the dimension, and so were discounted. However, the combined term 
behaviour-affective  was  considered,  along  with  instability,  and  externalising 
psychopathology.  
 
Similar  to  the  term  internalising  psychopathology  described  above,  the  term 
externalising  psychopathology  is  used  to  represent  a  higher  order  dimension  of 
psychopathology.  This  dimension  usually  includes  conduct,  anti-social  or  problem 
behaviour psychopathology, hyperactivity and inattention. To avoid confusion with 
the construct represented by externalising psychopathology in the literature this label 
was not considered further. 
 
The term instability encapsulates the fact that each of the items of psychopathology 
extracted in the third dimension represents a change from baseline. However, all items 
on the PPS-LD are only rated positively if there has been a change. Therefore, the 
concept of change could equally apply to all the dimensions. Furthermore, the term 
instability  implies  that  an  affect  or  behaviour  is  unstable,  changing  rapidly  and 
frequently. Whilst this feature is likely to be true for mood lability, it is less likely to   135 
be  the  case  for  other  items  of  psychopathology  loading  to  this  dimension.  For 
example, an individual may experience increased irritability or poor concentration as 
persistent changes that do not fluctuate over time. Due to these issues around the 
meaning of the term instability, it was discounted as a potential label for the third 
dimension. However, in section 5.1.5 the relevance of change or instability to the 
overall multi-dimensional model of psychopathology is discussed. 
 
The label finally accepted for the third dimension was, therefore, behaviour-affective. 
It was felt that this label adequately describes the balance in the different items of 
psychopathology  in  the  dimension.  Importantly,  behaviour-affective  is  a 
straightforward term, familiar to psychopathology researchers and the use of the term 
affective differentiates this dimension from the depressive dimension. 
 
Finally, the fourth dimension included 10 items of psychopathology: 
·  worrying 
·  generalised anxiety 
·  agoraphobia 
·  increased verbal communication 
·  increased energy levels 
·  initial insomnia greater than one hour 
·  increased appetite 
·  weight gain 
·  diurnal mood variation- worse in the evening 
·  increased need for reassurance. 
 
Terms considered as a potential label for this dimension included over-arousal, over- 
activation and anxiety. 
 
An aspect of the terms overarousal and overactivation considered was their use in the 
literature  to  link  psychopathology  with  a  specific  biologically-based  system.  For 
example,  sympathetic  overarousal  and  externalising  behaviour  in  children,  or 
hemispheric and temporal overactivation in schizophrenia. Although both these terms 
seem applicable to the items of psychopathology that loaded to this dimension, at this 
stage  in  researching  the  multi-dimensional  model  any  label  would  ideally  be   136 
descriptive.  Without  further  research  investigating  causative  mechanisms  it  is 
preferable to avoid the use of terms that imply involvement of specific biological 
systems. Therefore, overarousal and overactivation were not considered appropriate 
labels for this dimension. However, the concepts of arousal and activation are further 
discussed in section 5.1.5, in relation to constructs of relevance to a multi-dimensional 
model of psychopathology. 
 
Instead, the descriptive term anxiety was decided upon. Similar to labels used for the 
other dimensions it is simple and concisely describes the items that load to the fourth 
dimension. Each of the 10 items of psychopathology is readily associated to the label 
anxiety, and the label distinguishes this dimension from the previous three.  
 
Perhaps the items rating increased verbal communication and increased energy levels 
need  further  consideration  but  overall,  like  the  other  three  factors,  the  anxiety 
dimension is readily interpretable. 
 
Although the scree plot in figure 4.1 suggested examining two, three and four factor 
solutions there are two specific reasons to look at additional solutions. Firstly, factor 
four  in  table  4.3  has  10  items  loading  above  0.32-  significantly  greater  than  the 
minimum of three suggested by best practice guidance. This suggests that there may 
well  be  additional  stable  factors  that  could  be  extracted.  The  second  reason  for 
extending  the  examination  of  solutions  to  those  with  more  factors  relates  to  the 
previous studies that have used EFA to examine the  structure of psychopathology 
experienced by adults with intellectual disabilities (see section 1.6.1). Since there were 
eight  dimensions  of  psychopathology  identified  across  studies,  the  extraction  of  a 
greater number of factors than in the four dimensional model above might have been 
predicted. For these reasons, five and six factor solutions were examined to look at 
whether there are additional coherent dimensions that emerge from the data. 
 
The rejection of the six factor solution is straightforward. In table 4.5, there are only 
two items with loadings greater than 0.32 to the sixth factor. Therefore, the six factor 
solution does not meet the requirement that there are at least three items loading onto a 
factor  to  ensure  stability.  A  decision  on  which  solution  to  accept  as  the  final 
dimensional model in thus narrowed to between the four and five factor solutions. In   137 
table 4.4, we can see that in the five factor solution all the factors meet the criterion 
for at least three items loading to each factor- with five items loading to factor five: 
·  increased verbal communication 
·  increased energy levels 
·  initial insomnia greater than one hour 
·  mid-insomnia greater than one hour 
·  early morning wakening greater than one hour.   138 
Table 4.4: Non-rotated and rotated five factor solution for EFA of 41 items of 
psychopathology 
 
Non-rotated solution  Rotated solution  
Factor  Factor 
  
1  2  3  4  5  1  2  3  4  5 
worry  .145  .169  -.026  .543  -.152  .009  -.081  -.162  .623  .096 
generalised anxiety  .113  .220  -.085  .513  -.036  .046  -.136  -.209  .549  .179 
agoraphobia  .103  .062  -.131  .365  -.208  .082  -.073  -.184  .452  -.074 
animal phobia  .034  .128  .026  .017  -.181  -.011  -.128  -.120  -.114  -.116 
specific phobia  -.091  -.054  -.076  -.019  -.034  -.010  -.016  -.087  -.028  -.081 
rituals  -.081  -.040  .271  .108  .220  -.264  .180  .045  .003  .296 
orderliness  -.139  -.042  .247  .153  .052  -.311  .127  .026  .105  .150 
low mood  .662  .158  -.225  -.083  -.108  .661  -.080  .181  .078  -.087 
labile mood  .343  .260  .260  -.047  -.115  .075  -.064  .453  .100  .056 
irritability  .460  .290  .336  -.031  -.272  .091  -.061  .589  .202  -.035 
social withdraw  .631  .082  -.226  -.012  -.037  .625  .002  .085  .099  -.020 
anhedonia  .707  .019  -.313  -.098  .019  .762  .045  .054  -.006  -.033 
talk loss  .552  -.209  -.172  -.094  -.122  .523  .230  .054  .001  -.179 
talk gain  .091  .121  .353  .313  .266  -.231  .153  .100  .230  .485 
tearfulness  .469  .193  -.031  -.058  -.004  .385  -.063  .234  .042  .060 
reduced self care  .663  -.170  -.068  -.006  .020  .521  .308  .098  .052  .029 
loss of energy  .588  -.190  -.296  -.045  -.179  .626  .168  -.030  .075  -.243 
increased energy  .074  .269  .254  .263  .531  -.133  .029  .040  .092  .703 
loss of cognitive skills  .322  -.651  .149  .039  .041  .081  .733  -.065  -.032  -.014 
name loss  .202  -.575  .182  -.106  .117  .011  .644  .009  -.205  .018 
place loss  .161  -.666  .207  .043  .185  -.068  .756  -.117  -.111  .112 
reduced comprehension  .336  -.653  .266  .161  .100  -.015  .813  -.054  .064  .117 
loss of memory  .282  -.694  .197  .028  .094  .021  .789  -.065  -.075  .030 
change in personality  .321  -.535  .121  .129  -.114  .078  .599  -.051  .134  -.102 
initial insomnia   .228  .257  .166  .350  .140  -.004  -.024  .070  .352  .375 
mid-insomnia   .276  .230  .076  .036  .406  .179  -.008  .112  -.054  .474 
early morning wakening   .195  .231  .158  .083  .415  .052  .010  .119  -.022  .514 
increased daytime sleep  .255  -.052  -.120  -.132  .052  .300  .062  .033  -.122  -.021 
loss of appetite  .512  .156  -.454  .097  .285  .710  -.103  -.231  .060  .235 
increased appetite  .069  -.058  .295  .309  -.232  -.250  .176  .109  .397  -.014 
weight loss  .386  .170  -.350  .012  .337  .566  -.108  -.158  -.055  .273 
weight gain  .023  .001  .253  .263  -.532  -.261  .026  .184  .478  -.299 
diurnal variation - evening  .161  .081  -.057  .346  -.048  .087  -.014  -.133  .381  .094 
diurnal variation -morning  .173  .187  .185  -.225  -.104  .040  -.097  .409  -.111  -.053 
reduced concentration  .534  .071  .176  -.077  .043  .281  .150  .359  .002  .138 
increased verbal aggression  .367  .298  .496  -.290  -.039  -.021  -.016  .760  -.146  .122 
increased physical aggression  .332  .311  .441  -.394  -.047  .015  -.073  .772  -.245  .062 
need for reassurance  .490  .131  .037  .210  -.175  .278  .023  .166  .362  .010 
self harm/ SIB  .214  .302  .398  -.169  .024  -.081  -.070  .560  -.080  .174 
somatic concerns  .226  .152  .100  .202  -.157  .046  -.040  .134  .315  .019 
sexual behaviour  .190  .147  .199  -.141  -.058  .026  -.031  .353  -.054  .014 
eigenvalue  5.16  3.51  2.32  1.85  1.62  4.03  3.56  2.91  2.13  1.95 
% total variance  12.50  8.54  5.66  4.51  3.95  9.83  8.68  7.10  5.20  4.476   139 
Table 4.5: Non-rotated and rotated six factor solution for EFA of 41 items of 
psychopathology 
 
Non-rotated solution  Rotated solution 
Factor  Factor 
  
1  2  3  4  5  6  1  2  3  4  5  6 
worry  .145  .169  -.026  .543  -.152  -.139  .012  -.066  -.186  .619  .143  -.085 
generalised anxiety  .113  .220  -.085  .513  -.036  .226  .110  -.161  -.193  .509  .109  .264 
agoraphobia  .103  .062  -.131  .365  -.208  .265  .136  -.103  -.165  .419  -.146  .240 
animal phobia  .034  .128  .026  .017  .181  .128  .015  -.138  .122  .098  -.140  .116 
specific phobia  -.091  -.054  -.076  -.019  -.034  -.011  -.021  -.015  -.087  -.029  -.077  -.030 
rituals  -.081  -.040  .271  .108  .220  .677  -.122  .104  .118  -.047  .070  .767 
orderliness  -.139  -.042  .247  .153  .052  .680  -.175  .051  .096  .059  -.069  .746 
low mood  .662  .158  -.225  -.083  -.108  -.125  .634  -.068  .158  .079  -.035  -.237 
labile mood  .343  .260  .260  -.047  -.115  .006  .087  -.066  .445  .118  .058  .018 
irritability  .460  .290  .336  -.031  -.272  -.122  .082  -.049  .562  .240  .012  -.117 
social withdraw  .631  .082  -.226  -.012  -.037  .037  .633  -.004  .081  .084  -.022  -.056 
anhedonia  .707  .019  -.313  -.098  .019  -.002  .758  .042  .048  -.023  -.023  -.120 
talk loss  .552  -.209  -.172  -.094  -.122  .053  .530  .221  .053  -.006  -.184  -.047 
talk gain  .091  .121  .353  .313  .266  -.122  -.203  .166  .087  .236  .502  .058 
tearfulness  .469  .193  -.031  -.058  -.004  -.047  .381  -.059  .223  .045  .079  -.087 
reduced self care  .663  -.170  -.068  -.006  .020  .020  .541  .302  .094  .044  .025  -.020 
loss of energy  .588  -.190  -.296  -.045  -.179  .163  .646  .147  -.021  .053  -.277  .025 
increased energy  .074  .269  .254  .263  .531  -.065  -.095  .037  .038  .079  .693  .125 
loss of cognitive skills  .322  -.651  .149  .039  .041  .008  .111  .727  -.064  -.028  -.023  .055 
name loss  .202  -.575  .182  -.106  .117  .039  .038  .635  .016  -.199  -.004  .085 
place loss  .161  -.666  .207  .043  .185  -.169  -.064  .770  -.130  -.094  .149  -.067 
reduced comprehension  .336  -.653  .266  .161  .100  -.071  .017  .816  -.062  .074  .126  .037 
loss of memory  .282  -.694  .197  .028  .094  -.012  .050  .785  -.065  -.067  .024  .057 
change in personality  .321  -.535  .121  .129  -.114  -.004  .101  .595  -.056  .141  -.100  .022 
initial insomnia   .228  .257  .166  .350  .140  .007  .034  -.025  .066  .341  .363  .112 
mid-insomnia   .276  .230  .076  .036  .406  -.224  .168  .017  .091  -.052  .525  -.135 
early morning wakening   .195  .231  .158  .083  .415  -.222  .046  .035  .100  -.017  .562  -.101 
increased daytime sleep  .255  -.052  -.120  -.132  .052  .062  .306  .054  .039  -.132  -.038  .007 
loss of appetite  .512  .156  -.454  .097  .285  .002  .716  -.104  -.231  .017  .232  -.065 
increased appetite  .069  -.058  .295  .309  -.232  -.294  -.274  .207  .070  .434  .079  -.201 
weight loss  .386  .170  -.350  .012  .337  .124  .591  -.122  -.143  -.099  .228  .077 
weight gain  .023  .001  .253  .263  -.532  -.131  -.276  .040  .156  .514  -.241  -.116 
diurnal variation - evening  .161  .081  -.057  .346  -.048  -.219  .069  .009  -.161  .384  .163  -.182 
diurnal variation -morning  .173  .187  .185  -.225  -.104  .126  .055  -.111  .417  -.099  -.087  .096 
reduced concentration  .534  .071  .176  -.077  .043  .209  .335  .125  .374  -.006  .072  .210 
increased verbal aggression  .367  .298  .496  -.290  -.039  -.040  -.017  -.012  .749  -.106  .133  .000 
increased physical aggression  .332  .311  .441  -.394  -.047  .035  .022  -.077  .769  -.210  .052  .042 
need for reassurance  .490  .131  .037  .210  -.175  .204  .331  -.002  .175  .345  -.045  .183 
self harm/ SIB  .214  .302  .398  -.169  .024  -.033  -.074  -.066  .552  -.052  .180  .022 
somatic concerns  .226  .152  .100  .202  -.157  .075  .073  -.049  .132  .312  .001  .087 
sexual behaviour  .190  .147  .199  -.141  -.058  .177  .058  -.051  .367  -.050  -.039  .169 
eigenvalue  5.16  3.51  2.32  1.85  1.62  1.61  4.05  3.52  2.86  2.10  1.98  1.67 
% total variance  12.50  8.54  5.66  4.51  3.95  3.90  9.88  8.59  6.98  5.12  4.83  4.07   140 
This suggests that the factors have adequate stability. For the first time in any of the 
factor solutions, there is cross-loading of an item across factors. The initial insomnia 
item loads significantly to factors four and five. An overlap between factors four and 
five is also supported by the finding that two items that loaded onto factor four, in the 
four  factor  solution  in  table  4.3,  now  load  onto  factor  five-  increased  verbal 
communication and increased energy. 
 
The rotated four factor solution accounts for 31.4% of the total variance, whilst the 
rotated five factor solution accounts for 35.3%, suggesting that the fifth factor may 
make  a  significant  contribution  to  the  overall  dimensional  model.  However,  some 
issues arise when the coherence and interpretability of factor five is considered. It is 
possible  to  conceptualise  the  five  items  in  factor  five  as  a  mania/  hypomania 
dimension of psychopathology. The increased verbal communication and energy items 
of psychopathology are often experienced by individuals with hypomania. Similarly, 
the three sleep problem items could be conceptualised as part of a mania/ hypomania 
dimension.  
 
Although factor five is interpretable and makes a sizeable contribution to the five 
factor solution explaining a greater proportion of the total variance, there are reasons 
to be cautious over accepting the five factor solution. Three of the items in factor five 
(increased verbal communication, increased energy levels and initial insomnia) load 
significantly onto the anxiety dimension in the four factor solution. Therefore, it could 
be argued that the only additional contribution to the overall dimensional model is the 
inclusion of the mid-insomnia and early morning wakening items.  
 
Perhaps of greatest relevance is the fact that for the first time cross-loading of an item 
of psychopathology appears in the five factor solution. The cross-loading of initial 
insomnia across the anxiety and mania/ hypomania dimension could be interpreted as 
evidence that the dimensional model based on the five factor solution is less coherent 
and reliable. It is certainly recognised that it is preferable to have no cross-loading of 
items across factors in a rotated solution (Costello & Osborne 2005). 
 
Overall, there are arguments for and against using the five factor solution as the basis 
of the dimensional model of psychopathology. However, since there is cross-loading   141 
within the five factor solution, the four factor solution is chosen as the final solution 
on which to base the proposed dimensional model of psychopathology. 
 
In order to examine the stability of the four factor solution, two separate random 
samples were selected from the sample used for the EFA (n= 330).  To maintain the 
minimum case:item ratio of 5:1 each sample would need a minimum of 205 cases.  
 
SPSS was used to examine a random sample of 205 cases from the 330 used in the 
EFA.  The EFA extracting four factors was run for this first random sample. A second 
random sample of 205 cases was selected and the EFA run again. The results are 
shown in tables 4.6 and 4.7 below.   142 
Table 4.6: Non-rotated and rotated four factor solution from EFA of 41 items of 
psychopathology for random sample 1 (n=205)  
 
Non-rotated solution  Rotated solution 
Factor  Factor 
 
1  2  3  4  1  2  3  4 
worry  .158  -.128  .004  .504  .090  -.027  -.210  .550 
generalised anxiety  .174  -.218  -.004  .267  .110  -.143  -.040  .336 
agoraphobia  .173  -.088  -.166  .162  .236  -.128  -.091  .171 
animal phobia  .036  -.080  -.019  -.112  .040  .079  -.095  -.095 
specific phobia  -.109  .056  .005  -.001  -.085  -.051  .041  -.025 
rituals  -.038  -.016  .343  -.273  -.252  .071  .423  -.188 
orderliness  -.166  -.063  .346  -.168  -.365  .027  .337  -.093 
low mood  .691  -.101  -.212  .021  .683  -.081  .074  .097 
labile mood  .365  -.248  .234  .044  .107  -.087  .349  .209 
irritability  .485  -.223  .364  .075  .115  .003  .461  .285 
social withdraw  .675  .007  -.245  -.003  .704  .001  .023  .038 
anhedonia  .692  .023  -.294  -.135  .757  -.019  .065  -.104 
talk loss  .489  .279  -.273  -.043  .601  .210  -.120  -.094 
talk gain  .157  -.107  .538  .135  -.255  .141  .418  .311 
tearfulness  .587  -.144  .029  .041  .432  -.041  .229  .168 
reduced self care  .641  .200  -.100  -.053  .597  .220  .094  -.022 
loss of energy  .563  .212  -.282  -.034  .659  .156  -.088  -.062 
increased energy  .096  -.230  .331  .061  -.172  -.066  .323  .205 
loss of cognitive skills  .218  .595  .228  .006  .071  .657  .052  -.033 
name loss  .055  .635  .175  -.198  -.009  .626  .070  -.281 
place loss  .054  .671  .158  .162  -.010  .701  -.172  .062 
reduced comprehension  .200  .655  .341  .159  -.019  .773  .022  .130 
loss of memory  .122  .608  .313  .093  -.065  .701  .031  .056 
change in personality  .223  .562  .039  .059  .199  .565  -.114  -.019 
initial insomnia   .239  -.155  .121  .303  .081  -.025  .036  .398 
mid-insomnia   .381  -.119  .043  .148  .257  -.024  .102  .241 
early morning wakening   .231  -.082  .106  .083  .101  .005  .131  .160 
increased daytime sleep  .165  .247  -.162  -.029  .265  .182  -.134  -.097 
loss of appetite  .603  -.091  -.399  .119  .736  -.139  -.161  .131 
increased appetite  -.030  -.001  .246  .542  -.213  .160  -.146  .590 
weight loss  .472  -.085  -.288  -.088  .567  -.137  .007  -.067 
weight gain  -.068  -.076  .304  .474  -.287  .099  -.048  .547 
diurnal variation - evening  .133  -.128  -.061  .365  .120  -.074  -.184  .393 
diurnal variation -morning  .182  -.097  .231  -.373  -.005  -.030  .492  -.263 
reduced concentration  .578  .012  .226  -.101  .311  .155  .415  .041 
increased verbal aggression  .443  -.196  .416  -.248  .063  -.001  .673  -.034 
increased physical aggression  .453  -.193  .370  -.353  .106  -.028  .704  -.147 
need for reassurance  .509  -.042  .092  -.158  .332  .082  .150  .265 
self harm/ SIB  .266  -.272  .357  -.139  -.050  -.100  .531  .049 
somatic concerns  .279  -.131  .183  .141  .107  -.008  .128  .286 
sexual behaviour  .139  -.103  .204  -.291  -.025  -.040  .410  -.194 
eigenvalue  5.49  3.11  2.58  1.87  4.72  3.09  3.06  2.28 
% total variance  13.39  7.58  6.29  4.56  11.5  7.54  7.46  5.56   143 
Table 4.7: Non-rotated and rotated four factor solution for EFA of 41 items of 
psychopathology for random sample 2 (n=205)  
Non-rotated solution  Rotated solution 
Factor  Factor 
 
1  2  3  4  1  2  3  4 
worry  .027  -.103  -.038  .345  .088  -.054  -.142  .337 
generalised anxiety  -.002  -.174  -.121  .378  .122  -.152  -.206  .354 
agoraphobia  .072  .009  -.202  .170  .205  -.033  -.193  .124 
animal phobia  .024  -.120  .035  -.013  -.010  -.091  .087  .018 
specific phobia  -.063  .184  -.037  .055  -.012  .147  -.146  .010 
rituals  -.067  .003  .246  .208  -.187  .121  .056  .266 
orderliness  -.165  -.007  .250  .075  -.284  .076  .084  .136 
low mood  .671  -.142  -.241  -.041  .672  -.105  .172  -.039 
labile mood  .341  -.247  .272  -.125  .065  -.061  .490  .031 
irritability  .508  -.262  .244  -.208  .202  -.066  .584  -.043 
social withdraw  .615  .014  -.255  .067  .656  .034  .033  .027 
anhedonia  .714  .011  -.289  .053  .753  .033  .057  .010 
talk loss  .511  .234  -.223  -.121  .535  .196  .023  -.189 
talk gain  .083  -.047  .333  .556  -.084  .190  .038  .642 
tearfulness  .482  -.145  .032  -.105  .338  -.039  .327  -.032 
reduced self care  .637  .207  -.122  .012  .583  .256  .098  -.020 
loss of energy  .538  .234  -.391  -.063  .674  .140  -.117  -.183 
increased energy  .052  -.253  .435  .549  -.182  .042  .176  .701 
loss of cognitive skills  .265  .661  .195  .054  .101  .726  -.002  .008 
name loss  .198  .637  .142  -.022  .074  .659  -.025  -.081 
place loss  .094  .717  .262  .047  -.076  .770  -.040  -.001 
reduced comprehension  .186  .734  .256  .159  .015  .817  -.064  .107 
loss of memory  .249  .703  .245  .114  .064  .790  -.015  .071 
change in personality  .212  .629  .044  .013  .153  .620  -.106  -.074 
initial insomnia   .201  -.251  .325  .221  -.035  -.019  .310  .367 
mid-insomnia   .293  -.175  .322  .234  .042  .066  .314  .370 
early morning wakening   .178  -.172  .282  .200  -.025  .025  .251  .318 
increased daytime sleep  .381  .080  -.134  .019  .389  .091  .024  -.010 
loss of appetite  .512  -.184  -.368  .363  .683  -.167  -.163  .303 
increased appetite  .046  .157  .286  .032  -.145  .271  .161  .091 
weight loss  .459  -.200  -.257  .361  .568  -.146  -.096  .154 
weight gain  .055  .123  .120  .182  -.057  .144  .154  .334 
diurnal variation - evening  .068  -.126  -.041  .367  .125  -.064  -.129  .364 
diurnal variation -morning  .270  -.143  .059  -.351  .123  -.101  .371  -.272 
reduced concentration  .597  -.102  .014  .020  .456  .031  .287  .082 
increased verbal aggression  .418  -.230  .505  -.311  -.052  .040  .776  -.074 
increased physical aggression  .429  -.278  .379  -.408  .025  -.067  .749  -.195 
need for reassurance  .524  -.100  -.039  .047  .438  .001  .205  .087 
self harm/ SIB  .294  -.291  .463  -.121  -.099  -.028  .626  .096 
somatic concerns  .233  -.149  .062  .018  .139  -.060  .188  .079 
sexual behaviour  .310  -.119  .264  -.083  .054  .051  .407  .042 
eigenvalue  5.28  3.78  2.57  2.04  4.37  3.63  3.31  2.25 
% total variance  12.88  9.22  6.27  4.98  10.66  8.85  8.07  5.49   144 
To  examine  the  stability  of  the  four  factor  solution  the  correlations  between  item 
loadings from the rotated factors from the EFA using the two random samples were 
calculated. In table 4.8, the Pearson correlations and level of significance are shown. 
 
Table 4.8: Correlation of items loadings from rotated four factor solution, using 
two random samples  
 
 
  Pearson correlation  Level of significance 
Factor 1- depression  0.954  p< 0.001 
Factor 2- organic  0.968  p< 0.001 
Factor 3- behaviour- affective  0.809  p< 0.001 
Factor 4- anxiety  0.591  p= .003 
 
 
 
The significant correlations in table 4.8 suggest that the extracted four factor solution 
has good stability. However, whilst the factor solutions in table 4.6 and table 4.7 
remain coherent to a dimensional model of psychopathology, with dimensions labelled 
as depressive, organic, behaviour-affective and anxiety, there are differences in the 
loadings of individual items, compared to the four factors in the original EFA (table 
4.3). To allow comparison, table 4.9 below lists the items with loadings greater than 
0.32 from the four factor solutions, extracted from the three EFAs.  
 
In table 4.9, any changes in the EFAs using the two random samples, in comparison to 
the original EFA are highlighted in bold. One further point to note is that the item 
rating agoraphobia loads significantly to the anxiety dimension only in the original 
EFA.   145 
 
Table 4.9: Item loadings to the four factor solutions from the three separate EFAs. 
    Factor 1- depressive  Factor 2- organic  Factor 3- behaviour-affective  Factor 4- anxiety 
Original EFA  
(n=330) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
loss of appetite 
weight loss 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
increased mood lability 
increased irritability 
diurnal variation in mood- worse in 
the morning 
reduced concentration 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
agoraphobia 
increased verbal 
communication 
increased energy levels 
initial insomnia greater than 
one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
increased need for reassurance 
Random sample 1 
(n=205) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
loss of appetite 
weight loss 
increased need for 
reassurance 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
rituals 
excessive orderliness 
increased mood lability 
increased irritability 
diurnal variation in mood- worse in 
the morning 
reduced concentration 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
increased verbal 
communication 
increased energy levels 
initial insomnia greater than 
one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
 
Random sample 2 
(n=205) 
low mood 
social withdrawal 
anhedonia 
reduced verbal communication 
tearfulness 
reduced self-care  
lower energy levels 
increased daytime sleeping 
loss of appetite 
weight loss  
reduced concentration 
increased need for 
reassurance 
change in cognitive functioning 
forgetting the names of familiar 
people 
getting lost in familiar places 
reduced verbal comprehension 
memory problems 
change in personality 
increased mood lability 
increased irritability 
tearfulness 
diurnal variation in mood- worse in 
the morning 
increased verbal aggression 
increased physical aggression 
increased self harming or self-
injurious behaviour 
inappropriate sexual behaviour 
worrying 
generalised anxiety 
increased verbal 
communication 
increased energy levels 
initial insomnia > one hour 
mid-insomnia> one hour 
increased appetite  
weight gain 
diurnal mood variation- worse 
in the evening 
increased need for reassurance   146 
Although  some  differences  exist,  overall  it  appears  from  table  4.9  that  the  items 
loading to the four factors are largely unchanged across the three EFAs. The items 
loading  to  the  depressive  dimension  in  the  original  EFA  load  significantly  to  the 
depressive  dimension  in  the  EFAs  using  the  two  random  samples.  However,  two 
additions to the item loadings to the depressive dimension are noted with an item 
moving  from  the  original  behaviour-affective  dimension  (concentration)  and  the 
original anxiety dimension (increased need for reassurance). 
 
Perhaps the most interesting changes in the loadings are the four items that appear for 
the first time in the EFAs using the random samples- increased daytime sleeping loads 
to the depressive dimension, rituals and excessive orderliness load to the behaviour-
affective dimension, and mid-insomnia loads to the anxiety dimension.  
 
Despite these minor differences in the dimensions identified, the strong correlations 
between  dimensions  in  the  three,  separate  four  factor  solutions  indicate  that  this 
dimensional  model  of  psychopathology  is  statistically  stable.  Therefore,  null 
hypothesis one is rejected. 
 
4.2 The correlations between the four dimensions of psychopathology 
 
 
The correlations between the four factors from the rotated solution from the original 
EFA are shown in table 4.10. There were no significant correlations between the four 
dimensions  of  psychopathology.  On  the  one  hand  this  is  a  positive  finding  as  it 
demonstrates  the  four  factors  stand  alone  as  independent  dimensions  of 
psychopathology. However, from studies involving children, adolescents and adults 
who do not have intellectual disabilities it might have been expected to find greater 
correlations between the depressive and anxiety dimensions of psychopathology. Thus 
it would appear that the dimensions are independent, with no evidence for any higher 
order dimensions. Therefore, the null hypothesis is accepted. 
Null hypothesis two: 
There  are  no  significant  correlations  between  the  individual  dimensions  of 
psychopathology experienced by adults with intellectual disabilities.   147 
 
Table 4.10: The correlations between the dimensions of psychopathology from 
the four factor solution. 
 
  Depressive  Organic  Behavioural-
affective 
Anxiety 
Depressive  1.000  .194  .261  .227 
Organic  .194  1.000  .079  .014 
Behavioural-affective  .261  .079  1.000  .256 
Anxiety  .227  .014  .256  1.000 
 
 
 
4.3  The  bivariate  relationship  between  psychopathology  and  socio-
clinical variables 
 
Prior  to  considering  the  specific  hypotheses  relevant  to  dimensional  models  of 
psychopathology  and  socio-clinical  variables,  the  distributions  of  the  variables  are 
explored.  
 
4.3.1 The distribution of the measures of psychopathology  
Descriptive data and the normal distribution statistics for the measures representing 
the dimensional model of psychopathology (see section 3.5.1) are reported in table 
4.11 below: 
·  imension factor scores for depressive, organic, behavioural-affective and anxiety  
·  the total dimension factor score 
·  dimension  symptom  counts  for  depressive,  organic,  behavioural-affective  and 
anxiety  
·  the total dimension symptom count 
·  the EFA PPS-LD symptom count- 41. 
Null hypothesis three: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables. 
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From table 4.11, the z-scores for skewness and kurtosis and the Shapiro-Wilk test 
results suggest that the three overall measures of psychopathology (total dimension 
factor score, total dimension symptom count and EFA PPS-LD symptom count- 41) 
have normal distributions. Visual confirmation of this was provided in the histograms 
with superimposed normal distribution curves and the normal probability plots for 
these variables. Given that these overall measures of psychopathology have a normal 
distribution,  the  use  of  parametric  statistical  tests  is  considered  valid  for  these 
variables.  
 
As  well  as  informing  a  decision  on  whether  or  not  to  use  parametric  statistics, 
examining the distribution of each of the three overall measures allows consideration 
of whether psychopathology experienced by adults with intellectual disabilities has a 
continuous  or  bimodal  distribution.  To  illustrate  this,  the  histogram  for  the  total 
dimension factor score is shown in figure 4.2. Examining figure 4.2, there do not 
appear to be any clear break points in the distribution, or a two peaked distribution 
suggestive  of  bimodality.  Thus,  along  with  the  evidence  to  support  a  normal 
distribution in table 4.11, it appears that psychopathology assessed using the PPS-LD 
is best considered as a continuous measure. This suggests that a dimensional rather 
than categorical model of psychopathology may be appropriate.    149 
Table 4.11: Summary and normality data of the dimensional and overall measure of psychopathology  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
    Skewness  Kurtosis  Normality test 
   
 
Mean 
 
Min 
 
Max 
 
SD  S  z-score§  K  z-score§  Shapiro-Wilk  p 
Depressive  .16  -1.92  2.14  .99  .067  .337  -.909  2.301* 
.978*  .018 
Organic  .08  -.91  4.48  1.00  1.914  9.618***  3.668  9.286*** 
.748***  .000 
Behaviour-
affective 
.31  -1.40  2.77  .94  .442  2.221*  -.518  1.311 
.972**  .004 
Anxiety  .24  -1.77  3.44  1.05  .487  2.447*  .204  .516 
.981*  .039 
 
Dimension 
factor scores 
Total  .78  -3.32  5.88  1.96  .204 
 
1.01  -.35  .89  .99  .216 
Depressive  3.63  0  9.00  2.50  .169  .849  -1.02  2.582** 
.944***  .000 
Organic  .67  0  6.00  1.31  2.011  10.106***  3.517  8.904*** 
.582***  .000 
Behaviour-
affective 
2.79  0  8.00  1.88  .433  2.176*  -.540  1.367 
.940***  .000 
Anxiety  2.57  0  7.00  1.69  .554  2.784**  -.154  .390 
.932***  .000 
 
Dimension 
symptom 
counts 
Total  9.66  1  19.0  3.96  .17 
 
.85  -.52  1.32  .98  .05 
EFA PPS-LD symptom count- 
41 
11.12  2  22  4.13  .33 
 
1.66  -.31  .78  .98  .050   150 
 
Figure 4.2: A histogram showing the distribution of the total dimension factor 
score 
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In contrast to the three overall measures of psychopathology, the Shapiro-Wilk tests in 
table 4.11 suggest that all eight measures of psychopathology (the four individual 
dimension factor scores and symptom counts) differ  significantly from the normal 
distribution. The distribution of all variables is positively skewed to different extents- 
the depressive dimension factor scores are the least positively skewed, and the organic 
dimension  factor  scores  have  the  greatest  positive  skew.  To  try  and  move  the 
distribution of the variables closer to normality, initially a square root and logarithmic 
transformation  were  applied  separately  to  the  dimensional  measures  of 
psychopathology.  The  statistical  results  of  the  distributions  of  the  transformed 
variables are shown in table 4.12 below. It appears that the square root transformation 
has moved the distribution of the depressive, behaviour-affective and anxiety factor 
scores closer to normality. For all three variables, the skewness and kurtosis z-scores,   151 
and Shapiro-Wilk test are no longer significant, suggesting that the distributions no 
longer  differ  from  normality.  This  was  confirmed  in  the  histograms  and  normal 
probability  plots  for  square  root  transformed  depressive,  behaviour-affective  and 
anxiety factor scores. 
 
However, neither the square root nor logarithmic transformations moved the organic 
dimension factor score closer to a normal distribution on the statistical measures in 
table  4.12.  Therefore,  an  inverse  transformation  was  tried  and  lead  to  some 
improvement in the skewness (-.499; z-score= 2.508) and kurtosis (-.550; z-score= 
1.392).  However,  the  Shapiro-Wilk  score  (.949;  p<  .001)  suggested  that  the 
distribution  was  still  significantly  different  from  normality.  Overall,  none  of  the 
transformations moved the distribution of the organic dimension factor score closer to 
normality. Therefore, non-parametric methods were used in subsequent analyses using 
the organic dimension factor score. 
 
In table 4.12, it is apparent that the square root and logarithmic transformations did not 
move the distribution of the four dimension symptom counts towards normality. The 
Shapiro-Wilk  test  remains  significant  for  the  transformed  depressive,  organic, 
behaviour-affective and anxiety dimension symptom counts. Therefore, the inverse 
transformation of these was carried out there but there was no significant shift in the 
skewness and kurtosis, and the Shapiro-Wilk score in table 4.13 confirms that the 
distributions of the dimension symptom count variables differed significantly from 
normality. 
   152 
Table 4.12: Statistical tests of skewness, kurtosis and normality for square root and logarithmic transformed measures of psychopathology  
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
  Square root transformation  Logarithmic transformation 
  Skewness  Kurtosis  Normality test  Skewness  Kurtosis  Normality test 
  S  z-
score§ 
K  z-
score§ 
Shapiro
-Wilk 
p  S  z-score§  K  z-
score§ 
Shapiro-
Wilk 
p 
Depressive 
-.231  1.161  -.736  1.863  .982  .160  -.585  2.940**  -.165  .418  .975*  .035 
Organic 
1.496  7.517***  1.619  4.099***  .845***  .000  1.144  5.749***  .438  1.109  .893***  .000 
Behaviour-
affective 
.103  .518  -.658  1.666  .983  .193  -.274  1.377  -.419  1.061  .986  .342 
 
Dimension 
factor scores 
Anxiety 
-.015  .075  -.088  .414  .992  .759  -.549  2.759**  .315  .797  .967**  .008 
Depressive 
-.256  1.286  -1.036  2.623**  .942***  .000  -.709  3.563***  -.600  1.519  .931***  .000 
Organic 
1.659  8.337***  1.544  3.909***  .655***  .000  1.433  7.201***  .483  1.223  .655***  .000 
Behaviour-
affective 
-.040  .201  -.796  2.015*  .952**  .001  -.554  2.784**  -.433  1.096  .906***  .000 
 
Dimension 
symptom 
counts  Anxiety 
.038  .191  -.596  1.509  .950***  .000  -.509  2.558*  -.286  .724  .947***  .000   153 
 
Table 4.13: Statistical tests of skewness, kurtosis and normality for the inverse 
transformation of the symptom counts of the four dimensions of psychopathology  
 
 
 
Z-score values are calculated by dividing the statistic score by the standard errors 
.199 for skewness and .395 for kurtosis. 
* p < 0.05 
** p < 0.01 
*** p < 0.001 
 
 
All  of  the  distributions  remain  positively  skewed,  most  obviously  for  the  organic 
dimension symptom count, illustrated in figure 4.3. Part of the reason for this is the 
number of cases with zero scores on each the specific symptom count. This effect has 
been described previously for research using symptom count distributions (Melzer, 
2002). Therefore, as for the organic dimension factor score, the analyses involving the 
individual dimension symptom counts will use non-parametric statistical methods. 
Inverse transformation   
Skewness  Kurtosis  Normality test 
Symptom 
count 
stat  z-score  stat  z-score  S-W  p 
Depressive 
1.546  7.769***  1.153  2.919**  .723***  .000 
Organic 
-1.208  6.056***  -.405  1.025  .589***  .000 
Behaviour-
affective 
1.618  8.131***  1.960  4.962***  .761***  .001 
Anxiety 
1.673  8.407***  2.458  6.223***  .768***  .000   154 
 
 
Figure 4.3: The histogram showing the distribution of the organic dimension 
symptom count 
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4.3.2 Distribution of age 
The mean age of sample 2 is 43.5 years (range= 17-74; SD ± 13.1). Although, the 
Shapiro-Wilk  test  statistic  approaches  significance  (.982;  p=  0.053),  the  non-
significant skewness z-score of 0.317, and a non-significant kurtosis z-score of 1.56 
(z-score  ≥  ±  1.96,  is  significant  at  p  <  0.05)  suggest  there  is  a  slightly  flat 
distribution unlikely to be improved by transformation. Since, age in years has a 
distribution which is close to normality, it is assumed that it can be reliably used in 
parametric analyses. 
 
4.3.3 The association of psychopathology with gender 
The  descriptive  statistics  and  results  of  statistical  analyses  examining  the 
relationship between gender and psychopathology are shown in table 4.14. In the 
final  two  columns,  the  results  of  the  Student  t-tests  and  non-parametric  Mann-
Whitney tests suggest that there are no significant gender differences in any of the 
dimensional measures of psychopathology.   156 
Table 4.14: The relationship between gender and dimensional measures of psychopathology 
 
 
Gender  Mean 
 
 
Min - Max  SD  statistic 
 
 
p 
male  .14  -1.85 - 2.12  1.06  Depressive‡ 
female  .19  -1.92 - 2.14  .92 
-.458  .647 
male  .113  -.91 - 4.48  1.02  Organic  
female  .032  -.86 - 4.03  .98 
.614†  .539 
male  .35  -1.40 - 2.77  .99  Behaviour-
affective‡ 
  
female  .25  -1.22 - 2.57  .88  .459  .647 
male  .18  -1.77 - 2.69  1.00  Anxiety‡ 
   female  .30  -1.71 - 3.44  1.10 
-.685  .494 
male  .78  -3.32 - 5.05  2.07 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
   female  .78  -3.08 - 5.88  1.84 
.010  .992 
male  3.57  0 - 9  2.65  Depressive  
   female  3.71  0 - 9  2.33 
-.384†  .701 
male  .73  0 - 6  1.35  Organic  
   female  .60  0 - 6  1.26 
.678†  .497 
male  2.88  0 - 8  2.02  Behaviour-
affective  
  
female  2.68  0 - 7  1.71  .547†  .584 
male  2.44  0 - 8  1.54  Anxiety  
   female  2.72  0 - 7  1.86 
-.534†  .593 
male  9.62  1 - 18  4.23 
 
 
 
 
 
Dimension symptom 
counts 
Total  
   female  9.71  2 -19  3.65 
-.135  .892 
male  11.27  2 -20  4.28  EFA PPS-LD symptom count- 41  
   female  11.09  2 - 22  3.8 
.274  .785 
 
‡ The square root transformed variable was used in the statistic analysis 
† Non- parametric z-score from Mann-Whitney test   157 
 
4.3.4 The relationship between psychopathology and age 
The dimensional measures of psychopathology are examined against continuous and 
categorical measures of age, and the correlations reported in table 4.15. 
 
Table 4.15: The relationship between age and measures of psychopathology. 
 
 
 
  Age in years 
 
Measure of 
psychopathology  R 
 
 
p 
Depressive‡  .214**  .009 
Organic  .098†  .234 
Behaviour-affective‡  
 
-.217**  .008 
Anxiety‡ 
 
-.210*  .010 
 
 
 
 
Dimension factor 
scores 
Total  -.016  .850 
Depressive   .171†*  .038 
Organic  
  
.174†*  .034 
Behaviour-affective  
  
-.230†**  .005 
Anxiety  
  
-.215†**  .009 
 
 
 
 
Dimension 
symptom counts 
Total  -.018  .829 
EFA PPS-LD symptom count- 41   -.035  .669 
 
 
* significant at the p< .05 level  
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
† Non-parametric Spearman’s correlation co-efficient  
§ Non- parametric z-score from Mann-Whitney test   158 
Some  interesting  results  were  seen  in  table  4.15.  Age  in  years  is  significantly 
correlated to the depressive, behaviour-affective and anxiety factor scores, and all 
four dimension symptom counts. However, the direction of the correlation is not the 
same  for  all  four  dimensions  of  psychopathology.  The  depressive  factor  score, 
depressive symptom count and the organic dimension symptom count, are positively 
correlated with age in years i.e. the factor score and symptom counts increase as age 
increases.  In contrast, there is an inverse correlation between age and  the factor 
scores, and symptom counts, for the behaviour-affective and anxiety dimensions.  
 
4.3.5 Psychopathology and living circumstances 
Table 4.16 shows that only the organic and behaviour-affective dimension factor 
scores were significantly associated with living circumstances.  
 
A Bonferroni correction was used to take account of the multiple comparisons in the 
post-hoc  tests.  Since  there  are  two  separate  comparisons  for  each  variable  the 
accepted levels of significance are p < .025, p < .005 and p< .0005. Mann-Whitney 
tests were used for the post-hoc tests for the organic dimension factor score. There 
are  significant  differences  between  individuals  living  independently  compared  to 
individuals  with  support  from  family  carers  (z=-3.201,  p=.001)  and  individuals 
living with support from family carers against paid carers (z=-2.635, p=.008)  Post 
hoc  Bonferroni  tests  found  that  the  only  significant  difference  in  the  behaviour-
affective factor score was between individuals living independently and with paid 
carers (mean difference= 0.1744, p= .014).   
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Table 4.16: The relationship between living circumstances and psychopathology  
 
 
* significant at the p< .05 level   
** significant at the p< .01 level 
† Non-parametric Kruskall-Wallis test  
‡ square root transformed variable used in the analyses 
 
 
 
Living 
circumstances  Mean  SD  Min  Max 
 
 
F 
 
 
p 
Independent  1.79  .30  1.00  2.25 
Family carer  1.69  .29  1.13  2.16 
Depressive‡ 
 
Paid carer  1.73  .29  1.03  2.24 
.846  .431 
Independent  -.20  .75  -.91  2.18 
Family carer  .35  1.01  -.59  2.82 
Organic  
  
  
Paid carer  .052  1.04  -.86  4.48 
 
 
11.26†** 
 
 
.004 
Independent  1.48  .21  1.00  1.84 
Family carer  1.63  .26  1.18  2.20 
Behaviour-
affective‡  
Paid carer  1.66  .30  1.01  .27 
4.176*  .017 
Independent  1.78  .28  -1.68  2.64 
Family carer  1.65  .29  -1.25  3.44 
Anxiety‡  
  
 
Paid carer  1.71  .31  -1.77  1.95 
1.409  .248 
Independent  .46  1.97  -2.97  5.88 
Family carer  .72  1.81  -3.32  4.54 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor 
scores 
 
Total 
  
 
Paid carer  .91  2.03  -3.08  5.05 
.573  .565 
Independent  4.00  2.43  0  8 
Family carer  3.29  2.56  0  8 
Depressive 
  
  
   Paid carer  3.66  2.51  0  9 
1.241†  .538 
Independent  .41  .89  0  3 
Family carer  .97  1.44  0  4 
Organic 
Paid carer  .63  1.35  0  6 
3.206†  .201 
Independent  2.04  1.37  0  4 
Family carer  2.86  1.87  0  6 
Behaviour-
affective  
  
Paid carer  2.99  1.98  0  8 
4.513†  .105 
Independent  2.89  1.85  0  7 
Family carer  2.29  1.66  0  6 
Anxiety 
  
  
Paid carer  2.59  1.66  0  7 
1.844†  .398 
Independent  9.33  4.10  2  19 
Family carer  9.40  4.13  1  17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
  
Paid carer  9.86  3.89  2  18 
.277  .758 
Independent  10.70  4.11  1.23  2.44 
Family carer  11.00  4.09  1.02  2.34 
EFA  PPS-LD symptom 
count- 41  
  
   Paid carer  11.41  4.07  1.00  2.49 
.361  .698   160 
4.3.6 Psychopathology and level of intellectual disabilities 
The descriptive statistics for the measures of psychopathology are shown for participants 
with mild to profound intellectual disabilities in table 4.17. 
 
Post hoc, Bonferroni test results in table 4.18 clarify the nature of the between group 
differences for the psychopathology variables with significant differences from the initial 
ANOVA  tests.  Mann-Whitney  tests  were  used  as  the  post-hoc  tests  for  the  organic 
dimension  factor  score  and  behaviour-affective  symptom  count,  which  were  initially 
examined using the non-parametric Kruskall-Wallis test and the results shown in table 
4.19.  
 
Several  of  the  analyses  in  table  4.18  and  4.19  would  be  significant  if  the  accepted 
minimum level of significance was p < .05. However, to take account of the multiple 
comparisons a Bonferroni correction is used. Since there are three separate comparisons 
for each variable the accepted levels of significance are p < .0167, p < .003 and p< .0003. 
 
4.3.7 Psychopathology and categorical clinical variables 
Tables 4.20-4.24 show the results of analyses examining the associations between the 
dimensional  measures  of  psychopathology  and  categorical  social  variables-  epilepsy, 
diagnosis of autism, Down syndrome, visual impairment, hearing impairment, mobility 
problems, urinary incontinence and bowel incontinence.  
 
The  only  variable  that  was  significantly  associated  with  epilepsy  was  the  anxiety 
dimension factor score. Post hoc Bonferroni tests found that the only significant between 
group  difference  was  between  the  non-epilepsy  group  and  individuals  with  poorly 
controlled seizures (mean difference= 0.29, p=.001).   161 
Table 4.17: The relationship between intellectual disabilities and psychopathology 
 
 
Intellectual 
disabilities  Mean  SD  Min  Max 
F  p 
mild  .05  .96  -1.92  2.14 
moderate  .34  .92  -1.50  2.01 
severe  .13  .97  -1.69  2.06 
Depressive‡ 
 
profound  .15  1.08  -1.85  2.12 
.521  .669 
mild  -.13  .74  -.91  2.18 
moderate  .24  1.26  -.63  4.48 
severe  .42  1.13  -.86  2.82 
Organic  
  
  
  
profound  -.11  .81  -.71  2.55 
 
 
8.255†* 
 
 
.041 
mild  -.11  .62  -1.25  1.61 
moderate  .51  .93  -.70  2.57 
severe  .22  1.09  -1.36  2.77 
Behaviour-
affective‡  
  
  
   profound  .52  .94  -1.40  2.45 
3.712*  .013 
mild  .26  1.05  -1.68  2.64 
moderate  .72  1.10  -1.25  3.44 
severe  -.16  .91  -1.77  1.95 
Anxiety‡  
  
  
  
profound  .19  1.00  -1.71  2.60 
4.116**  .008 
mild  .07  1.99  -3.08  4.64 
moderate  1.81  1.95  -.68  5.88 
severe  .62  1.58  -2.89  4.05 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor scores 
 
Total 
  
  
  
profound  .74  1.98  -3.32  5.05 
4.750**  .003 
mild  3.38  2.44  0  8 
moderate  4.06  2.38  0  9 
severe  3.55  2.36  0  9 
Depressive 
  
  
  
profound  3.59  2.74  0  8 
 
 
1.393† 
 
 
.707 
mild  .47  .90  0  3 
moderate  .84  1.70  0  6 
severe  1.09  1.51  0  4 
Organic 
profound  .43  1.06  0  4 
 
 
4.895† 
 
 
.180 
mild  2.06  1.46  0  6 
moderate  3.19  1.70  0  7 
severe  2.55  2.14  0  8 
Behaviour-
affective  
  
  
   profound  3.18  1.94  0  7 
 
 
10.077†* 
 
 
.018 
mild  2.62  1.88  0  7 
moderate  3.26  1.79  0  7 
severe  2.09  1.31  0  5 
Anxiety 
  
  
  
profound  2.43  1.64  0  7 
 
 
7.003† 
 
 
.072 
mild  8.53  4.19  2  17 
moderate  11.35  3.77  7  19 
severe  9.27  3.28  3  17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
  
  
profound  9.63  4.09  1  18 
3.038*  .031 
mild  9.8  4.20  2  17 
moderate  12.94  4.12  7  22 
severe  10.70  3.34  4  18 
 
EFA  PPS-LD symptom 
count- 41  
 
profound  11.35  4.06  2  19 
 
 
3.554* 
 
 
.016   162 
 
 
 
 
 
Table 4.18: Post hoc Bonferroni tests of ANOVA between group differences for level of intellectual disabilities and measures of 
psychopathology 
 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mean 
Difference 
(I-J) 
Std. 
Error  p 
95% Confidence 
Interval 
mild  moderate  -.184  .069  .050  -.369  .0001 
   severe  -.087  .068  1.000  -.268  .095 
Behaviour affective‡ 
  
  
      profound  -.183  .062  .020  -.348  -.019 
moderate  mild  .135  .073  .407  -.061  .331 
   severe  .258*  .074  .004  .060  .456 
 Anxiety‡ 
  
  
      profound  .154  .067  .141  -.026  .334 
mild  moderate  -1.74**  .470  .002  -2.999  -.484 
   severe  -.547  .463  1.000  -1.784  .690 
Dimension  factor scores 
Total 
  
      profound  -.671  .419  .668  -1.793  .450 
mild  moderate  -1.13  .457  .085  -2.356  .0868 
   severe  -.487  .449  1.000  -1.689  .715 
Behaviour-affective  
  
      profound  -1.11  .407  .041  -2.207  -.0286 
mild  moderate  -2.825  .965  .024  -5.406  -.245 
   severe  -.743  .949  1.000  -3.283  1.796 
Dimension symptom 
counts  Total 
  
  
   profound  -1.098  .860  1.000  -3.399  1.203 
mild  moderate  -3.112*  .984  .011  -5.743  -.481 
   severe  -.873  .968  1.000  -3.462  1.716 
  
 EFA PPS-LD symptom count- 41 
 
   profound  -1.529  .878  .500  -3.876  .817 
 
* significant at the p< .0167 level ** significant at the p < .003 
‡ the square root transformed variable is used in the analyses   163 
 
 
 
 
 
 
Table 4.19: The non-parametric post hoc tests for the between group differences for level of intellectual disabilities and the organic 
dimension factor score and behaviour-affective and anxiety symptom counts 
 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mann-Whitney 
U  z  p 
moderate  mild  410  -1.537  .124 
   severe  486  -.343  .732 
   profound  559  -2.214  .027 
severe  mild  400  -2.019  .043 
   moderate  486  -.343  .732 
 
 
 
Dimension  factor scores 
Organic 
  
  
  
  
  
   profound  606  -2.157  .031 
mild  moderate  326  -2.693*  .007 
   severe  518  -552  .581 
Behaviour-affective  
  
  
   profound  571  -2.696*  .007 
mild  moderate  1332  -2.366  .018 
   severe  1541  -1.740  .082 
 
 
 
 
Dimension symptom 
counts 
Anxiety  
   profound  2361  -.563  .574 
 
* significant at the p< .0167 level    164 
 
 
 
Table 4.20: The relationship between epilepsy and psychopathology 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< .01 level 
‡ square root transformed variable used   
† Non- parametric χ² from Kruskall-Wallis test   
 
 
 
 Epilepsy  Mean  SD  Min  Max 
 
 
F 
 
 
p 
no  .24  1.00  -1.92  2.14 
good control  -.12  .93  -1.20  1.88 
Depressive‡ 
 
poor control  .15  .99  -1.12  2.12 
1.394  .251 
no  .05  .93  -.91  2.82 
good control  -.002  1.06  -.69  4.48 
Organic  
  
poor control  .43  1.31  -.59  4.02 
2.846†  .241 
no  .25  .93  -1.39  2.57 
good control  .46  1.00  -1.07  2.77 
Behaviour-
affective ‡ 
   poor control  .43  .90  -.80  1.78 
.765  .467 
no  .40  1.04  -1.77  3.44 
good control  .02  .82  -1.56  2.27 
Anxiety ‡ 
  
    poor control  -.49  1.14  -1.72  1.70 
7.020**  .001 
no  .94  1.86  -2.96  5.88 
good control  .36  2.20  -3.32  4.96 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor scores 
 
Total 
  
   poor control  .53  2.16  -3.08  4.27 
1.118  .330 
no  3.86  2.49  0  9 
good control  2.93  2.36  0  8 
Depressive 
  
  
   poor control  3.40  2.75  0  8 
 
3.294† 
 
.193 
no  .66  1.24  0  4 
good control  .48  1.30  0  6 
Organic 
poor control  1.13  1.73  0  6 
3.798† 
  .150 
no  2.64  1.82  0  7 
good control  3.10  2.04  0  8 
Behaviour-
affective  
   poor control  3.20  1.97  0  6 
2.133† 
  .344 
no  2.77  1.72  0  7 
good control  2.24  1.48  0  6 
Anxiety 
  
   poor control  1.80  1.66  0  5 
5.588†  .061 
no  9.92  3.76  2  19 
good control  8.76  4.28  1  17 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
  
   poor control  9.53  4.69  1  17 
.990  .374 
no  11.44  3.91  4  22 
good control  10.44  4.40  2  19 
EFA PPS-LD symptom count- 
41  
  
   poor control  10.87  4.52  2  18 
.724  .487   165 
 
Table 4.21: The relationship between autism, Down syndrome and psychopathology. 
 
    Autism  Down syndrome 
    Yes (n=19)  No (n=131)  Yes (n=24)  No (n=126) 
 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depression ‡ 
-.07  1.05  .20  .98  1.130  .260  .35  .99  .13  .99  -1.000  .319 
Organic  
-.31  .39  .13  1.05  -1.337†  .181  .74  1.14  -.05  .92  -3.388**†  .001 
Behaviour-
affective‡  
 
.30  1.14  .31  .91  .209  .835  -.0002  .91  .36  .93  1.824  .070 
Anxiety ‡ 
 
.40  .46  .21  1.11  -1.895§  .063  .20  .99  .24  1.06  .166  .868 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
.33  2.12  .85  1.94  1.086  .279  1.29  1.67  .68  2.00  -1.385  .168 
Depressive  
2.95  2.63  3.73  2.48  -1.367†  .172  4.33  2.44  3.50  2.50  1.625†  .104 
Organic  
  
.16  .50  .75  1.37  -1.779†  .075  1.50  1.64  .51  1.18  3.263**†  .001 
Behaviour-affective  
  
3.00  2.24  2.75  1.83  -.286†  .775  1.96  1.81  2.94  1.86  -2.371*†  .018 
Anxiety  
  
3.00  1.15  2.51  1.75  -1.749†  .080  2.25  1.54  2.63  1.72  -.847†  .397 
 
 
 
 
Dimension 
symptom counts 
Total 
9.11  4.67  9.74  3.87  .649  .517  10.04  3.51  9.58  4.05  -.517  .606 
EFA PPS-LD symptom count- 41  
10.58  4.57  11.28  3.99  .698  .486  11.75  3.57  11.08  4.16  -.739  .461 
 
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z score from Mann-Whitney test   166 
 
Table 4.22: The relationship between sensory impairments and psychopathology. 
 
    Visual impairment  Hearing impairment 
    Yes (n=27)  No (n=122)  Yes (n=12)  No (n=137) 
 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depressive‡ 
.26  .97  .14  1.00  -.636  .526  .10  .98  .17  .99  .213  .831 
Organic  
-.25  .58  .15  1.06  -2.198*†  .028  .04  1.08  .08  .99  -.467†  .640 
Behaviour-affective‡  
.28  .88  .31  .95  .090  .929  .30  .75  .31  .95  -.085  .932 
Anxiety ‡ 
.11  .98  .27  1.06  .640  .523  .46  1.31  .22  1.02  -.653  .515 
 
 
 
 
 
 
Dimension 
factor scores 
Total 
.41  1.58  .87  2.04  1.101  .273  .90  1.36  .77  2.01  -.210  .834 
Depressive  
3.93  2.51  3.57  2.51  -.638†  .524  3.50  2.32  3.64  2.53  -.063†  .950 
Organic  
.37  .74  .74  1.40  -.826†  .409  .67  1.56  .67  1.29  -.506†  .613 
Behaviour-affective 
2.59  1.78  2.83  1.91  -.495†  .621  2.50  1.62  2.81  1.90  -.478†  .633 
Anxiety  
  
2.26  1.63  2.64  1.71  -1.047†  .295  2.75  2.01  2.55  1.67  -.341†  .733 
 
 
 
 
Dimension 
symptom 
counts 
Total 
9.15  3.22  9.77  4.11  .737  .462  9.42  2.91  9.68  4.05  .219  .827 
EFA PPS-LD symptom count- 41  
10.78  3.50  11.28  4.18  .578  .564  11.25  2.34  11.18  4.19  -.088§  .931 
 
** significant at the p< 0.01 level 
‡ the square root transformed variable is used in the analyses 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z-score from Mann-Whitney test   167 
Table 4.23: The relationship between mobility problems and psychopathology. 
 
    Mobility problems 
    Yes (n=37)  No (n=113) 
 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p 
Depressive‡ 
.17  1.03  .16  .98  -.020  .984 
Organic   .16  1.12  .05  .96  -.009†  .993 
Behaviour-
affective‡  
 
.20  .89  .34  .95  .790  .431 
Anxiety‡  
 
-.27  1.01  .40  1.01  3.755***  .000 
 
 
 
 
 
 
Dimension factor 
scores 
Total 
.25  1.79  .96  2.00  1.912  .058 
Depressive  
3.62  2.74  3.64  2.43  -.031†  .975 
Organic  
  
.76  1.46  .64  1.26  -.230†  .818 
Behaviour-affective  
  
2.46  1.79  2.89  1.90  -1.146†  .252 
Anxiety  
  
1.79  1.53  2.83  1.67  -3.360**†  .001 
 
 
 
 
Dimension 
symptom counts 
Total 
8.62  3.91  10.00  3.94  1.849  .067 
EFA PPS-LD symptom count- 41  
10.24  3.70  11.50  4.14  1.641  .103 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
† Non- parametric z score from Mann-Whitney test 
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Table 4.24: The relationship between incontinence and psychopathology. 
 
    Urinary incontinence  Bowel incontinence 
    Yes (n=53)  No (n=97)  Yes (n=38)  No (n=112) 
 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
Depressive ‡ 
.26  .98  .11  1.00  -.946  .346  .25  1.02  .13  .98  -.600  .549 
Organic  
.23  1.23  -.01  .83  -.345†  .730  .17  1.14  .04  .95  -.100†  .920 
Behaviour-affective‡  
.55  .94  .17  .91  -2.383*  .018  .45  .94  .26  .94  -1.073  .285 
Anxiety ‡ 
 
-.03  1.06  .38  1.02  2.475*  .014  -.17  1.08  .38  1.00  3.142**  .002 
 
 
 
 
 
 
Dimension 
factor scores 
Total 
1.00  2.08  .66  1.89  -1.040  .300  .69  2.09  .81  1.93  .332  .741 
Depressive  
4.00  2.67  3.43  2.40  -1.306†  .192  3.87  2.70  3.55  2.44  -.735†  .463 
Organic  
  
.83  1.57  .58  1.14  -.598†  .550  .74  1.43  .65  1.27  -.113†  .910 
Behaviour-affective 
3.11  1.90  2.60  1.86  -1.577†  .115  2.89  1.93  2.75  1.87  -.473†  .636 
Anxiety 
2.17  1.67  2.79  1.67  -2.362*†  .018  1.97  1.71  2.77  1.64  -2.687**†  .007 
 
 
 
 
Dimension 
symptom 
counts 
Total 
10.11  4.05  9.41  3.92  -1.042  .299  9.47  4.15  9.72  3.92  .331  .741 
EFA PPS-LD symptom count- 41  
11.75  4.11  10.88  4.02  -1.268  .207  11.05  4.26  11.23  4.01  .237  .813 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
‡ the square root transformed variable is used in the analyses 
† Non- parametric z score from Mann-Whitney test     169 
 
 
Since there are several significant associations between measures of psychopathology 
and socio-clinical variables the null hypothesis is rejected. 
 
4.4  Multivariate  associations  between  measures  of  psychopathology 
and socio-clinical variables 
 
Several of the socio-clinical variables may be correlated, such as level of intellectual 
disabilities  and  epilepsy.  To  take  account  of  such  cross-correlations,  multiple  linear 
regression was used to explore whether any socio-clinical variables associated with the 
measures of psychopathology in the bivariate analyses are independently associated.  
 
Tables 4.25 and 4.26 give the results of the multivariate analyses for the dimension 
factor scores and dimension symptom counts. Each table provides the p value from the 
bivariate analyses in section 4.3, and the results of the multiple linear regression analysis 
for those variables retained in the final model. Since level of intellectual disabilities was 
the  only  socio-clinical  variable  significantly  associated  with  the  overall  measure  of 
psychopathology, EFA PPS-LD symptom count- 41, in the bivariate analyses, there is 
no requirement for a multivariate analysis.  
 
 
 
 
Null hypothesis four: 
There are no significant cross-sectional, multivariate relationships between 
dimensional measures of psychopathology and socio-clinical variables. 
   170 
 
 
Table 4.25: Multivariate associations of socio-clinical variables with dimension factor scores 
 
Bivariate associations (p< .1)  Multivariate associations 
Dimension of 
psychopathology  Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive ‡ 
Continuous measure of age (years)   .009** 
 
.005  .002  .214  .009**  .046 
Independent- 
family carer  Not retained in the model 
Living circumstances  .004** 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe  .467
a  .192  .195  .016* 
Categorical measure of intellectual 
disabilities  .041* 
 
Mild- profound  Not retained in the model 
Down syndrome  .001** 
 
.800  .208  .296  .000*** 
 
 
 
 
 
 
Organic 
Visual impairment  .028* 
 
Not retained in the model 
.156 
Continuous measure of age (years)  .008** 
 
-.005  .002  -.208  .010* 
Independent- 
family carer  Not retained in the model 
Living circumstances  .017* 
Independent- 
paid carer  Not retained in the model 
Mild-moderate 
.181  .067  .258  .008** 
Mild-severe 
.136  .067  .198  .046* 
Categorical measure of intellectual 
disabilities  .013* 
Mild-profound 
.195  .060  .326  .001** 
 
 
 
 
 
 
 
 
Behaviour-affective 
‡ 
 
Down syndrome  .070 
 
-.135  .061  -.175  .028* 
.141   171 
Visual impairment  .090 
 
Not retained in the model   
Urinary incontinence  .018* 
 
Not retained in the model   
Continuous measure of age (years)  .010* 
 
-.004  .002  -.163  .035* 
Mild-moderate 
.148  .060  .198  .015* 
Mild-severe 
Not retained in the model 
Categorical measure of intellectual 
disabilities  .013* 
Mild-profound 
Not retained in the model 
Diagnosis of autism  .063 
 
Not retained in the model 
Urinary incontinence  .014* 
 
Not retained in the model 
Bowel incontinence  .002** 
 
-.143  .063  -.205  .024* 
No epilepsy- 
poor seizure 
control 
-.215  .077  -.213  .006** 
Epilepsy  .001** 
No epilepsy- 
good seizure 
control 
Not retained in the model 
 
 
 
 
 
 
 
 
 
 
 
Anxiety‡ 
Mobility problems  .000*** 
 
-.115  .057  -.163  .048* 
.232 
Mild-moderate 
1.298  .383  .269  .001** 
Mild-severe 
Not retained in the model 
Categorical measure of intellectual 
disabilities  .003** 
Mild-profound 
Not retained in the model 
 
 
 
 
Total 
Mobility problems  .058 
 
Not retained in the model 
.073 
 
* significant at the p< .05 level ** significant at the p< .01 level *** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses   172 
Table 4.26: Multivariate associations of socio-clinical variables with dimension symptom counts 
 
Bivariate associations (p< .1)  Multivariate associations 
Dimension of 
psychopathology  Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive 
Continuous measure of age (years)  .038* 
 
.032  .016  .166  .043*  .028 
Continuous measure of age (years)  .034* 
 
.020  .008  .199  .012* 
Down syndrome  .001** 
 
.987  .276  .278  .000*** 
 
 
 
Organic 
Autism  .075 
 
Not retained in the model 
.117 
Continuous measure of age (years)  .005** 
 
-.027  .012  -.188  .021* 
Mild-moderate 
1.116  .440  .242  .012* 
Mild-severe 
Not retained in the model 
Categorical measure of intellectual 
disabilities  .018* 
Mild-profound 
1.229  .396  .311  .002** 
 
 
 
 
 
Behaviour-affective  
 
Down syndrome  .018* 
 
-1.112  .401  -.218  .006** 
.141 
Continuous measure of age (years)  .009** 
 
-.022  .010  -.172  .031* 
Mild-moderate 
.656  .328  .158  .048 
Mild-severe 
Not retained in the model 
Categorical measure of intellectual 
disabilities  .072 
Mild-profound 
Not retained in the model 
Diagnosis of autism  .080 
 
Not retained in the model 
 
 
 
 
 
 
 
 
Anxiety 
Urinary incontinence  .018* 
 
Not retained in the model 
.127   173 
Bowel incontinence  .007** 
 
Not retained in the model 
Epilepsy  .061 
 
Not retained in the model 
Mobility problems  .001** 
 
-.816  .313  -.209  .010 
 
Mild-moderate 
2.143  .783  .220  .007** 
Mild-severe 
Not retained in the model 
Categorical measure of intellectual 
disabilities  .031* 
Mild-profound 
Not retained in the model 
 
 
 
 
Total 
Mobility problems  .067 
 
Not retained in the model 
.048 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
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Although the final  regression models for the factor score and symptom count for a 
specific dimension of psychopathology are similar overall, there are some interesting 
differences. For example, older age is independently associated with higher scores on 
the organic dimension symptom count, but not the organic dimension factor score. A 
final  point  to  note  is  that  the  three  overall  measures  of  psychopathology  are  only 
independently associated with level of intellectual disabilities. These points of note and 
others are considered fully in the discussion in chapter 5. 
 
With  specific  reference  to  null  hypothesis  four,  there  are  socio-clinical  variables 
independently associated with each of the eight dimension factor scores and symptom 
counts, and the overall measures of psychopathology. Therefore, the null hypothesis is 
rejected. 
 
 4.5  The  cross-sectional  relationship  between  psychopathology  and 
measures of the severity of mental disorders 
 
This section examines the relationships between the dimensional and overall measures 
of psychopathology and the six measures of the severity of mental disorders.  
 
Prior to investigating the hypothesis, Table 4.27 reports the descriptive statistics and 
results  of  tests  examining  the  skewness,  kurtosis  and  overall  distribution  of  the  six 
measures  of  severity,  in  comparison  to  the  normal  distribution.  It  appears  that  the 
HONOS-LD total score, CGI rating, CANDID met needs and CANDID total needs have 
a distribution that does not differ significantly from normal. Therefore, it is appropriate 
to use parametric statistical tests in analyses including these variables. 
 
However, results from table 4.27 suggest that the distribution of GAF and the CANDID 
unmet needs scores differ significantly from normality. The difference from normality in 
Null hypothesis five: 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and the severity of mental disorders. 
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the distribution of the GAF scores is accounted for by the significant kurtosis score, 
indicative of a flat distribution. Since transforming the data has more of an effect on a 
skewed  distribution,  than  an  abnormal  kurtosis,  it  is  unlikely  to  move  the  GAF 
distribution closer to the normal distribution. Therefore, any analyses using the GAF 
scores will make use of non-parametric tests. 
 
The  distribution  of  the  CANDID-R  unmet  needs  scores  in  table  4.27  is  positively 
skewed. Square root and logarithmic transformations were used in an attempt to move 
the distribution closer to normality, and the results shown in table 4.28. The distribution 
of the square root transformed CANDID-R unmet needs scores still differ significantly 
from  normality  due  to  a  significant  positive  skew,  in  table  4.28.  A  logarithmic 
transformation has a greater effect on a positive skew than a square root transformation; 
however in table 4.28 we can see that it has flipped the distribution to a significant 
negative skew. An inverse transformation was not carried out, since it would further 
increase the negative skew seen in the logarithmic transformed variable. Since none of 
the  transformations  have  moved  the  CANDID-R  unmet  needs  scores  closer  to  the 
normal  distribution,  the  original  CANDID-R  unmet  needs  variable  will  be  used  in 
analyses, using non-parametric statistical tests. 
 
As  described  previously,  the  CANDID-R  total  needs  variable  was  not  included  in 
analyses as it is simply a composite measure of the unmet and met needs. Statistical 
analyses  examining  the  correlations  between  the  five  variables  representing  the 
measures of severity of mental disorder and the dimensional factor scores, dimensional 
symptom counts and overall measures of psychopathology are given in table 4.29-4.31. 
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Table 4.27: Summary and normality data of the measures of severity at baseline.  
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
   
 
  Skewness  Kurtosis  Normality test 
Outcome measure 
 
Mean 
 
Min 
 
Max 
 
SD  S  z-score§  K  z-score§  Shapiro-Wilk  p 
HoNOS-LD total   23.64  6  48  8.85  .380  1.910  -.410  1.038  .986  .08 
GAF  49.36  18  73  13.33  -.080  .402  -.952  2.41*  .973**  .005 
CGI  3.71  1  6  1.029  .039  .452  -.417  1.056  .991  .335 
CANDID- unmet   5.80  0  16  3.13  .946  4.754***  1.091  2.762**  .933***  .000 
CANDID- met  9.38  2  18  3.36  -.355 
 
1.784  -.161  .408  .980  .050 
CANDID- total  15.19  9  21  2.561  -.322  1.618  -.356  .901  .990  .203   177 
 
 
 
 
Table 4.28: Statistical tests of skewness, kurtosis and normality for square root and logarithmic transformed CANDID-R 
unmet needs scores 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.199 for skewness and 0.395 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
 
 
 
  Square root transformation  Logarithmic transformation 
  Skewness  Kurtosis  Normality 
test 
Skewness  Kurtosis  Normality 
test 
  S  z-score§  K  z-score§  Shapiro
-Wilk 
p  S  z-score§  K  z-score§  Shapiro-
Wilk 
p 
CANDID-R 
unmet needs 
.393  1.975*  .036  .091  .967**  .001  -.410  2.060*  .515  1.058  .962***  .000   178 
 
Although  there  is  some  variation  across  the  measures  of  psychopathology,  certain 
commonalities can be identified. In all cases where a significant correlation exists, a 
higher level of psychopathology is correlated with a greater score on the measure of 
severity of mental disorder indicative of a poorer outcome. Whilst there are differences 
between the results when dimension factor scores and symptom counts are used in the 
analyses,  the  factor  scores  and  symptom  counts  for  all  four  dimensions  of 
psychopathology  are  correlated  with  at  least  one  measure  of  the  severity  of  mental 
disorders. The three overall measures of psychopathology- total dimension factor score, 
total dimension symptom count and EFA PSS-LD symptom count-41- are correlated 
with all the measures of severity of mental disorder. 
 
Given the strong correlations between the measures of psychopathology and severity of 
mental disorder at baseline the null hypothesis is rejected.   179 
 
 
 
 
 
Table 4.29: The correlations between measures of severity of mental disorder and dimension factor scores. 
 
 
Depressive factor 
score‡ 
Organic factor 
score 
Behaviour-
affective factor 
score‡ 
Anxiety factor 
score‡  Total factor score 
 
R  p        R†  p  R  p  R  p       R  p 
HoNOS-LD total score  .421***  .000 
.104  .207  .348***  .000  .098  .236  .551***  .000 
GAF†  -.475***  .000  -.258**  .001  -.243**  .003  -.055  .506  -.583***  .000 
CGI 
  .494***  .000  .245**  .003  .220**  .007  .082  .319  .562***  .000 
CANDID-R unmet 
needs† 
  
.158  .054 
.143  .082  .175*  .033  .125  .130  .326***  .000 
CANDID-R met needs 
  -.153  .063  -.057  .490  .106  .200  -.206*  .012  -.185*  .024 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
‡ The square root transformed variable was used in the statistic analysis 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.30: The correlations between measures of severity of mental disorder and dimension symptom counts 
 
 
Depressive 
symptom count 
Organic 
symptom count 
Behaviour-
affective symptom 
count 
Anxiety 
symptom count 
Total symptom 
count 
 
R†  p        R†  p  R†  p  R†  p        R  p 
HoNOS-LD total score  .416***  .000  .207*  .011  .359***  .000  .135  .101  .585***  .000 
GAF  -.500***  .000  -.318***  .000  -.262**  .001  -.050  .546  -.587†***  .000 
CGI 
 
.543***  .000  .227**  .001  .254**  .002  .072  .386  .590***  .000 
CANDID-R unmet needs 
  
.165*  .044  .243**  .003  .206*  .012  .117  .157  .322†***  .000 
CANDID-R met needs 
 
-.139  .090  -.144  .080  .075  -.363  -.184*  .025  -.184*  .025 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.31: The correlations between measures of severity of mental 
disorder and the overall PPS-LD symptom count 
 
EFA PPS-LD 
symptom count - 41 
 
      R  p 
HoNOS-LD total score  .576*  .000 
GAF  -.590***  .000 
CGI 
 
.568***  .000 
CANDID-R unmet needs 
  
.308**  .003 
CANDID-R met needs 
 
-.163*  .047 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level  
*** significant at the p< 0.001 level 
† Non-parametric Spearman’s correlation co-efficient  
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4.6  Bivariate  associations  between  socio-clinical  variables  and  the 
severity of mental disorders 
 
4.6.1 The association between gender and measures of severity of mental disorder  
The  descriptive  statistics  and  results  of  Student  t-tests  and  Mann-Whitney  tests, 
examining  the  relationship  between  gender  and  measures  of  severity  of  mental 
disorder are shown in table 4.32. There are no significant gender differences in any 
of the measures of severity of mental disorder. 
 
Table 4.32: The relationship between gender and measures of severity of mental 
disorder  
 
 
† Non- parametric z-score from Mann-Whitney test 
§ Levene’s test found the between group variance is significant so the t-test results 
are for equal variances not assumed 
  Gender  Mean  SD  statistic 
 
 
p 
male  23.67  9.86  HoNOS-LD total score 
female  23.60  7.55 
.045§  .964 
male  50.10  14.452  GAF 
female  48.47  11.904 
-.827†  .408 
male  3.70  1.078  CGI 
   female  3.72  .975 
-.099  .921 
male  5.84  2.777  CANDID-R unmet 
needs 
  
female  5.75  3.534 
-.697†  .486 
male  9.32  3.320  CANDID-R met needs 
   female  9.46  3.431 
-.243  .808 
Null hypothesis six: 
There are no significant bivariate relationships between socio-clinical variables 
and measures of the severity of mental disorders.   183 
 
   
4.6.2 The association between age and measures of severity of mental disorder  
The  correlation  between  the  continuous  measure  of  age  and  measures  of  age  were 
examined and results shown in table 4.33. There is a significant indirect correlation 
between CANDID-R unmet needs and age, suggesting that younger participants have 
higher level of unmet needs. Although its does not reach statistical significance, the 
opposite result is found for met needs- with a direct correlation between age and met 
needs suggesting older participants have higher met needs.  
 
Table 4.33: The relationship between age and measures of severity of mental 
disorder 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< 0.05 level  
† Non-parametric Spearman’s correlation co-efficient  
   
 
 
4.6.3 Living circumstances and measures of severity of mental disorder 
In table 4.34 there are significant between group differences in the CANDID-R unmet, 
and met needs. For the CANDID-R unmet needs post hoc Mann-Whitney tests found 
significant  between  group  differences  for  individuals  living  independently  against 
participants  living  with  family  carers  (z=-2.53,  p=.012),  and  living  independently 
against living with support from paid carers (z=-2.876, p=.004). All three between group 
comparisons for the CANDID-R met needs were significant on the post hoc Bonferroni 
 
Continuous measure 
(age in years) 
  R 
p 
HoNOS-LD total score  -.093  .260 
GAF  -.060†  .468 
CGI 
 
.075  .364 
CANDID-R unmet needs 
  
-.177†*  .031 
CANDID-R met needs 
 
.153  .062   184 
tests- independent against family carer (mean difference=-3.174, p< .000), independent 
against paid carer (mean difference=-4.960, p<.000) and family against paid carer (mean 
difference=-1.787, p=.005).  
 
 
Table 4.34: The relationship between living circumstances and measures of severity 
of mental disorder  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level 
† Non-parametric Kruskall-Wallis test 
   
 
 
 
 
Living 
circumstances  Mean  SD  Min  Max 
 
 
F 
 
 
p 
Independent  22.56  7.62  6  35 
Family carer  21.11  8.47  8  42 
 
 
HoNOS-LD 
  Paid carer  24.99  9.17  8  48 
2.700  .071 
Independent  52.67  10.00  36  72 
Family carer  50.69  15.13  18  73 
 
GAF 
  
  
  
Paid carer 
47.79  13.36  23  72 
2.995†  .224 
Independent  3.41  .84  1  5 
Family carer  3.60  1.17  2  6 
CGI 
  
  
   Paid carer  3.85  1.01  2  6 
2.217  .113 
Independent  8.00  4.81  0  16 
Family carer  5.34  2.84  2  13 
CANDID-R 
unmet needs 
  
  
  
Paid carer 
5.30  2.21  1  11 
9.317†**  .009 
Independent  5.74  3.44  2  13 
Family carer  8.91  3.03  3  14 
CANDID-R 
met needs 
  
  
  
Paid carer 
10.70  2.49  5  18 
32.702***  .000   185 
4.6.4 The association between level of intellectual disabilities and measures of 
severity of mental disorder  
The descriptive statistics for the measures of severity of mental disorder and results for 
the  initial  analyses  using  ANOVA  are  shown  for  participants  with  mild,  moderate, 
severe  and  profound  intellectual  disabilities  in  table  4.35.  There  are  significant 
associations between level of intellectual disabilities and the HoNOS-LD score, CGI, 
and CANDID-R met needs. The result of the ANOVA for the CANDID-R unmet needs 
approaches significance (F=6.788, p=.079) and therefore level of intellectual disabilities 
will  be  included  in  the  multivariate  analysis  for  all  measures  of  severity  of  mental 
disorder 
 
Post hoc, Bonferroni test results in table 4.36 and non-parametric Mann Whitney tests 
for the CANDID-R unmet needs in table 4.37 clarify the nature of the between group 
differences  for  the  measures  of  severity  of  mental  disorder  with  significant  with 
significant between group differences from the initial ANOVA tests. 
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Table 4.35: The relationship between level of intellectual disabilities and measures 
of severity of mental disorder  
 
 
 
 
* significant at the p< 0.05 level  
** significant at the p< 0.01 level 
*** significant at the p< 0.001 level 
† Non-parametric Kruskall-Wallis test 
 
   
   
 
 
   
 
 
 
Level of 
intellectual 
disabilities  Mean  SD  Min  Max 
 
 
F 
 
 
p 
mild  19.65  7.511  6  35 
moderate  24.42  8.245  8  42 
severe  23.12  7.672  11  40 
HoNOS-LD 
total score 
 
profound  26.16  9.908  8  48 
4.036**  .009 
mild  54.47  11.08  36  73 
moderate  47.42  13.03  23  70 
severe  47.73  11.44  28  68 
GAF 
  
  
   profound  48.18  15.36  18  72 
6.222†  .101 
mild  3.32  .88  1  5 
moderate  4.06  1.03  2  6 
severe  3.73  .88  2  5 
CGI 
  
  
profound  3.75  1.15  2  6 
2.964*  .034 
mild  5.65  4.07  -1.68  2.64 
moderate  7.13  3.54  -1.25  3.44 
severe  5.36  2.16  -1.77  1.95 
CANDID-R unmet 
needs 
  
  
  
profound 
5.37  2.50  -1.71  2.60 
6.788†  .079 
mild  7.26  3.50  2  13 
moderate  8.23  3.20  3  14 
severe  10.48  2.59  6  18 
CANDID-R  
met needs 
  
  
  
profound 
10.78  2.87  3  16 
12.086***  .000   187 
 
 
 
 
 
Table 4.36: Post hoc Bonferroni tests of ANOVA between group differences for level of 
intellectual disabilities and measures of severity of mental disorder 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mean 
Difference 
(I-J) 
Std. 
Error  p 
95% Confidence 
Interval 
mild  moderate  -4.77  2.13  .161  -10.48  .93 
   severe  -3.47  2.10  .600  -9.09  2.14 
 
HoNOS-LD total 
  
   profound  -6.51*  1.90  .005  -11.60  -1.42 
mild  moderate  -.74*  .25  .022  -1.41  -.07 
   severe  -.40  .25  .622  -1.06  .26 
 
CGI 
  
      profound  -.42  .22  .366  -1.02  .18 
mild  moderate  -.96  .75  1.000  -2.98  1.06 
   severe  -3.22***  .74  .000  -5.20  -1.24 
   profound  -3.52***  .67  .000  -5.32  -1.72 
moderate  mild  .96  .75  1.000  -1.06  2.98 
  severe  -2.26  .76  .021  -4.29  -.23 
 
 
 
CANDID-R met needs 
  
  
  profound  -2.56*  .69  .002  -4.41  -.71 
 
 
* significant at the p< .0167 level  
** significant at the p < .003  
*** significant at the p < .0003   188 
 
 
 
 
Table 4.37: The non-parametric post hoc tests for the between group differences for 
level of intellectual disabilities and the CANDID-R unmet needs measure 
 
 
Dependent Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level of 
intellectual disability 
categories 
Mann-Whitney 
U  z  p 
mild  moderate  378  -1.968  .049 
  severe  520  -.519  .604 
  profound  827  -.368  .713 
moderate  mild             378  -1.968  .049 
   severe  362  -2.032  .042 
 
CANDID-R unmet 
needs 
  
  profound  543  -2.388*  .016 
 
* significant at the p< .0167 level  
** significant at the p < .003  
*** significant at the p < .0003   189 
 
Although  these  results  are  of  interest,  the  exact  relationship  between  level  of  intellectual 
disabilities and the measures of severity of mental disorder is not a straightforward linear 
effect. To understand this further plots of the mean scores on the measures of severity of 
mental disorder against level of intellectual disabilities are shown in figures 4.4- 4.8.   
 
 
   
Figure 4.4: Plot of mean baseline HoNOS-LD score against level of intellectual 
disabilities  
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Figure 4.5: Plot of mean baseline GAF score against level of intellectual 
disabilities  
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Figure 4.6: Plot of mean baseline CGI score against level of intellectual disabilities  
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Figure 4.7: Plot of mean baseline CANDID-R unmet against level of intellectual 
disabilities  
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Figure 4.8: Plot of mean baseline CANDID-R met against level of intellectual 
disabilities  
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It appears from figures 4.4- 4.8, that there is only a linear relationship between level of 
intellectual disabilities and CANDID-R met needs. For the other measures, the mean 
scores for the participants with moderate intellectual disabilities stands out as possibly 
discrepant  with  the  overall  relationship.  Possible  reasons  for  these  varying  and 
complex  relationships  between  level  of  intellectual  disabilities  and  measures  of 
severity of mental disorder are considered further in chapter 5. 
 
4.6.5 The association between categorical socio-clinical variables and measures of 
severity of mental disorder  
Table 4.38 shows the results of the ANOVA examining the associations between the 
measures of severity of mental disorder and epilepsy. From the post-hoc Bonferroni 
tests the only results of significant is that individuals with well controlled seizures (less 
than one/ month) have higher levels of met needs (mean difference= -2.502, p= .001) 
on the CANDID-R, compared to people who do not have epilepsy.  
 
There are no significant differences in measures of severity of mental disorder related 
to whether an individual has Down syndrome or a diagnosis of autism (table 4.39). 
However, some other categorical socio-clinical variables are significantly associated 
with the measures of need on the CANDID-R: 
·  individuals with visual impairment have higher unmet and met needs (table 4.40)  
·  having mobility problems is associated with higher met needs (table 4.41) 
·  participants  with  either  urinary  incontinence  or  bowel  incontinence  have 
significantly higher CANDID-R met needs (table 4.42).   195 
 
 
Table 4.38: The relationship between epilepsy and measures of severity of mental 
disorder  
 
 
** significant at the p< .01 level 
† Non- parametric χ² from Kruskall-Wallis test   
 
 
   Epilepsy  Mean  SD  Min  Max 
 
 
F 
 
 
p 
no  23.27  8.87  6  48 
good control  23.72  7.37  10  36 
 
 
HoNOS-LD total score 
  poor control  26.07  11.26  8  42 
.656  .521 
no  48.68  12.90  18  72 
good control  53.03  13.45  23  72 
 
GAF 
  
  
  
poor control 
47.00  15.59  27  73 
3.187†  .203 
no  3.78  1.01  1  6 
good control  3.48  .99  2  6 
CGI 
  
  
   poor control  3.67  1.23  2  5 
.970  .381 
no  6.06  3.31  0  16 
good control  5.21  2.46  1  11 
CANDID-R unmet needs 
  
  
   poor control  5.13  2.97  0  10 
1.532  .465 
no  8.70  3.23  2  14 
good control  11.21  2.76  6  18 
CANDID-R met needs 
  
  
   poor control  10.60  3.85  4  16 
8.104***  .000   196 
 
 
 
 
 
 
Table 4.39: The relationship between autism, Down syndrome and measures of severity of mental disorder 
 
 
  Autism  Down syndrome 
  Yes (n=19)  No (n=131)  Yes (n=24)  No (n=126) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
 statistic 
 
p 
 
 
HoNOS-LD total score 
 
25.58  12.38  23.35  8.23  -.759§  .456  22.50  9.49  23.86  8.74  .686  .494 
GAF 
  48.26  16.49  49.52  12.87  -.219†  .827  47.96  12.39  49.62  13.53  -.677†  .499 
CGI 
3.74  1.15  3.71  1.02  -.115  .909  3.75  .90  3.70  1.06  -.200  .842 
CANDID-R unmet needs 
  
  
  
6.00  3.09  5.77  3.15  -.691†  .489  5.13  2.29  5.93  3.26  -1.125†  .261 
CANDID-R met needs 
  
 
9.32  3.15  9.39  3.40  .092  .927  10.25  2.67  9.22  3.46  -.200  .842 
 
 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed 
† Non- parametric z score from Mann-Whitney test 
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Table 4.40: The relationship between sensory impairments and measures of severity of mental disorder 
 
 
  Visual impairment  Hearing impairment 
  Yes (n=27)  No (n=123)  Yes (n=12)  No (n=133) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
23.78  10.11  23.61  8.59  -.091  .928  20.00  8.42  23.96  8.842  1.491  .138 
GAF  51.63  12.67  48.85  13.47  -1.080†  .280  51.08  13.15  49.20  13.38  -.440†  .660 
CGI 
 
3.56  .93  3.75  1.05  .869  .386  3.50  1.00  3.73  1.03  .741  .460 
CANDID-R unmet 
needs 
 
4.52  2.59  6.08  3.18  -2.390†*  .017  5.33  3.73  5.84  3.09  -.774†  .439 
CANDID-R met 
needs 
 
11.11  2.81  9.00  3.36  -3.035**  .003  10.50  4.48  9.28  3.25  -1.203  .231 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
† Non- parametric z-score from Mann-Whitney test 
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Table 4.41: The relationship between mobility problems and measures of 
severity of mental disorder  
 
 
  Mobility problems 
  Yes (n=37)  No (n=113) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
22.97  8.60  23.86  8.96  .526  .600 
GAF 
48.65  14.71  49.59  12.91  -1.501†  .133 
CGI 
 
3.70  1.15  3.71  .99  .059  .953 
CANDID-R unmet needs 
 
5.22  2.56  5.99  3.29  -1.029†  .303 
CANDID-R met needs 
 
10.92  3.13  8.88  3.29  -3.314**  .001 
 
 
** significant at the p< .01 level 
† Non- parametric z-score from Mann-Whitney test 
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Table 4.42: The relationship between incontinence and measures of severity of mental disorder  
 
 
  Urinary incontinence  Bowel incontinence 
  Yes (n=53)  No (n=97)  Yes (n=38)  No (n=112) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HONOS-LD total 
26.06  8.94  22.30  8.55  -2.524*  .013  26.74  9.43  22.58  8.43  -2.548*  .012 
GAF  47.55  13.99  50.35  12.92  -1.127†  .260  47.61  14.53  49.95  12.91  -.889†  .374 
CGI 
 
3.83  1.07  3.65  1.01  -1.048  .297  3.79  1.19  3.68  .97  -.541  .590 
CANDID-R unmet 
needs 
 
5.38  2.40  6.03  3.47  -.822†  .411  5.11  1.98  6.04  3.42  -.1.106†  .269 
CANDID-R met 
needs 
 
11.04  2.77  8.47  3.32  -4.787***  .000  11.00  2.59  8.83  3.42  -3.572***  .000 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
*** significant at the p< 0.001 level 
† Non- parametric z-score from Mann-Whitney test 
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed   
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The only measure of severity of mental disorder other than CANDID-R significantly 
related  to  any  of  these  categorical  socio-clinical  variables  is  the  HONOS-LD- 
individuals  with  urinary  or  bowel  incontinence  have  significantly  higher  scores, 
suggestive of a greater severity of mental disorder.  
 
The  complex  relationships  between  the  baseline  measures  of  severity  of  mental 
disorders  and  socio-clinical  variables  need  further  clarification  in  multivariate 
statistical tests. However, the findings that there are significant bivariate associations 
between the measures of severity of mental disorder at baseline and the socio-clinical 
variables in this section means that null hypothesis six is rejected. 
 
4.7 Multivariate associations between measures of psychopathology, 
socio-clinical variables and severity of mental disorder 
 
This section examines which variables, found to be associated with the measures of 
severity  of  mental  disorder  in  bivariate  analyses  in  section  4.6,  are  independently 
associated  in  multivariate  linear  regression.  The  variables  that  are  significantly 
associated with the measures of severity of mental disorder (p<.05), and variables with 
associations approaching significance (.05 < p < .1) are included in separate linear 
regression analyses, using each of the measures of severity of mental disorder as the 
dependant  variable.  Separate  regression  analyses  are  shown  for  psychopathology 
dimension  factor  scores  and  symptom  counts,  and  the  three  overall  measures  of 
psychopathology. 
 
4.7.1 Psychopathology and socio-clinical variables independently associated with 
HoNOS-LD 
There was only one difference between the regression models using the HoNOS-LD 
total score as the dependant variable in the linear regression analyses that include the 
Null hypothesis seven: 
There are no significant multivariate associations between dimensional measures 
of psychopathology, socio-clinical variables and measures of the severity of mental 
disorders.   201 
dimension factor scores (table 4.43) and dimension symptom counts (table 4.44). The 
regression  model  that  includes  the  factor  scores  includes  two  dimensions  of 
psychopathology-  depressive  and  behaviour-affective-  whilst  the  symptom  count 
model has three- depressive, organic and behaviour-affective. Otherwise the models 
are similar: 
·  both multivariate analyses retain only the mild- profound intellectual disabilities 
between group difference in the HoNOS-LD as independently significant 
·  urinary and bowel incontinence were excluded from both models. 
 
It is likely that the reason that urinary and bowel incontinence are excluded from both 
models, in table 4.43 and 4.44, is that they are strongly correlated with the level of 
intellectual disabilities i.e. individuals with profound intellectual disabilities are more 
likely  to  experience  urinary  and  bowel  incontinence  than  individuals  with  mild 
intellectual disabilities.  
 
The overall measures of psychopathology based on the results of the EFA dimensions 
of psychopathology, the total dimension factor score and total dimension symptom 
count, are also independently associated with the HoNOS-LD score (table 4.45 and 
4.46).    202 
 
 
 
 
 
 
Table 4.43: Multivariate associations of dimension factor scores and socio-clinical variables with 
baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension factor score‡  .000*** 
 
13.120  2.068  .431  .000*** 
Behaviour-affective dimension factor 
score‡ 
.000*** 
 
10.297  2.135  .332  .000*** 
Mild- moderate  Not retained in the model 
Mild-severe  Not retained in the model 
Categorical measure of intellectual 
disabilities 
.009** 
Mild- profound  2.983  1.280  .160  .021* 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.330 
 
‡ the square root transformed variable is used in the analyses 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level  203 
 
 
 
 
 
Table 4.44: Multivariate associations of dimension symptom counts and 
socio-clinical variables with baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension symptom count  .000*** 
 
1.360  .241  .385  .000*** 
Organic dimension symptom count  .011* 
 
1.390  .469  .205  .004** 
Behaviour-affective dimension symptom 
count 
.000*** 
 
1.554  .318  .330  .000*** 
Mild- moderate  Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of intellectual 
disabilities 
.009** 
 
Mild- profound  3.501  1.243  .188  .006** 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.378 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.45: Multivariate associations of total dimension factor score, and socio-clinical 
variables with baseline HoNOS-LD scores  
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .000*** 
 
2.512  .298  .557  .000*** 
Mild- moderate 
Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of intellectual 
disabilities 
.009** 
 
Mild- profound  2.545  1.437  .137  .049* 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.366 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   205 
 
 
 
 
 
Table 4.46: Multivariate associations of total dimension symptom count and socio-clinical 
variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension symptom count  .000*** 
 
1.317  .143  .590  .000***  .404 
Mild- moderate  Not retained in the model 
 
Mild-severe  Not retained in the model 
 
Categorical measure of intellectual 
disabilities 
.009** 
 
Mild- profound  2.398  1.394  .129  .048*   
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   206 
 
Contrasting results for the overall measure of psychopathology based on the symptom 
count from the PPS-LD are shown in table 4.47. Whilst the EFA PPS-LD symptom 
count- 41 measures of psychopathology was retained as significant in the regression 
model, the results for the socio-clinical variables were different to the results for the 
regression analyses that were done for overall the measures of psychopathology related 
to the dimensional model of psychopathology (tables 4.45 & 4.46 above). 
 
Table 4.47: Multivariate associations of EFA PPS-LD symptom count- 41, and 
socio-clinical variables with baseline HoNOS-LD scores  
 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFA PPS-LD symptom 
count-41 
.000*** 
 
1.264  .142  .580  .000*** 
Mild- moderate  Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of 
intellectual disabilities 
.009** 
 
Mild- profound  Not retained in the model 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
4.390  1.320  .217  .001** 
.379   207 
4.7.2 Psychopathology and socio-clinical variables independently associated with 
GAF scores 
None of the socio-clinical variables were significantly associated with the GAF score 
in the bivariate analyses reported in section 4.6. Therefore, the results in this section 
are only for GAF regression models for analyses with factor scores, and symptom 
counts  for  the  depressive,  organic  and  behaviour-affective  dimensions  of 
psychopathology. 
 
 
Table 4.48: Multivariate associations of dimension factor scores with baseline 
GAF scores  
 
 
 
‡ the square root transformed variable is used in the analyses 
 
Table 4.49: Multivariate associations of dimension symptom counts with baseline 
GAF scores  
 
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p  B  SE B  β 
 
p 
 
R² 
Depressive dimension   .000***  -2.183  .358  -.410  .000*** 
Organic dimension   .000**  -3.123  .692  -.306  .000*** 
Behaviour-affective dimension   .001**  -1.988  .468  -.280  .000*** 
.392 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p  B  SE B  β 
 
p 
 
R² 
Depressive dimension ‡  .000***  -19.272  3.020  -.420  .000*** 
Organic dimension   .001**  -4.359  .884  -.326  .000*** 
Behaviour-affective dimension 
 ‡ 
.003**  -13.373  3.051  -.286  .000*** 
.387   208 
The results in tables 4.48 and 4.49 using the factor score and symptom count measures 
representing the three dimensions of psychopathology are very similar- with strong 
correlations  with  the  GAF  scores.  The  reasons  why  only  the  anxiety  dimension  of 
psychopathology is not significantly correlated with the GAF scores will be considered 
further in chapter 5. 
 
There are no potential covariates to include in a regression analysis with the overall 
measures of psychopathology. To allow  comparison, table 4.50 shows the statistics 
from  simple  regression  analyses  with  each  of  the  three  overall  measures  of 
psychopathology. 
 
Table 4.50: Simple regression statistics for the overall measures of psychopathology 
with GAF scores at baseline 
 
 
Bivariate associations (p<.1)  Multivariate associations 
Variable  p  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .000***  -3.910  .458  -.576  .000***  .332 
Total dimension symptom count  .000***  -1.969  .225  -.585  .000***  .343 
EFA PPS-LD symptom count- 41  .000***  -1.900  .221  -.579  .000***  .335 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
4.7.3 Psychopathology and socio-clinical variables independently associated with 
CGI scores  
Although the categorical measure of level of intellectual disabilities was associated 
with the CGI scores in the bivariate analysis, it was not retained in any of the final 
multivariate regression models. The dummy categorical variables representing level of 
intellectual disabilities are shown in the models including individual dimensions of 
psychopathology factor scores and dimension counts in table 4.51 & 4.52. Although the 
dummy categorical variables were included in  the separate  analyses  for the overall 
measures of psychopathology, they are not shown in table 4.53.   209 
Table 4.51: Multivariate associations of dimension factor scores and level of 
intellectual disabilities with baseline CGI scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension ‡  .000*** 
 
1.616  .237  .457  .000*** 
Organic dimension   .003** 
 
.275  .069  .266  .000*** 
Behaviour-affective 
dimension ‡ 
.003** 
 
.914  .239  .253  .000*** 
Mild- moderate 
Not retained in the model 
 
Mild- severe  Not retained in the model 
Categorical measure of 
intellectual disabilities  .034* 
 
Mild- profound  Not retained in the model 
.366 
 
 
‡ the square root transformed variable is used in the analyses 
 
Table 4.52: Multivariate associations of dimension symptom counts and level of 
intellectual disabilities with baseline CGI scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension   .000*** 
 
.192  .028  .468  .000*** 
Organic dimension   .001** 
 
.183  .054  .232  .001** 
Behaviour-affective 
dimension   .002** 
 
.135  .036  .248  .000*** 
Mild- moderate 
Not retained in the model 
 
Mild- severe  Not retained in the model 
Categorical measure of  
intellectual disabilities 
.034* 
 
Mild- profound  Not retained in the model 
.386 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.53: Multivariate associations for the overall measures of psychopathology 
with baseline CGI scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .000***  .295  .036  .562  .000***  .316 
Total dimension symptom count  .000***  .153  .017  .590  .000***  .349 
EFA PPS-LD symptom count- 41  .000***  .144  .017  .568  .000*** 
 
.322 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
 
4.7.4 Psychopathology and socio-clinical variables independently associated with 
the number of CANDID-R unmet needs at baseline 
The  results  for  the  multivariate  analyses  examining  variables  associated  with  the 
CANDID-R unmet needs, and including the dimensional factor scores and symptom 
counts are shown in table 4.54 and 4.55 respectively. From table 4.54, none of the 
psychopathology  dimension  factor  scores  are  independently  associated  with  the 
number  of  unmet  needs  on  the  CANDID-R.  However,  the  organic  and  behaviour-
affective dimension symptom counts are retained in the final regression model in table 
4.55. 
 
As  for  the  HoNOS-LD  and  the  GAF  and  regression  models  for  the  three  overall 
measures  of  psychopathology  are  very  similar  with  retention  of  the  measure  of 
psychopathology and the same socio-clinical variables- age, living circumstances, level 
of intellectual disabilities and visual impairment- in each model (tables 4.56 -4.58). 
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Table 4.54: Multivariate associations of dimension factor scores and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p<0.1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Behaviour-affective dimension 
factor score‡ 
.033* 
 
Not retained in the model 
Age   .031* 
 
-.035  .020  -.147  .048* 
Independent- 
family carer  -4.045  .795  -549  .000*** 
Living circumstance  .009** 
Independent- 
paid carer  -3.772  .794  -.595  .000*** 
Mild- moderate 
2.233  .747  .290  .003** 
 
Mild-severe  1.783  .811  .237  .030* 
Categorical measure of 
intellectual disabilities 
.079 
 
Mild- profound  1.510  .755  .229  .047* 
Visual impairment  .017* 
 
-1.701  .610  -.210  .006** 
.263 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses  212 
Table 4.55: Multivariate associations of dimension symptom counts and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension   .044* 
 
Not retained in the model 
Organic dimension   .003** 
 
.433  .190  .181  .024* 
Behaviour-affective dimension  .012* 
 
.296  .124  .178  .018* 
Age   .031* 
 
-.050  .019  -.208  .010* 
Independent- 
 family carer  -4.417  .761  -.599  .000*** 
Living circumstances  .009** 
Independent-  
paid carer  -3.740  .749  -.590  .000*** 
Mild- moderate 
1.908  .715  .248  .008** 
 
Mild-severe  1.413  .777  .188  .041* 
Categorical measure of  
intellectual disabilities 
.079 
 
Mild- profound  1.425  .719  .216  .030* 
Visual impairment  .017* 
 
-1.546  .582  -.191  .009** 
.339 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.56: Multivariate associations of total dimension factor score and socio-clinical 
variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .000*** 
 
.477  .116  .299  .000*** 
Age   .031* 
 
-.042  .018  -.176  .023* 
Independent- 
family carer  -3.906  .755  -.530  .000*** 
Living circumstances  .009** 
Independent-  
paid carer  -3.623  .745  -.572  .000*** 
Mild- moderate 
1.642  .731  .213  .026* 
 
Mild-severe  1.632  .776  .217  .037* 
Categorical measure of 
 intellectual disabilities 
.079 
 
Mild- profound  1.373  .721  .209  .048* 
Visual impairment  .017* 
 
-1.559  .584  -.192  .009** 
.328 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   214 
 
Table 4.57: Multivariate associations of total dimension symptom count and socio-
clinical variables with baseline CANDID-R unmet needs  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .000***  .226  .057  .285  .000*** 
Age   .031*  -.042  .018  -.176  .023* 
Independent-  
family carer  -3.817  .758  -.518  .000*** 
Living circumstances  .009** 
Independent-  
paid carer  -3.539  .747  -.558  .000*** 
Mild- moderate 
1.801  .726  .234  .014* 
 
Mild-severe  1.674  .778  .222  .033* 
Categorical measure of  
intellectual disabilities 
.079 
 
Mild- profound  1.403  .723  .213  .046* 
Visual impairment  .017*  -1.615  .585  -.199  .007** 
.328 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   215 
 
Table 4.58: Multivariate associations of EFA PPS-LD symptom count-41 and socio-
clinical variables with baseline CANDID-R unmet needs  
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFA PPS-LD symptom count-41  .000*** .210  .056  .272  .000*** 
Age   .031*  -.042  .018  -.173  .026* 
Independent-  
family carer  -3.841  .762  -.521  .000*** 
Living circumstances  .009** 
Independent-  paid 
carer  -3.535  .751  -.558  .000*** 
Mild- moderate 
1.780  .733  .231  .016* 
 
Mild-severe  1.647  .783  .219  .037* 
Categorical measure of  
intellectual disabilities 
.079 
 
Mild- profound  1.329  .729  .202  .049* 
Visual impairment  .017* 
 
-1.646  .588  -.203  .006** 
.316 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level  216 
 
4.7.5 Psychopathology and socio-clinical variables independently associated with 
the number of CANDID-R met needs at baseline 
The  results  of  the  multivariate  analyses  examining  the  relationships  between  the 
dimensional measures of psychopathology, socio-clinical variables and the met needs 
on the CANDID-R are shown in tables 4.59 and 4.60. This was the first measure of 
severity  of  mental  disorder  for  which  there  was  no  bivariate  association  with  the 
behaviour-affective dimension of psychopathology.  
 
Interestingly, the anxiety dimension factor score and symptom counts are not retained 
in  either  regression  model,  respectively.  However,  the  other  dimensions  of 
psychopathology are retained and remain indirectly associated with the CANDID-R 
met  needs.  Furthermore,  more  socio-clinical  variables  are  associated  with  the 
CANDID-R met needs than any other measure of severity of mental disorder- age, 
level  of  intellectual  disabilities,  epilepsy,  visual  impairment,  mobility  problems, 
urinary incontinence and bowel incontinence. 
 
We  can  see  in  tables  4.61-4.63,  below  that  including  the  overall  measures  of 
psychopathology in the regression models results in the same socio-clinical variables 
being retained in the model as for the analyses that use the measures representing the 
individual dimensions of psychopathology in tables 4.59 and 4.60. Overall, whilst the 
results for the regression analyses using the different measures of psychopathology in 
tables  4.59-4.63  are  very  similar,  the  results  are  very  different  than  for  the  other 
measures of severity of mental disorder. Potential reasons for this difference will be 
explored in the discussion in chapter 5.   217 
Table 4.59: Multivariate associations of dimension factor scores and socio-clinical 
variables with at baseline CANDID-R met needs  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension ‡  .063  -1.788  .747  -.155  .018* 
Anxiety dimension ‡  .012*  Not retained in the model 
Age   .062  .041  .018  .160  .021* 
Independent-  
family carer  2.969  .680  .376  .000*** 
Living circumstances  .000*** 
Independent-  
paid carer  3.862  .619  .568  .000*** 
Mild- moderate 
1.609  .701  .195  .023* 
 
Mild-severe  2.948  .690  .365  .000*** 
Categorical measure of  
intellectual disabilities 
.000*** 
 
Mild- profound  2.794  .678  .396  .000*** 
No-  
well controlled  2.040  .578  .241  .001** 
Epilepsy  .000*** 
No-  
poor control  1.492  .760  .134  .032 
Visual impairment  .003**  1.947  .555  .224  .001** 
Mobility problems  .001**  Not retained in the model 
Urinary incontinence  .000***  1.163  .478  .166  .016* 
Bowel incontinence  .000***  Not retained in the model 
.482 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses   218 
Table 4.60: Multivariate associations of dimension symptom counts and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension   .063  -.176  .087  -.131  .045* 
Organic dimension  .080  -.400  .169  -.156  .019* 
Anxiety dimension   .012*  Not retained in the model 
Age   .062  .048  .017  .187  .007** 
Independent-  
family carer  3.214  .674  .407  .000*** 
Living circumstances  .000*** 
Independent-  
paid carer  3.896  .606  .573  .000*** 
Mild- moderate 
1.609  .701  .195  .023* 
 
Mild-severe  2.948  .690  .365  .000*** 
Categorical measure of  
intellectual disabilities 
.000*** 
 
Mild- profound  2.794  .678  .396  .000*** 
No-  
well controlled  1.663  .535  .197  .002** 
Epilepsy  .000*** 
No-  
poor control  1.423  .703  .128  .045* 
Visual impairment  .003**  1.832  .547  .211  .001** 
Mobility problems  .001**  Not retained in the model 
Urinary incontinence  .000***  1.279  .472  .183  .008** 
Bowel incontinence  .000***  Not retained in the model 
.491 
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   219 
Table 4.61: Multivariate associations of total dimension factor score and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor score  .024*  -.308  .119  -.180  .011* 
Age   .062  .042  .018  .162  .019* 
Independent- 
family carer  3.152  .668  .399  .000*** 
Living circumstances  .000*** 
Independent- 
paid carer  4.206  .606  .619  .000*** 
Mild- moderate 
1.609  .701  .195  .023* 
 
Mild-severe  2.948  .690  .365  .000*** 
Categorical measure of  
intellectual disabilities 
.000*** 
 
Mild- profound  2.794  .678  .396  .000*** 
No-  
well controlled  2.040  .578  .241  .001** 
Epilepsy  .000*** 
No-  
poor control  1.492  .760  .134  .032 
Visual impairment  .003**  1.646  .584  .189  .006** 
Mobility problems  .001**  Not retained in the model 
Urinary incontinence  .000***  1.287  .539  .184  .018* 
Bowel incontinence  .000***  Not retained in the model 
.482 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.62: Multivariate associations of total dimension symptom count and socio-
clinical variables with baseline CANDID-R met needs 
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension symptom 
 count 
.024* 
 
-.149  .058  -.176  .011* 
Age   .062 
 
.042  .018  .162  .019* 
Independent-  
family carer  3.077  .670  .389  .000*** 
Living circumstances  .000*** 
Independent- 
paid carer  4.130  .607  .608  .000*** 
Mild- moderate 
1.500  .691  .182  .032* 
 
Mild-severe  2.895  .689  .359  .000*** 
Categorical measure of  
intellectual disabilities 
.000*** 
 
Mild- profound  2.758  .677  .391  .000*** 
No-  
well controlled  2.037  .578  .241  .001** 
Epilepsy  .000*** 
No- 
poor control  1.556  .759  .140  .042* 
Visual impairment  .003** 
 
1.680  .583  .193  .005** 
Mobility problems  .001** 
 
Not retained in the model 
Urinary incontinence  .000*** 
 
1.278  .539  .183  .019* 
Bowel incontinence  .000*** 
 
Not retained in the model 
.478 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level   221 
     
 
Table 4.63: Multivariate associations of EFA PPS-LD symptom count-41 and socio-
clinical variables with baseline CANDID-R met needs  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFA PPS-LD symptom  
count- 41 
.047*  -.141  .057  -.171  .014* 
Age   .062  .041  .018  .160  .021* 
Independent- 
family carer  3.107  .672  .393  .000 
Living circumstances  .000*** 
Independent- 
paid carer  4.145  .609  .610  .000 
Mild- moderate 
1.520  .695  .184  .003** 
 
Mild-severe  2.915  .690  .361  .000*** 
Categorical measure of 
intellectual disabilities 
.000*** 
 
Mild- profound  2.805  .679  .397  .000*** 
No-  
well controlled  2.063  .578  .244  .001** 
Epilepsy  .000*** 
No-  
poor control  1.532  .760  .138  .041* 
Visual impairment  .003**  1.697  .584  .195  .004** 
Mobility problems  .001**  Not retained in the model 
Urinary incontinence  .000***  1.278  .540  .183  .019** 
Bowel incontinence  .000***  Not retained in the model 
.475 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
     
   
Since  there  are  dimensional  and  overall  measures  of  psychopathology,  and  socio-
clinical variables independently associated with all five measures of the severity of 
mental disorders, the null hypothesis is rejected.    222 
4.8 Comparing the contribution of dimensional and categorical 
models of psychopathology to the severity of mental disorders   
 
In  section  4.3.4,  dimensional  measures  of  psychopathology  were  shown  to  be 
independently related to measures of the severity of mental disorders. This section 
examines whether categorical diagnoses from DC-LD are related to the severity of 
mental disorders. 
 
4.8.1 Examining the relationship of a categorical diagnosis to severity of mental 
disorder  
The binary variable of whether or not an individual meets the criteria for a DC-LD 
categorical diagnosis replaces the dimensional measures in the regression analyses in 
section 4.7. The variable for categorical diagnosis was retained as significant in the 
regression analyses for the HoNOS-LD total score table 4.64.  
 
Although no socio-clinical variables were associated with the GAF score at baseline 
simple  linear  regression  was  run  to  examine  if  there  was  a  significant  association 
between  having  a  categorical  diagnosis.  The  association  approached  significance 
(B=4.108, SE B= 2.348, β=.143, p= 0.082) but did not meet the accepted level of 
significance (p < .05). Similarly, having a categorical diagnosis was not associated 
with the CGI, baseline number of unmet or met needs on the CANDID-R (tables 4.65- 
4.67). 
Null hypothesis eight: 
There are no significant differences in the associations of dimensional and categorical 
models of psychopathology with measures of the severity of mental disorders 
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Table 4.64: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with baseline HoNOS-LD scores  
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-LD 
(Y/N) 
N/A 
 
3.405  1.516  .178  .026* 
Mild- moderate  4.750  2.104  .219  .025* 
Mild-severe  4.017  2.084  .189  .046* 
Categorical measure of 
intellectual disabilities 
.009** 
Mild- profound  6.610  1.876  .356  .001* * 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.108 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
 
Table 4.65: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with baseline CGI scores  
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-LD 
(Y/N) 
N/A 
 
Not retained in the model 
Mild- moderate  4.750  2.104  .219  .025* 
Mild-severe  Not retained in the model 
Categorical measure of 
intellectual disabilities 
.034* 
Mild- profound  Not retained in the model 
.080   224 
Table 4.66: Multivariate associations of categorical DC-LD diagnosis and socio-
clinical variables with CANDID-R unmet needs at baseline 
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis of mental 
disorder on DC-LD (Y/N)  N/A 
 
Not retained in the model 
Age   .031* 
 
-.035  .020  -.147  .048* 
Independent- 
family carer  -4.045  .795  -.549  .000*** 
Living circumstance  .009** 
Independent- 
paid carer  -3.772  .794  -.595  .000*** 
Mild- moderate 
2.233  .747  .290  .003** 
 
Mild-severe  1.783  .811  .237  .030* 
Categorical measure of 
intellectual disabilities 
.079 
 
Mild- profound  1.510  .755  .229  .047* 
Visual impairment  .017* 
 
-1.701  .610  -.210  .006** 
.263 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level  225 
Table 4.67: Multivariate associations of categorical DC-LD diagnosis and socio-clinical 
variables with CANDID-R met needs at baseline 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis of mental 
disorder on DC-LD (Y/N) 
N/A 
 
Not retained in the model 
Age   .062 
 
.030  .018  .118  .044* 
Independent- 
family carer  2.803  .716  .355  .000*** 
Living circumstances  .000*** 
Independent- 
paid carer  3.660  .678  .539  .000*** 
Mild- moderate 
Not retained in the model 
 
Mild-severe  1.156  .620  .143  .048* 
Categorical measure of 
intellectual disabilities  .000*** 
 
Mild- profound  1.309  .552  .185  .019* 
No- well 
controlled  1.935  .550  .229  .001** 
Epilepsy  .000*** 
No- poor 
control  1.619  .714  .145  .025* 
Visual impairment  .003** 
 
1.821  .565  .209  .002** 
Mobility problems  .001** 
 
Not retained in the model 
Urinary incontinence  .000*** 
 
1.163  .478  .166  .016* 
Bowel incontinence  .000*** 
 
Not retained in the model 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
.453 
* significant at the p< .05 level ** significant at the p< .01 level **** significant at the p< .001 level  226 
 
 
4.8.2 Examining whether dimensional and categorical models of psychopathology 
are  both  retained  as  independently  associated  with  the  severity  of  mental 
disorders  
Since  having  a  DC-LD  categorical  diagnosis  was  only  retained  as  significantly 
associated with the HoNOS-LD total score this was the only measure for which the 
final  regression  analysis,  including  both  models  of  psychopathology,  could  be 
examined.  However, the variable representing the categorical model was not retained 
as significant in the regression models for the dimension factor scores and symptom 
counts in tables 4.68 and 4.69. 
 
This suggests that no additional variance in the HoNOS-LD total score was explained 
by  the  categorical  model,  over  and  above  the  variance  accounted  for  by  the 
dimensional  model  of  psychopathology.  Therefore,  it  was  concluded  that  the 
dimensional model of psychopathology was more strongly related to the severity of 
mental disorder. The null hypothesis is rejected.   227 
Table 4.68: Regression model examining dimension factor scores, DC-LD categorical 
diagnosis and socio-clinical variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension factor score‡  .000*** 
 
13.120  2.068  .431  .000*** 
Behaviour-affective dimension factor 
score‡ 
.000*** 
 
10.297  2.135  .332  .000*** 
Categorical diagnosis of mental disorder 
on DC-LD (Y/N) 
N/A 
 
Not retained in the model 
Mild- moderate  Not retained in the model 
Mild-severe  Not retained in the model 
Categorical measure of intellectual 
disabilities 
.009** 
Mild- profound  2.983  1.280  .160  .021* 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.330 
 
 
‡ the square root transformed variable is used in the analyses 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level  228 
Table 4.69: Regression model examining dimension symptom counts, DC-LD categorical diagnosis 
and socio-clinical variables with baseline HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension symptom count  .000*** 
 
1.360  .241  .385  .000*** 
Organic dimension symptom count  .011* 
 
1.390  .469  .205  .004** 
Behaviour-affective dimension symptom 
count 
.000*** 
 
1.554  .318  .330  .000*** 
Categorical diagnosis of mental disorder 
on DC-LD (Y/N) 
N/A 
 
Not retained in the model 
Mild- moderate  Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of intellectual 
disabilities 
.009** 
 
Mild- profound  3.501  1.243  .188  .006** 
Urinary incontinence  .013* 
 
Not retained in the model 
Bowel incontinence  .012* 
 
Not retained in the model 
.378 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   229 
 
4.9 The association of psychopathology and the longitudinal outcome 
of mental disorders  
 
This  section  considers  the  relationship  between  psychopathology  and  outcome. 
Whereas the cross-sectional relationships are better conceptualised at looking at the 
relationships of psychopathology and socio-clinical variables with severity of mental 
disorders,  by  following  up  individuals  with  intellectual  disabilities  and  mental 
disorders, the extent to which psychopathology and other variables at baseline are a 
significant predictor of outcome is examined.  
 
As described in chapter 3.4.3.5, the longitudinal outcome was taken as the change in 
the measure of outcome between baseline and follow up. Since higher scores on the 
GAF and CANDID-R met needs variables represents a better outcome, the sign of the 
longitudinal  outcome  score  was  reversed  for  these  variables  in  order  that  all  five 
outcome measures can be compared. 
 
4.9.1 Change in the measures of outcome over time 
Prior to addressing the null hypothesis, table 4.70 shows the mean scores and standard 
deviation of the measures of outcome at baseline and follow-up, and the results of 
statistical tests to examine if there is a significant change in the measures over time. 
There is a significant change in all the measures of outcome over time.  
 
 
Null hypothesis nine: 
Dimensional measures of psychopathology are not significantly correlated to the 
longitudinal outcome of mental disorders.   230 
 
Table 4.70: The significance of change in measures of outcome over time 
 
 
 
* p < .05 
** p < .01 
*** p < .001 
 
 
 
4.9.2 Examining the distribution of the longitudinal measures of outcome  
Table 4.71 shows the results of tests examining the skewness, kurtosis and overall 
distribution of the six longitudinal measures of outcome, in comparison to the normal 
distribution.  None  of  the  measures  are  significantly  different  from  the  normal 
distribution and therefore parametric tests are used in the analyses. 
 
  Baseline  Follow-up  Change over 
time 
Wilcoxon signed 
ranks test 
Outcome 
measure 
Mean  SD  Mean  SD  Mean  SD  Z  p 
HoNOS-
LD total  
25.50  8.93  16.68  11.28  -8.82  13.85  -3.442  .001** 
GAF 
44.40  11.547  57.75  17.86  -13.35  13.33  -3.552  .000*** 
CGI  3.93  1.02  2.85  1.48  -1.08  1.65  -3.579  .000*** 
CANDID- 
unmet  
6.35  3.09  3.40  3.947  -2.95  4.19  -3.778  .000*** 
CANDID- 
met  9.80  2.92  12.85  4.07  -3.05  3.82  -4.261 
 
.000***   231 
 
 
4.9.3 The correlations of baseline psychopathology and longitudinal measures of 
outcome 
To examine whether baseline psychopathology dimension factor scores and symptom 
counts are significant predictors of longitudinal outcome, correlations are shown in 
table 4.72 and 4.73. The correlations of the EFA PPS-LD symptom count- 41 overall 
measure of psychopathology with the measures of longitudinal outcome are shown in 
table 4.74.  
 
The dimensional and overall measures of psychopathology are significantly correlated 
with the longitudinal change in the HoNOS-LD, GAF and CGI scores. However, only 
the  three  overall  measures  of  psychopathology  at  baseline  are  correlated  with  the 
change  in  the  CANDID-R  unmet  needs,  and  there  are  no  significant  correlations 
between baseline psychopathology and change in the CANDID-R met needs. 
 
Null hypothesis nine is rejected. 
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Table 4.71 Summary and normality data of the longitudinal measures of outcome  
 
 
 
 
 
 
 
 
 
 
 
 
§ z-score values are calculated by dividing the statistic score by the standard errors 0.374 for skewness and 0.733 for kurtosis. 
* p < .05 
** p < .01 
*** p < .001 
 
   
   
   
  Skewness  Kurtosis  Normality test 
Outcome measure 
 
Mean 
 
Min 
 
Max 
 
SD  S  z-score§  K  z-score§  Shapiro-Wilk  p 
HONOS-LD total   8.82  -21  33  13.85  -.236  .63  -.598  .815 
.978  .605 
GAF  13.35  -17  49  13.33  .035  .009  -.973  1.327 
.954  .104 
CGI  1.08  -2  5  1.65  .018  .048  -.442  .603  .951  .084 
CANDID- unmet   2.95  -6  10  4.19  -.336  .898  -.912  1.244 
.942  .051 
CANDID- met  -3.05  -11  4  3.82  -.183 
 
.489  -.950  1.296 
.958  .148 
CANDID- total  -.25  -6  10  3.00  .924  2.47*  2.63  3.588*** 
.923  .010*   233 
 
 
 
Table 4.72: The correlations between psychopathology dimension factor scores and longitudinal outcomes 
 
 
 
 
 
* 
significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
‡ The square root transformed variable was used in the statistical analysis 
† Non-parametric Spearman’s correlation co-efficient 
 
Depressive factor 
score‡ 
Organic factor 
score 
Behaviour-
affective factor 
score‡ 
Anxiety factor 
score‡  Total factor score 
Outcome variable change    R  p  R†  p  R  p  R  p  R  p 
 
HONOS-LD total score  .373*  .018  -.216  .180  .518**  .001  .167  .303  .414**  .008 
GAF  .460**  .003  .039  .813  .437**  .005  .121  .456  .555***  .000 
CGI 
  .420**  .007  .062  .705  .446**  .004  .032  .846  .457**  .003 
CANDID-R unmet needs 
   .227  .159  .106  .515  .253  .115  .086  .599  .378*  .016 
CANDID-R met needs 
  .047  .772  -.043  .792  .005  .978  .105  .518  .107  .513   234 
 
 
 
 
Table 4.73: The correlations between psychopathology dimension symptoms counts and longitudinal outcomes 
 
 
Depressive 
symptom count 
Organic 
symptom count 
Behaviour-
affective symptom 
count 
Anxiety 
symptom count 
Total symptom 
count 
Outcome change  
variable   R†  p  R†  p  R†  p  R†  p  R  p 
 
HoNOS-LD total score  .409**  .009  -.266  .097  .432**  .005  .135  .407  .450**  .004 
GAF  .556***  .000  .006  .971  .361*  .022  .033  .841  .562***  .000 
CGI 
  .509**  .001  -.051  .757  .365*  .020  .025  .880  .504**  .001 
CANDID-R unmet 
needs 
  
.299  .060 
.052  .750  .193  .234  .045  .784  .329*  .038 
CANDID-R met needs 
  .034  .835  .060  .713  .061  .711  .075  .645  .090  .581 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
† Non-parametric Spearman’s correlation co-efficient  
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Table 4.74: The correlations between baseline EFA PPS-LD symptom count- 41 
and longitudinal outcome  
 
  EFA PPS-LD symptom count - 41 
Outcome change variable 
              R  p 
 
HoNOS-LD total score  .485**  .002 
GAF  .581***  .000 
CGI 
 
.516**  .001 
CANDID-R unmet needs 
  
.367*  .020 
CANDID-R met needs 
 
.063  .700 
 
* significant at the p< .05 level  
** significant at the p< .01 level  
*** significant at the p< .001 level 
 
 
4.10 Baseline socio-clinical variables as predictors of longitudinal 
outcome 
 
4.10.1 Gender as a predictor of longitudinal outcome 
In table 4.75, there is no significant difference in longitudinal outcome between women 
and men. However, as the result for the CGI measure approaches significance (.05 < p 
<  .1),  gender  will  be  included  as  a  dependant  variable  in  the  linear  regression  to 
examine the interaction of covariates in the prediction of longitudinal change in the 
CGI.
Null hypothesis ten: 
Socio-clinical  measures  are  not  significantly  associated  with  the  longitudinal 
outcome of mental disorders. 
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Table  4.75:  The  relationship  between  gender  and  measures  of  longitudinal 
outcome  
 
 
 
   
4.10.2 Age as a predictor of longitudinal outcome 
No significant correlation was found between age and longitudinal outcome in table 
4.76. 
 
Table 4.76: The relationship between age and measures of longitudinal outcome. 
 
Age in years 
  R 
p 
HoNOS-LD total score  .005  .975 
GAF  -.064  .696 
CGI  -.033  .839 
CANDID-R unmet 
needs 
  
.054 
.742 
CANDID-R met needs  .091  .271 
 
 
 
 
  Gender  Mean  SD  statistic 
 
 
p 
male  11.28  12.04  HoNOS-LD total score 
female  6.82  15.15 
1.014  .317 
male  16.94  20.75  GAF 
female  10.41  18.57 
1.050  .300 
male  1.56  1.58  CGI 
   female  .68  1.64 
1.701  .097 
male  4.06  3.86  CANDID-R unmet 
needs 
  
female  2.05  4.33  1.534  .133 
male  3.50  4.37  CANDID-R met needs 
   female  2.68  3.37 
.669  .508   237 
4.10.3 Living circumstances and longitudinal outcome 
Table  4.77  shows  the  correlations  between  baseline  living  circumstances  and 
longitudinal outcome. From the post hoc Bonferroni tests, the only significant between 
group differences were for individuals living independently against with support from 
paid carers for GAF (mean difference= -25.31, p=.021) and CGI (mean difference= -
2.28, p= .011). There were no significant between group differences for the HoNOS-
LD. 
 
4.10.4 Level of intellectual disabilities as a predictor of longitudinal outcome 
The descriptive statistics for the measures of longitudinal outcome and results for the 
initial analyses using ANOVA are shown for participants with mild, moderate, severe 
and profound intellectual disabilities in table 4.78. The only measure of longitudinal 
outcome for which there are no significant between group differences is the change in 
the CANDID-R met needs over time.  
 
Post hoc Bonferroni test results in table 4.79 clarify the nature of the between group 
differences for the measures of longitudinal outcome that showed significant between 
group differences from the initial ANOVA tests. Since there are four variables and 
three comparisons, the appropriate conservative level of significance is used (p< .0167) 
for the post-hoc analysis.  
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Table 4.77: The relationship between living circumstances and longitudinal 
measures of outcome  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* significant at the p< .05 level  
** significant at the p< .01 level 
 
   
   
   
 
 
 
 
 
 
   
   
   
   
   
 
 
 
 
 
 
 
Living 
circumstances  Mean  SD  Min  Max 
 
 
F 
 
 
p 
Independent  -3.00  3.39  -7.00  2.00 
Family carer  3.00  14.81  -15.00  31.00 
 
 
HoNOS-LD 
  Paid carer  12.74  13.17  -21.00  33.00 
4.204  .023 
Independent  -7.60  9.74  -16.00  3.00 
Family carer  11.75  23.37  -17.00  44.00 
 
GAF 
  
  
  
Paid carer 
17.70  17.61  -16.00  49.00 
4.113  .024 
Independent  -.80  .84  -2.00  1.00 
Family carer  .88  1.64  -1.00  3.00 
CGI 
  
  
  
Paid carer  1.48  1.55  -2.00  5.00 
4.900  .013 
Independent  6.22  6.04  -6.00  16.00 
Family carer  4.43  3.47  -3.00  12.00 
CANDID-R 
unmet needs 
  
  
  
Paid carer 
4.66  2.51  -3.00  10.00 
2.315  .102 
Independent  6.22  6.04  -6.00  16.00 
Family carer  4.43  3.47  -3.00  12.00 
CANDID-R 
met needs 
  
  
  
Paid carer 
4.66  2.51  -3.00  10.00 
1.084  .341   239 
Table 4.78: The relationship between level of intellectual disabilities and measures 
of longitudinal outcome  
 
* significant at the p< .05 level  
** significant at the p< .01 level 
*** significant at the p< .001 level 
 
   
   
   
 
 
 
Level of 
intellectual 
disabilities  Mean  SD  Min  Max 
 
 
F 
 
 
p 
mild  -7.33  7.39  -17  2 
moderate  8.38  15.08  -11  33 
severe  7.90  14.18  -21  23 
 
 
HoNOS-LD 
Total score 
 
profound  15.69  9.90  -1  31 
5.432**  .003 
mild  -7.50  8.34  -16  3 
moderate  14.00  24.69  -17  44 
severe  12.60  14.32  -16  29 
 
GAF 
  
  
  
profound 
21.31  18.07  -14  49 
3.837*  .018 
mild  -.83  .75  -2  0 
moderate  1.13  1.64  -1  3 
severe  1.00  1.41  -2  3 
CGI 
  
  
profound  1.81  1.56  -1  5 
4.827**  .006 
mild  4.24  4.81  -6  14 
moderate  6.19  4.23  -2  16 
severe  4.64  2.42  -3  10 
CANDID-R 
unmet needs 
  
  
  
profound 
4.69  2.82  -3  12 
6.994**  .001 
mild  5.50  4.17  -3  12 
moderate  5.45  5.43  -6  14 
severe  6.21  7.75  -11  18 
CANDID-R  
met needs 
  
  
  
profound 
6.33  7.63  -10  16 
1.933  .142   240 
Table 4.79: Post hoc Bonferroni tests of ANOVA between group differences for level of 
intellectual disabilities and measures of longitudinal outcome 
 
 
 
Dependent 
Variable 
(I) Reference level of 
intellectual disability 
category 
(J) Comparison level 
of intellectual 
disability categories 
Mean 
Difference 
(I-J) 
Std. 
Error  p 
95% Confidence 
Interval 
mild  moderate  -15.71  6.46  .121  -33.74  2.32 
   severe  -15.23  6.17  .111  -32.47  2.01 
HoNOS-LD total 
  
   profound  -23.02**  5.72  .002  -39.00  -7.04 
mild  moderate  -21.50  9.59  .188  -48.28  5.28 
   severe  -20.10  9.17  .210  -45.71  5.51 
GAF 
   profound  -28.81*  8.50  .010  -52.55  -5.07 
mild  moderate  -1.96  .79  .104  -4.15  .23 
   severe  -1.83  .75  .118  -3.93  .26 
CGI 
  
  
  
   profound  -2.65*  .70  .003  -4.59  -.70 
mild  moderate  -6.50*  1.87  .008  -11.73  -1.27 
   severe  -7.10**  1.79  .002  -12.10  -2.10 
CANDID-R unmet 
needs 
  
  
   profound  -7.19**  1.66  .001  -11.82  -2.55 
  
* significant at the p< .0167 level 
** significant at the p < .003 
*** significant at the p < .0003  241 
 
4.10.5 Categorical socio-clinical variables as predictors of longitudinal outcome 
The only longitudinal measure of outcome, in table 4.80, significantly different across 
the three categories within the epilepsy variable is the CGI. Although the post hoc 
Bonferroni tests do not show any significant between group differences, the epilepsy 
variable will be included in the linear regression analyses for the CGI. 
 
 
Table 4.80: The relationship between epilepsy and measures of longitudinal 
outcome 
 
 
 
* significant at the p< .05 level 
   
A diagnosis of autism, Down syndrome (table 4.81), visual impairment (table 4.82) and 
mobility problems (table 4.83) are not associated with any of the longitudinal measures 
of  outcome.  The  significant  associations  for  the  variables  representing  hearing 
impairment (table 4.82), urinary incontinence and bowel incontinence (table 4.84) are 
solely with the longitudinal change in the HoNOS-LD, GAF and CGI. 
 
 
   Epilepsy  Mean  SD  Min  Max 
 
 
F 
 
 
p 
no  8.25  13.36  -21  31 
good control  13.38  14.17  -15  33 
 
 
HoNOS-LD total 
score 
 
poor control 
3.75  18.04  -17  26 
.714  .496 
no  12.54  18.55  -17  49 
good control  22.50  20.09  -11  48 
 
GAF 
  
  
  
poor control 
.75  22.71  -16  34 
1.791  .181 
no  .96  1.48  -2  5 
good control  2.13  1.55  -1  4 
CGI 
  
  
  
poor control  -.25  2.22  -2  3 
3.305*  .048 
no  2.86  4.08  -4  2.86 
good control  4.88  3.56  -2  4.88 
CANDID-R unmet 
needs 
  
  
  
poor control 
-.25  5.06  -6  -.25 
2.131  .133 
no  3.25  3.90  -11  2 
good control  3.13  4.42  -8  4 
CANDID-R met needs 
  
  
   poor control  1.50  1.91  -3  1 
.357  .702   242 
 
 
 
 
 
 
Table 4.81: The relationship between autism, Down syndrome and measures of longitudinal 
outcome 
 
 
Autism  Down syndrome 
Yes (n=6)  No (n=34)  Yes (n=6)  No (n=34) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
 statistic 
 
p 
 
 
HoNOS-LD total score 
 
7.33  9.69  9.09  14.56  .283  .779  3.33  16.16  9.79  13.44  1.055  .298 
GAF 
  8.17  21.17  14.26  19.51  .698  .490  15.00  26.84  13.06  18.56  -.221  .826 
CGI 
.67  1.37  1.15  1.71  .651  .519  .67  1.97  1.15  1.62  .651  .519 
CANDID-R unmet needs 
  
  
  
1.33  4.08  3.24  4.21  1.025  .312  3.83  3.19  2.79  4.37  -.555  .582 
CANDID-R met needs 
  
 
1.67  3.14  3.29  3.92  .960  .343  2.67  4.03  3.12  3.84  .263  .794 
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Table 4.82: The relationship between sensory impairments and measures of longitudinal outcome 
 
Visual impairment  Hearing impairment 
Yes (n=5)  No (n=35)  Yes (n=5)  No (n=35) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
6.00  15.51  9.23  13.79  .483  .632  -4.60  13.07  10.74  13.02  2.464*  .018 
GAF  4.00  23.22  14.69  19.05  1.145  .260  -12.00  5.43  16.97  18.15  7.404§***  .000 
CGI 
 
.20  1.79  1.20  1.62  1.274  .210  -.80  .84  1.34  1.57  2.968**  .005 
CANDID-R unmet 
needs 
 
1.20  5.17  3.20  4.06  .997  .325  .80  3.11  3.26  4.27  1.234  .225 
CANDID-R met 
needs 
 
2.20  3.96  3.17  3.85  .527  .602  1.20  4.15  3.31  3.76  1.162  .252 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
† Non- parametric z-score from Mann-Whitney test    
§ Levene’s test found the between group variance is significant so the t-test results are for equal variances not assumed    244 
 
 
 
Table 4.83: The relationship between mobility problems and measures of 
longitudinal outcome 
 
 
Mobility problems 
Yes (n=7)  No (n=33) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
9.29  16.59  8.73  13.49  -.096  .924 
GAF  14.71  25.90  13.06  18.50  -.200  .842 
CGI 
 
1.29  2.56  1.03  1.45  -.255§  .806 
CANDID-R unmet 
needs 
 
3.43  3.55  2.85  4.36  -.329  .744 
CANDID-R met 
needs 
 
3.57  3.87  2.94  3.86  .393  .697 
 
 
** significant at the p< .01 level 
 
§ Levene’s test found the between group variance is significant so 
the t-test results are for equal variances not assumed 
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Table 4.84: The relationship between incontinence and measures of longitudinal outcome 
 
 
Urinary incontinence  Bowel incontinence 
Yes (n=15)  No (n=25)  Yes (n=11)  No (n=29) 
  Mean 
 
SD  Mean 
 
SD 
 
statistic 
 
p   
Mean 
 
SD 
 
Mean 
 
SD 
 
statistic 
 
p 
HoNOS-LD total 
13.87  11.44  5.80  14.48  -1.837  .074  15.00  13.18  6.48  13.58  -1.785  .082 
GAF  22.67  15.73  7.76  19.84  -2.476*  .018  24.45  17.84  9.14  18.84  -2.328*  .025 
CGI 
 
1.67  1.50  .72  1.67  -1.802  .080  1.91  1.64  .76  1.57  -2.042*  .048 
CANDID-R unmet 
needs 
 
3.93  3.75  2.36  4.41  -1.154  .256  2.91  3.67  2.97  4.44  .038  .970 
CANDID-R met 
needs 
 
3.27  3.58  2.92  4.03  .274  .785  2.82  3.25  3.14  4.07  -.233  .817 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
*** significant at the p< .001 level 
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Since  several  of  the  socio-clinical  variables  at  baseline  are  significantly  related  to 
longitudinal outcome the null hypothesis is rejected. 
 
4.11  Examining  measures  of  psychopathology  and  socio-clinical 
variables as independent predictors of longitudinal outcome. 
 
Linear  regression  is  used  to  examine  which  baseline  variables  predict  longitudinal 
outcome (dependant variables in the linear regression). As for the previous analyses, 
separate multiple linear regression analyses are carried out using the psychopathology 
dimensional factor scores, dimensional symptom counts and the three overall measures 
of psychopathology. All regression analyses are adjusted for the baseline score on the 
specific measure of outcome. 
 
4.11.1 Independent predictors of longitudinal outcome measured with the HoNOS-
LD total score 
Different dimension factor scores, and symptom counts are significant  predictors of 
longitudinal outcome on the HoNOS-LD in tables 4.85 and 4.86. Only the behaviour-
affective factor score at baseline is an independent predictor, whilst the depressive and 
organic symptom counts predict longitudinal outcome on the HoNOS-LD. The other 
independent predictors of outcome across the two regression analyses is the level of 
intellectual disabilities. 
 
Null hypothesis eleven: 
Dimensional  measures  of  psychopathology,  and  socio-clinical  variables  are  not 
independently associated with the longitudinal outcome of mental disorders. 
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Table 4.85: Multivariate associations of dimension factor scores and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.018* 
 
Not retained in the model 
Behaviour-
affective 
dimension factor 
score‡ 
.001** 
 
13.898  6.255  .292  .033* 
Independent-
family carer  Not retained in the model 
Living 
circumstances 
023* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
14.990  6.002  .439  .018* 
 
Mild-severe  15.342  5.478  .486  .008** 
Categorical 
measure of 
intellectual 
disabilities 
.003** 
 
Mild- profound  18.733  5.374  .671  .001** 
Hearing 
impairment  .018* 
 
Not retained in the model 
Urinary 
incontinence 
.074 
 
Not retained in the model 
Bowel 
incontinence 
.082 
 
Not retained in the model 
.546   248 
 
 
Table 4.86: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension 
symptom count 
.009** 
 
1.633  .737  .297  .034* 
Organic dimension 
symptom count 
.097 
 
-3.727  1.279  -.382  .006** 
Behaviour-affective 
dimension symptom 
count 
.004** 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .023* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
17.731  5.588  .519  .003** 
 
Mild-severe  19.513  5.424  .618  .001** 
Categorical measure 
of intellectual 
disabilities 
.003** 
 
Mild- profound  18.854  5.187  .676  .001** 
Hearing impairment  .018* 
 
Not retained in the model 
Urinary incontinence  .074 
 
Not retained in the model 
Bowel incontinence  .082 
 
Not retained in the model 
.601 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
 
All three overall measures of psychopathology were retained as independent predictors 
of outcome in the regression models. The results are shown in table 4.87-4.89 for the 
linear  regression  analysis  with  the  total  dimension  factor  score,  total  dimension 
symptom count and the EFS PPS-LD symptom count- 41, respectively.   249 
 
Table 4.87: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor 
score 
.008** 
 
3.210  .858  .427  .001** 
Independent-
family carer  Not retained in the model 
Living circumstances  .023* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
20.119  5.843  .589  .002** 
 
Mild-severe  18.762  5.545  .594  .002** 
Categorical measure of 
intellectual disabilities 
.003** 
 
Mild- profound  24.124  5.058  .864  .000*** 
Hearing impairment  .018* 
 
Not retained in the model 
Urinary incontinence  .074 
 
Not retained in the model 
Bowel incontinence  .082 
 
Not retained in the model 
.546 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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Table 4.88: Multivariate associations of total dimension symptom count and socio-
clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension 
symptom count 
.004** 
 
2.445  .435  .395  .001** 
Independent-
family carer  Not retained in the model 
Living circumstances  .023* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
17.438  5.164  .510  .001** 
 
Mild-severe  16.551  4.886  .524  .002** 
Categorical measure of 
intellectual disabilities 
.003** 
 
Mild- profound  16.723  4.914  .599  .002*** 
Hearing impairment  .018* 
 
Not retained in the model 
Urinary incontinence  .074 
 
Not retained in the model 
Bowel incontinence  .082 
 
Not retained in the model 
.614 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.89: Multivariate associations of EFS PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in HoNOS-LD scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFS PPS-LD symptom 
count- 41 
.002** 
 
1.472  .401  .426  .001** 
Independent-
family carer  Not retained in the model 
Living circumstances  .023* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
16.773  4.664  .521  .002** 
 
Mild-severe  17.175  4.905  .584  .002** 
Categorical measure of 
intellectual disabilities 
.003** 
 
Mild- profound  21.849  5.375  .873  .000*** 
Hearing impairment  .018* 
 
Not retained in the model 
Urinary incontinence  .074 
 
Not retained in the model 
Bowel incontinence  .082 
 
Not retained in the model 
.541 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level  252 
 
 
4.11.2 Independent predictors of longitudinal outcome measured with the GAF  
There is only one difference between the variables from the bivariate analysis included 
in the HoNOS-LD and  GAF multivariate analyses- the  organic dimension symptom 
count was not associated with the GAF. The independent predictors of longitudinal 
outcome on the GAF are, therefore, similar to those for the HoNOS-LD. 
 
In  the  regression  models  that  include  the  depressive  and  behaviour-affective  factor 
scores (table 4.90) and symptom counts (table 4.91) level of intellectual disabilities and 
hearing impairment were retained as independent predictors of longitudinal outcome on 
the GAF. However, whilst both dimensions are retained for the model using factor 
scores, only the depression symptom count is a significant predictor of outcome in the 
model shown in table 4.91. 
 
Similar to the findings for the HoNOS-LD in the previous section, all three overall 
measures of psychopathology were independent, significant predictors of longitudinal 
outcome on the GAF. The models for the overall measures of psychopathology were 
very  similar.  For  each  regression  model,  in  addition  to  the  overall  measure  of 
psychopathology, level of intellectual disabilities and hearing impairment are significant 
predictors of outcome, and the regression models account for 67.2-69.6% of the overall 
variance.  The  details  of  the  regression  models  for  all  three  overall  measures  of 
psychopathology are shown in table 4.92-4.94.   253 
 
 
 
Table 4.90: Multivariate associations of dimension factor scores and socio-clinical 
variables with longitudinal change in GAF scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.003** 
 
23.201  7.057  .342  .002** 
Behaviour-affective 
dimension factor 
score‡ 
.005** 
 
16.438  7.522  .244  .036* 
Independent-
family carer  Not retained in the model 
Living 
circumstances 
.024* 
Independent 
paid carer  Not retained in the model 
Mild- moderate 
18.860  8.247  .390  .029* 
 
Mild-severe  18.400  7.470  .412  .019* 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound  18.470  7.691  .467  .022* 
Hearing impairment  .000*** 
 
-28.252  6.226  -.483  .000*** 
Urinary 
incontinence 
.018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.646 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
‡ the square root transformed variable is used in the analyses   254 
Table 4.91: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension 
symptom count 
.000*** 
 
3.404  .800  .437  .000*** 
Behaviour-affective 
dimension symptom 
count 
.022* 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .024* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
22.585  7.472  .467  .005** 
 
Mild-severe  19.630  7.120  .439  .009** 
Categorical measure of 
intellectual disabilities 
.018* 
 
Mild- profound  21.808  6.848  .552  .003** 
Hearing impairment  .000*** 
 
-28.089  6.033  -.480  .000*** 
Urinary incontinence  .018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.633 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   255 
 
Table 4.92: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension 
factor score 
.000*** 
 
5.289  1.026  .496  .000*** 
Independent-
family carer  Not retained in the model 
Living 
circumstances 
.024* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
14.097  8.094  .291  .041* 
 
Mild-severe  15.883  7.111  .355  .032* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound  21.318  6.444  .539  .002** 
Hearing 
impairment  .000*** 
 
-30.514  5.526  -.521  .000*** 
Urinary 
incontinence 
.018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.696 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   256 
Table 4.93: Multivariate associations of total dimension symptom count and socio-
clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension 
symptom count  .000*** 
 
2.375  .527  .459  .000*** 
Independent-
family carer  Not retained in the model  Living 
circumstances  .024* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
17.698  7.252  .366  .020* 
 
Mild-severe  16.318  6.900  .319  .037* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound  22.898  5.963  .554  .001** 
Hearing 
impairment  .000*** 
 
-29.493  5.856  -.504  .000*** 
Urinary 
incontinence 
.018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.672 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level   257 
 
 
Table 4.94: Multivariate associations of EFA PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFS PPS-LD 
symptom count- 41 
.000*** 
 
2.317  .495  .474  .000*** 
Independent-
family carer  Not retained in the model 
Living 
circumstances 
.024* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
16.594  7.209  .343  .027* 
 
Mild-severe  17.558  7.967  .390  .012* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound  21.933  5.922  .531  .001** 
Hearing 
impairment  .000*** 
 
-29.286  5.778  -.500  .000*** 
Urinary 
incontinence 
.018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.681 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level   258 
 
4.11.3 Independent predictors of longitudinal outcome measured with the CGI 
In  comparison  to  the  HoNOS-LD  and  GAF,  gender  and  epilepsy  are  added  to  the 
variables  included  in  the  analyses  looking  at  the  variables  that  are  independent 
predictors  of  longitudinal  outcome  on  the  CGI.  Epilepsy  is  retained  across  all  the 
regression models but otherwise the variables at baseline that independently predict 
longitudinal outcome on the CGI are similar to those for the GAF. 
 
Tables 4.95 and 4.96 show the results of the linear regression analyses that include the 
depression  and  behaviour-affective  dimension  factor  scores  and  symptom  counts. 
Similar to findings for the GAF, both dimension factor scores, but only the depressive 
dimension symptom count, are significant independent predictors of outcome on the 
CGI. In addition to epilepsy, level of intellectual disabilities and hearing impairment are 
also significant predictors of outcome on the CGI. 
 
In contrast to the results for the HoNOS-LD and GAF linear regression analyses that 
included the three overall measures of psychopathology, the results are slightly different 
across the three final regression models with the CGI as the dependant variable. The 
common findings across the three models in tables 4.97-4.99 are: 
·  all  three  overall  measures  of  psychopathology  are  significant  independent 
predictors of outcome on the CGI 
·  only the mild-profound dummy variables for level of intellectual disabilities are 
retained 
·  hearing impairment is retained across all three models 
·  there are differences across the models in the results for the epilepsy variable. 
   259 
 
 
Table 4.95: Multivariate associations of dimension factor scores and socio-
clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations 
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive 
dimension factor 
score‡ 
.007** 
 
2.136  .615  .373  .001** 
Behaviour-affective 
dimension factor 
score‡ 
.004** 
 
1.695  .614  .298  .009** 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living 
circumstances 
.013* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
1.262  .696  .309  .079 
 
Mild-severe  1.478  .614  .392  .022* 
Categorical 
measure of 
intellectual 
disabilities 
.018* 
 
Mild- profound  1.746  .628  .523  .009** 
No- well 
controlled  1.084  .449  .265  .022* 
Epilepsy  .048* 
No- poor 
control  -1.139  .587  -.209  .041* 
Hearing 
impairment  .005** 
 
-1.638  .532  -.331  .004** 
Urinary 
incontinence 
.080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.655 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
‡ the square root transformed variable is used in the analyses   260 
 
Table 4.96: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in CGI scores  
 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive dimension 
symptom count 
.001** 
 
.279  .071  .425  .000*** 
Behaviour-affective 
dimension symptom 
count 
.020* 
 
Not retained in the model 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .013* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
1.591  .637  .389  .018* 
 
Mild-severe  1.597  .590  .423  .011* 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound  2.053  .563  .616  .001** 
No- well 
controlled  .910  .444  .223  .048* 
Epilepsy  .048* 
No- poor 
control  -1.057  .565  -.194  .046** 
Hearing impairment  .005** 
 
-1.780  .553  -.360  .003** 
Urinary incontinence  .080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.683   261 
Table 4.97: Multivariate associations of total dimension factor score and socio-
clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p<.1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension factor 
score 
.004** 
 
.454  .088  .505  .000*** 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .013* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of 
intellectual disabilities  .018* 
 
Mild- profound  1.025  .344  .307  .005** 
No- well 
controlled  1.427  .416  .349  .002** 
Epilepsy  .048* 
No- poor 
control  Not retained in the model 
Hearing impairment  .005** 
 
-1.474  .497  -.298  .005** 
Urinary incontinence  .080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.681 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level   262 
 
 
Table 4.98: Multivariate associations of total dimension symptom count and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Total dimension symptom 
count 
.001** 
 
.194  .045  .445  .000 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .013* 
Independent- 
paid carer  Not retained in the model. 
Mild- moderate 
Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of 
intellectual disabilities  .018* 
 
Mild- profound  .817  .345  .245  .024* 
No- well 
controlled  1.276  .427  .312  .005** 
Epilepsy  .048* 
No- poor 
control  -1.180  .568  -.217  .045* 
Hearing impairment  .005** 
 
-1.569  .503  -.318  .004** 
Urinary incontinence  .080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.694 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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Table 4.99: Multivariate associations of EFA PPS-LD symptom count- 41 and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
EFA PPS-LD symptom count- 
41 
.001** 
 
.175  .042  .423  .000*** 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .013* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
Not retained in the model 
 
Mild-severe  Not retained in the model 
Categorical measure of 
intellectual disabilities 
.018* 
 
Mild- profound  .797  .350  .239  .029 
No- well 
controlled  1.073  .425  .263  .017 
Epilepsy  .048* 
No- poor 
control  -1.152  .563  -.212  .049 
Hearing impairment  .005** 
 
-1.649  .507  -.334  .003 
Urinary incontinence  .080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.687 
 
 
* significant at the p< .05 level 
** significant at the p< .01 level 
**** significant at the p< .001 level 
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4.11.4 Independent predictors of longitudinal outcome measured with CANDID-R 
unmet needs 
In the bivariate analyses, of the individual dimensional measures of psychopathology 
only the symptom count for the depressive dimension was found to be significantly 
correlated with the change in the CANDID-R unmet needs. However, it was not an 
independent predictor of outcome in the linear regression analyses in table 4.100. 
 
 
In  fact,  this  was  also  the  case  for  the  three  overall  measures  of  psychopathology. 
Therefore, the only significant predictor of outcome on the CANDID-R unmet needs is 
level of intellectual disabilities, with the results in table 4.100 consistent across the 
analyses using the overall measures of psychopathology. 
 
Table 4.100: Multivariate associations of dimension symptom counts and socio-
clinical variables with longitudinal change in CANDID-R unmet needs 
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Depressive 
dimension symptom 
count 
.060 
 
Not retained in the model 
Mild- moderate 
6.500  1.874  .628  .001** 
 
Mild-severe  7.100  1.792  .742  .000*** 
Categorical measure 
of intellectual 
disabilities 
.012* 
 
Mild- profound  7.188  1.661  .850  .000*** 
.368 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
 
 
     
There were no variables associated with the CANDID-R met needs in the bivariate 
analyses.  Therefore,  it  is  concluded  that  there  are  no  significant  predictors  of 
longitudinal outcome on the CANDID-R met needs. 
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However,  the  overall  findings  were  that  baseline  measures  of  psychopathology  and 
socio-clinical variables that predict longitudinal outcome. Therefore, the null hypothesis 
is rejected. 
 
4.12 Comparing the predictive validity of categorical and dimensional 
measures of psychopathology 
 
 
 
The regression models examining dimensional models of psychopathology, and socio-
clinical variables as predictors of longitudinal outcome were presented in section 4.11 
above. Measures representing dimensional models of psychopathology were significant, 
independent predictors of longitudinal outcome measured with the HoNOS-LD (tables 
4.85 and 4.86), GAF (tables 4.90 and 4.91) and CGI (4.95 and 4.96). To examine null 
hypothesis  eleven,  these  models  for  dimensional  models  of  psychopathology  were 
compared to models using a categorical model of psychopathology (individual meets 
criteria  for  a  DC-LD  diagnosis  of  mental  disorder)  and  models  including  both 
dimensional  and  categorical  models.  The  socio-clinical  variables  with  bivariate 
associations  to  the  HoNOS-LD,  GAF  and  CGI  were  also  included  in  the  linear 
regression analyses, to allow direct comparison between the models. 
 
4.12.1  Examining  categorical  diagnosis  of  mental  disorder  as  a  predictor  of 
longitudinal outcome 
Twenty six individuals (65%) in sample 3 met the criteria for a DC-LD categorical 
diagnosis at baseline, shown in table 3.4. The binary variable was included in the linear 
regression analyses with longitudinal outcome on HoNOS-LD, GAF and CGI as the 
dependent variables. 
 
Null hypothesis twelve: 
There are no significant differences in the associations of dimensional and 
categorical models of psychopathology with the longitudinal outcome of mental 
disorders.    266 
The categorical model of psychopathology was not retained in the regression model for 
HoNOS-LD. However, the final models for GAF and CGI are shown in tables 4.101 
and 4.102. 
 
 
Table 4.101: Multivariate associations of categorical DC-LD diagnosis and 
socio-clinical variables with longitudinal change in GAF scores  
 
 
Bivariate associations (p< .1)  Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis of 
mental disorder on DC-
LD (Y/N) 
N/A 
 
10.518  5.515  .259  .045* 
Independent-
family carer  Not retained in the model 
Living circumstances  .024* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
30.107  7.493  .622  .000*** 
 
Mild-severe  33.997  8.058  .760  .000*** 
Categorical measure of 
intellectual disabilities 
.018* 
 
Mild- profound  31.950  6.509  .809  .000*** 
Hearing impairment  .000*** 
 
-36.181  6.893  -.618  .000*** 
Urinary incontinence  .018* 
 
Not retained in the model 
Bowel incontinence  .025* 
 
Not retained in the model 
.586 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level   267 
 
 
 
Table 4.102: Multivariate associations of categorical DC-LD diagnosis and 
socio-clinical variables with longitudinal change in CGI scores  
 
 
Bivariate associations  
(p< .1) 
Multivariate associations 
Variable  p 
Dummy 
variable  B  SE B  β 
 
p 
 
R² 
Categorical diagnosis 
of mental disorder on 
DC-LD (Y/N) 
N/A 
 
.879  .477  .257  .044 
Gender  .097 
 
Not retained in the model 
Independent-
family carer  Not retained in the model 
Living circumstances  .013* 
Independent- 
paid carer  Not retained in the model 
Mild- moderate 
2.605  .648  .638  .000*** 
 
Mild-severe  2.937  .697  .778  .000*** 
Categorical measure 
of intellectual 
disabilities 
.018* 
 
Mild- profound  2.890  .563  .867  .000*** 
No- well 
controlled  Not retained in the model 
Epilepsy  .048* 
No- poor 
control  Not retained in the model 
Hearing impairment  .005** 
 
-2.732  .596  -.553  .000*** 
Urinary incontinence  .080 
 
Not retained in the model 
Bowel incontinence  .048* 
 
Not retained in the model 
.565 
 
 
* significant at the p< 0.05 level 
** significant at the p< 0.01 level 
**** significant at the p< 0.001 level 
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The variable representing the categorical model of psychopathology was retained as a 
significant, independent predictor of outcome on the GAF and CGI. Comparing the 
standardised coefficients (β) across models, for longitudinal outcome on the GAF the 
depressive dimension factor score (β= .342) and symptom count (β= .437) are stronger 
predictors of outcome than the categorical model of psychopathology (β= .259), which 
is  a  stronger  predictor  than  the  behavioural  affective  dimension  symptom  score 
(β=.244).  Similarly  for  longitudinal  outcome  on  the  CGI  the  depressive  dimension 
factor score (β= .282) and symptom count (β= .437) are stronger predictors of outcome 
than the categorical model of psychopathology (β= .257), which is a stronger predictor 
than the behavioural affective dimension symptom score (β=.238).  
 
The final regression models using the dimensional model of psychopathology explain a 
greater proportion of the variance in longitudinal outcome on the GAF and CGI than the 
models using the categorical model of psychopathology. 
 
4.12.2 Examining whether categorical and dimensional models of psychopathology 
are co-predictors of longitudinal outcome 
To  examine  if  the  categorical  and  dimensional  models  of  psychopathology  have 
complimentary effects on predicting outcome, a final set of linear regression models 
were examined including both sets of variables, and run separately for dimension factor 
scores  and  dimensions  symptom  counts.  However,  the  variable  representing  the 
categorical of psychopathology was not retained as significant in the final models for 
the  longitudinal  outcome  on  the  HoNOS-LD,  GAF  and  CGI,  which  were  therefore 
unchanged from those reported in section 4.11 for the dimensional models. 
 
Therefore, the evidence suggests that dimensional models of psychopathology are better 
predictors of longitudinal outcome than categorical models, and are considered to have 
better predictive validity. Null hypothesis twelve is rejected. 
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4.13 Summary of results 
Prior to discussing the findings and implications in detail in Chapter 5, the results 
relevant to the twelve null hypotheses are summarised. 
 
Four  dimensions  were  identified,  interpreted  as  representing  depressive,  organic, 
behaviour-affective  and  anxiety  dimensions  of  psychopathology.  There  were  minor 
changes in the items of psychopathology included in the four dimensions extracted from 
the  original  EFA,  and  separate  analyses  using  two  random  sub-samples.  However, 
across the separate analyses there was excellent agreement in the loadings of individual 
items  of  psychopathology  to  the  four  dimensions.  Therefore,  the  stability  of  the 
dimensions appears good. 
 
Since there were no significant correlations between the four dimensions, they appear to 
be independent dimensions of psychopathology. 
 
 
The  socio-clinical  variables  significantly  associated  with  the  measures  of 
psychopathology, in the bivariate analyses, are shown in table 4.103 below. Only gender 
and hearing impairment were not associated with any measure of psychopathology. 
 
Null hypothesis one: Rejected 
There are no stable, identifiable dimensions of psychopathology experienced by 
adults with intellectual disabilities. 
 
Null hypothesis two: Accepted 
There  are  no  significant  correlations  between  the  individual  dimensions  of 
psychopathology experienced by adults with intellectual disabilities. 
 
Null hypothesis three: Rejected 
There are no significant cross-sectional, bivariate relationships between dimensional 
measures of psychopathology and socio-clinical variables. 
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Table  4.103:  Socio-clinical  variables  significantly  associated  with  higher 
levels of psychopathology 
 
 
 
* Variables included in the multivariate analyses since they are associated with the 
specific measure of psychopathology with a significance level less than .1 but 
greater than .05 
  Socio-clinical variables 
Depressive  Older age 
Living with family carers 
More severe level of intellectual disabilities 
Down syndrome 
 
Organic  
  
   Does not have visual impairment 
Younger age 
Living with paid carers 
Severe level of intellectual disabilities 
Down syndrome* 
Behaviour-affective  
  
  
  
Urinary incontinence 
Younger age 
Severe level of intellectual disabilities 
Does not have pilepsy 
Autism* 
Does not have mobility problems 
Does not have urinary incontinence 
Anxiety 
  
  
  
 
 
Does not have bowel incontinence 
Moderate intellectual disabilities 
 
 
 
 
 
 
 
 
 
 
 
Dimension 
factor 
scores 
 
Total 
  Does not have mobility problems * 
Depressive  Older age 
Older age 
Autism* 
Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective  
  
   Does not have Down syndrome 
Younger age 
Moderate intellectual disabilities* 
Does not have epilepsy* 
Autism* 
Does not have mobility problems 
Does not have urinary incontinence 
Anxiety 
  
  
  
 
 
 
Does not have bowel incontinence 
Moderate intellectual disabilities 
 
 
 
 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total 
   Does not have mobility problems * 
EFA  PPS-LD symptom count- 41   Moderate intellectual disabilities   271 
 
 
 
 
In table 4.104 the socio-clinical variables retained as independently associated with the 
measures of psychopathology are shown. The socio-clinical variables retained in the 
final regression models varies between the dimensional measures of psychopathology. It 
is evident that there are a greater number of socio-clinical variables associated with the 
dimensional  measures  of  psychopathology,  than  with  the  three  overall  measures  of 
psychopathology.  
Null hypothesis four: Rejected 
There  are  no  significant  cross-sectional,  multivariate  relationships  between 
measures of psychopathology and socio-clinical variables.   272 
 
Table 4.104: Socio-clinical variables retained as independently associated 
with measures of psychopathology in the final regression models  
 
 
 
 
 
 
 
 
 
 
 
  Socio-clinical variables 
Depressive  Older age 
More severe level of intellectual disabilities  Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective 
 
   Down syndrome 
Younger age 
Moderate  intellectual disabilities 
Does not have epilepsy 
Does not have mobility problems 
Anxiety 
 
 
  
  Does not have bowel incontinence 
 
 
 
 
 
Dimension 
factor 
scores 
Total  Moderate  intellectual disabilities 
Depressive  Older age 
Older age  Organic 
Down syndrome 
Younger age 
More severe level of intellectual disabilities 
Behaviour-affective  
  
   Down syndrome 
Younger age 
Moderate intellectual disabilities 
Anxiety 
  
   Mobility problems 
 
 
 
 
 
 
Dimension 
symptom 
counts 
Total  Moderate intellectual disabilities 
EFA  PPS-LD symptom count- 41   Level of intellectual disabilities   273 
 
 
 
 
 
Each of the four dimensional factor scores, and symptom counts, were correlated with 
one or more measure of severity. These correlations are summarised in table 4.105. The 
only clear difference between the correlations of factor scores and symptom counts for 
an individual dimension of psychopathology is seen for the organic dimension. All three 
overall measures of psychopathology were significantly correlated with each of the five 
measures of severity.  
 
Null hypothesis five: Rejected 
There are no significant cross-sectional, bivariate relationships between 
dimensional measures of psychopathology and measures of the severity of mental 
disorders.   274 
Table 4.105: Summary of the dimensional measures of psychopathology 
correlated with the measures of severity  
 
 
a  higher
  level  of  psychopathology  is  associated  with  greater  severity  of 
mental disorder on all measures 
 
* Variables included in the multivariate analyses since they are associated 
with the measure of severity with a significance level less than .1 but greater 
than .05 
 
 
Measure of severity  Dimension factor score  Dimension symptom count 
Depressive 
a  Depressive 
Behaviour-affective  Organic 
Behaviour-affective 
 
 
HoNOS-LD 
Total 
Total 
Depressive  Depressive 
Organic  Organic 
Behaviour-affective  Behaviour-affective 
 
 
 
GAF 
Total  Total 
Depressive  Depressive 
Organic  Organic 
Behaviour-affective  Behaviour-affective 
 
 
CGI 
Total  Total 
Depressive*  Depressive 
Organic*  Organic 
Behaviour-affective  Behaviour-affective 
 
 
CANDID-R unmet 
needs 
Total  Total 
Depressive*  Depressive* 
Anxiety  Organic* 
Anxiety 
 
 
CANDID-R met needs  
Total 
Total   275 
 
Of the socio-clinical variables included in the analysis, gender, Down syndrome and 
hearing impairment were not associated with any of the measures of severity. The cross-
sectional relationships between the other variables and the measures of severity are 
shown in table 4.106. 
 
 
Table  4.107  summarises  the  dimensional  measures  of  psychopathology  and  socio-
clinical variables independently associated with the measures of severity. The retained 
socio-clinical variables are identical in both sets of models. However, the dimension 
factor  scores  and  symptom  counts  retained  vary.  The  three  overall  measures  of 
psychopathology were all retained as independently associated with the five measures 
of outcome. Identical socio-clinical variables were retained to those shown for each of 
the measures of outcome in table 4.107. 
 
 
 
 
Null hypothesis six: Rejected 
There are no significant bivariate relationships between socio-clinical variables and 
measures of the severity of mental disorders. 
Null hypothesis seven: Rejected 
There are no significant multivariate associations between dimensional measures of 
psychopathology,  socio-clinical  variables  and  measures  of  the  severity  of  mental 
disorders.   276 
 
 
Table 4.106: Socio-clinical variables significantly associated with 
greater severity of mental disorder 
 
 
 
 
Measure of severity  Socio-clinical variable 
Living with a paid carer* 
More severe intellectual disabilities 
Urinary incontinence 
 
 
HoNOS-LD 
Bowel incontinence 
GAF  No significant bivariate associations 
CGI  Moderate intellectual disabilities 
Younger age 
Living indepedently 
Moderate intellectual disabilities* 
 
 
CANDID-R unmet needs 
Visual impairment 
Older age* 
Living with a family or paid carer 
More severe intellectual disabilities  
Autism* 
Epilepsy- well controlled seizures 
Visual impairment 
Mobility problems 
Urinary incontinence 
 
 
 
 
 
 
CANDID-R met needs  
Bowel incontinence   277 
Table  4.107:  Measures  of  psychopathology  and  socio-clinical  variables 
independently associated with greater severity of mental disorder, apart from 
met needs 
 
Measure of 
severity  Models including dimension factor 
scores and socio-clinical variables 
Models including dimension 
factor scores and socio-clinical 
variables 
Depressive dimension  Depressive dimension 
Behaviour-affective dimension  Organic dimension 
Behaviour-affective dimension 
HoNOS-LD 
Profound intellectual disabilities 
Profound intellectual disabilities 
Depressive dimension  Depressive dimension 
Organic dimension  Organic dimension 
GAF 
  
Behaviour-affective dimension  Behaviour-affective dimension 
Depressive dimension  Depressive dimension 
Organic dimension  Organic dimension 
CGI 
Behaviour-affective dimension  Behaviour-affective dimension 
Younger age  Organic dimension 
Living independently  Behaviour-affective dimension 
More severe intellectual disabilities  Younger age 
Living  independently 
More severe intellectual disabilities 
CANDID-R 
unmet needs  
Does not have visual impairment 
Does not have visual impairment 
Depressive dimension  Depressive dimension 
Older age  Organic dimension 
Living with family or paid carer  Older age 
Mores severe intellectual disabilities  Living with family or paid carer 
Epilepsy- well controlled seizures  More severe intellectual disabilities 
Visual impairment  Epilepsy- well controlled seizures 
Visual impairment 
CANDID-R 
met needs 
Urinary incontinence 
Urinary incontinence   278 
 
 
The  categorical  model  of  psychopathology  was  only  significantly  associated  with 
severity  measured  on  the  HoNOS-LD.  However,  when  both  the  dimensional  and 
categorical  models  of  psychopathology  were  included  in  the  regression  analysis  the 
categorical model was not retained. Therefore, it appears that the categorical model does 
not  explain  any  additional  variance,  over  and  above  the  dimensional  model  of 
psychopathology.  It is  concluded that the dimensional model of psychopathology is 
more strongly related to measures of the severity of mental disorders. 
 
 
Only the anxiety dimension of psychopathology was not significantly associated with 
any measure of outcome. No baseline measure of psychopathology was associated with 
longitudinal outcome measured on the CANDID-R met needs. 
 
 
 
 
 
Null hypothesis eight: Rejected 
There  are  no  significant  differences  in  the  associations  of  dimensional  and 
categorical  models  of  psychopathology  with  measures  of  the  severity  of  mental 
disorders. 
 
Null hypothesis nine: Rejected 
Dimensional measures of psychopathology are not significantly correlated to  
the longitudinal outcome of mental disorders. 
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Table 4.108: Summary of the baseline measures of psychopathology correlated 
with poorer longitudinal outcome 
 
 
 
* Variables included in the multivariate analyses since they are associated 
with the specific measure of psychopathology with a significance level less 
than .1 but greater than .05 
 
 
Only the CANDID-R met needs was not associated with any socio-clinical 
variable.in table 4.109 
 
 
 
Measure of outcome  Dimension factor score  Dimension symptom count 
Depressive  Depressive 
Behaviour-affective  Organic* 
Behaviour-affective 
HoNOS-LD 
Total 
Total 
Depressive  Depressive 
Behaviour-affective  Behaviour-affective 
GAF 
Total  Total 
Depressive  Depressive 
Behaviour-affective  Behaviour-affective 
CGI 
Total  Total 
Depressive*  CANDID-R unmet 
needs 
Total 
Total 
CANDID-R met needs   None  None 
Null hypothesis ten: Rejected 
Socio-clinical measures are not significantly associated with the longitudinal outcome 
of mental disorders. 
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Table  4.109:  Socio-clinical  variables  associated  with  poorer  longitudinal 
outcome 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*  Variables  included  in  the  multivariate  analyses  since  they  are 
associated  with  the  specific  measure  of  psychopathology  with  a 
significance level less than .1 but greater than .05 
 
Measure of severity  Socio-clinical variable 
Living independently* 
Mild intellectual disabilities 
Hearing impairment 
Does not have urinary incontinence* 
HoNOS-LD 
Does not have bowel incontinence* 
Living independently 
Mild intellectual disabilities 
Hearing impairment 
Does not have urinary incontinence 
GAF 
Does not have bowel incontinence 
Gender* 
Living independently 
Mild intellectual disabilities 
Epilepsy 
Hearing impairment 
Does not have urinary incontinence * 
CGI 
Does not have bowel incontinence 
CANDID-R unmet needs  Mild intellectual disabilities 
CANDID-R met needs   None   281 
 
Varying  combinations  of  measures  of  psychopathology  and  socio-clinical 
variables were retained as significant predictors of outcome on the HoNOS-LD, 
GAF, CGI and CANDID-R unmet needs, shown in table 4.110.  
 
 
 Table 4.110: Measures of psychopathology and socio-clinical variables 
independently associated with poorer longitudinal outcome 
  Models including dimension 
factor scores and socio-clinical 
variables 
Models including dimension 
factor scores and socio-clinical 
variables 
Behaviour-affective dimension  Depressive dimension 
Organic dimension 
HoNOS-LD 
Mild intellectual disabilities 
Mild intellectual disabilities 
Depressive dimension  Depressive dimension 
Behaviour-affective dimension  Mild intellectual disabilities 
Mild  intellectual disabilities  Hearing impairment 
GAF 
  
Hearing impairment   
Depressive dimension  Depressive dimension 
Behaviour-affective dimension  Mild intellectual disabilities 
Mild intellectual disabilities  Epilepsy-poorly  seizure control 
Epilepsy-poorly  seizure control  
CGI 
Hearing impairment 
Hearing impairment 
CANDID-R 
unmet needs  
Level of intellectual disabilities  Level of intellectual disabilities 
CANDID-R 
met needs 
No significant associations  No significant associations 
Null hypothesis eleven: Rejected 
Dimensional measures of psychopathology, and socio-clinical variables are  
not independently associated with the longitudinal outcome of mental disorders. 
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The variable representing the categorical model of psychopathology was retained as a 
significant, independent predictor of outcome on the GAF  and CGI. However, the 
dimensional model of psychopathology was also associated with the HoNOS-LD and 
was  more  strongly  associated  with  the  GAF  and  CGI.  When  both  models  were 
included in a regression analysis the categorical model of psychopathology was not 
retained in the final model. Therefore, it is concluded that the dimensional model of 
psychopathology is a better predictor of longitudinal outcome of mental disorders.  
Null hypothesis twelve: Rejected 
There  are  no  significant  differences  in  the  associations  of  dimensional  and 
categorical  models  of  psychopathology  with  the  longitudinal  outcome  of  mental 
disorders.   283 
Chapter 5 Discussion 
This chapter aims to fully consider the findings from chapter 4 in the context of previous 
research. The first section discusses the principal findings in relation to the 12 research 
null hypotheses.  For the purposes of the discussion the null hypotheses are grouped 
together into five sections, corresponding to the research aims of the thesis: 
·  the dimensional model of psychopathology  (Null hypotheses one and two) 
·  the  relationships  between  psychopathology  and  socio-clinical  variables  (Null 
hypotheses three and four) 
·  psychopathology and the severity of mental disorders (Null hypotheses five to seven) 
·  psychopathology as a predictor of the longitudinal outcome of mental disorders (Null 
hypotheses nine to eleven) 
·  comparing dimensional and categorical models of psychopathology (null hypotheses 
eight and twelve). 
 
Following on from the discussion of the specific findings in comparison with previous 
literature,  the  strengths  and  limitations  of  the  research  carried  out  to  address  the 
hypotheses are considered in the second section. Finally, the implications of the findings 
for  clinical  practice  and  research  in  the  field  of  mental  disorders  and  intellectual 
disabilities are discussed. 
 
5.1. The multi-dimensional model of psychopathology  
Exploratory factor analysis of the PPS-LD data resulted in a model of psychopathology 
with four dimensions, labeled as depressive, organic, behavioural affective and anxiety. 
This  multi-dimensional  model  explains  just  over  31%  of  the  total  variance  in  the 
psychopathology data collected using the PPS-LD. 
 
In  the  studies  summarised  in  table  1.2,  the  different  instruments  used  to  assess 
psychopathology,  the  different  samples,  and  even  issues  relating  to  the  labelling  of 
dimensions affects the comparison with the results in this thesis. For example, the PAS-
ADD  checklist  does  not  include  items  of  psychopathology  related  to  problem   284 
behaviours, and Kellett et al. (2004) included only participants with mild intellectual 
disabilities. The issue with labelling is illustrated by the dimensions that include items 
describing affective psychopathology, in studies in table 1.2. These are described using 
different labels- such as depression, mood, anxiety, and dementia/ anxiety.  To add to the 
problems with labelling, confusingly, two studies using the PAS-ADD checklist included 
two  separate  dimensions labelled  as depression (Moss  et  al. 1998;  Hatton & Taylor 
2008). These variations between studies are considered where relevant below, in the 
comparisons of studies reporting multi-dimensional models of psychopathology. 
 
Compared with the previous studies (table 1.2), the number of dimensions identified and 
the overall variance explained in the model described in this thesis was placed towards 
the  midpoint.  The  number  of  dimensions  in  the  previous  studies  varies  from  one 
(Sturmey et al. 1996; Tsiouris et al. 2003) to nine (Linaker 1991). These models also 
vary  considerably  in  the  proportion  of  the  overall  variance  in  psychopathology  they 
account  for-  ranging  from  9.4%  (Tsiouris  et  al.  2003)  to  61.25%  (Hatton  &  Taylor 
2008). Whilst accounting for a higher proportion of overall variance could be seen as 
desirable, it is not the case that a higher overall variance should be  accepted at the 
expense of including additional factors, which are unstable, or un-interpretable. 
 
Compared to other studies in table 1.2, the methods used for the EFA in this thesis more 
closely followed best practice guidelines (Costello & Osborne 2005). Although this will 
have reduced the overall number of factors extracted, and therefore the proportion of the 
overall variance explained, it would have maximised the stability of the final multi-
dimensional model of psychopathology. In particular, a case: item ratio less than 5:1 
(Matson et al. 1984; Linaker 1991; Gustafsson & Sonnander 2005; Watson et al. 1988; 
Sturmey et al. 1996; Sturmey et al. 2003; Tsiouris et al. 2003), the use of eigenvalues to 
decide the number of factors extracted in models (Matson et al. 1984; Linaker, 1991; 
Balboni et al. 2000; Gustafsson & Sonnander 2005; Watson et al. 1988; Moss et al. 
1998; Hatton & Taylor 2008; Hove & Havik 2008; Kellet et al. 2004), acceptance of 
factors with less than three items (Moss et al. 1998; Hatton & Taylor 2008; Hove & 
Havik 2008) and cross-loading of items across factors (Moss et al. 1998; Sturmey et al.   285 
2005; Sturmey et al. 1996; Kellet et al. 2004) have a negative effect on the stability of 
the final multi-dimensional models in studies reported in table 1.2. The methods of EFA 
used in a study will also have contributed to the difference in the proportion of variance 
models account for even when they have used the same instrument of assessment. A 
clear example of this is seen in the differing results from the three studies using the PAS-
ADD checklist (Moss et al. 1996; Sturmey et al. 2005; Hatton & Taylor 2008).  
 
The decisions on which items of psychopathology from the PPS-LD to include in the 
EFA is relevant to comparisons of the results with those of other studies. Items that 
occurred  at  an  overall  frequency  less  than  5%,  or  were  dependent  on  the  verbal 
communication of participants i.e. couldn’t be observed by an informant, were excluded 
from the EFA. This was done to improve the stability and generalisability of the final 
multi-dimensional  model  of  psychopathology.  Whilst  this  left  41  items  of 
psychopathology for inclusion in the EFA, it had a differential effect on specific forms of 
psychopathology.  For  example,  most  items  of  affective  or  problem  behaviour 
psychopathology are included in the EFA but this was not the case for other forms of 
psychopathology. Studies using the PIMRA (Matson 1984; Linaker 1993; Balboni 2000; 
Gustafsson & Sonnander 2005), PAS-ADD checklist (Moss et al. 1998; Sturmey et al. 
2005; Hatton & Taylor 2008), RSMB (Sturmey et al. 1996) and DASH-II (Sturmey et al. 
2004) identified psychosis dimensions of psychopathology. The exclusion of items of 
psychopathology relating to psychosis meant that this was not possible in this thesis. 
Therefore,  the  multi-dimensional  model  described  here  cannot  be  considered  as 
representing  all  forms  of  psychopathology  experienced  by  adults  with  intellectual 
disabilities. Rather, it is a model of commonly experienced psychopathology that can be 
identified, and reported, across the full range of abilities. 
 
Despite the differences between studies, the four dimensions are similar to dimensions 
reported  in  previous  studies  (table  1.2).  Furthermore,  equivalents  to  the  depressive, 
organic, behaviour-affective and anxiety dimensions are included in the nine dimensions 
identified across studies using different instruments to assess psychopathology, listed in 
table 1.3. However, there are no previous studies that have reported a final model with   286 
an identical combination of these four dimensions. Each of the four dimensions included 
in the final model, and aspects of the overall model, are discussed below.  
 
5.1.1 The depressive dimension of psychopathology 
In the EFA reported in section 4.1, the depressive dimension was extracted first- with 
nine  items  of  psychopathology,  representing  the  greatest  proportion  of  the  overall 
variance of the four dimensions (9.8%). A depressive dimension, or equivalent, was 
identified in seven previous studies using the informant version of the PIMRA (Matson 
et al. 1984; Watson et al. 1988), PAS-ADD checklist (Moss et al. 1996; Sturmey et al. 
2005; Hatton & Taylor 2008), MOSES (Sturmey et al. 2003), CBCPID (Tsiouris et al. 
2003) and BSI (Kellet et al. 2004) instruments of assessment, Furthermore, of the seven 
studies  that  identified  a  depressive  dimension  it  was  extracted  as  the  first  factor, 
explaining the highest variance, in five of the studies (Moss et al. 1996; Sturmey et al. 
2005; Hatton & Taylor 2008; Tsiouris  et  al. 2003; Kellet  et  al. 2004). Therefore,  a 
depressive dimension of psychopathology is consistently identified across studies with 
adults  with  intellectual  disabilities  as  participants,  and  accounts  for  a  significant 
proportion of the psychopathology. This finding is in keeping with studies diagnosing 
mental  disorders  using  categorical  diagnostic  classification  systems.  For  example,  a 
large-scale,  population  based  study  found  that,  after  problem  behaviours,  DC-LD 
depressive  disorder  had  the  highest  point  prevalence  (4.6%)  of  any  mental  disorder 
(Cooper et al. 2007c).  
 
Since  a  depressive  dimension  is  identified  within  the  majority  of  multi-dimensional 
models of psychopathology, it is relevant to consider possible reasons why it was not 
reported in a minority of studies in table 1.2. It is seen from the results of the study by 
Hove and Havik (20008) that depressive psychopathology is located within a dimension 
labelled  as  severe  psychopathology.  As  well  as  depressive  psychopathology,  this 
dimension also includes psychopathology described as dementia, mania and psychosis. 
On closer inspection of the methodology used in the EFA, the items used in the analysis 
are  the  scores  from  the  18  checklists,  rather  than  the  260  individual  items  of 
psychopathology. Thus, the results of this study do not present an empirically defined,   287 
multi-dimensional  model  of  psychopathology.  Rather,  the  model  describes  which 
checklists of psychopathology correlate with one another. However, this study based the 
checklists on diagnostic criteria for specific categorical diagnoses in DC-LD- in turn 
derived form the ICD and DSM categorical classification systems. Therefore, rather than 
describing higher order dimensions of psychopathology (Achenbach & Edelbrock 1978; 
Cantwell 1996; Slade & Watson 2006; Slade 2007) the results describe the associations 
of  DC-LD  categories.  This  is  maybe  a  reflection  of  the  poor  discriminant  validity 
described  for  categorical  diagnoses  (section  1.4.2,  Brown  et  al.  2001;  Kessler  et  al. 
2005). Studying a multi-dimensional model of psychopathology could be achieved by 
using the data on the 260 individual items of psychopathology in the EFA (Hove and 
Havik, 2008). However, since the study by Hove & Havik (2008) is not a true EFA of 
individual items of psychopathology it will not be used further in the comparison of 
results. 
 
Of the five studies that extracted a multi-dimensional model of psychopathology from 
the  informant  version  of  the  PIMRA,  only  two  identified  a  depressive  dimension 
(Matson et al. 1984; Watson et al. 1988). Since these five studies have used the same 
items of psychopathology, and a similar methodology for the EFA, it is not clear why the 
depressive dimension was not identified across all the studies. For example, the items 
that loaded to the affective dimensions in the studies by Matson et al. (1984) and Watson 
et al. (1988) are not extracted in any of the dimensions in the study by Linaker (1991), 
are distributed across the anxiety, adjustment and psychosomatic dimensions in Balboni 
et al. (2000) and across the psychosis and anxiety dimensions of Gustafson & Sonnander 
(2003).  All these studies have used methods of EFA that reduce the reliability and 
stability of the results. One additional potential explanation for the variations between 
studies  using  the  PIMRA  is  that  there  is  a  problem  with  the  56  items  of 
psychopathology. The PIMRA items of psychopathology are said to be based on criteria 
within DSM -III, organised into eight sub-scales (Matson et al. 1984): 
·  schizophrenic disorders 
·  affective disorders 
·  psychosexual disorders   288 
·  adjustment disorders 
·  anxiety disorders 
·  somatoform disorders 
·  personality disorders 
·  inappropriate mental adjustment. 
 
It appears from the description of the questions included in the PIMRA that some items 
are similar to those in the PPS-LD depressive dimension (Matson et al. 1984). Therefore, 
the variation across studies is not due to an absence of relevant items.  However, within 
the PIMRA items there are some confusing questions, which seem to lack relevance to 
the assessment of psychopathology. For example, “Do you wish you were a tree instead 
of a man/ woman?....When things go bad for you do you feel OK?.... Is it bad to be 
sick?”.  It  could  be  that  the  inclusion  of  incongruous  items  leads  to  variation  in  the 
response to questions on psychopathology across studies- especially when it is being 
translated for use in different countries (Linaker 1991; Balboni et al. 2000; Gustafson & 
Sonnander 2005). This question over the PIMRA items highlights the influence that the 
items included in any EFA can have on the results. 
 
Of the items of psychopathology that loaded significantly to the depressive dimension in 
this thesis, all nine are included in the DC-LD criteria for depressive episode, seven are 
included within the ICD-10 criteria for depressive episode and eight in the DSM-IV-TR 
criteria for the categorical diagnosis of a major depressive disorder. The two items that 
are included in DC-LD but not ICD-10 criteria are “tearfulness” and “reduction of verbal 
communication”- which is also the item not included in DSM-IV criteria. Interestingly, 
the DM-ID notes that “has decreased or stopped talking” may be reported by informants, 
and  should  be  considered  as  indicative  of  the  DSM-IV-TR  diagnostic  criterion, 
psychomotor  agitation  or  retardation.  The  depressive  dimension  is  therefore  most 
similar to the DC-LD depressive disorder category.  
 
Several instruments for assessment of psychopathology used in the EFA studies in table 
1.2 do not include items similar to “tearfulness” or “reduction in verbal communication”   289 
(PIMRA, PAS-ADD checklist, DASH-II, BSI). Of those that do, the equivalent items to 
“tearfulness” and “reduction in verbal communication” did not load to the depression 
dimension extracted from the MOSES (Sturmey et al. 2003) or CBCPID (Tsiouris et al. 
2003). Therefore, although this thesis provides some support for including these two 
additional  criteria  for  depressive  disorder  in  DC-LD,  further  work  investigating  the 
relevance of these items to the classification of depressive psychopathology is required.   
 
As well as the items of psychopathology extracted as part of the depressive dimension, it 
is useful to consider items that did not load to this dimension in the EFA. In DC-LD and 
DM-ID,  irritable  mood  can  be  used  as  an  alternative  to  depressed  mood,  as  a  key 
criterion that should be present. Therefore, it is of interest that “increased irritability” is 
not  part  of  the  depressive  dimension  from  the  PPS-LD  data.  Instead  “increased 
irritability”  is  one  of  the  items  that  load  significantly  to  the  behaviour-affective 
dimension. The irritability item loaded to similar mixed dimensions, comprising mood 
and  problem  behaviour  items  of  psychopathology,  in  the  studies  using  the  RSMB 
(Sturmey et al. 1996), MOSES assessment instrument (Sturmey et al. 2003), DASH II 
(Sturmey et al. 2004) and BSI (Kellet et al. 2004). However, the results in studies using 
the PAS-ADD checklist varied considerably. In one study the irritability item loaded to 
the depressive dimension (Moss et al. 1998), in another it did not load to any of the three 
interpretable dimensions- including one labelled mood (Sturmey et al. 2005), and formed 
a  second  depressive  dimension  with  one  other  item  “attempts  suicide/  talks  about 
suicide”  in  the  most  recently  published  study  (Hatton  &  Taylor  2008).  Finally,  the 
irritability item did not load to the depressive dimension from the CBCPID (Tsiouris et 
al. 2003). Therefore, in only one study does the irritability item load significantly to a 
coherent depressive dimension. There is stronger evidence, from the PPS-LD model in 
this thesis, and studies using four other assessment instruments (Sturmey et al. 1996; 
Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004), for irritability forming part 
of a behaviour-affective dimension of psychopathology.  
 
Reduced concentration is also included in the diagnostic criteria for depressive episodes 
in DC-LD,  ICD-10  and DSM-IV-TR. Similar to “increased irritability”, the PPS-LD   290 
item “reduced concentration” loaded significantly to the behaviour-affective dimension 
rather than the depressive dimension of psychopathology. However, unlike “increased 
irritability”, there is less evidence from other studies to support the finding that “reduced 
concentration”  loads  to  the  behaviour-affective  dimension.  Instead,  “reduced 
concentration”  loads  to  different  dimensions  across  studies  in  table  1.2-  including 
depressive dimensions (PAS-ADD checklist- Sturmey et al. 2005; MOSES-Sturmey et 
al.  2003),  a  restlessness  dimension  (PAS-ADD  checklist-  Moss  et  al.  1998)  and 
cognitive impairment/ organic dimensions (BSI- Kellet et al. 2004; PAS-ADD checklist- 
Hatton & Taylor 2008). Some of these differences could have been influenced by the 
different sample or methodologies in the studies- a view that is supported by there being 
different findings across the three studies using the PAS-ADD checklist (Moss et al. 
1998; Sturmey et al. 2005; Hatton & Taylor 2008). Alternatively, the variation across 
studies may suggest that psychopathology that relates to concentration is experienced 
across several different types of disorder. This is in keeping with the inclusion of items 
relating to concentration in diagnostic criteria for depressive disorders, manic episodes, 
generalised anxiety disorder, and ADHD in categorical diagnostic classification systems. 
Therefore,  the  relevance  of  the  “reduced  concentration”  item  of  psychopathology  to 
depressive, or other diagnostic, categories require further examination. 
 
The other items that were expected to be extracted as part of the depressive dimension 
are those items from the PPS-LD that relate to sleep problems. However, in the multi-
dimensional model reported here, none of the four items on sleep problems included in 
the EFA loaded to the depressive dimension. This isn’t too dissimilar to the findings 
from other studies. Of the seven studies that reported a depressive dimension in table 1.3, 
any form of sleep problem only loaded significantly to the depressive dimension in the 
study that used the CBCPID (Tsiouris et al. 2003). In the studies using the PAS-ADD 
checklist, two reported a specific sleep problem dimension (Moss et al. 1998; Hatton & 
Taylor,  2008),  and  the  other  extracted  sleep  problems  in  the  restlessness  dimension 
(Sturmey et al. 2005). Sleep problems were extracted as an item in the somatisation 
dimension of the BSI (Kellet et al. 2004) and did not load significantly to any dimension 
in studies using the PIMRA (Matson et al. 1984) and MOSES (Sturmey et al. 2003).   291 
Although none of the four sleep problem items from the PPS-LD loaded significantly to 
the depressive dimension, initial insomnia was included in the anxiety dimension.  
 
This discussion of the depressive dimension raises a question of why certain items of 
psychopathology,  often  considered  to  be  part  of  depressive  psychopathology,  load 
significantly to the behaviour-affective, and anxiety dimensions. 
 
5.1.2 The behaviour-affective dimension of psychopathology  
Eight items of psychopathology from the PPS-LD loaded significantly to the behaviour-
affective dimension of psychopathology. Four items relate to problem behaviours and 
four are commonly described affective symptoms- together accounting for 7.46% of the 
overall variance in the  psychopathology.  It is relevant to consider the  fact that both 
affective and problem behaviour psychopathology load significantly to this dimension, 
with  a  view  to  developing  an  understanding  of  the  relationship  between  problem 
behaviours  and  other  forms  of  psychopathology.  One  point  of  interest  is  that  this 
dimension does not easily map onto any one diagnostic category in DC-LD, DM-ID, 
ICD-10 or DSM-IV-TR. In fact, as discussed in section 5.1.1, the behaviour-affective 
dimension includes items of psychopathology that are often included in the diagnostic 
criteria for several different disorders.  
 
Four  of  the  studies  summarised  in  table  1.2  explicitly  identify  dimensions  of 
psychopathology  related  to  problem  behaviours-  using  the  PIMRA  (Linaker  1991), 
RSMB (Sturmey et al. 1996), DASH II (Sturmey et al. 2004) and BSI (Kellet et al. 
2004). Of these, on inspection of the items of psychopathology that loaded to these 
dimensions,  three  are  a  mixture  of  problem  behaviour  and  affective  items  of 
psychopathology  (Sturmey  et  al.  1996;  Sturmey  et  al.  2004;  Kellet  et  al.  2004). 
Although not labelled as such, the irritability/ depression dimension extracted from the 
MOSES data (Sturmey et al. 2003) is also a mixed behaviour-affective dimension that 
includes  items  on  oppositional  problem  behaviours,  physical  aggression  and  verbal 
aggression. The relative consistency of a behaviour-affective dimension across studies 
suggests that this may be a valid dimension of psychopathology experienced by adults   292 
with intellectual disabilities. Similarly, DC-LD (Royal College of Psychiatrists 2001) 
and DM-ID (Fletcher et al. 2007) both recognize that affective disorders presenting with 
depressive  and  manic  episodes  may  both  be  associated  with  an  increase  in  problem 
behaviours in adults with intellectual disabilities. However, only the DC-LD criteria for 
a depressive episode lists an increase in problem behaviours as a specific item within the 
diagnostic criteria.  
 
The relationships between affective and problem behaviour psychopathology have been 
considered in previous studies. One relevant area is research on problem behaviours as 
potential  depressive  equivalents  in  adults  with  intellectual  disabilities  and  depressive 
disorders.  The  studies  have  used  categorical  diagnostic  classification  systems  with 
equivocal  findings.  Studies  are  split  between  those  that  have  found  a  link  between 
affective psychopathology and problem behaviours (Lowry & Sovner 1992; Charlot et 
al. 1993; Marston et al. 1997; Moss et al. 2000; Cain et al. 2003; Kishore et al. 2005; 
Tyrer et al. 2006; Hurley 2008) and those that do not (Holden & Gitlesen 2003; Tsiouris 
et al. 2003; Rojahn et al. 2004). The findings reported here, and in the four studies in 
table  1.2  that  identified  an  equivalent  behaviour-affective  dimension  (Sturmey  et  al. 
1996; Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004) suggest that there is a 
link between affective psychopathology and problem behaviours. However, the findings 
suggest that this link may be distinct from depressive psychopathology. 
 
One  explanation  to  examine  is  that  the  link  between  affective  psychopathology  and 
problem behaviours is explained by psychopathology related to mania/ hypomania. If 
this is the case then the behaviour-affective dimension from the PPS-LD would be better 
viewed as a mania/ hypomania dimension. This explanation is supported by the finding 
from several studies, using categorical diagnostic classification systems, that reported 
increased problem behaviours in individuals meeting diagnostic criteria for hypomania/ 
mania compared to depressive disorders (Cain et al. 2003; Holden & Gitlesen 2004; 
Hurley  2008).  Furthermore,  the  items  of  psychopathology  relevant  to  irritability 
(Sturmey et al. 1996; Sturmey et al. 2003; Sturmey et al. 2004; Kellet et al. 2004) and 
impaired concentration (Sturmey et al. 1996) that were extracted within the behaviour-  293 
affective dimension, in this and other studies, are common to the diagnostic criteria for 
depressive episode and manic episode in DC-LD and DM-ID. 
 
To examine this further, it is useful to consider the results in more detail. One point to 
note is that several items of psychopathology from the PPS-LD of potential relevance to 
a  mania/  hypomania  dimension  were  excluded  from  the  EFA.  The  items  expansive 
mood, reckless irresponsible mood and social disinhibition were excluded as they were 
reported  by  less  than  5%  of  participants.  A  low  base  rate  of  these  items  of 
psychopathology  is  in  keeping  with  reported  low  incidence  and  prevalence  rates  of 
hypomania/ mania (Smiley et al. 2007; Cooper et al. 2007c). Although other relevant 
items  from  the  PPS-LD  were  included,  without  the  full  range  of  items,  a  mania/ 
hypomania dimension is less likely to be extracted from any EFA.  
 
In  considering  whether  the  behaviour-affective  dimension  is  better  considered  as  a 
mania/ hypomania dimension, the results from the EFA that extracted five dimensions of 
psychopathology  are  important.  This  five-dimension  model  was  rejected  because  of 
cross-loading of items between the anxiety and fifth dimensions. The fifth dimension 
included  five  items  of  psychopathology-  increased  verbal  communication,  increased 
energy levels, initial insomnia greater than one hour, mid-insomnia greater than one 
hour, early morning wakening greater than one hour. Although not entirely coherent, the 
fifth dimension was recognised as a possible mania/ hypomania dimension. However, it 
can be seen that no items from the behaviour-affective dimension in the four factor 
solution moved to this fifth dimension. Rather, the items of psychopathology that loaded 
to the fifth dimension were previously included in the anxiety dimension in the four 
factor solution.  If the behaviour-affective dimension is more accurately  considered a 
mania/  hypomania  dimension,  at  least  some  items  of  psychopathology  would  have 
loaded significantly to the fifth dimension. This suggests that the link between affective 
psychopathology  and  problem  behaviours  in  the  PPS-LD  is  not  due  to  mania/ 
hypomania.  
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Two of the assessment instruments used in the studies that reported an equivalent to the 
behaviour-affective  dimensions  include  items  of  psychopathology  related  to 
mania/hypomania, such as euphoric/ elevated mood and over activity (RSMB- Sturmey 
et al. 1996; DASH-II- Sturmey et al. 2004). In neither of these studies do these items of 
psychopathology  load  significantly  to  the  equivalent  of  the  behaviour-affective 
dimension. The absence of items relevant to mania/ hypomania in the studies reporting 
behaviour-affective dimension using the MOSES (Sturmey et al. 2003) and BSI (Kellett 
et al. 2004) preclude the results from clarifying this issue. A lack of relevant items of 
psychopathology also explains why from all the studies in table 1.2 only two, both using 
the  PAS-ADD  checklist,  report  a  specific  mania/  hypomania  dimension  of 
psychopathology (Moss et al. 1998; Hatton & Taylor 2008). However, since the PAS-
ADD checklist does not have items on problem behaviours these two studies do not 
provide any additional data relevant to this issue. 
 
To summarise, results from studies using categorical diagnostic classification systems 
are  equivocal  on  whether  problem  behaviours  and  depressive  psychopathology  are 
associated  Although  there  are  fewer  studies  using  categorical  models  of  mania/ 
hypomania,  the  evidence  more  consistently  reports  a  specific  association  between  a 
diagnosis of mania/ hypomania and problems behaviours. However, the studies using 
dimensional  models  of  psychopathology,  suggest  the  link  between  affective 
psychopathology and problem behaviours, may be distinct from depressive or mania/ 
hypomania psychopathology. Since this issue cuts across the multi-dimensional model of 
psychopathology it is discussed further in section 5.1.5 
 
5.1.3 The anxiety dimension of psychopathology 
Anxiety was the final dimension of psychopathology extracted from the PPS-LD data. 
Ten items of psychopathology loaded to the dimension, which explained 5.49% of the 
overall  variance  in  the  psychopathology.  Similar  anxiety  dimensions  were  identified 
using the PIMRA (Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & 
Sonnander 2005; Watson et al. 1988), PAS-ADD checklist (Moss et al. 1998; Hatton & 
Taylor  2008),  DASH-II  (Sturmey  et  al.  2004),  and  the  BSI  (Kellett  et  al.  2004).   295 
However, the DASH-II dimension is distinct since, of the seven items that load to the 
dementia/  anxiety  dimension  four  are  related  to  cognitive  impairment,  and  the  three 
anxiety items are visibly sweats with certain objects/ situations, trembles/ shakes for no 
obvious reason and extremely happy/ cheerful for no reason. 
 
Examining the PPS-LD anxiety dimension in more detail, the items labeled generalized 
anxiety  and  agoraphobia  stand  out  from  the  others  that  loaded  significantly  to  the 
dimension. Firstly, whilst the other items describe individual changes in behaviour or 
mood,  these  two  items  are  more  accurately  thought  of  as  combinations  of  items  of 
psychopathology.  In  the  PPS-LD,  the  item  of  psychopathology  labeled  generalized 
anxiety includes prompts for the characteristic free-floating anxiety and fear, autonomic 
arousal  symptoms,  and  symptoms  of  tension.  Similarly,  the  agoraphobia  item  of 
psychopathology incorporates prompts on characteristic symptoms that are triggered by 
identifiable situations and are associated with avoidance. Thus, both these items in the 
PPS-LD  are  composite  measures,  requiring  several  items  of  psychopathology  to  be 
present before they can be rated positively. For the purposes of using EFA to identify a 
multi-dimensional model of psychopathology, it would be preferable for each of the 
items of psychopathology within the composite items to be rated individually. These 
additional items could then be included in the EFA, and may add to our understanding of 
anxiety psychopathology experienced by adults with intellectual disabilities.  
 
One reason why it is preferable to include individual items of psychopathology is that 
anxiety dimensions from intellectual disabilities studies appear different to results from 
studies  with  participants  who  do  not  have  intellectual  disabilities.  Many  studies  that 
include  anxiety  related  psychopathology  identify  two  distinct  dimensions  (Watson 
2005),  labeled  with  various  terms  to  represent  a  general  distress  dimension  (often 
including depressive psychopathology and free floating symptoms, restlessness, tension) 
and  an  anxious,  fear  dimension  (including  avoidance,  panic,  phobic  and  obsessional 
symptoms). In contrast, the multi-dimensional model of psychopathology identified from 
the PPS-LD, and other assessment instruments in table 1.2, generally report a single 
dimension that includes both  generalized and fear/  phobic items of psychopathology   296 
(Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & Sonnander 2005; 
Watson et al. 1988; Moss et al. 1998; Sturmey et al. 2004; Kellett et al. 2004). Although 
one study reported separate anxiety and avoidant/ anxious dimensions (Linaker 1991), 
both dimensions are made up of general anxiety psychopathology with no items relating 
to phobic behaviours, panic or avoidance.  
 
It may be that individuals with intellectual disabilities experience, and report, anxiety 
psychopathology differently from individuals who do not have intellectual disabilities. 
However,  similar  to  the  PPS-LD,  none  of  the  assessment  instruments  used  in  the 
previous studies included a comprehensive range of items relevant to all forms of anxiety 
psychopathology.  This  may  explain  why  the  results  are  different  from  the  studies 
involving participants who do not have intellectual disabilities. Future studies with the 
PPS-LD, or other assessment instruments, should consider including additional, or more 
specific, items relevant to anxiety psychopathology.  
 
It is interesting to note that the items increased appetite and weight gain from the PPS-
LD load significantly to the anxiety dimension. Of the other assessment instruments in 
table  1.2,  only  the  PAS-ADD  checklist  asks  about  either  of  these  items  of 
psychopathology; increased appetite loads to the anxiety dimension in one study (Moss 
et al. 1998) and the hypomania dimension in another (Hatton & Taylor 2008). This 
apparent  association  between  anxiety  psychopathology  and  increased  appetite  and 
weight gain would benefit from further study. However, this finding is relevant to the 
significantly  increased  prevalence  of  obesity  in  children  (Emerson  2009)  and  adults 
(Melville  et  al.  2007;  Bhaumik  et  al.  2008;  Melville  et  al.  2008)  with  intellectual 
disabilities. 
 
An association between anxiety and weight gain (Stice 2002; Torres & Nowson 2007), 
and anxiety  and obesity (Jorm  et  al. 2003; Scott  et  al. 2008) has been described in 
individuals who do not have intellectual disabilities. However, no intellectual disabilities 
studies to date have reported an association between anxiety and weight gain, or obesity. 
There is a general lack of understanding of the determinants of obesity in individuals   297 
with  intellectual  disabilities,  and  few  studies  have  examined  the  relationships  with 
psychopathology (Melville et al. 2007). However, two recent population based studies 
found no significant, independent associations between obesity (defined as a body mass 
index greater than 30) and a diagnosis of a mental disorder (Melville et al. 2008) or 
problem  behaviours  (Melville  et  al.  2008;  Bhaumik  et  al.  2008).  The  loading  of 
increased appetite and weight gain to the anxiety dimension in this study, suggests that 
there is value in examining the relationships between psychopathology, weight gain and 
dimensional models of psychopathology in adults with intellectual disabilities. 
 
5.1.4 The organic dimension of psychopathology 
The  six  items  of  psychopathology  that  were  extracted  in  the  organic  dimension 
accounted for 8.7% of the total variance in the psychopathology. All six items that were 
extracted are included as relevant items of psychopathology within DC-LD diagnostic 
criteria for dementia. The criteria in ICD-10 and DSM-IV-TR are somewhat different in 
that  rather  than  listing  specific  items  of  psychopathology,  broader  descriptions  of 
psychopathology  associated  with  neurological  impairment  are  used.  These  include 
memory impairment, aphasia (language disturbance), apraxia (impaired ability to carry 
our motor activities), agnosia (failure to recognize objects) and disturbance in executive 
functioning  (i.e.  planning,  organizing,  sequencing  and  abstracting).  Despite  these 
differences between the categorical diagnostic classification systems, overall the items 
included in the organic dimension of psychopathology are in keeping with commonly 
reported phenomena reported as part of organic disorders, such as dementia. 
 
It  is  worth  noting  that  several  items  of  psychopathology  that  are  often  considered 
indicative of organic disorders were excluded from the EFA as they were reported in less 
than 5% of cases: 
·  mixing up day and night 
·  loss of literary skills 
·  loss of financial skills 
·  word finding difficulties. 
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It is likely that the items on literary and financial skills, and word finding difficulties are 
identified  infrequently  because  many  of  the  participants  with  intellectual  disabilities 
have low baseline levels of abilities relevant to these items. Therefore, it is difficult for 
informants and clinicians to detect change in these domains of functioning. The reason 
why the item on “mixing up day and night” is reported infrequently is less clear. Perhaps 
this is explained by the fact that the majority of participants receive support from carers.  
Prompts from carers about time of day, and routines around waking and sleep, may be 
strong  enough  to  counter-act  any  change  in  this  area  of  functioning  due  to  organic 
disorders. 
 
From  a  statistical  point  of  view  there  are  reasons  to  exclude  from  EFA  items  of 
psychopathology that occur infrequently, as the low variance has a negative impact on 
the stability and reliability of the final model (Hair et al. 1998a). By reducing the number 
of relevant items included in the EFA, inevitably the number of potential items that can 
be extracted is reduced. However, this does not reduce the potential face validity of the 
dimension, since these items are occurring at low frequencies in the total sample.  
 
Of  previous  studies,  three  identified  similar  dimensions  to  the  organic  dimension 
reported  here  (DASH-II-  Sturmey  et  al.  2004;  BSI-Kellett  et  al.  2004;  PAS-ADD 
checklist- Hatton & Taylor 2008). The PIMRA (Matson et al. 1984), RSMB (Sturmey et 
al. 1996) and CBCPID (Tsiouris et al. 2003) assessment instruments do not include 
items of psychopathology relevant to change in memory and other cognitive functioning, 
explaining why no equivalent to the organic dimension were reported. Since the MOSES 
is designed for use with older adults, the absence of an organic dimension from the final 
model is noteworthy (Sturmey et al. 2003). The authors describe a self-help dimension 
accounting for 20.6% of the overall variance that includes items of psychopathology 
relating to change in dressing, bathing, grooming, incontinence & toileting, and an item 
relating to problems with awareness of time. It is surprising that only one of the items 
rating change in cognitive functioning loaded significantly to this dimension. On the 
basis of the self-help dimension, the authors suggest the MOSES would be useful for the 
diagnosis of dementia and one study has shown that the MOSES differentiates between   299 
individuals with intellectual disabilities and Alzheimer’s type dementia (Dalton et al. 
2002). However, since memory impairment is central to current concepts of dementia the 
absence of the item rating memory impairment from the self-help dimension suggests the 
MOSES  requires  further  study  before  being  used  routinely  in  clinical  or  research 
settings. 
 
A coherent organic dimension is consistently  extracted when assessment instruments 
include  relevant  items  of  psychopathology.  Therefore,  it  is  necessary  to  include  the 
organic dimension within comprehensive methods of assessment and management of 
mental disorders experienced by adults with intellectual disabilities.  
 
5.1.5  General  issues  of  relevance  to  the  multi-dimensional  model  of 
psychopathology 
The prior discussion of the individual dimensions extracted within the PPS-LD multi-
dimensional model of psychopathology identified several issues relevant to the overall 
model.  
 
The  finding  that  the  four  dimensions  of  psychopathology  were  not  significantly 
correlated,  suggests  that  there  are  no  higher  order  internalising  and  externalising 
dimensions.  Rather, the finding of three independent dimensions including affective 
items  of  psychopathology-  depressive,  behaviour-affective  and  anxiety  suggests  a 
different model. Importantly, certain items of psychopathology (irritability and impaired 
concentration),  included  in  the  criteria  for  a  diagnosis  of  depressive  disorders  in 
categorical  diagnostic  classification  systems,  are  more  strongly  associated  with  the 
behaviour-affective  dimensions  in  this  and  other  studies.  Finally,  the  consistent 
identification  of  a  behaviour-affective  dimension,  distinct  from  depressive  or  mania/ 
hypomania  psychopathology,  may  help  to  clarify  the  relationship  between  affective 
psychopathology and problem behaviours, and will also be discussed. 
 
Although, there were no significant correlations between the four dimensions, or cross-
loading of items to more than one dimension there may be useful links between the   300 
dimensions  that  suggest  areas  of  study  to  examine  solutions  to  the  poor  validity  of 
categorical  models  of  psychopathology.  For  example,  conceptualising  a  broader 
dimensional  model  of  psychopathology  that  cuts  across  the  boundaries  of  diagnostic 
categories may provide an understanding of the significant comorbidity between anxiety 
and depressive disorders. 
 
Of  the  four  dimensions  extracted  in  the  EFA,  the  organic  dimension  appears  to  be 
qualitatively distinct from the other three dimensions, labelled depressive, behaviour-
affective and anxiety. The depressive, behaviour-affective and  anxiety  dimensions all 
include  items  of  psychopathology  that  can  be  conceptualised  as  affective  and 
behavioural. However, the organic dimension is made up of items of psychopathology 
linked to cognitive functioning and change in daily living skills. Therefore, the discussion 
of the broader aspects of a multi-dimensional model of psychopathology will be limited 
to consideration of the depressive, behaviour-affective and anxiety dimensions.  
 
The  majority  of  items  of  psychopathology  in  the  depressive,  behaviour-affective  and 
anxiety dimensions are related to affects or behaviours. This suggests that there may be 
value  in  examining  an  affective-behaviour  model  of  psychopathology.  The  research 
literature recognises a close relationship between affects and behaviour. Although there is 
no single accepted conceptualisation of affects, the influence of affects on behaviour is 
central to the definition, and function of affects (Mauss et al. 2005). Therefore, the term 
affective  model  of  psychopathology  will  be  used  to  consider  a  global  model  of 
psychopathology based on the affective and behavioural items of psychopathology in the 
depressive, behaviour-affective and anxiety dimensions.   
 
As  stated  in  section  4.1,  items  of  psychopathology  on  the  PPS-LD  were  only  rated 
positively  if  there  was  a  clear  change  from  an  individual’s  baseline  functioning. 
Therefore, affective change, or stability, can be viewed as an overarching aspect of the 
three affective dimensions of psychopathology extracted from the PPS-LD data; in turn 
affective  stability  is  encapsulated  within  the  construct  of  affect  regulation  within  the 
research literature.   301 
 
The  study  of  affect  regulation  has  been  heavily  influenced  by  work  in  the  fields  of 
developmental psychology and psychopathology. It is clear from the literature is that the 
term affect regulation is used to refer to a complex and diverse range of processes which 
are central to affective and psychological functioning (Gross & Thompson 2007). Given 
this complexity, it is perhaps not surprising that there does not seem to a single accepted 
definition of what is meant by affect regulation (Cole et al. 2004). However, several key 
aspects of affect regulation are important to mention prior to a discussion of the multi-
dimensional model of psychopathology. 
 
Importantly  for  the  consideration  of  the  relevance  of  affect  regulation  across  the 
depressive, behaviour-affective and anxiety dimensions of psychopathology identified in 
this  thesis,  affect  regulation  does  not  seem  to be  specific  to  which  affects  are  being 
regulated.  Rather,  affect  regulation  refers  to  changes  or  processes  that  apply  equally 
across affects, and therefore, potentially, across the three distinct affective dimensions.  
 
Each  of  the  three  dimensions  includes  affective  and  behavioural  items  of 
psychopathology.  Within  the  construct  of  affect  regulation  it  is  recognised  that  two 
related phenomena can be identified, and described, as regulating and regulated (Cole et 
al. 2004). Therefore, emotion regulation can be applied to changes in specific affects, as 
in the case of sadness in the depressive dimensions (affect as regulated), and the effects 
of changes in affects on behaviour e.g. increased verbal and physical aggression related 
to changes in irritability/ anger (affect as regulated) . 
 
Finally, affect regulation involves both internal and external processes. For example, one 
model of affect regulation proposes five families of processes (Gross & Thompson 2007):  
·  situation selection e.g. avoidance of situations known to provoke negative affect 
·  situation modification e.g. moving to a quieter area of a busy centre to reduce fear 
·  attentional deployment e.g. concentrating on the non-aversive aspects of a situation 
·  cognitive change e.g. using learnt cognitive strategies to reappraise an intense affect   302 
·  response modulation e.g. using learnt strategies or drugs to alter affects or associated 
behaviours. 
 
The finding that affect regulation involves internal and external processes has specific 
relevance to an affect regulation model of psychopathology experienced by adults with 
intellectual disabilities. In section 1.3.1, the challenges inherent in the assessment and 
measurement of psychopathology in adults with intellectual disabilities were described. 
Similarly, only a minority of adults with intellectual disabilities will have the level of 
verbal communication and cognitive abilities necessary to the study of internal processes 
involved in affect regulation. This is particularly relevant to the cognitive change family 
in  the  model  above.  On  the  other  hand,  the  other  four  families  of  processes  include 
readily observable processes or behaviours, which could be either directly observed or 
reported by informants. Furthermore, the importance of situational and environmental 
elements  to  affect  regulation  suggests  that  appropriate  support  from  others,  or 
environmental modifications may impact on psychopathology. 
 
To summarise, the construct of affect regulation: 
·  appears to apply across dimensions of psychopathology 
·   incorporates affective and behavioural items of psychopathology  
·  can be studied using self and proxy report, or direct observation  
·  potentially offers opportunities to develop novel interventions. 
 
This suggests that affect regulation is an area of research that could offer insights into 
psychopathology experienced by adults with intellectual disabilities. Since the construct 
of affect regulation has emerged from the disciplines of developmental psychology and 
psychopathology (Cicchetti et al. 1995), it is surprising that relatively few studies have 
involved individuals with intellectual disabilities. For example, the ability to regulate 
affect  has  been  shown  to  impact  on  the  development  of  problem  behaviours  and 
difficulties with interpersonal relationships in typically developing children (Eisenberg et 
al. 2001; Spinrad et al. 2006) and children with developmental delay (Crnic et al. 2004). 
However, affect regulation does not seemed to have been examined in relationship to   303 
psychopathology experienced by adults with intellectual disabilities. Given the relevance 
of affect regulation to the findings in this thesis and the potential applicability of the 
construct across the boundaries of categorical diagnostic classification systems suggests 
that further research is merited. 
 
Affective  arousal  or  activation  is  another  construct  of  relevance  to  the  depressive, 
behaviour-affective  and  anxiety  dimensions  of  psychopathology.  Arousal  and  valence 
were proposed as the two key dimensions underlying the circumplex model of affect 
(Russell 1980) and subsequently incorporated into integrated models of affective states 
(Posner et al, 2005). Neurobiological research has begun to report evidence to support 
proposed  distinct  neural  circuitry  underlying  the  dimensions  of  affective  arousal  and 
valence (Gerber et al. 2008; Posner et al. 2009). 
 
There are items of psychopathology in each of the depressive, behaviour-affective and 
anxiety dimensions that can be interpreted as changes in affective arousal: 
·  depressive  dimension  (under-arousal)-  low  mood,  social  withdrawal,  anhedonia, 
lower energy levels and reduced appetite 
·  behaviour-affective  dimension  (over-arousal)-  increased  mood  lability,  increased 
irritability, increased verbal and physical aggression 
·  anxiety  dimension  (over-arousal)-  generalised  anxiety,  increased  verbal 
communication, increased energy, initial insomnia, increased appetite. 
 
Therefore,  affective  arousal  appears  to  be  a  construct  that  appears  to  be  relevant  to 
psychopathology commonly experienced by adults with intellectual disabilities. Despite 
models recognising the relevance of affective arousal to psychopathology (Bradley et al. 
2000), compared to affect regulation, overall, there is less evidence on the relationship 
between affective arousal and psychopathology. Part of the reason for this may be that 
arousal has been incorporated into the broader model of affect regulation (Fox & Calkins, 
2003: Schore 2005), or the focus of arousal research has been on psychophysiology and 
autonomic arousal (Brown, Chorpita & Barlow 1998). Regardless, the evidence available 
suggests that the construct of affective arousal should be considered for further study of   304 
psychopathology. For example, a putative model examining the relationships between 
attachment, affective arousal and problem behaviours experienced by individuals with 
intellectual disabilities has been proposed (Janssen et al. 2002). 
 
Alongside  arousal,  valence  was  the  second  dimension  of  affect  proposed  by  Russell 
(1980),  conceptualised  as  comprising  positive  and  negative  affect.  An  established 
tripartite  model  of  depression  and  anxiety  psychopathology  (Clark  &  Watson  1991) 
emerged from further study of the valence of affect. The description of three affective 
dimensions of psychopathology linked by in this thesis, and one other study in table 1.2 
(Kellett  et  al.  2004),  is  very  similar  to  this  tripartite  model.  Using  EFA,  and  other 
multivariate  statistical  methods  of  analysis,  this  tripartite  model  has  been  shown,  to 
explain the relationship between depressive, anxiety and other affective psychopathology 
(Clark & Watson 1991). However, the tripartite model has seldom been examined in 
relation to psychopathology experienced by adults with intellectual disabilities.  
  
This tripartite model emerged from a broader model that proposes that there are two 
independent  dimensions  of  affect,  termed  negative  affect  and  positive  affect.  The 
negative affect dimension consists of psychopathology reflecting unpleasant affective 
states, associated with distress- such as sadness, fear, and disgust (Watson & Tellegen 
1985; Clark & Watson 1991; Watson et al. 1995). The positive affect dimension includes 
states such as happiness, engagement and energy (Clark & Watson 1991; Watson et al. 
1995). Rather than being two opposite ends of a single dimension, studies have shown 
that  these  two  dimensions  are  relatively  independent  (Watson  et  al.  1988;  Clark  & 
Watson 1988). Initial studies of the two dimensional model of affect in individuals with 
mood  and  anxiety  disorders  suggested  that  a  characteristic  distribution  could  be 
identified with three dimensions of psychopathology, called the tripartite model. The 
three dimensions of psychopathology in the tripartite model are: 
·  a  depressive  dimension-  comprising  increased  scores  on  the  negative  affect 
dimension and low scores on the positive affect dimension 
·  an anxiety dimension- with high scores on the dimensions of negative affect and 
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·  a general distress dimension- that includes items of psychopathology common to 
various emotionally distressed states, including irritability, impaired concentration 
and restlessness (Watson et al. 1995). 
 
The tripartite model has been shown to be a valid model of affective psychopathology in 
children and adolescents (Joiner & Lonigan 2000; Chorpita & Daleiden 2002; Cannon & 
Weems 2006) and adults (Watson et al. 1995; Brown et al. 1998; Beck et al. 2003; Cook 
et al. 2004). In fact the level of evidence is such that some authors have called for the 
tripartite  model  to  be  incorporated  into  DSM-V  (Watson  2005).  However,  the 
intellectual disabilities studies on psychopathology are clearly not at this level.  
 
Although  the  study  by  Kellett  et  al.  (2004)  identified  three  dimensions  of  affective 
psychopathology the authors did not consider the results against the tripartite model of 
depression  and  anxiety  psychopathology.  One  study  used  EFA  to  examine  the 
dimensional structure of psychopathology assessed with the Beck Depression Inventory-
II (BDI-II) and Beck Anxiety Inventory (BAI; Lindsay & Skene 2007). The authors 
concluded that a two dimensional structure- representing depression and anxiety- best 
fitted the data. This result contrasts with EFA of data from the BDI-II and BAI in college 
students (Joiner 1996) which found that the data best fitted a tripartite model; perhaps 
suggesting that there is a difference in psychopathology identified by these assessment 
instruments when used with adults with intellectual disabilities. No other intellectual 
disabilities  studies  examining  the  tripartite  model  of  depression  and  anxiety 
psychopathology were identified. 
 
The results of the EFA using PPS-LD data appears to be a reasonable fit for the tripartite 
model  of  depression  and  anxiety  psychopathology.  Characteristic  affective  items  of 
psychopathology described in the tripartite model (Clark & Watson 1991), are included 
in  the  depressive  (low  mood,  anhedonia,  reduced  energy),  anxiety  (hyperarousal- 
increased energy, increased verbal communication, initial insomnia) and general distress 
(irritability, impaired concentration) dimensions. As in the tripartite model (Watson et al. 
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independent. Despite the possible relevance of the tripartite model of depression and 
anxiety psychopathology, this finding needs further study. Nonetheless, since problem 
behaviour psychopathology was included in the tripartite model described here, and in 
the three affective dimensions described by Kellett et al. (2004), perhaps the tripartite 
model can further our understanding on the relationship between problem behaviours 
and affective psychopathology. 
 
As  described  in  section  5.1.3,  research  that  has  used  categorical  models  of 
psychopathology has produced inconsistent evidence on whether there is an association 
between  depressive  psychopathology  and  problem  behaviours.  The  PPS-LD  multi-
dimensional model of psychopathology could be interpreted as suggesting that problem 
behaviours are associated with the general distress dimension of a tripartite model, rather 
than  a  depressive  dimension.  This  has  not  been  reported  previously  for  adults  with 
intellectual disabilities, and the relationship between the tripartite model and conduct 
problems in children and adolescents, or antisocial behaviours in adults, does not appear 
to  have  been  studied  previously.  Thus,  further  work  is  needed  to  examine  whether 
problem behaviours experienced by adults with intellectual disabilities are associated 
with the general distress dimension of a tripartite model.  
 
To achieve this, studies would collect data on a broad range of psychopathology, with a 
particular  focus  on  including  items  relevant  to  affective  and  problem  behaviour 
psychopathology. Although the PPS-LD includes items relevant to problem behaviours, 
these  are  limited  to  physical  and  verbal  aggression,  self-injurious  behaviour  and 
sexually-inappropriate  behaviours.  The  assessment  process  could  include  structured 
instruments in addition to the PPS-LD. For example, structured assessments relevant to 
DC-LD criteria for problem behaviours have been devised for use in epidemiological 
studies (Jones et al. 2008; Hove & Havik 2009). Regardless of which instruments are 
used  the  key  issue  is  to  include  the  items  of  psychopathology  relating  to  problem 
behaviours and other mental disorders in a single EFA.  
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The exclusion of items of psychopathology from the EFA will have impacted on the 
final  multi-dimensional  model  of  psychopathology  identified  from  the  PPS-LD. 
Essentially, the items of psychopathology included in the EFA are those which can be 
observed  and  reported  by  an  informant,  in  circumstances  where  self-report 
psychopathology is not available. Most often an individual with intellectual disabilities is 
unable to self-report because the cognitive and communication demands for an item, or 
assessment instrument, are out with that person’s level of abilities. Rather than excluding 
items of psychopathology from the EFA another strategy is to only include participants 
with mild intellectual disabilities (Kellet et al. 2004). Whilst, this potentially increases 
the number of items of psychopathology included in, and, therefore, extracted from the 
EFA, the final result cannot be considered generalisable across the range of abilities of 
adults with intellectual disabilities. Excluding items from the EFA, and including only a 
sub-sample of participants, both have advantages and disadvantages depending on the 
research  questions  being  examined.  Problem  behaviours  are  more  prevalent  in 
individuals with more severe intellectual disabilities (Jones et al. 2008). Therefore, if 
future  studies  are  going  to  examine  further  the  relationship  between  affective 
psychopathology and problem behaviours, it would be preferable to include individuals 
across the full range of abilities. Hence, it is likely that the strategy used in this thesis 
will be used- resulting in inclusion of only those items of psychopathology that can 
either be self-reported, or reported by an appropriate informant. 
 
From the original 90 PPS-LD items of psychopathology, 25 were not included based on 
a  base  rate  of  less  than  5%,  or  on  the  basis  that  the  required  cognitive  and  verbal 
communication abilities for an item was not achieved across the entire sample. Items of 
psychopathology can be reported infrequently for several different reasons. Certain items 
of  psychopathology  are  rarely  reported  within  any  clinical  population  or  research 
sample.  For  example,  items  of  psychotic  psychopathology,  such  as  made  affect  or 
delusional  perception  are  reported  at  frequencies  less  than  5%  in  many  studies 
(Andreasen  &  Flaum  1994;  Nordgaard  et  al.  2008).  The  rate  that  items  of 
psychopathology are reported also differs across cultures and ethnic minority groups 
(Ndetei  &  Vadher  1984;  Kulhara  &  Chakrabarti  2001).  Base  rates  of  items  of   308 
psychopathology will also be affected by the cognitive and communication abilities of 
individuals  with  intellectual  disabilities.  Items  that  are  dependent  on  individual  self-
report and verbal communication will inevitably be less likely to be identified in studies 
involving adults with intellectual disabilities as participants. This effect acts to increase 
the number of items of psychopathology with low base rates in adults with intellectual 
disabilities.  
 
In conclusion, the multi-dimensional model of psychopathology from the PPS-LD raises 
issues relevant to future research on psychopathology and the clinical management of 
mental disorders experienced by adults with intellectual disabilities. 
 
5.2 The multi-dimensional model of psychopathology and socio-clinical 
variables 
Relatively  few  studies  in  the  field  of  intellectual  disabilities  have  examined  the 
associations  of  socio-clinical  variables  with  psychopathology.  Therefore,  there  is  a 
limited understanding of potential risk factors for psychopathology and mental disorders- 
compared to the evidence on risk for children, adolescents and adults who do not have 
intellectual disabilities. Although longitudinal, prospective studies are the gold standard 
research  methodology  to  identify  risk  factors,  more  often  putative  risk  factors  are 
identified from cross-sectional studies. 
 
In this study, several socio-clinical variables were found to be independently associated 
with  the  multi-dimensional  model  of  psychopathology.  Since  no  previous  studies 
examining the associations of socio-clinical variables with empirically derived multi-
dimensional models of psychopathology were identified in section 1.7, the results will be 
compared  with  population  studies  based  on  categorical  models  of  psychopathology 
(table 1.4).  
 
Prior to comparing these results to previous studies there is an issue relevant to one study 
in table 1.4 to clarify. It is difficult to compare the results of this study with the study of 
Taylor et al. (2004). Female gender and younger age was found to be associated with   309 
above threshold scores on the affective/ neurotic subscale on the PAS-ADD checklist 
(Taylor et al. 2004). However, the affective/ neurotic sub-scale lacks specificity, as it 
includes  items  of  psychopathology  that  are  relevant  to  the  depressive,  behaviour-
affective and anxiety dimensions. Therefore, rather than comparing the results of all 
three dimensions to this study it is excluded from the discussion. 
 
The socio-clinical variables were included in the analyses in this thesis because they 
were  associated  with  psychopathology  in  the  previous  population-based  studies 
identified. Several of these variables were not independently associated with any of the 
dimensional, or overall, measures of psychopathology- including gender, a diagnosis of 
autism, sensory impairments and urinary incontinence. Despite the negative finding, a 
discussion of gender is included below. The reason for this is gender was consistently 
shown to be associated with psychopathology across studies summarised in table 1.4, 
and additional evidence from other fields of research highlight the potential value of 
gender research in psychopathology. 
 
To explore whether the dimensional model can be used to derive overall measures of 
psychopathology, three overall measures were included in the analyses. All three overall 
measures were only independently associated with level of intellectual disabilities in the 
multivariate  analyses  examining  measures  of  psychopathology  and  socio-clinical 
variables.  In  contrast,  the  dimensional  measures  of  psychopathology  were  associated 
with  a  greater  number,  and  varying,  socio-clinical  variables  (table  4.103).  Similar 
findings were found in the multivariate analyses that used the measures of severity and 
longitudinal outcome as the dependent variables. Therefore, it is concluded that there is 
little  value  in  creating  overall  measures  of  psychopathology  by  adding  together  the 
individual  factor  scores,  or  dimension  counts,  from  the  dimensional  model  of 
psychopathology. The use of the individual dimensions provides results more likely to 
inform an understanding of the relationships between psychopathology, socio-clinical 
variables and  measures of severity and outcome. 
   310 
In  the  studies  summarised  in  table  1.4,  the  evidence  for  the  associations  of  autism, 
sensory impairments and urinary incontinence with psychopathology is less convincing. 
Therefore, these variables are discussed in section 5.2.5 on categorical socio-clinical 
variables. 
 
5.2.1 Gender and psychopathology 
Gender was not associated with any of the four dimensions of psychopathology, the 
overall  multi-dimensional  model  of  psychopathology  or  the  overall  measure  of 
psychopathology  that  was  independent  of  the  dimensional  model  (EFA  PPS-LD 
symptom  count-  41).  This  contrasts  with  the  findings  from  studies  using  categorical 
diagnostic classification systems in table 1.4. Women were more likely to be diagnosed 
with  any  mental  disorder  (Cooper  et  al.  2007a;  Hassiotis  et  al.  2008),  depressive 
disorders (Cooper et al. 2007c) and problem behaviours (Jones et al. 2008). 
 
One possible explanation for the contrasting finding with these studies is the different 
samples used. The studies in table 1.4 used populations based samples. However, the 
sample used to examine the associations between the PPS-LD multi-dimensional model 
of  psychopathology  and  socio-clinical  variables  was  a  clinical  sample,  comprising 
referrals to the Glasgow UCEDD over a defined time period. Therefore, participants 
included in the sample used in this study will have complained of, or been recognised by 
informants or professionals to be experiencing, problems suggestive of mental disorders. 
It would be expected that the UCEDD sample would be biased towards the inclusion of 
individuals with more severe psychopathology, in comparison to a population- based 
sample. Since this effect is likely to be similar for both genders in the sample it could act 
to mask any actual differences in the distribution of psychopathology against gender.  
 
An  alternative  explanation  is  that  there  is  a  gender  bias  that  impacts  on  categorical 
diagnostic  classification  systems  differentially  from  multi-dimensional  models  of 
psychopathology  (Hartung  &  Widiger  1998).  Ideally,  diagnostic  criteria  should  be 
gender neutral but this is difficult to achieve for disorders which present differently in 
females and males. Of relevance here is the suggestion that depressive disorders present   311 
differently, with existing diagnostic criteria more closely describing psychopathology 
experienced by females (Kockler & Heun 2002). For example, studies show that women 
are more likely to report somatic depressive psychopathology such as appetite or sleep 
disturbance  (Silverstein  1999).  Any  such  gender  bias  has  been  shown  to  have  been 
introduced  into  assessment  instruments  derived  from  diagnostic  criteria  (Cole  et  al. 
2000). Although this effect is unlikely to explain the differences in the findings between 
this  study  and  the  population  based  studies  in  table  1.4,  it  highlights  the  potential 
relevance of gender to psychopathology research. 
 
Research  on  the  effects  of  gender  bias  upon  the  identification  and  management  of 
psychopathology  has  largely  involved  participants  who  do  not  have  intellectual 
disabilities.  Studies  have  focussed  on  conduct  problems  (Hartung  et  al.  2006)  and 
psychopathology  relevant  to  attention,  concentration  and  overactivity  in  children 
(Waschbusch  &  King  2006),  and  affective  psychopathology  (Piccinelli  &  Wilkinson 
2000) in adults. Several different influences have been identified including measurement 
bias i.e. assessment instruments include items that are more commonly reported by either 
men or women (Stommel et al. 1993); observer bias, i.e. informants or clinicians being 
more likely to report or rate positively psychopathology in males (Ohan & Visser 2009) 
and  sampling  bias,  particularly  within  clinical  samples  (Hartung  &  Widiger  1998). 
Although very little research has examined the potential influence of gender bias on 
psychopathology experienced by individuals with intellectual disabilities, all of these 
influences of gender bias are potentially relevant. Of particular interest would be the 
influence of gender bias on informant reporting of psychopathology. For example, within 
the developing literature on staff attributions and problem behaviours no studies have 
examined  whether  staff  make  different  attributions  depending  on  gender  (Willner  & 
Smith 2008).  
 
It  has  been  proposed  that  examining  the  relationship  between  gender  and 
psychopathology can potentially contribute to an understanding of the pathophysiology 
of mental disorders (Rutter et al. 2003). Therefore, research on gender in relation to the   312 
prevalence, presentation and assessment of psychopathology should be considered as a 
relevant area of study in the field of intellectual disabilities. 
 
5.2.2 Age and psychopathology 
In this study, younger age was associated with higher scores on the behaviour-affective 
and  anxiety  dimensions,  and  older  age  was  associated  with  higher  scores  on  the 
depressive dimension.  
 
One of the population-based studies in table 1.4 reported an association between younger 
age and problem behaviours (Hove & Havik 2010) but the other study that examined it 
found there was no independent relationship between age and problem behaviours (Jones 
et al. 2008). Although both these studies are based on the DC-LD criteria for problem 
behaviours, the study methodologies differed in how psychopathology was rated. The 
study  by  Jones  et  al.  (2008)  gathered  data  on  problem  behaviours  using  checklists 
derived for the DC-LD criteria and used the  DC-LD categorical criteria to diagnose 
problem behaviours as being present. Hove & Havik (2010) also used checklists based 
on DC-LD criteria to gather the data on problem behaviours. However, the analysis was 
carried out using a derived overall problem behaviour score, rather than a categorical 
diagnosis of a problem behaviour. Therefore, the continuous measure of Hove & Havik 
(2010) is closer to the dimensional model of psychopathology used in this thesis. This 
may explain the similar results from these two studies, which contrast to the study using 
the categorical model of psychopathology (Jones et al. 2008). 
 
The use of dimensional and categorical models of psychopathology may also explain the 
different results on the relationship between age and the depressive dimension, and a 
categorical diagnosis of depressive disorder (Cooper et al. 2007c). However, the study 
using the scores from the DC-LD checklists as a continuous measure also did not find a 
significant association between age and the score from the DC-LD depression checklist 
(Hove & Havik 2010).  
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Population  based  samples  in  the  studies  using  categorical  diagnostic  classification 
systems (Cooper et al. 2007c; Jones et al. 2008) have important advantages over the 
study described here. In particular, population-based samples are more representative 
and less likely to influence the findings through sampling bias. This could explain the 
different results examining the associations of psychopathology with age. For example, 
health professionals may be less likely to refer older people with problem behaviours for 
assessment, assuming that the psychopathology is long-standing, or an integral feature of 
ageing,  and  unlikely  to  respond  to  available  management  options.  Despite  this 
possibility, the agreement in the findings for problem behaviours with Hove and Havik 
(2010)  raises  the  possibility  that  there  are  advantages  to  the  use  of  dimensional,  or 
continuous, models of psychopathology in research. 
 
However,  looking  beyond  the  limited  intellectual  disabilities  research,  there  is  no 
consistent pattern in the relationship between age and depressive psychopathology (Jorm 
2000;  Stordal  et  al.  2003).  Therefore,  the  different  results  could  be  attributable  to 
challenges  inherent  to  research  examining  the  relationship  between  age  and 
psychopathology. Certainly, data from longitudinal studies would help to clarify any 
changes in the risk of depressive psychopathology with age (Jorm 2000) and would also 
contribute to an understanding of developmental models of psychopathology (Rutter & 
Sroufe 2000; Hudziak et al. 2007) relevant to intellectual disabilities. For example, age 
has been proposed as a key factor to study in relation to developing valid models of the 
development of anti-social problem behaviours (Lahey et al. 1999). 
 
5.2.3 Level of intellectual disabilities and psychopathology 
A  significant,  independent  association  was  found  between  level  of  intellectual 
disabilities  and  the  organic,  behavioural-affective  and  anxiety  dimensions  of 
psychopathology. Level of intellectual disabilities was also associated with all three of 
the overall measures of psychopathology. In all models the relationship was a direct 
relationship such that as the severity of intellectual disabilities increased the scores on 
the  organic,  behavioural-affective  and  anxiety  dimensions,  and  the  overall  measures,   314 
increased.  However,  none  of  the  relationships  were  consistent  across  the  range  of 
abilities, suggesting that the relationships are non-linear. 
 
Only  for  the  behaviour-affective  dimension  factor  scores  were  the  three  dummy 
variables  representing  the  full  range  of  intellectual  disabilities  retained  in  the  final 
regression model. This suggests that this is the dimension which has the most coherent 
relationship with intellectual disabilities. If there was a linear relationship we would 
expect the value of β to gradually increase, or decrease, across the mild-moderate, mild-
severe and mild-profound dummy variables. However, the standardised coefficients (β) 
in table 4.25 show that, even controlling for potential confounding effects of the other 
socio-clinical variables, the relationship is not linear. The effect is even greater for the 
behaviour-affective symptom count where the mild-severe variable drops out of the final 
model. It is difficult to be certain of the reasons for this non-linear relationship between 
level of intellectual disabilities and the dimensions of psychopathology from the PPS-
LD. Of the models that retain level of intellectual disabilities, the mild-moderate variable 
is  retained  as  the  only  dummy  variable  for  the  anxiety  dimension  factor  scores  and 
symptom counts, and for all three overall measures of psychopathology. However, it is 
the mild-severe dummy variable that is retained as significant in the regression model for 
the organic dimension factor score. Therefore, there does not appear to be a consistent 
pattern  of  association  between  level  of  intellectual  disabilities  and  psychopathology 
across the dimensions of psychopathology. 
 
The  linearity  of  the  relationship  between  level  of  intellectual  disabilities  and 
psychopathology was examined in the study by Hove & Havik (2010). Similar to the 
findings reported here, a non-linear relationship between level of intellectual disabilities 
and the measures of organic, problem behaviour, anxiety, depressive and obsessional 
psychopathology  was  reported.  However,  a  linear  relationship  was  reported  for 
psychosis psychopathology, with a linear decrease in psychopathology as the severity of 
intellectual disabilities increased (Hove & Havik 2010).  
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At  a  general  level,  these  findings  highlight  the  complexity  of  understanding  the 
influences on psychopathology experienced by individuals with intellectual disabilities. 
Although multivariate statistics were used to control for the effects of relevant variables 
(Hove & Havik 2010), it could be that there are confounding effects from other variables 
that could explain the non-linear relationships. For example, bias from the methods used 
to assess psychopathology could have differential effects across the range of intellectual 
disabilities.  An  example  of  such  a  bias  is  similar  to  that  described  for  diagnostic 
overshadowing.  The  study  by  Hove  and  Havik  (2010)  used  informant  ratings  of 
psychopathology  across  the  entire  sample.  Perhaps  participating  in  an  assessment 
relevant to mental disorders, informants attribute  changes in mood, or  behaviour for 
individuals with profound intellectual disabilities to a person’s intellectual disabilities, 
rather than reporting the changes as indicative of psychopathology. Alternatively, the 
items of psychopathology included in assessment instruments may not be appropriate for 
use across the full range of intellectual disabilities. 
 
Similar to this study, a direct relationship between severity of intellectual disabilities and 
problem behaviour (Jones et al. 2008; Hove & Havik 2010) and overall psychopathology 
(Cooper & Bailey 2001; Cooper et al. 2007a; Bailey 2007; Hove & Havik 2010) was 
reported  in  more  than  one  population-based  study.  It  is  of  note  that  this  finding  is 
consistent  across  studies  using  dimensional,  continuous  (Hove  &  Havik  2010)  and 
categorical  models  of  psychopathology  (Jones  et  al.  2008;  Cooper  &  Bailey  2001; 
Cooper et al. 2007a; Bailey 2007. Problem behaviour is included in the overall measure 
of psychopathology in several (Cooper et al. 2007a; Bailey 2007; Hove & Havik 2010), 
but not all studies (Cooper & Bailey 2001). This and the direct relationship between 
severity of intellectual disabilities and anxiety reported here and one other study (Hove 
& Havik 2010) suggest the association is not entirely due to psychopathology related to 
problem behaviours. 
 
No association between level of intellectual disabilities and depressive psychopathology 
was found in this thesis, or the other two studies summarised in table 1.4 that examined 
this (Cooper et al. 2007c; Hove & Havik 2010). Within the context of the tripartite   316 
model of affective psychopathology suggested by the results of the EFA, it is interesting 
to  discuss  the  possible  relevance  of  the  different  relationships  between  severity  of 
intellectual disabilities and depressive, behaviour-affective and anxiety psychopathology.  
 
Level  of  intellectual  disabilities  and  age  are  both  considered  of  relevance  to 
developmental models of psychopathology used in intellectual disabilities (Dosen 2007)- 
younger age and more severe intellectual disabilities considered as lower developmental 
levels of functioning.   In this study, higher levels on the behaviour-affective and anxiety 
dimension  were  associated  with  younger  age  and  increasing  severity  of  intellectual 
disabilities. Therefore, there is a strong suggestion that behaviour-affective and anxiety 
psychopathology  are  associated  with  a  lower  developmental  level  of  functioning. 
Although higher levels on the depressive dimension correlated with older age, there was 
no association with severity of intellectual disabilities. The findings on the association 
between  depressive  psychopathology  and  older  age  are  inconsistent  in  section  5.2.2. 
Taken with the more consistent lack of association between depressive psychopathology 
and  level  of  intellectual  disabilities  (Cooper  et  al.  2007c;  Hove  &  Havik  2010),  a 
tentative  conclusion  is  that  depressive  psychopathology  is  not  associated  with 
developmental level of functioning. 
 
Independent depressive, behaviour-affective and anxiety dimensions, in keeping with the 
tripartite model of depression and anxiety psychopathology, were described in this thesis 
and one other multi-dimensional model of psychopathology in table 1.4 (Kellet et al. 
2004).  Given  that  these  dimensions  are  distinct  and  have  different  associations  with 
variables  relevant  to  development,  further  study  of  developmental  aspects  of  the 
tripartite  model  should  be  considered.  For  example,  of  relevance  to  understanding 
pathophysiology studies have described phenotypic and genetic associations with the 
tripartite model in middle childhood (Hallett et al. 2009).  
 
5.2.4 Down syndrome and psychopathology 
Individuals  with  Down  syndrome  were  found  to  have  higher  scores  on  the  organic 
dimension, and lower scores on the behaviour-affective dimension of psychopathology.   317 
These results are in agreement with one study, summarised in table 1.4, using categorical 
model of psychopathology for DC-LD problem behaviours (Jones et al. 2008), and the 
study using the continuous measures of organic psychopathology derived from the DC-
LD (Hove & Havik 2010). 
 
Down syndrome is known to be associated with a higher risk of dementia. Considerable 
research has been done to examine the nature of the association in the hope that it will 
further our understanding of dementia and Alzheimer’s disease more broadly. In contrast 
to the increased risk of dementia- and other disorders, including congenital heart disease, 
autoimmune  disorders  and  haematological  malignancies-  individuals  with  Down 
syndrome are thought to be protected against other disorders, including solid tumours 
(Hasle et al. 2000) and hypertension (McIntyre et al. 1999). It is relevant to examine the 
reasons  these  disorders  are  less  frequently  experienced  by  individuals  with  Down 
syndrome. Problem behaviours are known to have a significant negative impact on the 
quality of life of individuals with intellectual disabilities, some of whom have Down 
syndrome (Beadle-Brown et al. 2009), their families and carers (Jenkins et al. 1997; 
Hastings 2002). Therefore, research on problem behaviours should be seen as a priority 
and could  examine further the  findings that individuals with Down syndrome are  at 
lower  risk  of  psychopathology  related  to  problem  behaviours.  It  is  possible  that 
identifying  protective  factors  could  inform  prevention  and  intervention  strategies  for 
individuals  with  Down  syndrome,  and  other  persons.  Understanding  the  factors 
protecting  individuals  with  Down  syndrome  against  the  development  of  problem 
behaviours could also have relevance for broader models of aggression (Loeber & Hay 
1997; Eley et al. 2003). 
 
5.2.5 Other categorical socio-clinical variables and psychopathology 
Participants with epilepsy, mobility problems and bowel incontinence  were  found to 
have  lower  scores  on  the  anxiety  dimension  of  psychopathology.  This  seems 
counterintuitive, as it might be expected that individuals with additional health needs 
would be at greater risk of anxiety, or other forms of psychopathology (Deb et al. 2001). 
However, other population based studies in table 1.4 also found that individuals with   318 
similar  health  problems,  to  those  included  in  the  analyses  have  lower  levels  of 
psychopathology. 
 
Individuals with mobility problems were less likely to be diagnosed with any mental 
disorder (Cooper et al. 2007a), persons with epilepsy were at lower risk of psychosis 
(Cooper  et  al.  2007b)  and  anxiety  (Hove  &  Havik  2010),  and  having  a  hearing 
impairment was  associated with a lower risk of an affective disorder (Cooper  et  al. 
2007c). However, it is noted that the more expected direction of association was also 
reported- visual impairment was directly associated with psychosis (Cooper et al; 2007b) 
and problem behaviours (Jones et al. 2008); urinary incontinence was associated with 
being  diagnosed  with  any  mental  ill-health  (Cooper  et  al.  2007a)  and  problem 
behaviours (Jones et al. 2008). 
 
Even in the context of similar findings from other studies, it is not easy to explain why 
individuals with epilepsy, mobility problems and incontinence would have lower levels 
of anxiety psychopathology. One possibility is that the management of a specific health 
problem has an impact on psychopathology. For example anti-epileptic drugs are known 
to have a positive effect on affective psychopathology (Muzina et al. 2005) and have 
been suggested to have a role in the management of anxiety (Mula et al. 2007). It could 
also be that individuals with additional health needs are supported by family or paid 
carers  in  a  way  that  reduces  the  risk  of  experiencing  anxiety.  Although  entirely 
speculative, if carers tend to support individuals with complex health problems in their 
own  home  this  would  reduce  an  individual’s  risk  of  exposure  to  anxiety  provoking 
triggers.  
 
These  additional  health  needs  occur  with  increased  frequency  in  persons  with  more 
severe intellectual disabilities. Therefore, informant report is more likely to form the 
basis of any assessment of psychopathology in individuals with these needs. Perhaps the 
reduced  levels  of  anxiety  are  an  artifact  related  to  informant  reporting  of 
psychopathology in individuals with more severe intellectual disabilities. This is unlikely 
as we would expect reduced anxiety to be reported universally across all the health needs   319 
included in the analyses. Nonetheless, this does raise the issue of the reliability of the 
assessment of psychopathology, using self-report and informant/ proxy report across the 
full range of intellectual disabilities (Bramston & Fogarty 2000; Ross & Oliver 2003).  
 
Compared to most other socio-clinical variables, there have been more studies published 
specifically  examining  the  relationship  between  epilepsy  and  psychopathology. 
However,  no  studies  using  an  empirically  defined  dimensional  model  of 
psychopathology  were  identified.  Most  studies  used  a  categorical  model  to  compare 
psychopathology  in  individuals  with  epilepsy  against  individuals  who  do  not  have 
epilepsy. Although one study reported an increased risk in individuals who do not have 
epilepsy  (Deb  &  Hunter  1991),  studies  have  tended  to  report  no  between  group 
differences in the risk of psychopathology (Espie et al. 1989; Gillies et al. 1989; Deb & 
Hunter 1991; Matson et al. 1999; Chung & Cassidy 2001). However, analyses including 
more detailed seizure- related data suggest that greater seizure intensity and frequency 
(Gillies,  Espie  &  Montgomery,  1989;  Espie  et  al.  2003)  and  treatment-resistance  of 
seizures  (Espie,  Pashley  et  al.  1987)  are  associated  with  an  increased  risk  of 
psychopathology.  A  meta-analysis  of  psychopathology  in  children  with  epilepsy 
highlights the potential value of using a dimensional model of psychopathology in future 
studies  (Rodenburg  et  al.  2005).  Children  with  epilepsy  had  higher  scores  on 
internalising  and externalising dimensions of psychopathology, than  controls (studies 
involving  participants  with  severe  intellectual  disabilities  were  excluded  from  the 
analysis).  
 
Autism was not associated with psychopathology in this study. This disagrees with the 
finding  of  increased  levels  of  anxiety  psychopathology  reported  by  Hove  &  Havik 
(2010). However, another population based study found no difference in the prevalence 
and incidence of mental disorders, or problem behaviours, between adults with autism 
and intellectual disabilities and controls with intellectual disabilities, matched for gender, 
age, level of intellectual disabilities and Down syndrome (Melville et al. 2008). These 
conflicting results suggest further research in this area is required. 
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5.2.6 Key issues on risk factors for mental disorders in intellectual disabilities 
This  exploratory  study  of  the  relationships  between  a  dimensional  model  of 
psychopathology identified several findings of interest: 
1.  multi-dimensional models of psychopathology offer a useful adjunct to the use of 
categorical diagnostic classification systems in studying risk factors 
2.  studying  the  complex  relationships  between  psychopathology  and  socio-clinical 
variables  can  potentially  elucidate  the  causes  and  pathophysiology  of  mental 
disorders.  
3.  examining  the  associations  between  psychopathology  and  gender,  age,  level  of 
intellectual disabilities and behavioural phenotypes are of particular relevance. 
4.  psychopathology research in intellectual disabilities should aim to have a  broader 
relevance to the understanding of the pathophysiology of mental disorders. 
 
5.3 Psychopathology, socio-clinical variables and the severity of mental 
disorders 
Section  4.7  examined  the  independent  relationships  between  the  multi-dimensional 
model  of  psychopathology,  socio-clinical  variables  and  measures  of  the  severity  of 
mental disorders. This offers an insight into the contribution that psychopathology makes 
to impairment and need associated with mental disorders. Socio-clinical variables were 
included  in  the  analyses  as  potential  confounders  but  also  to  identify  if  any  are 
independently associated with the severity of mental disorders. 
 
The depressive, organic and behaviour-affective dimensions of psychopathology were 
independently  associated,  in  varying  combinations,  with  all  of  the  measures  of  the 
severity of mental disorders. However, the anxiety dimension was not correlated with 
any  measure  of  severity.  Since  the  association  of  socio-clinical  variables  with  the 
measures of severity of disorder did not show any particular pattern, these are discussed 
individually below. 
 
It is important to discuss the relevance of the CANDID-R met needs as a measure of 
severity of mental disorders. Met needs is reported as standard in studies using the CAN   321 
or CANDID. The original CAN is most often used in epidemiological studies or needs 
assessment in relation to a specific clinical service, or population. Met needs are relevant 
to these types of study, as they give an indication of what level of needs a service should 
be resourced to address. Thus, they can be helpful to strategic planning and delivery of 
clinical services. However, the total number of met needs is less useful as a measure of 
severity of disorder. A higher score is a reflection of the degree to which services are 
meeting an individual’s needs, whilst a lower score reflects that an individual has fewer 
needs that services are currently meeting. Since neither of these circumstances provide 
any relevant issue relevant to severity, the CANDID-R met needs will not be discussed 
here.  
 
The individual measures of severity were found to have different associations with the 
psychopathology and socio-clinical measures. This finding suggests that the measures of 
severity assess distinct aspects of the severity of mental disorders. Thus, they can be 
considered to be complementary and useful to include within a battery of measures of 
severity.  Not unexpectedly, the results for the two overall measures of severity, the GAF 
and CGI were similar. These were both included because of the limited evidence on their 
use, and concerns that the GAF may not be reliable in intellectual disabilities (Hurley 
2001; Shedlack et al. 2005; Hurley et al. 2007). However, the results for the HoNOS-
LD, the two global measures and the CANDID-R unmet need are quite distinct. These 
are examined in detail below, after first considering some relevant findings for the multi-
dimensional model of psychopathology. 
 
5.3.1  The  multi-dimensional  model  of  psychopathology  and  severity  of  mental 
disorders 
Greater levels of psychopathology on the depressive dimension were associated with 
increased severity measured with the HoNOS-LD, GAF and CGI. The GAF and CGI are 
global measures, with an explicit focus on psychopathology. Therefore, the association 
with  HoNOS-LD  could  be  considered  of  greater  significance  as  it  suggests  that 
depressive psychopathology has an impact on broader aspects of the severity of mental 
disorders, such as physical health, interpersonal functioning, self-care, and occupation   322 
and  activities.  Two  previous  studies  (table  1.5)  examined  the  relationship  between 
depressive psychopathology  and the severity  of mental disorders (Lunsky  & Benson 
2001; Endermann & Zimmermann 2009). However, only the study including participants 
with  mild  intellectual  disabilities  (Lunsky  &  Benson  2001)  found  a  significant 
association between higher depressive psychopathology and greater severity, measured 
as a lower quality of life. These results suggest that effective management of depressive 
psychopathology could have a significant positive impact on the lives of individuals with 
intellectual disabilities.  
 
Examining  the  CANDID-R  and  HoNOS-LD  in  table  3.6  it  is  seen  that  there  is 
considerable  overlap  in  the  items  included  in  the  two  measures.  Therefore,  since 
depressive psychopathology was associated with severity measured on the HoNOS-LD, 
an association with unmet needs on the CANDID-R might have been expected. Although 
the scoring system across the CANDID-R and HoNOS-LD are different, if this explained 
why  depressive  psychopathology  was  not  significantly  related  to  unmet  need,  the 
association with organic and behaviour-affective psychopathology to both measures of 
severity  would  not  have  been  found.  Therefore,  it  is  not  clear  why  depressive 
psychopathology was associated with all the measures of severity apart from the level of 
unmet need on the CANDID-R. 
 
The organic and behaviour-affective dimensions of psychopathology, within the multi-
dimensional  model,  were  significantly  associated  with  all  four  measures  of  disease 
severity. None of the studies summarised in table 1.5 examined the relationship between 
organic  psychopathology  and  disease  severity.  Therefore,  the  impact  on  severity 
highlights  the  importance  of  including  items  relevant  to  organic  psychopathology  in 
research studies - which was also only done in a minority of the previous studies of 
multi-dimensional  models  of  psychopathology  in  the  table  1.2.  Combined  with  the 
increased prevalence of dementia in adults with intellectual disabilities (Strydom et al. 
2007), the strong relationship with severity of mental disorders, suggests that organic 
psychopathology should be a priority for research and clinical services (Janicki & Dalton 
2000).    323 
 
An association of the behaviour-affective dimension with severity of mental disorder 
offers some validation of the novel dimension, hypothesized to fit within a tripartite 
model of depression and anxiety psychopathology (Clark & Watson 1991).  Since this 
dimension  is  correlated  with  all  measures  of  severity,  it  appears  to  be  of  potential 
significance to the lives of adults with intellectual disabilities. Some support for this is 
provided by the previous study that reported an association of problem behaviours with 
severity of mental disorders (Beadle-Brown et al. 2009).  
 
Given the link to severity, one area of relevance to consider is how comorbid affective 
and problem behaviour psychopathology could be effectively managed. There is some 
evidence  on  the  separate  assessment  and  management  of  affective  psychopathology 
(Masi et al. 1997; McCabe et al. 2006) and problem behaviours (Tyrer et al. 2009; 
Harvey et al. 2009) experienced by individuals with intellectual disabilities. However, 
research  on  the  co-morbidity  of  the  two  forms  of  psychopathology  is  more  limited- 
largely focused on examining problem behaviours as equivalent criteria for the diagnosis 
of depressive disorders (Lowry & Sovner 1992; Charlot et al. 1993; Marston et al. 1997; 
Moss et al. 2000; Holden & Gitlesen 2003; Tsiouris et al. 2003; Cain et al. 2003; Rojahn 
et al. 2004; Kishore et al. 2005; Tyrer et al. 2006; Hurley 2008). Interestingly, research 
is beginning to consider the effectiveness of interventions based on the tripartite model 
(Barlow et al. 2004; Diefenbach & Goethe 2006). If the model is confirmed as valid in 
future studies it may offer novel treatment strategies for problem behaviours.  
 
One previous study reported a correlation between neuroticism (as a proxy measure of 
anxiety) and severity of mental disorders (Endermann & Zimmermann 2009). However, 
the  anxiety  dimension  of  psychopathology  was  not  significantly  correlated  with  any 
measure of severity in this thesis. Given that the  other dimensions are  correlated to 
severity, it is not clear why the findings for the anxiety dimension are quite different. 
One possibility is that the measures of severity are not sensitive to the impact of anxiety 
psychopathology. However, the GAF and CGI are designed to be used across any form 
of mental disorder and the items included in the HoNOS-LD and CANDID-R, shown in   324 
table 3.4, would appear to be relevant. That said, only 8% of participants in the HoNOS-
LD pilot study had an ICD-10 neurotic disorder and there were no participants with 
neurotic/ anxiety disorders in the CANDID-R pilot study. Therefore, the psychometric 
properties of these measures when used by individuals with anxiety psychopathology 
would benefit from clarification. 
 
5.3.2 Socio-clinical variables associated with the severity of mental disorders 
The only socio-clinical variable independently associated across more than one measure 
of the severity of mental disorders was the level of intellectual disabilities. This finding 
is  consistent  with  the  previously  described  direct  relationship  between  severity  of 
intellectual disabilities and severity of mental disorder, rated as lower quality of life 
(Beadle-Brown  et  al.  2009).  Compared  to  the  mild  intellectual  disabilities  reference 
category - moderate, severe and profound intellectual disabilities were associated with 
higher levels of unmet needs on the CANDID-R, and profound intellectual disabilities 
was associated with greater severity on the HoNOS-LD. Since the findings reported here 
are independent of the impact of psychopathology, and other variables, it suggests that 
either: 
·  the impact of psychopathology increases as the severity of intellectual disabilities 
increases 
·  interventions  and  services  provided  to  individuals  with  mental  disorders  are  less 
effective with increasing severity of intellectual disabilities. 
 
One explanation that could account for both of these effects is the challenge inherent in 
identifying  psychopathology  as  the  level  of  intellectual  disabilities  of  individuals’ 
increases. Verbal communication and methods of self-report are central to the reliable 
identification  and  assessment  of  psychopathology.  As  the  severity  of  intellectual 
disabilities increases, the level of functioning in the verbal communication domain is 
reduced.  As  a  consequence,  the  assessment  of  psychopathology  is  increasingly 
dependent on informant report and observation. However, informants have been found to 
be less likely to identify psychopathology, and recognise the need for treatment, in adults 
with more severe intellectual disabilities (Edelstein & Glenwick 2001). Furthermore, it   325 
has been found that there is poor agreement in the items of psychopathology reported by 
individuals with intellectual disabilities and informants (Moss et al. 1996). Therefore, 
this dependence on informant report has been recognised as a potential barrier to the 
recognition of psychopathology (Ruddick 2005) and other health problems (NHS Health 
Scotland 2004). These issues surrounding informant report could therefore lead to the 
delayed identification and assessment of psychopathology in persons with more severe 
intellectual disabilities.  
 
Intellectual  disabilities  research  on  the  impact  of  the  delayed  presentation  of 
psychopathology is limited. However, such delayed presentation has been shown to be 
associated with increased severity of mental disorders in children (Keller et al. 1992) and 
adults who do not have intellectual disabilities (Coryell et al. 1995; Scully et al. 1997). 
Potential solutions to improve informant recognition and report of psychopathology are 
proactive  screening  for  psychopathology  (Cooper  et  al.  2006;  Baxter  et  al.  2006), 
training programs for carers (Costello et al. 2006; Woodwards & Halls 2009) and the use 
of reliable and valid informant-report measures of psychopathology (Cuthill et al. 2003).  
 
Despite this possible effect associated with informant report of psychopathology, the 
positive impact of support from carers is supported by the lower level of unmet needs, 
and higher met needs, for individuals living with family or paid carers- compared to 
individuals living independent of support. This was not examined in previous studies 
(Lunsky & Benson 2001; Beadle-Brown et al. 2009; Endermann & Zimmermann 2009). 
However, the key role that carers have in supporting the health and social needs of adults 
with intellectual disabilities is widely recognised (McGrother et al. 1996; McConkey et 
al. 2006). 
 
Younger age was found to be independently associated with severity of mental disorders, 
indicated by higher levels of unmet needs. Once again, none of the previous studies 
examining correlates with severity included age in the analysis (Lunsky & Benson 2001; 
Beadle-Brown et al. 2009; Endermann & Zimmermann 2009). Although younger age 
was found to be associated with higher levels of psychopathology in the behaviour-  326 
affective  and  anxiety  dimensions,  the  association  of  younger  age  with  severity  is 
independent of the effects of psychopathology. It is not certain why this might be but one 
possibility could be that younger individuals are more likely to be presenting to services 
for the first time, or are at an earlier stage of contact with services. Therefore, unmet 
needs which have been addressed through previous, or longer, contact with services in 
older people have not yet been addressed for younger people.  
 
Generally, researchers have highlighted the health needs of older people with intellectual 
disabilities (Janicki et al. 1999; Evenhuis et al. 2000; Janicki et al. 2002). Perhaps the 
finding reported here serves as a reminder that mental disorders starting in childhood and 
adolescence  can  continue  to  have  an  impact  into  adulthood  in  individuals  with 
intellectual disabilities (Maughan et al. 1999; Beadle-Brown et al. 2008). Furthermore, 
the transition period into adulthood is recognised as a period of increased risk for the 
development of mental disorders (NHS Health Scotland 2004). 
 
 5.3.3.  Key  issues  on  psychopathology,  socio-clinical  and  severity  of  mental 
disorders 
1.  the  multi-dimensional  model  of  psychopathology  is  related  to  severity  of  mental 
disorders  measured  with  a  battery  of  measures  that  include  the  impact  of 
psychopathology  on  physical  health,  interpersonal  functioning,  self-care  and 
occupation and activities. 
2.  increased severity of intellectual disabilities is associated with greater severity of 
mental disorders, even after controlling for the effects of psychopathology and other 
potential confounding variables.  
 
5.4  Psychopathology  as  a  predictor  of  the  longitudinal  outcome  of 
mental disorders 
A key criticism of the prevailing categorical model of psychopathology is that it lacks 
predictive  validity;  that  is  to  say,  categorical  models  of  psychopathology  are  poorly 
correlated  with  longitudinal  outcome  and  thus  provide  little  information  on  an 
individual’s prognosis. Therefore, the examination of psychopathology and longitudinal   327 
outcome  is  an  important  aspect  of  understanding  psychopathology  experienced  by 
persons with intellectual disabilities. 
 
5.4.1 Psychopathology and longitudinal outcome 
The finding that the depressive and behaviour-affective dimensions of psychopathology 
are  related  to  positive  longitudinal  outcome  is  similar  to  some  previously  published 
studies (tables 1.6 and 1.7). Follow up studies of adults with intellectual disabilities have 
reported  that  problem  behaviours  (van  Minnen  et  al.  1997)  and  affective/  neurotic 
psychopathology (Spiller et al. 2007) are correlated to outcome. Only one previous study 
found  an  association  between  childhood  psychopathology  and  outcome  in  adulthood 
(McCarthy  2008).  These  three  studies  used  only  a  single  measure  of  outcome  (van 
Minnen et al. 1997; Spiller et al. 2007; McCarthy  2008). The one study that included a 
battery of measures of outcome, including the GAF used in this thesis, did not find any 
significant correlation between psychopathology and outcome (Xenitidis et al. 2004). 
 
The organic dimension symptom count was negatively correlated with the change in the 
HoNOS-LD over time. This is in keeping with the progressive nature of most types of 
dementia. Although there is some suggested efficacy of cognitive-enhancers in adults 
with Down syndrome (Lott et al. 2002; Prasher et al. 2002) this research is at an early 
stage  and  there  is  less  evidence  on  the  use  of  cognitive  enhancers  in  adults  with 
intellectual disabilities not associated with Down syndrome. Furthermore, with the four-
five year follow-up, it would be expected that progression of the dementia would have 
occurred even if an individual had received cognitive enhancers.  The limited evidence 
base on non-pharmacological management of organic psychopathology experienced by 
individuals  with  intellectual  disabilities  has  also  been  recognized  (Courtenay  et  al. 
2010). 
  
Of equal relevance is the finding that the anxiety dimension of psychopathology was not 
related to longitudinal outcome. Since there was no significant change in this dimension 
over  time  (table  4.70),  this  could  be  attributed  to  the  lack  of  effectiveness  of 
interventions and services on this dimension of psychopathology. Although adults with   328 
intellectual disabilities experience high rates of anxiety psychopathology, there is little 
evidence  on  the  effectiveness  of  pharmacological  and  psychosocial  interventions 
(Dagnan & Jahoda 2006; Davis et al. 2008) for anxiety psychopathology. 
 
Give  the  strong  association  between  psychopathology  and  longitudinal  outcome, 
research on the assessment and management of psychopathology should be a priority.  
Based  on  these  findings,  developing  effective  interventions  and  services  and  may  
improve outcomes and quality of life of adults with intellectual disabilities and mental 
disorders.  
 
5.4.2  Level  of  intellectual  disabilities  and  the  longitudinal  outcome  of  mental 
disorders 
Independent of psychopathology and the effects of other variables, outcome is better for 
individuals  with  moderate,  severe  and  profound  intellectual  disabilities  compared  to 
persons with mild intellectual disabilities. This contrasts with findings from one study 
(van Minnen et al. 1997) that reported poorer outcomes for individuals with lower levels 
of  social  competence,  whilst  another  found  no  significant  association  between 
intellectual disabilities and outcome (Spiller et al. 2007). The use of social competence 
as  a  proxy  measure  of  level  of  intellectual  disabilities,  and  a  composite  measure  of 
psychopathology  as  the  sole  measure  of  outcome  could  partly  explain  the  different 
finding from the study by van Minnen et al. (1997). Clearly, in light of limited evidence 
on the influence of level of intellectual disabilities on the outcome of mental disorders, 
further research would be desirable.  
 
Although living circumstances were not independently associated with outcome, it could 
be that the improved outcome for adults with  more severe intellectual disabilities is 
related  to  support  arrangements.  Since  individuals  with  more  severe  intellectual 
disabilities will receive increased support from carers, this could influence outcomes. For 
example,  perhaps  individuals  living  with  support  from  family  or  paid  carers  have 
improved compliance with pharmacological and psychosocial interventions for mental   329 
disorders. This again highlights the positive impact that carers can maybe have on the 
outcome of mental disorders. 
 
5.4.3 Other socio-clinical variables associated with outcome 
The  finding  that  individuals  with  poorly  controlled  seizures  have  poorer  outcomes 
highlights  the  relevance  of  epilepsy  to  the  management  of  mental  disorders  in 
individuals  with  intellectual  disabilities.    This  is  in  keeping  with  the  finding  that 
individuals with intellectual disabilities and poorly controlled seizures are more likely to 
report  psychopathology  (Espie  et  al.  2003;  Ring  et  al.  2007).  Previous  studies  have 
rarely  examined  the  influence  of  epilepsy  on  the  outcomes  of  mental  disorders 
experienced by adults with intellectual disabilities. However, potential barriers to the 
effective  management  of  mental  disorders  (Barry  et  al.  2008)  and  the  interaction 
between seizures and the efficacy of interventions (Kanner 2004) have been recognized 
in  non-intellectual  disabilities  research.  The  poorer  outcome  of  individuals  with 
psychopathology  and  seizures  supports  the  suggested  need  for  specialist  intellectual 
disabilities  services  for  individuals  with  comorbid  mental  disorders  and  epilepsy 
(McGrother et al. 2006; Fitzgerald & Ring 2009). 
 
Individuals with hearing impairment were found to have poorer outcomes on the GAF 
and CGI. It is difficult to understand why this would be the case. Hearing impairment 
was included in the analysis on the basis that a previous study showed that individuals 
with intellectual disabilities and a hearing impairment were less likely to be diagnosed 
with  an  affective  disorder  (Cooper  et  al.  2007c).  More  generally,  individuals  with 
hearing impairments are described as being at increased risk of mental disorders (Carvill 
2008).  The  poorer  outcome  for  individuals  with  hearing  impairment  can  perhaps  be 
needs to be understoodin the context of the complex physical and mental health needs of 
adults with intellectual disabilities. 
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5.4.4 Key issues on psychopathology, socio-clinical variables and the outcome of 
mental disorders 
1.  the  multi-dimensional  model  of  psychopathology  is  useful  to  developing  an 
understanding of the longitudinal outcome of mental disorders 
2.  further research is required to examine if the efficacy of interventions and services 
for individuals with mental disorders varies with level of intellectual disabilities  
3.  the complex physical health needs of adults with intellectual disabilities could impact 
on the longitudinal outcome of mental disorders. 
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5.5  Comparisons  of  dimensional  and  categorical  models  of 
psychopathology 
The categorical model of psychopathology was independently associated with severity of 
mental disorder on the HoNOS-LD, and longitudinal outcome on the GAF and CGI. 
However, the multi-dimensional model of psychopathology was associated with all four 
measures  of  severity,  and  longitudinal  outcome  on  the  HoNOS-LD,  GAF  and  CGI. 
Further, the categorical model was no longer associated with any measure of severity or 
longitudinal  outcome,  when  both  models  of  psychopathology  were  included  in  the 
regression analysis. Therefore, the categorical model does not provide any additional 
contribution to the variance in measures of severity & outcome, over and above the 
dimensional model of psychopathology. It is concluded that the multi-dimension model 
is  a  better  representation  of  psychopathology  when  considering  the  severity,  and 
longitudinal  outcome,  of  mental  disorders.  This  finding  strongly  suggests  that 
dimensional  models  of  psychopathology  are  of  relevance  to  future  research  on 
psychopathology experienced by individuals with intellectual disabilities, and may be of 
value to the strategic planning and provision of clinical services. 
 
No intellectual disabilities studies have compared dimensional and categorical models of 
psychopathology.  Although  one  study  of  psychosis  found  that  dimensional  and 
categorical models of psychopathology were equally relevant to predicting longitudinal 
outcome (Dikeos  et  al.  1996), the finding that  the multi-dimensional model is more 
strongly associated with severity of disorder (van Os et al. 1999a; Prisciandro & Roberts 
2009) and outcome (van Os et al. 1996; van Os et al. 1999b) is in keeping with most 
studies examining dimensions of psychosis. The potential relevance of the finding that 
dimensional models of psychopathology are more closely associated with severity, and 
outcome, of mental disorders is worth considering. 
 
This thesis used similar methods to the general research comparing the association of 
dimensional and categorical models with severity and outcome of psychosis (van Os et 
al. 1996; van Os et al. 1999b; van Os et al. 1999a Dikeos et al. 2006) and affective 
disorders (Prisciandro & Roberts 2009).  It has  been suggested that the methodology   332 
examines the predictive validity of different models of psychopathology (Prisciandro & 
Roberts 2009). However, before accepting that there there is a need to consider some 
aspects of the methodology.  
 
The strength of dimensional models of psychopathology over categorical models has 
been attributed to the retention of greater information describing the person to person 
variability in psychopathology (Kraemer 2007). Examining the requirements for a good 
classification  system  for  mental  disorders  in  section  1.2.1,  this  suggests  that  a 
dimensional model has better face validity than a categorical model of psychopathology. 
The improved face validity of dimensional models is also supported by the findings that 
psychopathology has a continuous rather than bimodal distribution (section 1.5.1), which 
is  better  represented  by  a  dimensional  model  of  psychopathology.  The  retention  of 
greater information relevant to the psychopathology an individual is experiencing within 
the  dimensional  model,  which  can  be  used  to  derive  continuous  measures,  is  also 
recognised to improve the sensitivity to change, compared to a categorical model of 
psychopathology (Hemingway et al. 1997; Haslam 2003). It could be that the improved 
face validity and sensitivity of a dimensional model of psychopathology, at least in part, 
explains the stronger relationships with severity and longitudinal outcome, compared to 
a  categorical  model.  However,  the  research  is  at  an  early  stage  and  further  work 
examining  the  advantages  and  disadvantages  of  both  models  of  psychopathology  is 
required. 
 
The severity of an individual’s mental disorder is closely tied to decisions by clinician’s 
about need for treatment. This is a complex process, which at some level will always 
involve clinicians making a categorical decision (Pickles & Angold 2003).  However, the 
validity  of  using  categorical  models  of  psychopathology  within  the  decision  making 
process has been questioned.  Decisions on the need for treatment of mental disorders 
are,  at  least  in  part,  influenced  by  whether  the  psychopathology  an  individual  is 
experiencing meets the criteria for a disorder, defined within a categorical diagnostic 
classification system (Kraemer et al. 2004). Certain systems of health care operate a 
policy  where  the  costs  for  treatment  will  only  be  met  by  health  insurance  in   333 
circumstances where the diagnostic criteria are met. In these circumstances categorical 
models of psychopathology act as barriers to care for some individuals. Clinical decision 
making  processes  based  on  a  categorical  model  of  psychopathology,  run  the  risk  of 
viewing all individuals who meet the diagnostic criteria as identical (Widiger & Samuel 
2005) and excluding individuals from care who have significant impairments and would 
benefit from treatment (Angst et al. 1997; Wagner et al. 2000; Cuijpers et al. 2004; 
Chuan et al. 2008). Overall, this represents a loss of relevant data to inform the decision 
making process. The multi-dimensional model of psychopathology was more closely 
related to severity than the DC-LD categorical model in this thesis, and previous studies 
of psychosis (van Os et al. 1999a). This suggests that incorporating dimensional models 
into assessments could have advantages for clinical decision-making processes based on 
the severity of mental disorders.  
 
In this thesis, the multi-dimensional model of psychopathology was also more strongly 
associated  with  the  outcome  of  mental  disorders  than  the  categorical  model.  This 
suggests  that  dimensional  models  may  hold  advantages  in  monitoring  response  to 
treatment  in  clinical  services  and  intervention  studies,  and  understanding  change  in 
psychopathology  in  longitudinal  studies.  Of  course,  continuous  measures  of 
psychopathology  are  often  used  as  outcome  measures  in  intervention  studies. 
Instruments have been developed for the assessment of depressive (Cuthill et al. 2003), 
anxiety (Mindham & Espie 2003; Charlot et al. 2007) and problem behaviour (Rojahn et 
al.  2009)  psychopathology  in  adults  with  intellectual  disabilities.  Examining  multi-
dimensional models of psychopathology derived through EFA, and other multivariate 
methods, can help to ensure the validity of these measures. For example, further work 
examining the relationship between affective and problem behaviour psychopathology 
could lead to the development of new assessment instruments. 
 
What is likely to be more challenging is the incorporation of dimensional models of 
psychopathology into routine clinical practice. Even with robust instruments to assess 
and  monitor  dimensions  of  psychopathology,  changing  clinical  practice  to  routinely 
monitor psychopathology or outcomes has been shown to be problematic. The reasons   334 
for this are likely to be complex but one possibility is that the categorical model of 
psychopathology  already  meets  the  needs  of  clinicians  (Kendell  &  Jablensky  2003; 
Mellsop et al. 2007; Bell et al. 2008).  
 
In fact, although multi-dimensional models appear to be more closely related to severity 
and  outcome  of  mental  disorders,  there  is  no  suggestion  that  they  should  replace 
categorical  models  of  psychopathology.  As  described  in  section  1.4.1,  categorical 
models  have  several  strengths-  particularly  when  used  in  clinical  practice.  Rather, 
current proposals explore means by which dimensional and categorical models can be 
used side-by-side, to complement one another (Achenbach et al. 2005; Kraemer 2007). 
This will capture the strengths of both approaches to understanding psychopathology and 
hopefully  take  forward  the  study  and  management  of  mental  disorders.  It  will  be 
interesting to see if dimensional models of psychopathology are incorporated into ICD-
11 and DSM-V, due for publication in the near future.  
 
5.6 Strengths and limitations 
This study followed best practice guidelines on EFA to identify a multi-dimensional 
model of psychopathology experienced by adults with intellectual disabilities. A review 
highlighted  the  methodological  weaknesses  in  studies  that  use  EFA  in  the  field  of 
developmental disabilities (Norris & Lecavalier 2010). The EFA reported in this thesis 
meets  the  criteria  set  out  in  the  review  paper  and  current  best-practice  guidelines 
(Costello & Osborne 2005). None of the previous studies, summarised in table 1.2, that 
describe  a  dimensional  model  of  psychopathology  meet  these  criteria,  with  specific 
methodological limitations related to sample size and a case: item ratio of less than 5:1 
(Tabachnik & Fidell 2001; Matson et al. 1984; Linaker 1991; Gustafsson & Sonnander 
2005; Watson et al. 1988; Sturmey et al. 1996; Sturmey et al. 2003; Tsiouris et al. 
2003), the sole use of eigenvalues to decide the number of factors extracted in models 
(Matson et al. 1984; Linaker 1991; Balboni et al. 2000; Gustafsson & Sonnander 2005; 
Watson et al. 1988; Moss et al. 1998; Hatton & Taylor 2008; Hove & Havik 2008; 
Kellet et al. 2004), acceptance of factors with less than three items loading significantly 
(Moss et al. 1998; Hatton & Taylor 2008; Hove & Havik 2008) and cross-loading of   335 
items across factors (Moss et al. 1998; Sturmey et al. 2005; Sturmey et al. 1996; Kellet 
et al. 2004). 
 
A further strength of the EFA described here is the use of a method of factor analysis 
appropriate to the analysis of categorical data (Wood et al. 2003). Most psychopathology 
assessment instruments collect data that is categorical, usually either ordinal or binary in 
nature. Common factor and principal components analysis are designed for use with 
continuous variables (Linting et al. 2007). Comparative analyses have shown that the use 
of  these  methods  with  categorical  data  produces  models  with  poor  reliability  and 
stability,  compared to non-linear methods of  analysis (Woods 2002).  In this EFA, a 
specific form of non-linear analysis better suited to the binary PPS-LD data was used.  
The method of analysis used is based on inter-item  tetrachoric correlations (du Toit 
2003),  carried  out  with  TESTFACT  software.  As  is  common  in  published 
psychopathology  research,  all  the  studies  in  table  1.2  use  the  principal  components 
method to analyse categorical data. Clearly, further studies of intellectual disabilities of 
psychopathology  using  appropriate  and  reliable  multivariate  methods  of  analysis  are 
required. 
 
The use of an appropriate method to assess psychopathology in this study will have 
impacted  positively  on  the  data  used  for  the  EFA.  PPS-LD  is  a  psychopathology 
assessment  instrument  specifically  developed  for  use  with  adults  with  intellectual 
disabilities. Inclusion of items of psychopathology from the SCAN, with additional items 
relevant to mental disorders experienced by persons with intellectual disabilities, ensured 
appropriate psychopathology  was included in the analysis. Although items related to 
psychosis and mania/ hypomania were not included in the analysis, the results represent 
a  broad,  multi-dimensional  model  of  commonly  experienced  psychopathology. 
Previously  described  multi-dimensional  models  are  limited  by  the  range  of  items  of 
psychopathology included in the assessment instruments, e.g. the PAS-ADD checklist 
(Moss et al. 1998; Sturmey et al. 2004; Hatton & Taylor, 2008) or the CBCPID (Tsiouris 
et al. 2003). The inclusion of an extensive range of items of psychopathology also makes 
it more likely that the reported model of psychopathology is potentially valid.     336 
 
Despite the comprehensive nature of the PPS-LD, as discussed in section 5.1, there are 
items of psychopathology of potential relevance to the behaviour-affective and anxiety 
dimensions that could not be included in the EFA. To improve the coverage of items of 
psychopathology  in  the  PPS-LD  for  future  studies,  consideration  should  be  given  to 
extending the items assessing problem behaviours, and separating out items on free-
floating anxiety, autonomic overarousal and avoidance that are currently incorporated in 
composite items. 
 
Although the use of the PPS-LD can be considered a strength of this thesis, it is relevant 
to consider the strengths and limitations of other available instruments. 
 
At  the  start  of  the  period  of  study  relevant  to  this  thesis,  the  only  comprehensive 
instrument for the assessment of psychopathology in adults with intellectual disabilities 
that was available was the PAS-ADD (Moss et. al 1993). The PAS-ADD is a semi-
structured interview schedule based on the Psychiatric Assessment Schedule (PAS: Gask 
1988). Since the items of psychopathology in the PAS were included in order to be able 
to  diagnoses  depression,  generalised  anxiety,  dysythymia,  panic  disorder  and 
agoraphobia,  additional  items  for  the  assessment  of  psychopathology  relevant  to 
psychoses and autism were included in the PAS-ADD.  
 
The  researchers  who  developed  the  PAS-ADD  found  it  to  be  a  reliable  and  valid 
instrument for the assessment of psychopathology in adults with intellectual disabilities 
(Moss et al. 1993; Moss et al. 1997). Furthermore, the semi-structured format of the 
PAS-ADD interview included several innovations designed to maximise its utility in the 
identification  of  psychopathology  experienced  by  adults  with  intellectual  disabilities. 
These innovations included parallel participant and informant interviews and the use of 
an anchor event to improve recall.  
 
Despite  these  strengths,  certain  limitations  in  the  range  of  items  of  psychopathology 
included  in  the  PAS-ADD  limited  its  suitability  for  use  in  the  EFA  to  examine  the   337 
dimensional  structure  of  psychopathology  experienced  by  adults  with  intellectual 
disabilities.  In  particular,  the  PAS-ADD  does  not  include  items  of  psychopathology 
relevant  to  problem  behaviour  and  obsessional  psychopathology.  Since  problem 
behaviours are the most commonly experienced form of psychopathology experienced by 
adults with intellectual disabilities the absence of these in the PAS-ADD was considered 
to limit its use to examine research hypothesis one, in this thesis. 
 
As the PPS-LD includes a broader range of items of psychopathology than the PAS-
ADD, and crucially includes items relevant to problem behaviours it was used in this 
thesis. Another instrument for the assessment of a broad range of psychopathology in 
adults  with  intellectual  disabilities  has  been  published  since  the  start  of  the  work 
described in this thesis- the Developmental  Behaviour Checklist for Adults (DBC-A; 
Mohr  et  al.  2005).  The  DBC-A  was  developed  from  an  established  checklist  of 
psychopathology for completion by carers of children with intellectual disabilities called 
the  DBC  (Einfeld  &  Tonge,  1992).  To  decide  on  the  items  of  psychopathology  for 
inclusion in the DBC-A, the items of psychopathology described in the clinical notes of 
six hundred and five adults with intellectual disabilities seen at a specialist centre in 
Victoria, Australia were compared against the 94 items of psychopathology included in 
the  DBC.    Twelve  items  of  psychopathology  were  added  to  those  in  the  DBC.  The 
resultant 106 items of psychopathology in the DBC-A were reported to have satisfactory 
inter-rater reliability, and concurrent validity compared to the PAS-ADD. 
 
Since  the  development  of  the  DBC-A  was  informed  by  a  “bottom  up  process”  that 
examined psychopathology recorded in a large sample of case notes it is likely that it 
assesses  a  comprehensive  range  of  psychopathology  However,  the  researchers  that 
developed the DBC-A note that the clinical assessments were unstructured and are thus 
dependant on the training and clinical practice of professionals working in the specialist 
centre (Mohr et al. 2005). Nonetheless, like the PPS-LD, the DBC-A includes items of 
psychopathology commonly experienced by adults with intellectual disabilities that are 
not included in generic psychopathology assessments e.g. problem behaviours. Therefore, 
the breadth and relevance of items of psychopathology in the DBC-A suggest it may be   338 
suitable for use in an EFA to examine the dimensional structure of psychopathology 
experienced by adults with intellectual disabilities.  
 
A second checklist of psychopathology published recently is the P-AID (Hove & Havik 
2008)  used  in  the  EFA  described  in  table  1.2.  The  P-AID  comprises  260  items  of 
psychopathology based on diagnostic criteria in DC-LD (Royal College of Psychiatrists 
2001), including problem behaviours. Although the 260 items of psychopathology are 
organised into 18 separate checklists that correspond to DC-LD categorical diagnoses, as 
described in section 5.1.1, use of the 260 items of psychopathology in an EFA could be 
done to examine the dimensional structure of psychopathology.  
 
The PPS-LD (Cooper 1997), DBC-A (Mohr et  al. 2005) and P-AID (Hove & Havik 
2008) all include a comprehensive range of psychopathology relevant to mental disorders 
experienced by adults with intellectual disabilities, and use a similar checklist format to 
rate items of psychopathology. Therefore, future research should consider comparing the 
multi-dimensional model of psychopathology extracted from the three instruments. 
 
Since the items of psychopathology included in the EFA can be identified by self and 
informant  report,  the  model  is  applicable  to  individuals  across  the  range  of  mild-
profound intellectual disabilities. Although the model from the BSI (Kellett et al. 2004) 
is similar, the design of the assessment instrument and the sample used mean the results 
are not generalisable beyond individuals with mild intellectual disabilities. Adults with 
intellectual  disabilities  are  heterogeneous  across  many  variables,  and  using  inclusion 
criteria  to  define  samples  more  tightly  could  be  advantageous  for  some  types  of 
psychopathology  research.  For  example,  studies  of  psychosis  psychopathology  could 
limit the samples to individuals with mild intellectual disabilities.  However, one aspect 
of the thesis was comparing a dimensional model of psychopathology to the categorical 
models in diagnostic classification systems. Since systems such as DC-LD and DM-ID 
are designed for use across mild-profound intellectual disabilities it was necessary to 
include participants across a similar range of abilities. The use of a sample that includes 
individuals  with  severe-profound  intellectual  disabilities  meant  that  psychopathology   339 
relevant  to  problem  behaviours  was  more  likely  to  be  included  in  the  EFA.  This 
contributed  to  finding  a  potentially  important  model  to  explain  the  relationship  of 
problem behaviours to other commonly experienced psychopathology. Finally, a broad 
sample makes the findings more likely to be of relevance to professionals working in the 
field of intellectual disabilities and clinical services.  
 
All  the  psychopathology  assessments  were  done  by  psychiatrists  trained  by  the 
intellectual  disabilities  psychiatrist  who  originally  developed  the  PPS-LD  (Cooper 
1997). This ensures the consistent use of the PPS-LD. The collection of psychopathology 
data was done in the context of the standardised UCEDD clinical assessment. Since this 
includes  a  full  clinical  history  and  examination,  consideration  is  given  to  changes 
attributable to physical health problems or side-effects of medication and avoids falsely 
rating long-standing traits as psychopathology associated with a mental disorder. This 
standardised  process  will,  therefore,  have  improved  the  reliability  of  the 
psychopathology data used in the EFA.  
 
Further to the use of the PPS-LD, the use of standardised methods to assess level of 
intellectual  disabilities  and  outcome  is  a  further  strength  of  this  study.  Level  of 
intellectual disabilities was assessed by psychiatrists trained in the use of the Vineland’s 
adaptive  behaviour  scales  (Sparrow  et  al.  1984).  The  Vineland’s  adaptive  behaviour 
scales have been endorsed for use in the assessment of functioning by the World Health 
Organisation (World Health Organisation 1994) and the Royal College of Psychiatrists 
(2001). Furthermore, they were used in the process to examine the standardization of the 
Weschler Adult Intelligence Scale-Third Edition (Weschler 1997), which is commonly 
used to measure IQ. A field trial to test the psychometric properties of the Vineland’s 
adaptive  behavior  scales  and  derive  population  norms  for  adults  with  intellectual 
disabilities living in institutional and community settings was used as part of the process 
to  develop  the  Vineland’s  adaptive  behavior  scales  (Sparrow  et  al.  1984).  This 
established the Vineland’s as reliable and valid for the assessment of level of functioning 
in adults with intellectual disabilities. Despite these strengths, some specific weaknesses 
of  the  Vineland’s  scales  when  compared  to  other  measures  of  ability  have  been   340 
highlighted (Beail 2003). The version of the Vineland’s used in this thesis has been 
replaced by an updated version which addresses criticisms that the previous version, 
piloted in 1984, was outdated. To complete the Vineland’s adaptive behaviour scales a 
trained interviewer administers the scale with an informant who knows the person with 
intellectual disabilities, covering a broad range of functioning. It has been suggested that 
more direct assessments of an individual’s functioning would improve the reliability and 
validity of the Vineland’s adaptive behaviour scales (Beail 2003). Whilst this is the case, 
and  more  comprehensive  batteries  of  assessments  are  available,  these  require 
considerable  more  time  and  resource.  One  advantage  of  the  Vineland’s  adaptive 
behaviour scales is that a trained interviewer can complete it in 20-30 minutes. It is 
therefore useful as a standardised way to assess level of functioning in circumstances 
where a more comprehensive battery of assessments is not feasible, such as large-scale 
research studies, or in busy clinical services.  
 
This study uses four measures of outcome designed to be complementary and provide a 
battery  of  assessments  relevant  of  mental  disorders  experienced  by  adults  with 
intellectual disabilities. HoNOS-LD (Roy et al. 2002) and the CANDID-R (Xenitidis et 
al. 2000) were developed specifically for use with adults with intellectual disabilities. 
Although they have only been used in a limited number of published research studies, 
both include items of relevance to the lives of adults with intellectual disabilities and 
have  been  shown  to  be  reliable,  valid  and  sensitive  to  change.  In  keeping  with 
recommendations on the use of different forms of outcome measures, the HoNOS-LD 
and CANDID-R are designed to measure different aspects of outcome. HoNOS-LD, like 
the generic HoNOS, aims to measure a person’s health and social functioning, against a 
theoretical  “optimal  functional  autonomy”  (Wing  et  al.  1998).  The  CANDID-R 
measures need across the 25 domains (Xenitidis et al. 2000). A strength of these two 
measures is that they cover a broad range of domains that could be impacted upon by 
psychopathology associated with mental disorders. Thus they avoid the criticism aimed 
at other measures of outcome that they are limited in scope and place too much emphasis 
on measuring symptoms.   
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Two global outcome measures were also used. The GAF and CGI are the two most 
commonly  used  global  measures  in  psychopathology  research.  Since  they  were  not 
developed for specific use in intellectual disabilities, and the psychometric properties 
have not been studied it was decided to use both measures. Researchers have raised 
concerns that GAF scores in intellectual disabilities may be scored down due to the 
influence of a person’s intellectual disabilities on functioning. However, in contrast to 
previous studies (Oliver et al. 2003; Shedlack et al. 2005; Hall et al. 2006) this study 
used the recommended modified scoring method (Hurley 2001) which rates the GAF 
purely on the impact of psychopathology. 
 
Although this thesis used several measures of outcome, there are some available forms 
of outcome measure that were not used. In a review of different measures of outcome 
used in non-intellectual disabilities mental disorder research seven relevant categories of 
outcome measure were identified (Slade  2002): 
·  well-being e.g. quality of life 
·  cognition/ emotion- symptom or psychopathology 
·  behavior- psychopathology and functioning 
·  physical health 
·  interpersonal functioning- social functioning and relationships  
·  society- carer burden, employment and welfare benefits 
·  services- service use, satisfaction with services and health economics. 
 
Despite certain gaps, overall the measures of outcome used in this thesis provide an 
assessment relevant to the majority of these categories of outcome. The HoNOS-LD and 
CANDID-R include items of relevance to cognition/ emotion, behavior, physical health, 
interpersonal functioning and society. The battery of measures of outcome could have 
been made more comprehensive by the inclusion of a measure relevant to the categories 
of well-being and services. Quality of life research is well established in intellectual 
disabilities research, and several specific quality of life measures have been developed 
and  validated  for  use.  Therefore,  future  studies  would  benefit  from  inclusion  of  a 
measure of well-being; for example using the QoLQ (Schalock & Keith 1993) or LSS   342 
(Harner & Heal 1993), used in two of the studies summarised in table 1.5. No measures 
of service use or satisfaction with services have been developed for use in the field of 
intellectual  disabilities.  The  use  of  generic  instruments  in  studies  with  adults  with 
intellectual  disabilities  as  participants  could  be  considered  following  research  to 
establish the utility, reliability and validity of such measures.  
 
Perhaps the most significant limitation in the study is the low rate of participation in the 
follow  up  research  interviews.  Of  150  individuals  assessed  in  the  UCEDD  clinical 
services 40 (26.7%) consented to participate in the interviews. However, since there 
were  no  significant  differences  in  the  socio-clinical  characteristics  of  sample  2  and 
sample 3 the follow up sample is representative. What is less certain is whether a latent 
difference between participants in sample 2 and individuals who chose not to participate 
could have biased the results. For example, if individuals were more likely to take part in 
the  follow-up  interviews  if  there  had  been  an  improvement  from  baseline  in  the 
psychopathology they experience this could introduce a systematic bias to the findings. 
Alternatively,  individuals  may  be  more  likely  to  participate  if  they  are  still  using 
specialist intellectual disabilities services which could mean they continue to experience 
significant  levels  of  psychopathology.  Although  it  is  difficult  to  be  certain  of  the 
influence of the attrition rate on the findings, perhaps of  greater relevance is giving 
consideration as to how to improve recruitment rates in future follow up studies. 
 
One methodological change that may improve follow-up would be to reduce the duration 
of time between interviews. For example, in a recent two-year incidence study of mental 
disorders the follow-up rate was 70% (Smiley et al. 2007). Even if the aim of the study is 
to  follow  up  participants  over  a  longer  period,  perhaps  contacting  participants  more 
frequently would help to improve retention. Serial follow-up research interviews would 
also give valuable detail on changes in psychopathology over time, and could address the 
research  questions,  discussed  in  section  5.2,  about  the  relationship  between 
psychopathology and age, and developmental aspects of the proposed tripartite model. 
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5.7 Implications for clinical practice 
The findings in this thesis raise several issues of relevance to clinical practice, and the 
delivery of services, for individuals with intellectual disabilities and mental disorders. 
Identification  of  a  mixed  behaviour-affective  dimension  in  the  EFA  highlights  the 
importance of comprehensive assessments of psychopathology, whenever an individual 
presents to services. From this thesis, and other epidemiological studies, it appears that 
as severity of intellectual disabilities increases the risk and severity of psychopathology 
also  increases.  This  suggests  that  mental  health  promotion  interventions  should  be 
targeted at individuals with more severe intellectual disabilities. Finally, the follow-up 
study  emphasizes  the  potential  usefulness  of  incorporating  outcome  measures  into 
routine clinical practice.  
 
In clinical services, individuals presenting with problem behaviours are often referred to 
psychologists and psychiatrists see individuals with other forms of psychopathology. 
This model of service provision could encourage an unhelpful focus on a restricted range 
of psychopathology when assessing individuals at the time of presentation.  The finding 
that affective and problem behaviour items of psychopathology loaded significantly to a 
single  dimension  reinforces  the  need  to  assess  the  full  range  of  psychopathology, 
regardless of the primary presenting complaint. To achieve this, structured assessments 
of psychopathology should be used in clinical practice.  
 
The  prevention  of  mental  disorders,  and  mental  health  promotion,  have  received 
increasing  attention  in  national  mental  health  strategies  and  clinical  guidelines. 
Resources  have  been  provided  to  educational  and  clinical  interventions  to  support 
children and young people to develop resilience, and parenting interventions to improve 
outcomes for at risk children. Since individuals with more severe intellectual disabilities 
appear to be at greater risk of mental disorders, consideration should be given to how 
best  to  reduce  the  risk.  Some  aspects  of  generic  resilience  models  may  be  of  use. 
However,  it  is  likely  that  prevention  and  mental  health  promotion  interventions  for 
persons with intellectual disabilities will have a broader focus beyond an individual. A   344 
social model of disability would suggest that interventions with parents and families, 
schools and communities should be considered as well as work with individuals. 
 
Although routine monitoring of outcome in clinical practice is often advocated, it is 
seldom achieved. Several different outcome measures were used in this study, all of 
which are appropriate for use in clinical settings. It is unlikely that clinicians would 
move from not using any measure, to using four. Therefore, it is more realistic to invite 
clinicians  to  incorporate  one  measure  of  outcome  into  clinical  practice.  Although 
concerns over the use of the GAF in intellectual disabilities have been raised, the revised 
scoring method (Hurley 2001) described in DM-ID appeared to produce similar results 
to the other outcomes- including the HoNOS-LD and CANDID-R designed for use in 
intellectual disabilities. Therefore, since the GAF is linked to the DM-ID, appears to be 
valid, likely to be familiar to clinicians and takes the minimum time to complete- it may 
be appropriate to introduce first. Of course, the GAF is limited in scope compared to 
other measures and it would be hoped that clinicians may use other measures once the 
value of using the GAF routinely is recognized. Since the GAF is a continuous measure 
of outcome, its use alongside the prevailing categorical models of psychopathology may 
be the first step towards incorporating dimensional models in routine clinical practice. 
 
5.8 Future research 
This thesis described the first multi-dimensional model of psychopathology experienced 
by adults with intellectual disabilities; derived using data collected using the PPS-LD. 
The value of intellectual disabilities psychopathology research has been demonstrated 
and  suggests  possible  directions  of  future  research.  One  obvious  stream  of  future 
research is to further examine the reliability and stability of the dimensional model of 
psychopathology. Given that problem behaviours have a negative impact on the lives of 
persons with intellectual disabilities, the finding that problem behaviours was extracted 
within a behaviour-affective dimension of psychopathology merits further study. Finally, 
a common theme running throughout the thesis is the challenge of reliably identifying 
psychopathology experienced by persons with intellectual disabilities. Thus, returning to   345 
a  basic  level  of  research  to  improve  methods  of  self,  and  informant,  report  of 
psychopathology should be considered. 
 
Possible methods to study the reliability and validity of the multi-dimensional model of 
psychopathology are repeating the EFA described here using a different sample, and the 
use  of  confirmatory  factor  analysis.  The  only  two  psychopathology  assessment 
instruments for which more than one EFA has been published are the PIMRA (Matson et 
al. 1984) and the PAS-ADD checklist (Moss et al. 1998; Sturmey et al. 2004; Hatton & 
Taylor  2008).  Inclusion  of  items  of  psychopathology  in  the  PIMRA  of  questionable 
validity, the limited range of items in the PAS-ADD checklist and the broader limitations 
of the methods of EFA used in these studies have been described previously. Therefore, 
replicating any multi-dimensional model of psychopathology would add significantly to 
the evidence-base. If possible, using a larger population-based sample, or a random sub-
sample  of  such  a  sample  would  maximize  the  reliability  and  validity  of  the  multi-
dimensional model.  
 
Confirmatory factor analysis (CFA) can be used to examine whether a multi-dimensional 
model of psychopathology derived using EFA is verified in a separate sample. Although 
none of the models from previous intellectual disabilities studies have been tested with 
CFA, it has been used previously to verify the dimensional model of psychopathology in 
psychosis (Dollfus & Everitt 1998), ADHD in children (Gomez et al. 2003) and autism 
(Frazier  et  al.  2008).  Various  different  methods  can  be  used  for  CFA  but  most 
commonly structural equation modeling is used. Thus the methods of CFA are quite 
separate from those used in EFA, which might partly explain why few EFA studies in 
intellectual disabilities have lead on to research with CFA.  Either through replicating the 
EFA or using CFA, examining further the PPS-LD could develop the understanding of 
the  relationship  between  a  putative  tripartite  model  of  depression  and  anxiety 
psychopathology and problem behaviours. 
 
Another  future  study  of  value  to  understanding  the  multi-dimensional  model  of 
psychopathology would improve the coverage of items of psychopathology included in   346 
the analysis. In particular, including additional items of psychopathology relevant to the 
presentation of anxiety, and inclusion of problem behaviours in addition to physical and 
verbal aggression, and self-injurious behaviour in PPS-LD could be considered. As well 
as potentially improving the validity of any resultant model, this could potentially reveal 
additional dimensions of psychopathology or higher order dimensions.  
 
Examining  the  existing  research  literature,  it  appears  that  the  relationship  between 
problem behaviours and other forms of psychopathology is of interest to researchers and 
clinicians alike. This thesis has shown that EFA offers one method to examine this area 
in more detail. One hypothesis that arises is that problem behaviours are associated with 
a  general  distress  dimension,  within  a  tripartite  model  of  depression  and  anxiety 
psychopathology. As well as future research involving EFA and CFA, methodologies to 
examine this area could include: 
·  longitudinal  studies  involving  detailed  and  frequent  assessments  of  affective 
psychopathology in individuals with clinically significant problem behaviours. This 
would inform an understanding of the relationship in time between changes in affect 
and behaviour  
·  follow  up  studies  of  individuals  receiving  interventions  for  the  management  of 
disorders presenting with mixed affective psychopathology and problem behaviours. 
If these two forms of psychopathology are part of a single dimension, and possibly 
share  an  underlying  pathophysiology,  it  would  be  predicted  that  effective 
interventions would lead to improvements in both. 
 
Such  studies  offer  an  opportunity  for  close  working  between  intellectual  disabilities 
psychiatrists and psychologists. Both professions have important, and complementary, 
contributions to make to the study of psychopathology. Bringing together the distinct 
areas of expertise could potentially lead to new models and management approaches for 
problem behaviours and other psychopathology. 
 
The inclusion of affective items of psychopathology across the depressive, behaviour-
affective and anxiety dimensions suggests examining the relevance of global affective   347 
models of psychopathology. Findings from this thesis support studying models of affect 
regulation, affective arousal and valence models of affect in relation to psychopathology 
experienced by persons with intellectual disabilities.  
 
 A  potential  use  for  dimensional  models  of  psychopathology  is  in  the  study  of  the 
pathophysiology of mental disorders. Genetic and neurobiological research has already 
evidenced  the  relevance  of  dimensions  of  psychopathology  and  endophenotypes  to 
pathophysiology. In the field of intellectual disabilities, this is most likely to be of value 
in behavioural phenotype research. The use of categorical models of psychopathology 
has  produced  potentially  important  findings  in  understanding  psychopathology 
experienced by individuals with Prader-Willi syndrome (Soni et al. 2008) and Williams 
syndrome (Einfeld  et  al. 1997; Dodd  et  al. 2009). However, the insights offered by 
moving  beyond  categorical  models  of  autism  spectrum  disorders  in  individuals  with 
fragile X syndrome (Kaufmann et al. 2004; Hagerman 2006), is a useful example of the 
potential  offered  by  the  study  of  dimensions  and  endophenotypes.  The  sample  sizes 
required  for  EFA  may  be  larger  than  those  in  many  published  behaviour  phenotype 
studies. However, initiative to promote collaboration between researchers working on 
phenotype, such as the European Prader- Willi syndrome Clinical Research Database 
(Holland  et  al. 2009), offer  an opportunity to examine the relevance of dimensional 
models of psychopathology to behaviour phenotypes. 
 
5.9 Conclusions 
The findings presented in this thesis highlight the value of research on psychopathology 
experienced by individual with intellectual disabilities. Psychopathology research in the 
field  of  intellectual  disabilities  is  at  an  earlier  stage  compared  to  the  evidence  from 
studies  involving  children,  adolescents  and  adults  who  do  not  have  intellectual 
disabilities.  However,  research  using  categorical  and  dimensional  models  of 
psychopathology  can  further  our  understanding  of  mental  disorders  experienced  by 
individuals with intellectual disabilities. 
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Categorical models of psychopathology are integral to existing classification systems for 
mental  disorders.  With  the  improved  utility  and  reliability  of  categorical  diagnostic 
classification  systems  it  is  likely  that  they  will  continue  to  be  used  for  clinical  and 
research  purposes.  The  findings  of  this  thesis  suggest  that  the  use  of  multivariate 
statistical methods to identify dimensional models of psychopathology can contribute to 
research  examining  the  validity  of  categorical  diagnostic  classification  systems.  For 
example, the validity of including  “tearfulness” and “reduced verbal communication” in 
the  DC-LD  criteria  for  a  depressive  episode  is  supported  by  item  loadings  to  the 
depressive  dimensions.  However,  since  “increased  irritability”  did  not  load  to  the 
depressive dimension. Therefore, including irritable mood as an alternative to depressed 
mood in the DC-LD criteria for a depressive episode needs further study and validation. 
 
One  potential  advantage  of  dimensional  models  of  psychopathology  compared  to 
categorical models is improved validity. The results of this thesis are in agreement with 
previous research suggesting that dimensional models of psychopathology have stronger 
associations with the severity and outcome of mental disorders, and therefore greater 
predictive validity. Further research is needed to examine the validity of both categorical 
models, which are central to diagnostic classification systems, and dimensional models. 
However, perhaps exploring ways to combine the utility and reliability of categorical 
models with the advantages for validity of dimensional models offers an opportunity to 
develop classification systems.  
 
On the basis of the increased prevalence and negative impact on the lives of adults with 
intellectual disabilities, psychopathology associated with problem behaviors is a priority 
area for research. This study highlights the relevance of examining problem behaviours 
within  broader  models  of  psychopathology.  The  findings  in  this  thesis  support  new 
research  hypotheses  on  psychopathology  experienced  by  adults  with  intellectual 
disabilities. A dimensional model with similarities to the tripartite model of depression 
and  anxiety  psychopathology  was  defined  by  the  exploratory  factor  analysis.  Items 
representing problem behaviour psychopathology were extracted within the dimension 
similar to the general distress, rather than the  depressive, dimension of the tripartite   349 
model. Few intellectual disabilities studies have studied the relevance of the tripartite 
model  of  depression  and  affective  psychopathology.  Therefore,  further  research  is 
required to examine hypotheses that: 
·  affective psychopathology experienced by adults with intellectual disabilities is best 
represented  by  a  tripartite  model  of  depressive,  anxiety  and  general  distress 
dimensions. 
·  problem  behaviours  are  associated  with  a  general  distress  dimension  of 
psychopathology. 
 
Psychopathology research offers opportunities to develop an understanding of mental 
disorders experienced by adults with intellectual disabilities. There are advantages to 
considering novel models, methods and hypotheses alongside those derived from the 
prevailing categorical model of psychopathology. 
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Appendix I Information sheets 
 
                   
   
 
 
SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
 
PARTICIPANT INFORMATION SHEET 
 
We would like to invite you to take part in a research study. The 
information sheet tells you about the study. Please read the information 
sheet, or ask someone to read it with you. This information sheet is for 
you to keep. It is also available on a tape.  
 
You can talk to your family and friends about the study. Ask them what 
they think about it.  
 
What will the research study find out? 
This  research  study  will  find  out  how  mental  health  problems  affect 
people with learning disabilities.  
 
Why do you want me to take part? 
We would like to invite you to take part because you used the Learning 
Disabilities Psychiatry Service.  Your name was given to us by the 
psychiatrist you met with to talk about your mental health. We would 
like to speak to people who used the Learning Disabilities Psychiatry 
Service four to five years ago.  
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What will the study involve? 
A researcher will contact you and ask to visit you.  You do not have to 
meet the researcher. Please let us know if you do not want to see the 
researcher. 
 
You can ask the researcher questions about the study.  The researcher 
will invite you to decide if you want to take part in the research study.  If 
you say yes, you will be asked to sign a form.  You can keep a copy of 
the consent form.  
 
If you take part, the researcher will arrange to meet you, at a place that is 
suitable for you.  The meeting will last about one hour.  If this seems too 
long for you, you can choose to have two shorter meetings instead. 
 
The researcher will ask you questions about:  
￿  The things you do in your life, and yourself 
￿  Any symptoms of mental ill-health you still have 
￿  The problems caused by mental ill-health 
 
We would like to speak to someone who knows you well like a relative, 
or carer.  We would also like to look at your Learning Disabilities 
Psychiatry casenotes.  This will provide us with information about the 
time when you first started using the Learning Disabilities Psychiatry 
Service.   387 
If you have a mental illness which is not being treated we will discuss 
this.  We will offer to arrange an appointment with a psychiatrist from 
the health service.  Your GP could be involved in getting you help for 
your mental illness. 
 
If you are harmed by taking part in this research project, there are no 
special compensation arrangements.  If you are harmed due to 
someone’s negligence, then you may have grounds for a legal action but 
you may have to pay for it.  Regardless of this if you wish to complain 
about any aspect of the way you have been treated during the course of 
this study, the normal National Health Service complaints mechanism 
will be available to you. 
 
Has ethical approval been granted for this study? 
This study has been granted ethical approval by the MREC for Scotland, 
Committee A, and the local research ethics committee for the Primary 
Care Division of NHS Greater Glasgow. 
 
Will taking part in the study help me? 
If you decide to take part, it won’t benefit you now.  It may help people 
with learning disabilities in the future.  This study will also help people 
who plan services. 
 
What will happen if I decide not to take part in the study? 
You do not have to take part in this research study.  It is OK to say no.  
If you don’t want to take part, this will not affect the care and support 
you receive.   388 
 
 
What if I change my mind and do not want to take part during the 
study? 
You can change your mind about taking part, or stop, at any time.  You 
do not have to give a reason.  If you change your mind this will not 
affect the care and support you receive.  
 
Where would the interviews take place? 
If it is OK with you, the researcher will arrange to see you at your home.  
If you want the researcher can arrange to see you somewhere else.  
 
What will happen to the information the researcher collects? 
All the information about you is kept safe. It will be treated with strict 
confidence. It will be kept secret. They will not tell 
anyone  your  name.  The  information  will  be  kept  very  safely  on  a 
computer. The Data Protection Act will be followed at all times. 
 
What will happen to the results of the study? 
When the research study is finished, the research team will write to you 
about  the  research  findings.  They  will  also  write  reports  about  the 
research. Your name will not be used in the reports. No one will be able 
to tell from the reports if you took part in the research. 
 
Who is organising the research? 
This study is organised by the Learning Disabilities Research Group, at 
the University of Glasgow.  
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How can I find out more about the study? 
You can ask the researcher questions about the study.  The name and 
telephone number of the researcher are shown below.  The names of the 
members of the research team are below. You can contact them at any 
time to ask questions. 
 
If  you  would  like  to  take  part please  complete  the  reply  slip  below.  
After two weeks we will phone to ask if you would like to take part. 
 
Thank you for taking the time to read this information sheet. 
 
 
Researcher  
Dr Craig Melville 
Section of Psychological Medicine, Division of Community Based 
Sciences, Academic Centre, Gartnavel Royal Hospital, 1055 Great 
Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
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Research Team 
 
Professor  Sally-Ann  Cooper,  Professor  of  Learning  Disabilities, 
University of Glasgow.   
Telephone: 0141 211 0690 
 
Dr. Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.   
Telephone: 0141 211 0693 
 
……………………………………………………………………………………… 
 
 
Name ………………………………………………… 
 
 
Address ………………………………………………. 
 
……………………………………………………….. 
 
……………………………………………………….. 
 
Telephone Number ………………………………….. 
 
I would like to find out more about the study       Yes   
 
                     No   
Please return this form to: 
 
Dr Craig Melville 
Section of Psychological Medicine 
University of Glasgow 
Academic Centre 
Gartnavel Royal Hospital 
1055 Great Western Road 
GLASGOW 
G12 0XH 
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SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
RELATIVE, WELFARE GUARDIAN INFORMATION SHEET 
 
We would like to invite the person with learning disabilities whom you support to 
take part in a research study.  We do not think that this person has the capacity to 
consent to participate in research.  However, under the provisions of the Adults with 
Incapacity (Scotland) Act you are able to provide consent.  Before you make your 
decision about whether to give consent for them to participate in this study, it is 
important  that  you  understand  why  the  research  is  being  done  and  what  it  will 
involve. Please take time to read the following information carefully and discuss it 
with the person with learning disabilities whom you support, and others if you wish.  
Ask us if there is anything that is not clear or if you would like more information.  
Please keep this information sheet, which is also available on cassette tape. Thank 
you for reading this information sheet. 
 
What will the research study find out? 
 
This research study wants to examine the impact and outcomes of mental ill-health 
on adults with learning disabilities.  We would like to find out if the person you 
support  still  experiences  symptoms  of  mental  ill-health,  and  learn  about  any 
changes, or problems that have come about as a consequence of the mental ill-health 
they have experienced.  No one has ever looked carefully at this before.  If we know 
how mental ill-health affects people with learning disabilities, this will help us to 
plan the services that might be needed.  The study will not be of immediate benefit 
for the person you support, or you, but it may help people with learning disabilities 
in the future. 
 
Why do you want the person I support to take part? 
 
The person with learning disabilities whom you support has been invited to take part 
in the study as he/she has used the Learning Disabilities Psychiatry Service.  We 
were given the name of the person with learning disabilities you support by the 
psychiatrist, who helped the person you support with their mental ill-health.  We 
would  like  to  speak  to  as  many  people  as  possible,  who  were  assessed  by  the 
Learning Disabilities Psychiatry Service between January 2000 and August 2002.  
We are interested to find out what has happened in the life of the person you support 
since that time.  In addition, we want to look at whether their mental ill-health has 
improved, and the impact that it has had on their life. 
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What will the study involve? 
 
The study involves a researcher meeting with the person with learning disabilities 
whom  you  support,  and  a  carer  where  appropriate.    This  meeting  will  take 
approximately  one  hour.    However,  if  this  seems  too  long,  the  meeting  can  be 
divided into two or more shorter meetings.  At this meeting, the researcher will ask 
questions  about  the  life  of  person  with  learning  disabilities  whom  you  support, 
including  things  they  enjoy  doing,  questions  about  health  and  the  support  they 
receive, and questions about symptoms of mental ill-health that they still experience. 
 
We  would  also  like  to  examine  the  learning  disabilities  psychiatric  casenotes 
belonging  to  the  person  with  learning  disabilities  whom  you  support.  This  will 
provide us with information about the time when the person you support first started 
using the service, and the way in which they have used the service since then.  You 
will  be  asked  separately  to  decide  whether  to  give  consent  to  the  researcher 
examining the casenotes of the person with learning disabilities whom you support. 
 
If  the  information  we  gather  suggests  that  the  person  you  support  has  a  mental 
illness which is not being managed we will discuss this with you.  The GP of the 
person you support may be able to help with the problem.  We will offer to arrange 
for  an  assessment  to  be  carried  out  by  a  psychiatrist  working  for  the  Glasgow 
Learning Disability Partnership. 
 
If the person you support is harmed by taking part in this research project, there are 
no special compensation arrangements.  If the person you support is harmed due to 
someone’s negligence, then he/she may have grounds for a legal action but he/she 
may have to pay for it.  Regardless of this if the person  you support wishes to 
complain about any aspect of the way he/she has been treated during the course of 
this  study,  the  normal  National  Health  Service  complaints  mechanism  will  be 
available to him/her. 
  
Will taking part in the study help me, or the person I support? 
 
If you decide to take part, there will be no direct benefits for you, or the person you 
support.  However, the information we gather from the study may help the people 
who plan services for people with learning disabilities who experience mental ill-
health to provide better services in the future. 
 
What  will  happen  if  I  decide  to  give  consent  to  the  person  I  support 
participating in the study? 
 
If you decide to give consent for the participation of the person you support in this 
research study, you will be asked to sign a written consent form.  You will be given 
a copy of the consent form to keep.  The researcher will then arrange to meet with 
the person with learning disabilities, and a carer where appropriate.   
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What  will  happen  if  I  decide  not  to  give  consent  to  the  person  I  support 
participating in the study? 
 
You do not have to give consent for the participation of the person you support in 
this research study.  It is OK to say ‘no’.  If you decide you do not want the person 
you support to take part in the study this will not affect the care that they receive 
from the psychiatrist, or from anybody else who provides care or support to that 
person.  
 
 
 
What if I change my mind about the person I support taking part during the 
study? 
 
You can change your mind about the person you support taking part, at any time.  
You do not have to give a reason for changing your mind.  If you change your mind 
this will not affect the care the person you support receives from the psychiatrist, or 
anyone else who provides care to that person. 
 
Where would the interview take place? 
 
The researcher will arrange to meet with the person with learning disabilities at a 
place that is convenient for them.  You may like to help the person with learning 
disabilities choose where they want to meet the researcher.  The researcher could 
meet the person at the home.  If this is not suitable, the researcher will arrange to 
meet with the person with learning disabilities somewhere that is suitable for them. 
 
What will happen to the information the research team collect? 
 
The research team will keep all the information you provide in strict confidence.  No 
one outside of the research team will have access to the information you provide.  
The  information  will  be  kept  very  safely  on  a  computer  database.    The  Data 
Protection Act will be adhered to at all times. 
 
Who is organising and funding the research? 
 
This research study is organised by members of the Learning Disability Research 
Group at the University of Glasgow.  The study was funded by the Baily Thomas 
Charitable Trust. 
 
Has ethical approval been granted for this study? 
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This study has been granted ethical approval by the MREC for Scotland Committee 
A and the local Research Ethics Committee for the Primary Care Division of NHS 
Greater Glasgow. 
 
 
What will happen to the results of the study? 
 
We will post out information about the findings of this research study to everyone 
who takes part, after the study is finished.  Findings of this study will also be given 
to managers of learning disabilities health and social work services.  The research 
findings will be written into reports which will be published.  It will not be possible 
to identify any of the individuals who take part in the study from the reports, as all 
the  information  will  be  anonymised,  with  information  from  many  individuals 
grouped together. 
 
 
 
How can I find out more about this study? 
 
If you would like to discuss any aspect of this study, or wish to ask any questions 
please ask the researcher, or contact any of the research team, at any stage of the 
study. 
 
Thank you for taking the time to read this information sheet. 
 
 
Researcher         
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Tel. 0141 211 3878 
 
Research Team  
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 3878 
                     
 
 
   395 
 
 
SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC  
DISORDERS 
 
CARER INFORMATION SHEET 
 
We would like to invite the person with learning disabilities whom you support to 
take part in a research study.  Please keep this information sheet, which is also 
available on CD.  Before you decide it is important to understand why the research is 
being  done  and  what  it  will  involve.    Please  take  time  to  read  the  following 
information carefully and discuss it with others if  you wish.  Ask us if there is 
anything that is not clear or if you would like more information.  Take time to decide 
whether or not you wish to take part.  Thank you for reading this. 
 
What will the research study find out? 
 
This research study wants to examine the impact and outcomes of mental ill-health 
on adults with learning disabilities.  We would like to find out if the person you 
support  still  experiences  symptoms  of  mental  ill-health,  and  learn  about  any 
changes, or problems that have come about as a consequence of the mental ill-health 
they have experienced.  No one has ever looked carefully at this before.  If we know 
how mental ill-health affects people with learning disabilities, this will help us to 
plan the services that might be needed.  The study will not be of immediate benefit 
for the person you support, or you, but it may help people with learning disabilities 
in the future. 
 
Why do you want the person I support to take part? 
 
The person with learning disabilities whom you support has been invited to take part 
in the study as he/she has used the Learning Disabilities Psychiatry Service.  We 
were given the name of the person with learning disabilities you support by the 
psychiatrist, who helped the person you support with their mental ill-health.  We 
would like to speak to as many people as possible, who were assessed previously by 
the Learning Disabilities Psychiatry Service.  We are interested to find out what has 
happened in the life of the person you support since that time.  In addition, we want 
to look at whether their mental ill-health has improved, and the impact that it has had 
on their life. 
 
What will the study involve? 
 
If the person you support wants to find out more, a researcher will contact them to 
arrange a time to meet.  This meeting would be to discuss the study, and answer any 
questions about the study.  If the person you support does not wish to meet the 
researcher, please let us know.   396 
 
The researcher will explain the study to the person you support, and answer any 
questions.  If the person you support chooses to take part in the research project 
there will be a consent form to sign.  He/she will be given a copy of the consent 
form to keep.  The person you support does not have to take part in the project it is 
OK to say ‘no’ and this will not affect the care that the person you support receives 
from  the  Learning  Disabilities  Psychiatry  Service.    Some  people  with  learning 
disabilities are unable to consent to participation in research.  If this is the case, 
under the procedures of the Adults with Incapacity  (Scotland) Act a relative, or 
welfare guardian will be asked to consider providing consent to participation. 
 
If the person you support chooses to take part in the study, the researcher would like 
to meet for about one hour.  If this seems too long, you can choose to have two or 
more shorter meetings.  At this meeting, the researcher would like to ask questions 
about  aspects  of  the  life  of  the  person  you  support,  including  things  they  enjoy 
doing, questions about their health and the support they receive, and questions about 
symptoms of mental ill-health that they still experience. 
 
After  meeting  the  person  you  support,  we  would  like  to  examine  the  learning 
disabilities psychiatric casenotes belonging to the person that you support.  This will 
provide us with information about the time when the person you support first started 
using the service, and the way in which they have used the service since then.   
 
If  the  information  we  gather  suggests  that  the  person  you  support  has  a  mental 
illness which is not being managed we will discuss this with you.  The GP of the 
person you support may be able to help with the problem.  We will offer to arrange 
for  an  assessment  to  be  carried  out  by  a  psychiatrist  working  for  the  Glasgow 
Learning Disability Partnership. 
 
If the person you support is harmed by taking part in this research project, there are 
no special compensation arrangements.  If the person you support is harmed due to 
someone’s negligence, then he/she may have grounds for a legal action but he/she 
may have to pay for it.  Regardless of this if the person  you support wishes to 
complain about any aspect of the way he/she has been treated during the course of 
this  study,  the  normal  National  Health  Service  complaints  mechanism  will  be 
available to him/her. 
  
Will taking part in the study help me, or the person I support? 
 
If the person you support decides to take part, there will be no direct benefits for the 
person you support.  However, the information we gather from the study may help 
the people who plan services for people with learning disabilities who experience 
mental ill-health to provide better services in the future. 
 
What will happen if the person I support decides not to take part in the study? 
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The person with learning disabilities whom you support does not have to take part in 
this research study.  It is OK to say ‘no’.  If he/she decides not to take part in the 
study this will not affect the care that the person you support receives from the 
psychiatrist, or from anybody else who provides care or support to that person.  
 
 
What if the person I support changes his/her mind about taking part during the 
study? 
 
The person you support can change his/her mind about taking part, or stop, at any 
time.  He/she does not have to give a reason for changing their mind.  If he/she 
changes their mind about taking part in the study this will not affect the care the 
person you support receives from the psychiatrist, or anyone else who provides care 
to that person. 
 
Where would the interview take place? 
 
The researcher will arrange to meet with the person with learning disabilities at a 
place that is convenient for them.  He/she can choose where they want to meet with 
the researcher.  The researcher could meet at the home of the person you support.  If 
this is not suitable, the researcher will arrange to meet somewhere that is suitable for 
the person you support.  The person you support will be invited to choose whether 
they would like a friend, family member or carer to be present during the interview. 
 
What will happen to the information the research team collect? 
 
The research team will keep all the information you provide in strict confidence.  No 
one outside of the research team will have access to the information you provide.  
The  information  will  be  kept  very  safely  on  a  computer  database.    The  Data 
Protection Act will be adhered to at all times. 
 
Who is organising the research? 
 
This research study is organised by members of the Learning Disability Research 
Group at the University of Glasgow.   
 
Has ethical approval been granted for this study? 
 
This study has been granted ethical approval by the MREC for Scotland, Committee 
A, and the local Research Ethics Committee for the Primary Care Division of NHS 
Greater Glasgow. 
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What will happen to the results of the study? 
 
We will post out information about the findings of this research study to everyone 
who takes part, after the study is finished.  Findings of this study will also be given 
to managers of learning disabilities health and social work services.  The research 
findings will be written into reports which will be published.  It will not be possible 
to identify any of the individuals who take part in the study from the reports, as all 
the  information  will  be  anonymised,  with  information  from  many  individuals 
grouped together. 
 
 
How can I find out more about this study? 
 
If you would like to discuss any aspect of this study, or wish to ask any questions 
please ask the researcher, or contact any of the research team, at any stage of the 
study. 
 
Thank you for taking the time to read this information sheet. 
 
Researcher                                                                                      
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Tel. 0141 211 0693 
 
Research Team  
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 0693 
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Appendix II Consent forms 
 
 
 
       
 
SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS 
 
PARTICIPANT CONSENT FORM 
 
This form asks if I will take part in a research study. 
A researcher will ask me questions about mental ill-health. 
The researchers will keep my information confidential (secret) and safe. 
Taking part in the research study won’t immediately help me. 
Please tick the box if you agree with what it says. 
 
I have been given an information sheet about the study.  Yes 
      
     
I have asked all the questions I want to.  Yes 
      
     
I have been given enough answers to my questions.  Yes 
      
     
I know it is OK to say ‘No’ to taking part in the study.   
I don’t have to take part.  I don’t have to say why. 
Yes    
     
     
Saying ‘No’will not affect my future health care or support 
in any way.  I know I can change my mind and say ‘No’ 
later on. 
Yes    
     
     
I  know  the  research  team  will  write  about  the  study 
results.  I know the results will not include my name.  No 
one will be able to identify me from the results. 
Yes    
                     400 
Signed 
…………………………………………………………………………………………
. 
Name 
……………………………………………………………………………………… 
Date 
……………………………………………………………………………………… 
 
Reviewing your casenotes 
We would like to look at your Learning Disabilities Psychiatry casenotes.  This will 
provide information about your use of the clinical service.  Only members of the 
research team will have access to  your casenotes. This information will be kept 
confidential (secret) and safe.  If you do not want us to look at your casenotes it is 
OK. 
 
I am happy for you to look at my Learning Disabilities 
Psychiatry casenotes. 
Yes    
 
Signed  
………………………………………………………………………………….. 
Name  
………………………………………………………………………………… 
Date  
……………………………………………………………………………………. 
 
 
 
Researcher  
            
Dr Craig Melville   401 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
Fax: 0141 357 4899 
 
Research Team  
    
Sally-Ann Cooper, Professor of Learning Disabilities, 
University of Glasgow.  Tel. 0141 211 0690 
 
Andrew Jahoda, Senior Lecturer in Learning Disabilities,  
University of Glasgow.  Tel. 0141 211 0693 
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SOCIO-CLINICAL OUTCOMES OF PSYCHIATRIC 
DISORDERS  
RELATIVE, WELFARE GUARDIAN CONSENT FORM 
 
This form asks if I will consent to my relative, or the person I support 
taking part in a study. 
 
I have been asked to do this as my relative, or the person I support, does not have the 
capacity to consent to participation in research.  I understand that under the 
provisions of the Adults with Incapacity (Scotland) Act 2000, I can provide consent 
to the person participating in the research study. 
 
If I provide consent to my relative, or the person I support, participating in the study, 
a researcher will ask questions about health and the learning disabilities services. 
  
The researchers will keep all the information confidential. Only members of the 
research team will have access to the information I discuss. 
 
I understand that if I provide consent, participation in the study won’t directly help 
me, or the person with learning disabilities whom I support. 
 
I  am  completing  this  form  as  the  nearest  relative/welfare  guardian.  (Delete  as 
appropriate) 
 
My relationship to the participant is ………………………………………………  
 
As the nearest relative, I confirm that there is no welfare 
guardian or nearer relative. 
Yes    
     
     
I have been given an information sheet about the study.  Yes 
      
     
I have asked all the questions I want to.  Yes 
      
     
I am satisfied that my questions have been thoroughly 
answered. 
Yes    
     
     
I know it is OK to say ‘no’ to taking part in the study.  I 
don’t have to take part.  I don’t have to say why.  
Yes      403 
     
     
If I say ‘no’, I know it will not affect the future health care, 
or support, that the person I support receives. 
Yes    
     
     
If I decide to take part in the study, I know I can still 
change my mind and say ‘no’ later on. 
Yes    
     
     
I  know  the  research  team  will  write  about  the  study 
results.  However, the results will not include my name, or 
the name of the person I support. No one will be able to 
identify  me,  or  the  person  with  learning  disabilities  I 
support, from the results. 
Yes    
     
     
I agree to my relative, or the person I support taking part 
in the research study. 
Yes    
 
 
 
 
Reviewing the casenotes of your relative/the person you support 
We would like to look at the Learning Disabilities Psychiatry casenotes of your 
relative/the person you support.  This will provide information about his/her use of 
the clinical service.  Only members of the research team will have access to the 
casenotes.  This information will be kept confidential and safe.  If you do not want 
us to look at the casenotes of your relative/the person you support, it is OK. 
 
 
 
I am happy for you to look at the Learning Disabilities 
Psychiatry casenotes of my relative/the person I support. 
Yes    
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Signed  
 
………………………………………………………………………………………… 
Name  
………………………………………………………………………………………… 
Date 
………………………………………………………………………………………… 
 
Researcher  
            
Dr Craig Melville 
Section of Psychological Medicine, 
Division of Community Based Sciences, 
Academic Centre, Gartnavel Royal Hospital, 
1055 Great Western Road, Glasgow, G12 0XH. 
Telephone: 0141 211 0693 
Fax: 0141 357 4899      405 
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